data_4a4g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4a4g _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.408 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 . . . . . 0 C--O 1.243 0.712 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.4 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 25.4 pttm -131.15 154.32 48.48 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.97 135.56 27.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.139 0.576 . . . . 0.0 110.156 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.67 11.92 57.48 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.006 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.4 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 3.4 m-20 -99.68 143.56 29.78 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.871 0.367 . . . . 0.0 110.364 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.15 144.72 30.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.16 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.0 p -159.31 -169.89 2.78 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.6 m -132.95 146.05 51.44 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 160.94 37.23 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.722 0.639 . . . . 0.0 111.107 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.1 mm -91.92 117.1 34.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -67.96 126.99 31.21 Favored 'General case' 0 C--O 1.203 -1.357 0 O-C-N 123.571 0.544 . . . . 0.0 109.694 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -57.92 -28.65 64.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.46 -41.22 16.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -109.6 -17.75 13.65 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.702 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.87 7.5 88.46 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.625 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.59 161.76 14.23 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -77.35 127.77 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.713 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.02 151.24 73.38 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 123.453 0.701 . . . . 0.0 109.313 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.77 129.98 18.52 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.521 2.147 . . . . 0.0 111.685 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.37 151.96 36.2 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 120.889 0.376 . . . . 0.0 110.539 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.0 m -114.1 148.11 37.67 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -75.01 124.48 32.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.48 -36.62 10.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.268 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.5 p -159.19 149.56 19.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.423 HG21 HD22 ' A' ' 138' ' ' LEU . 98.2 mt -126.39 129.11 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.451 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 12.1 t70 -112.77 101.63 9.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 173.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -67.25 -24.23 65.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.89 -38.64 64.32 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.466 ' O ' HG21 ' A' ' 122' ' ' THR . 98.0 mtt180 -81.59 -9.48 59.67 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 61.56 25.26 15.22 Favored 'General case' 0 C--O 1.252 1.234 0 C-N-CA 125.274 1.429 . . . . 0.0 108.469 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 120' ' ' ARG . 68.1 p -129.38 168.82 15.72 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.435 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.681 ' SG ' HD12 ' A' ' 141' ' ' LEU . 5.7 p -148.5 151.27 34.85 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.31 132.64 40.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.9 m -119.6 149.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 133' ' ' ARG . 96.7 t -111.09 118.51 57.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.19 118.12 11.68 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.827 0.705 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 m -65.32 131.37 46.29 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.38 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.89 -19.42 53.08 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -111.74 -44.96 3.4 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.705 0.288 . . . . 0.0 111.511 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.33 0.98 67.02 Favored Glycine 0 C--N 1.311 -0.809 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.876 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -73.69 152.37 40.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.3 ppt_? -137.94 135.74 36.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 120.773 0.321 . . . . 0.0 110.864 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -151.94 159.53 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -93.8 131.63 38.99 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.099 0.952 . . . . 0.0 111.105 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.404 ' OE1' HG23 ' A' ' 125' ' ' VAL . 7.5 mp0 -123.39 165.07 17.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 125.572 1.549 . . . . 0.0 109.629 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 35.7 m-80 -89.72 142.92 27.24 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.448 HD21 ' SG ' ' A' ' 123' ' ' CYS . 63.4 mt -58.79 -36.64 74.77 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.43 0.692 . . . . 0.0 110.682 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 t -79.55 -16.63 55.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.477 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 4.1 t70 -89.62 -28.05 19.78 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.73 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.681 HD12 ' SG ' ' A' ' 123' ' ' CYS . 62.8 mt -54.87 134.81 48.4 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.983 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.71 167.03 10.45 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.479 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.316 -0.89 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.058 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-O 120.95 0.405 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -130.96 159.34 37.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.08 132.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.49 10.55 57.98 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.834 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.13 141.3 29.68 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -81.15 144.09 31.92 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.37 0.605 . . . . 0.0 110.985 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -156.65 -171.57 3.73 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.16 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 142.21 50.82 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.6 160.62 37.92 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 123.493 0.496 . . . . 0.0 110.002 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.76 117.11 35.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 8.8 t90 -64.74 121.14 13.84 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.536 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 27.7 t -58.3 -24.38 59.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -83.25 -42.07 17.63 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.14 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.402 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.9 t70 -111.5 -18.04 12.94 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.563 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 7.09 88.88 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.663 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.0 m -92.94 158.4 15.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mm -77.87 130.78 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.774 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -138.67 148.73 59.71 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.94 127.46 12.95 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.115 1.877 . . . . 0.0 111.024 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.89 150.41 38.37 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.391 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.1 m -111.84 147.61 35.38 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.0 mt -76.13 124.89 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.631 0.253 . . . . 0.0 110.818 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.19 12.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.872 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -160.8 152.54 19.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 123' ' ' CYS . 82.0 mt -132.48 139.89 48.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 122.979 0.512 . . . . 0.0 110.817 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -111.91 97.48 6.71 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -68.19 -23.9 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.04 -39.14 63.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.774 0.321 . . . . 0.0 110.977 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.75 -7.56 56.04 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.251 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 63.07 33.74 14.37 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.303 1.002 . . . . 0.0 108.84 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 53.8 p -123.62 161.75 24.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 110.402 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.709 ' SG ' HD12 ' A' ' 141' ' ' LEU . 4.6 p -149.43 151.91 34.81 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.5 t -96.32 130.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.0 m -118.69 145.94 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.4 t -112.4 118.6 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.82 118.84 14.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 123.802 0.689 . . . . 0.0 110.911 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.2 m -63.63 131.56 48.37 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.716 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.18 -29.85 8.9 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.824 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.92 -40.64 6.8 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.702 0.287 . . . . 0.0 111.321 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.54 74.79 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.078 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -80.37 153.87 28.08 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.1 ppt_? -136.0 137.9 41.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.536 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 6.8 pt-20 -154.23 158.92 40.98 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.8 tt0 -99.37 132.22 44.85 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.519 0.676 . . . . 0.0 111.526 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.484 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -132.2 163.46 28.52 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.653 1.181 . . . . 0.0 109.681 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 24.7 m-80 -85.06 146.7 27.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.409 HD22 HG21 ' A' ' 116' ' ' ILE . 84.3 mt -57.21 -35.57 69.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.738 0.78 . . . . 0.0 111.177 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.4 m -80.08 -20.28 45.5 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.097 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -13.89 39.86 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.709 HD12 ' SG ' ' A' ' 123' ' ' CYS . 63.8 mt -71.68 145.14 49.06 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.625 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -114.98 159.5 20.67 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.39 -3.434 0 C-N-CA 123.755 0.822 . . . . 0.0 108.953 178.25 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 82.7 m95 . . . . . 0 N--CA 1.423 -1.816 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.552 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.7 ptpp? -131.21 161.34 32.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.7 t -63.84 127.71 24.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.89 13.91 38.57 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.15 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.552 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 28.2 m-20 -96.82 142.46 28.8 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -152.72 -170.58 3.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 143.55 51.22 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HB2' ' NE2' ' A' ' 136' ' ' GLN . . . -135.39 160.4 38.55 Favored 'General case' 0 C--N 1.278 -2.529 0 O-C-N 123.644 0.59 . . . . 0.0 110.005 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 mm -92.36 116.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -64.8 126.62 28.53 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 123.601 0.563 . . . . 0.0 109.904 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.1 m -58.27 -28.16 64.69 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.4 -41.82 15.09 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.077 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.91 -17.83 13.53 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.722 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.88 90.0 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.736 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.91 161.99 14.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.55 130.47 36.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.425 0.69 . . . . 0.0 109.657 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -139.29 151.0 66.28 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.679 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.7 127.78 14.3 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.664 2.242 . . . . 0.0 111.028 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.36 150.82 36.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 120.914 0.387 . . . . 0.0 110.557 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -111.88 147.59 35.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.422 HD13 ' HB2' ' A' ' 96' ' ' ASP . 69.3 mt -79.35 121.8 33.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.781 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.42 -35.32 12.39 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.785 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -159.14 144.65 16.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.433 HG21 HD22 ' A' ' 138' ' ' LEU . 99.0 mt -122.13 134.78 64.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.399 0.28 . . . . 0.0 110.416 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -113.13 96.64 6.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -64.39 -25.83 68.19 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HZ3' ' HB3' ' A' ' 119' ' ' LYS . 3.7 mmmp? -69.16 -37.35 78.16 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.03 -7.24 52.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.464 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 62.59 25.11 14.96 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 108.558 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 71.5 p -122.82 161.96 23.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.546 -0.721 . . . . 0.0 111.422 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.676 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.6 p -148.03 153.18 38.61 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 78.9 t -96.26 130.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.4 m -119.22 145.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-O 121.171 0.51 . . . . 0.0 109.88 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.0 t -110.41 118.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.543 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.436 ' HH ' ' CD ' ' A' ' 134' ' ' GLU . 99.6 m-85 -71.73 117.95 13.95 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -65.85 131.82 47.18 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.48 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.61 -17.16 55.9 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.69 -39.95 4.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.893 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.68 23.58 57.73 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.821 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -95.28 153.27 17.75 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.0 ppt_? -137.94 135.7 36.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.679 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.436 ' CD ' ' HH ' ' A' ' 127' ' ' TYR . 10.3 pt-20 -154.34 159.16 41.04 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -94.83 133.22 38.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.468 0.651 . . . . 0.0 111.855 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.486 ' NE2' ' HB2' ' A' ' 100' ' ' ALA . 5.7 mp0 -131.78 163.66 27.73 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.84 1.256 . . . . 0.0 110.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 26.8 m-80 -85.51 146.86 26.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 116' ' ' ILE . 67.0 mt -59.22 -37.4 77.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.548 0.69 . . . . 0.0 109.964 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.8 m -74.4 -22.14 59.31 Favored 'General case' 0 N--CA 1.405 -2.711 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.433 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 m-20 -91.32 -13.46 32.53 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.676 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.0 mt -71.19 144.13 50.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.089 0.471 . . . . 0.0 110.676 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.2 165.52 12.84 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.8 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.31 -1.123 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.833 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.442 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 95.4 m95 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 110.852 -0.055 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 64.5 pttt -131.45 159.97 36.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 16.29 68.42 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.586 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 6.8 t0 -100.08 136.15 40.43 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -85.04 141.86 29.98 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.442 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -150.14 -167.87 2.95 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -130.13 143.61 50.88 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.58 160.56 38.1 Favored 'General case' 0 C--N 1.281 -2.408 0 O-C-N 123.439 0.462 . . . . 0.0 110.101 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.29 117.88 36.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -67.02 122.46 17.82 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.436 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 11.1 t -65.31 -16.26 63.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 118.052 0.387 . . . . 0.0 111.804 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -85.3 -38.44 18.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -115.16 -18.33 11.18 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.408 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 6.29 88.73 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.022 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.62 162.51 13.92 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.69 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.42 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.35 150.87 73.71 Favored Pre-proline 0 C--N 1.284 -2.244 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.358 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.15 127.46 13.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.988 1.792 . . . . 0.0 110.861 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.09 35.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 m -112.21 148.19 34.62 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 71.3 mt -77.18 121.63 30.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.857 0.36 . . . . 0.0 110.995 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.35 -39.76 12.5 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.713 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.2 m -158.5 149.8 20.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 138' ' ' LEU . 95.3 mt -125.11 136.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.98 0.419 . . . . 0.0 110.494 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -112.11 99.29 7.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.95 -23.46 65.06 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.894 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.17 -36.36 66.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.954 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.33 -8.91 54.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.485 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 59.98 28.69 18.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.209 1.004 . . . . 0.0 109.0 -172.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 76.1 p -122.84 162.86 21.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 121.405 -0.81 . . . . 0.0 110.671 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.649 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.5 p -148.69 152.35 36.51 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 122.617 0.367 . . . . 0.0 110.521 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.9 t -95.31 131.12 42.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.1 m -118.43 145.65 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 91.4 t -111.49 118.67 58.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -69.14 121.9 17.7 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 123.734 0.646 . . . . 0.0 110.887 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.4 m -62.8 131.21 48.09 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.389 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.09 18.22 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.4 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.86 -42.14 5.94 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 122.508 -0.407 . . . . 0.0 111.566 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.35 61.99 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.822 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -89.4 152.66 21.38 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.8 ppt_? -133.98 140.22 46.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.496 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.3 pt-20 -153.68 158.04 40.46 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 21.9 tt0 -98.21 129.75 44.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.496 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.4 mp0 -126.56 163.16 24.03 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 124.333 1.053 . . . . 0.0 109.676 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.3 m-80 -82.88 146.98 28.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.428 HD22 HG21 ' A' ' 116' ' ' ILE . 57.3 mt -60.76 -34.34 74.31 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.316 1.055 . . . . 0.0 109.251 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.5 t -80.11 -8.33 59.35 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.088 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -104.89 -15.67 15.09 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.529 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.649 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.2 mt -66.37 146.82 54.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.205 0.526 . . . . 0.0 111.166 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.29 161.76 18.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.709 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.396 -3.132 0 C-N-CA 124.548 1.139 . . . . 0.0 110.303 -179.196 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.408 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 85.8 m95 . . . . . 0 C--O 1.248 1.01 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.593 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -131.17 162.87 28.97 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.85 132.32 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.91 12.47 56.56 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.275 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 75.4 m-20 -97.26 149.42 22.07 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.402 0.62 . . . . 0.0 109.839 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -86.89 139.81 30.27 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.275 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -155.96 -172.38 4.09 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.114 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -131.2 146.89 52.5 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.18 37.42 Favored 'General case' 0 C--N 1.274 -2.701 0 O-C-N 123.69 0.619 . . . . 0.0 109.791 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.93 118.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -65.87 120.55 13.26 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.612 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 9.0 t -61.55 -19.58 62.31 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.065 0.228 . . . . 0.0 111.324 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.97 -42.07 15.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.85 -17.91 12.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.075 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.62 89.16 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.108 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.16 161.46 14.41 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.17 130.53 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.94 150.28 64.69 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 132.26 24.32 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.326 2.017 . . . . 0.0 111.156 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.5 149.65 32.02 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.024 0.44 . . . . 0.0 110.208 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -111.53 147.26 35.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.55 125.69 36.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.5 -35.43 10.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.02 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.2 m -158.65 148.04 19.15 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.407 HG21 HD22 ' A' ' 138' ' ' LEU . 88.7 mt -125.98 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 122.64 0.376 . . . . 0.0 110.051 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.95 98.81 7.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -24.03 66.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.288 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.77 -37.41 67.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.694 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.88 -8.87 57.77 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.376 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.01 28.87 18.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.534 1.134 . . . . 0.0 108.432 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 70.2 p -125.2 160.73 28.49 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.685 -0.634 . . . . 0.0 110.492 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.661 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.2 p -148.19 153.73 39.17 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 122.704 0.402 . . . . 0.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.5 t -95.52 130.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.51 145.72 24.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.0 t -111.36 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -68.79 117.73 10.85 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.849 0.718 . . . . 0.0 111.111 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 m -60.77 131.14 49.74 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.531 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.62 -28.28 7.84 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.987 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -101.01 -42.9 6.22 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 122.508 -0.407 . . . . 0.0 111.494 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.52 14.6 63.33 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.422 -0.895 . . . . 0.0 111.891 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -86.78 151.35 23.45 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.92 135.77 39.92 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 123.131 0.269 . . . . 0.0 111.129 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.7 pt-20 -153.69 158.16 40.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.0 tt0 -96.35 131.4 42.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.482 0.658 . . . . 0.0 111.689 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.471 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.2 mp0 -128.16 163.64 24.23 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 125.27 1.428 . . . . 0.0 109.763 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 29.2 m-80 -82.67 147.55 28.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 116' ' ' ILE . 72.7 mt -59.37 -35.99 74.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.878 0.847 . . . . 0.0 110.06 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.0 m -76.82 -19.52 57.44 Favored 'General case' 0 N--CA 1.405 -2.69 0 C-N-CA 124.164 0.986 . . . . 0.0 111.63 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -93.25 -10.06 36.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.049 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.661 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -72.37 147.36 46.32 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.529 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.62 163.18 18.43 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.308 -1.204 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.1 m95 . . . . . 0 C--O 1.255 1.36 0 CA-C-O 120.56 0.219 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.8 pttm -131.98 160.82 34.72 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.57 129.21 26.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 13.97 39.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.591 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 71.6 m-20 -97.91 141.03 31.4 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -84.48 144.99 28.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.01 -169.37 3.05 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -130.35 144.21 51.25 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.55 161.0 37.08 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.116 0.26 . . . . 0.0 110.431 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -92.37 119.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.46 125.77 27.52 Favored 'General case' 0 C--O 1.205 -1.254 0 O-C-N 123.436 0.46 . . . . 0.0 109.795 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -57.96 -26.79 62.76 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -84.73 -41.83 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.248 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.89 -17.35 12.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.914 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.28 90.19 Favored Glycine 0 C--O 1.222 -0.644 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.177 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.9 m -93.15 162.05 14.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.9 mm -78.39 131.05 35.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.123 0.969 . . . . 0.0 109.605 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -140.26 151.42 64.44 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.636 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 129.7 16.76 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.433 2.088 . . . . 0.0 111.209 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.32 150.48 35.82 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.991 0.424 . . . . 0.0 110.661 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.9 m -111.94 147.58 35.56 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.446 HD13 ' HB2' ' A' ' 96' ' ' ASP . 75.5 mt -77.6 120.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.41 -33.84 13.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.836 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.8 m -162.05 146.82 12.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.4 mt -121.54 138.6 51.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.79 96.05 5.75 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -65.2 -24.04 67.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.359 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.06 -39.99 71.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.396 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -85.6 -9.02 57.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 61.54 30.72 18.85 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.877 1.271 . . . . 0.0 109.141 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.9 p -129.2 165.33 21.55 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.91 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.745 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.6 p -148.71 153.67 38.55 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 122.4 0.28 . . . . 0.0 110.965 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 46.9 t -95.92 130.1 45.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.94 146.06 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.661 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 90.8 t -110.4 118.84 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -69.59 118.31 12.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.752 0.658 . . . . 0.0 110.96 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 m -64.94 130.93 45.23 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.53 -19.59 43.27 Favored Glycine 0 N--CA 1.428 -1.836 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.22 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -107.68 -43.37 4.51 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.808 0.337 . . . . 0.0 111.659 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.19 8.41 66.62 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.092 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -81.3 152.76 27.41 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.5 OUTLIER -139.47 136.42 34.57 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.932 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.477 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.36 158.48 41.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -94.6 133.84 37.81 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.351 0.596 . . . . 0.0 111.475 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.477 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.3 mp0 -128.88 163.29 25.59 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 124.832 1.253 . . . . 0.0 110.376 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 36.6 m-80 -81.24 148.47 29.46 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.61 -31.0 71.77 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.442 0.639 . . . . 0.0 110.763 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.2 t -80.29 -25.39 39.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.378 0.609 . . . . 0.0 109.758 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.48 ' O ' HD13 ' A' ' 142' ' ' LEU . 32.6 t70 -74.77 -31.25 61.71 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.568 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 ' SG ' ' A' ' 123' ' ' CYS . 54.1 mt -58.54 134.14 56.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.39 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 140' ' ' ASP . 5.1 mp -109.51 159.41 17.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.173 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.392 -3.332 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.59 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.0 m95 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.5 pttm -130.83 159.28 37.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.67 128.38 25.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.03 7.32 52.86 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.153 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.45 ' HB2' HD13 ' A' ' 113' ' ' ILE . 60.5 m-20 -91.13 137.17 32.57 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -80.71 141.11 35.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.14 -166.27 2.32 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 m -131.32 146.95 52.51 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.07 161.92 36.71 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 122.98 0.175 . . . . 0.0 110.687 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.5 mm -91.12 116.04 31.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 123.819 0.7 . . . . 0.0 109.814 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -65.74 119.39 11.11 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 t -65.79 -14.95 62.36 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 118.205 0.457 . . . . 0.0 112.013 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.19 -41.84 19.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.69 -0.404 . . . . 0.0 112.028 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.94 -16.99 12.58 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.26 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.0 8.5 87.59 Favored Glycine 0 C--N 1.307 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.705 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.7 m -93.83 160.61 14.67 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.4 mm -77.17 129.64 37.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.888 0.875 . . . . 0.0 109.553 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -138.6 150.08 64.77 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 123.087 0.555 . . . . 0.0 109.966 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.06 128.3 14.67 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.556 2.171 . . . . 0.0 110.8 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.66 150.4 34.29 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.422 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.0 m -111.51 147.82 34.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 96' ' ' ASP . 62.5 mt -78.06 121.91 31.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.12 -32.6 13.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -159.05 148.65 18.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 116' ' ' ILE . 91.2 mt -129.05 139.68 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 122.893 0.477 . . . . 0.0 109.977 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.68 99.1 7.89 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.55 -24.04 65.48 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.085 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -73.97 -41.61 61.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.636 0.255 . . . . 0.0 110.749 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -86.64 -8.89 57.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.029 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 61.56 32.85 18.59 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.327 1.017 . . . . 0.0 108.671 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 59.2 p -122.96 159.68 27.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.85 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.611 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.1 p -149.02 152.61 36.57 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 122.776 0.43 . . . . 0.0 111.039 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.3 t -96.37 131.22 43.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.8 m -119.45 145.3 25.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.5 t -110.18 118.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -72.41 116.91 13.43 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 123.698 0.624 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.7 m -63.76 131.61 48.38 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.24 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.19 -22.08 36.68 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.988 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.23 -40.07 5.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.38 78.51 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.065 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -73.92 149.26 41.53 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.94 135.82 39.92 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -152.58 158.13 42.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.6 tt0 -93.71 132.7 37.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.307 0.575 . . . . 0.0 110.923 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -133.55 163.67 28.88 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 125.097 1.359 . . . . 0.0 107.396 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 34.4 m-80 -83.74 151.42 25.24 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 116' ' ' ILE . 75.5 mt -62.26 -36.32 81.66 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.07 0.938 . . . . 0.0 108.963 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -33.16 74.46 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -15.56 45.45 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.439 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.611 HD12 ' SG ' ' A' ' 123' ' ' CYS . 58.9 mt -65.13 146.98 54.27 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.14 0.495 . . . . 0.0 111.862 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.84 161.16 20.18 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.405 -2.725 0 C-N-CA 124.443 1.097 . . . . 0.0 110.568 -178.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.417 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 79.5 m95 . . . . . 0 N--CA 1.438 -1.043 0 CA-C-O 120.627 0.251 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.529 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.9 ptpp? -128.88 155.95 44.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -63.65 127.47 24.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.7 33.09 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.69 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.529 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 29.2 m-20 -96.2 141.3 29.73 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -82.14 143.51 31.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.417 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 27.0 p -155.23 -170.47 3.48 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 m -131.4 142.9 50.12 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.65 160.46 38.04 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.093 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.47 120.23 41.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -67.15 126.1 28.12 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.6 m -58.77 -27.16 64.72 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -85.21 -41.86 15.23 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.51 -16.36 13.68 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.318 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.77 89.89 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.06 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.5 160.47 15.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mm -78.44 128.28 38.4 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.347 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -136.14 151.24 73.18 Favored Pre-proline 0 C--N 1.287 -2.145 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.66 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.88 127.9 15.15 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.411 2.074 . . . . 0.0 110.797 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.05 150.17 36.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 120.849 0.356 . . . . 0.0 110.29 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -112.04 147.83 35.17 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 96' ' ' ASP . 70.9 mt -81.35 118.91 29.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-O 120.831 0.348 . . . . 0.0 110.746 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.87 15.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.077 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.6 m -161.43 146.62 13.67 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.409 HG21 HD22 ' A' ' 138' ' ' LEU . 94.3 mt -128.64 135.97 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 122.843 0.457 . . . . 0.0 110.534 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.59 102.7 10.76 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.67 -26.09 66.03 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.041 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -70.14 -40.42 74.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.304 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.45 -8.8 58.18 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.021 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 60.36 27.57 17.16 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.23 1.014 . . . . 0.0 109.12 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -124.85 160.17 29.4 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 121.143 -0.973 . . . . 0.0 110.871 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.705 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.4 p -148.3 153.83 39.19 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 50.7 t -95.91 130.42 44.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 86.4 t -111.57 119.05 59.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -70.42 120.24 15.77 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.539 0.685 . . . . 0.0 111.068 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.1 m -64.59 132.09 48.82 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.156 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.68 -20.9 32.48 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.051 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -106.82 -50.3 3.14 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.914 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.05 3.42 59.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.489 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.4 154.49 34.81 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.7 ppt_? -137.12 139.35 41.15 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.6 pt-20 -153.51 158.28 41.07 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.72 129.69 44.75 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.504 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 5.9 mp0 -127.5 163.48 24.02 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 124.298 1.039 . . . . 0.0 110.037 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -82.14 148.4 28.53 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.409 HD22 HG21 ' A' ' 116' ' ' ILE . 67.8 mt -61.15 -31.62 71.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.084 0.945 . . . . 0.0 109.659 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.2 m -78.19 -24.09 47.28 Favored 'General case' 0 N--CA 1.392 -3.328 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.422 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.411 ' O ' HD13 ' A' ' 142' ' ' LEU . 26.1 t70 -81.82 -32.29 31.32 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.386 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.705 HD12 ' SG ' ' A' ' 123' ' ' CYS . 54.7 mt -56.01 141.55 39.44 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 124.587 1.179 . . . . 0.0 111.689 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 140' ' ' ASP . 5.4 mp -113.79 162.32 16.46 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.485 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.639 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 24.6 pttm -131.77 161.59 32.53 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.29 130.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.17 23.3 38.22 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.986 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.2 t0 -101.43 139.91 36.44 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -83.3 141.57 31.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.38 -170.95 3.52 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -129.6 141.89 50.86 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.29 160.66 35.57 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.253 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mm -91.99 116.88 34.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -65.7 125.51 25.5 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -30.81 63.49 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 123.539 0.736 . . . . 0.0 112.821 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -85.2 -40.7 16.38 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.33 -17.81 13.91 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.383 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.69 89.95 Favored Glycine 0 CA--C 1.507 -0.449 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.035 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 95.0 m -93.55 162.77 13.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.74 128.47 37.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.682 0.614 . . . . 0.0 109.536 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -136.3 151.41 73.23 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.86 128.02 14.48 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.185 1.923 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.85 146.36 27.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.098 0.475 . . . . 0.0 110.108 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.5 m -111.84 147.95 34.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.8 mt -75.87 123.53 32.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.581 0.229 . . . . 0.0 110.651 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.9 -32.47 12.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.2 m -160.96 146.54 14.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.42 HG21 HD22 ' A' ' 138' ' ' LEU . 98.1 mt -124.47 135.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 0.0 111.049 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.16 100.9 8.94 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -67.78 -24.16 65.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.342 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.88 -37.43 70.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.879 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -87.86 -8.71 55.48 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.294 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 61.08 30.05 19.25 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.171 0.988 . . . . 0.0 108.435 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 78.2 p -126.16 163.66 22.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.635 -0.666 . . . . 0.0 111.407 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.4 p -148.74 153.32 38.03 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.1 0.56 . . . . 0.0 110.455 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.34 130.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.9 m -118.89 145.54 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.4 t -109.95 118.87 57.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -71.58 121.2 18.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.801 0.688 . . . . 0.0 110.565 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -62.09 130.98 48.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.536 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.62 -16.59 39.83 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.538 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -104.56 -43.39 5.17 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.155 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.01 12.29 63.87 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.77 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.7 m-20 -85.28 151.64 23.9 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -137.72 135.26 36.25 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.06 158.03 39.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -99.75 127.52 45.89 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.491 0.663 . . . . 0.0 111.796 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -123.04 163.68 20.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.985 1.314 . . . . 0.0 110.007 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.0 m-80 -84.69 146.52 27.4 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 116' ' ' ILE . 58.8 mt -59.5 -32.69 70.51 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.215 1.007 . . . . 0.0 109.063 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -75.25 -22.54 57.77 Favored 'General case' 0 N--CA 1.394 -3.254 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.708 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 t70 -93.29 -19.35 21.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 123' ' ' CYS . 78.1 mt -61.34 141.22 57.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.919 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 140' ' ' ASP . 5.2 mp -114.61 162.94 16.11 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.822 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--N 1.314 -0.952 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 89.6 m95 . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.545 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.1 ptpp? -130.89 161.27 32.22 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.6 t -63.55 128.17 25.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.26 8.05 48.01 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.612 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.545 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.3 m-20 -97.1 150.01 21.32 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HD2' HG21 ' A' ' 112' ' ' THR . 27.1 mmmt -91.35 140.55 29.66 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.575 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.422 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.9 p -152.65 -169.38 3.32 Favored 'General case' 0 C--N 1.262 -3.228 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.852 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 m -130.77 146.09 52.13 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.07 160.48 38.5 Favored 'General case' 0 C--N 1.275 -2.66 0 O-C-N 123.83 0.706 . . . . 0.0 109.665 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mm -91.54 120.38 40.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.54 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 11.4 t90 -69.28 127.29 32.52 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 123.497 0.498 . . . . 0.0 109.955 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.9 m -57.79 -28.54 64.11 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.96 -42.81 14.59 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.58 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.03 -18.62 13.86 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.028 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.47 6.36 88.03 Favored Glycine 0 C--O 1.222 -0.615 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.793 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.83 163.0 13.69 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.2 mm -77.94 130.23 36.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.199 0.6 . . . . 0.0 109.385 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -137.79 149.35 64.24 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.304 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.49 128.65 14.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.268 1.979 . . . . 0.0 110.777 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.41 153.02 41.49 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.207 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.42 HG21 ' HD2' ' A' ' 97' ' ' LYS . 4.4 m -112.08 147.42 36.08 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.01 121.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 120.856 0.36 . . . . 0.0 110.604 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.83 -39.42 11.21 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -159.46 148.57 18.14 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.425 HG21 HD22 ' A' ' 138' ' ' LEU . 90.8 mt -126.13 134.73 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.281 0.363 . . . . 0.0 111.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -112.33 99.7 8.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -64.69 -28.18 69.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.325 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.7 -39.65 64.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.188 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -81.23 -8.59 59.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.042 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 62.02 26.41 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.938 1.295 . . . . 0.0 109.055 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 82.1 p -125.65 161.73 26.6 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 121.481 -0.762 . . . . 0.0 111.055 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.622 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.6 p -147.78 152.33 37.53 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.5 t -96.07 131.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.7 m -119.34 148.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 87.9 t -109.61 118.43 56.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.54 ' OH ' ' HA ' ' A' ' 102' ' ' TRP . 94.7 m-85 -71.34 120.84 17.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 109.496 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.2 m -66.27 131.99 47.39 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.548 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.36 40.42 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.042 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.8 -43.49 4.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.015 0.436 . . . . 0.0 111.415 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.2 2.46 64.09 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.201 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.0 m-20 -74.92 150.11 39.22 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.3 ppt_? -135.12 135.42 41.14 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.5 159.62 41.09 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -93.77 136.43 34.05 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 121.865 0.84 . . . . 0.0 110.824 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -129.46 165.55 21.39 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 126.224 1.81 . . . . 0.0 108.772 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 31.2 m-80 -89.4 147.82 23.83 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 116' ' ' ILE . 74.7 mt -61.11 -34.14 74.48 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.758 0.79 . . . . 0.0 110.296 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -71.62 -29.99 65.29 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.656 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.53 -14.55 45.54 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.622 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.7 mt -67.74 147.45 52.6 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.259 0.552 . . . . 0.0 111.074 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.82 163.39 19.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.096 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.405 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 93.4 m95 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 120.727 0.298 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 47.4 pttt -131.01 155.23 47.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.12 128.09 25.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.66 14.92 51.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.27 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 3.6 t0 -93.69 142.5 27.28 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -80.52 141.32 35.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.405 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.2 p -158.55 -171.36 3.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 m -130.61 146.45 52.12 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.8 161.09 36.92 Favored 'General case' 0 C--N 1.278 -2.539 0 O-C-N 123.26 0.35 . . . . 0.0 110.489 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mm -92.41 115.37 31.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -64.44 121.35 14.17 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.54 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 8.1 t -66.44 -15.27 63.2 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 118.216 0.462 . . . . 0.0 111.831 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -84.86 -41.93 15.55 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.992 0.425 . . . . 0.0 110.876 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -110.79 -18.0 13.22 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.662 0.744 . . . . 0.0 110.847 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.29 90.52 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.202 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.3 m -94.05 163.85 13.31 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mm -77.51 130.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 123.445 0.698 . . . . 0.0 110.109 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.29 150.61 64.91 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.327 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.84 129.92 18.35 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.53 2.153 . . . . 0.0 111.367 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.65 149.97 32.41 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.065 0.46 . . . . 0.0 110.851 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 m -112.17 147.95 35.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -76.16 128.01 37.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.637 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.96 -31.79 10.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.258 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -160.29 145.64 14.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.413 HG21 HD22 ' A' ' 138' ' ' LEU . 98.4 mt -124.09 134.35 66.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 122.85 0.46 . . . . 0.0 110.568 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.42 97.94 6.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -61.95 -25.47 67.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.63 -39.91 64.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.35 -9.17 58.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 60.96 24.83 14.88 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.953 1.301 . . . . 0.0 109.04 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.412 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 68.3 p -122.37 159.99 26.35 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.654 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.3 p -146.21 153.14 40.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.859 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 67.4 t -95.45 130.89 43.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.1 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 85.1 t -109.92 118.46 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.01 118.45 12.87 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.801 0.688 . . . . 0.0 111.236 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 131.71 46.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.93 -17.23 56.17 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.079 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.85 -49.28 3.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.952 0.406 . . . . 0.0 110.711 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.63 4.78 59.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.314 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.81 154.93 33.45 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 122.178 0.191 . . . . 0.0 110.549 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.48 136.29 39.31 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.364 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.54 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.8 pt-20 -153.37 158.72 41.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 24.5 tt0 -96.55 129.12 43.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.598 0.713 . . . . 0.0 111.987 -175.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.484 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.9 mp0 -128.19 163.42 24.74 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.245 1.418 . . . . 0.0 110.007 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.0 m-80 -82.17 146.25 29.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 116' ' ' ILE . 67.7 mt -59.43 -34.72 72.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.09 0.948 . . . . 0.0 109.724 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -77.04 -20.34 56.02 Favored 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.424 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 6.2 t70 -90.01 -28.14 19.28 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -175.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.654 HD12 ' SG ' ' A' ' 123' ' ' CYS . 77.1 mt -52.2 137.48 28.17 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 124.695 1.247 . . . . 0.0 111.739 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.19 162.68 14.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.975 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.399 -2.976 0 C-N-CA 123.796 0.838 . . . . 0.0 109.344 177.876 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 83.5 m95 . . . . . 0 N--CA 1.424 -1.734 0 CA-C-O 120.823 0.344 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 21.9 pttm -131.11 162.64 29.42 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.3 129.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.73 13.99 41.93 Favored Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.835 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' HD11 ' A' ' 113' ' ' ILE . 53.8 m-20 -96.43 140.06 31.64 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -84.89 139.91 31.51 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -151.96 -169.49 3.38 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 123.551 0.532 . . . . 0.0 109.573 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.4 m -130.03 144.23 51.22 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.504 ' HB2' ' NE2' ' A' ' 136' ' ' GLN . . . -134.5 160.24 38.62 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.949 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.67 114.64 31.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -61.71 126.9 28.98 Favored 'General case' 0 C--O 1.203 -1.348 0 O-C-N 124.03 0.831 . . . . 0.0 110.325 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.7 m -57.17 -29.9 64.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.24 -37.27 20.26 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.0 -17.07 10.45 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.509 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.8 8.23 87.71 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.257 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.4 160.07 15.27 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.97 131.22 35.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.89 149.47 59.11 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.03 128.04 16.09 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.602 2.201 . . . . 0.0 111.055 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.88 35.61 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.848 0.356 . . . . 0.0 110.379 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -111.8 147.49 35.59 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 96' ' ' ASP . 68.5 mt -78.9 120.17 29.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.71 -31.95 13.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.495 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -159.97 144.96 15.05 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 138' ' ' LEU . 83.6 mt -120.83 134.69 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 120' ' ' ARG . 12.3 t70 -113.35 98.52 7.15 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -67.72 -23.86 65.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.36 -40.43 85.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.875 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' OD2' ' A' ' 117' ' ' ASP . 95.6 mtt180 -87.95 -8.66 55.39 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.16 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 63.28 27.25 15.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.954 1.301 . . . . 0.0 108.585 -175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 60.9 p -125.76 166.74 16.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.9 p -148.38 151.95 36.19 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 122.911 0.484 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.0 t -95.81 129.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.5 145.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 121.133 0.492 . . . . 0.0 109.706 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 93.3 t -109.29 118.97 57.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -71.28 121.09 17.82 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.313 0.577 . . . . 0.0 110.857 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.0 m -69.03 131.4 44.98 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.034 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.03 57.29 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.665 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -111.12 -48.81 3.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 122.453 -0.439 . . . . 0.0 111.608 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.34 10.79 57.94 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -83.13 153.02 25.04 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.91 135.73 38.04 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.35 158.69 40.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -96.79 130.39 44.06 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.797 0.808 . . . . 0.0 112.229 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.504 ' NE2' ' HB2' ' A' ' 100' ' ' ALA . 6.2 mp0 -126.0 163.36 23.18 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.36 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.7 m-80 -84.28 144.9 28.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.428 HD22 HG21 ' A' ' 116' ' ' ILE . 70.4 mt -60.06 -35.39 75.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.535 0.683 . . . . 0.0 110.614 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -73.32 -29.34 62.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -82.51 -14.06 55.61 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.788 -177.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.639 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.1 mt -66.23 143.93 56.93 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.573 0.546 . . . . 0.0 111.517 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.05 158.83 23.51 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.1 m95 . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 111.071 0.026 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.9 ptpp? -131.57 161.53 32.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.91 128.23 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 15.22 33.67 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.739 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.432 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 72.7 m-20 -102.29 145.54 29.31 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -88.06 141.42 28.58 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.167 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.24 -171.52 3.94 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 123.892 0.745 . . . . 0.0 109.056 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 m -131.69 143.86 50.58 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 173.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB2' ' NE2' ' A' ' 136' ' ' GLN . . . -135.22 160.92 36.86 Favored 'General case' 0 C--N 1.273 -2.733 0 O-C-N 123.514 0.509 . . . . 0.0 110.211 -174.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 mm -92.21 118.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -67.46 124.81 24.22 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 m -59.0 -26.42 64.5 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -84.49 -41.84 16.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.998 -173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -111.38 -17.47 13.12 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.864 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 4.74 89.9 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.105 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.62 160.18 15.13 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -76.71 129.02 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 O-C-N 124.002 0.814 . . . . 0.0 109.442 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -137.97 148.04 58.78 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.17 127.72 16.35 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.62 2.214 . . . . 0.0 110.895 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.51 38.33 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.752 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -112.16 147.48 36.04 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 62.6 mt -77.46 121.86 30.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 123.076 0.235 . . . . 0.0 110.368 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.65 13.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.1 p -160.63 145.14 14.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.692 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.417 HG21 HD22 ' A' ' 138' ' ' LEU . 97.8 mt -124.42 135.24 64.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 110.784 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -112.9 101.81 9.85 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.63 -24.97 65.51 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.72 0.295 . . . . 0.0 111.198 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.25 -37.09 66.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.304 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -86.81 -8.95 56.86 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.841 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 60.35 28.98 18.63 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 122.634 1.207 . . . . 0.0 109.184 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.8 p -126.33 162.39 25.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.852 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.651 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.7 p -148.33 152.16 36.6 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.261 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 99.4 t -95.37 130.96 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.9 m -118.3 145.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.9 t -110.7 118.38 57.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -68.42 119.13 12.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.694 0.621 . . . . 0.0 110.568 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.6 m -63.6 131.01 46.66 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.756 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.0 -18.0 47.41 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.269 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -108.33 -37.57 5.96 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 122.395 -0.474 . . . . 0.0 111.747 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 13.52 76.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.623 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -85.59 151.97 23.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.488 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 7.5 ppt_? -135.66 137.26 41.64 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.193 0.308 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.0 pt-20 -153.62 158.69 41.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 20.6 tt0 -97.91 129.75 44.82 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.537 0.684 . . . . 0.0 111.353 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.521 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.1 mp0 -126.53 163.58 23.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 124.494 1.118 . . . . 0.0 109.755 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.8 m-80 -82.14 145.48 30.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 116' ' ' ILE . 76.5 mt -57.95 -36.35 72.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.742 0.782 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -77.58 -19.54 55.47 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.4 t70 -84.96 -30.91 23.87 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.844 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.651 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.9 mt -51.9 132.12 31.7 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.655 1.222 . . . . 0.0 111.918 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.39 164.16 12.07 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.953 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.308 -1.215 0 O-C-N 124.172 0.92 . . . . 0.0 109.07 -179.741 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.434 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 92.6 m95 . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.8 ptpp? -131.25 162.48 29.91 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.6 t -63.74 128.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.64 13.64 37.25 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.918 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.6 m-20 -100.64 141.5 33.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -83.02 143.62 30.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.97 -169.48 3.27 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 m -132.59 145.98 51.54 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.37 161.2 36.94 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 123.781 0.676 . . . . 0.0 110.08 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.0 119.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.27 125.14 25.78 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -58.77 -24.59 61.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -85.0 -41.74 15.53 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.933 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -111.51 -17.86 12.97 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 118.733 -1.187 . . . . 0.0 111.187 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.26 89.73 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.181 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.19 162.29 14.08 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -77.58 129.79 37.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.856 0.723 . . . . 0.0 109.687 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -137.8 151.4 70.41 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 123.639 0.776 . . . . 0.0 109.137 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.96 128.62 14.25 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.11 149.46 36.58 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.976 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -111.51 147.5 35.22 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 64.4 mt -77.12 122.09 30.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.505 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.89 -33.11 12.33 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.735 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.7 m -160.58 148.73 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 138' ' ' LEU . 93.2 mt -126.44 135.72 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.91 99.86 8.44 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -66.43 -23.94 66.38 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.079 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.24 -37.65 69.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.235 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -87.79 -8.9 55.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.994 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 30.4 tt0 61.03 24.74 14.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p -122.77 161.08 24.64 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.625 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.0 p -146.53 151.9 38.1 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.427 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.7 t -95.37 130.21 44.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.04 145.68 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.7 t -111.0 118.67 57.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -69.07 118.67 12.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 123.718 0.636 . . . . 0.0 110.21 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 53.1 m -63.66 131.02 46.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.403 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.39 -26.56 10.08 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.896 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -96.84 -47.27 5.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.967 0.413 . . . . 0.0 110.616 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.8 60.1 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.363 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -82.76 152.1 25.86 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -139.03 136.31 35.16 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.169 0.293 . . . . 0.0 110.77 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.5 pt-20 -153.07 158.07 41.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -95.8 133.21 40.2 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.455 0.645 . . . . 0.0 112.077 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.415 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 8.5 mp0 -131.98 163.78 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 125.157 1.383 . . . . 0.0 109.967 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.4 m-80 -81.15 148.2 29.69 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.428 HD22 HG21 ' A' ' 116' ' ' ILE . 65.2 mt -59.21 -36.11 74.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.261 1.029 . . . . 0.0 108.933 175.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.3 m -75.53 -18.09 59.9 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.992 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -98.06 -7.29 30.03 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.379 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.625 HD12 ' SG ' ' A' ' 123' ' ' CYS . 63.7 mt -72.97 139.89 47.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.417 0.627 . . . . 0.0 111.042 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.9 166.06 11.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.781 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--N 1.31 -1.119 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.519 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.8 m95 . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 63.5 pttt -126.36 157.95 37.16 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.72 131.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 18.71 54.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.737 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 4.7 t0 -100.8 133.21 45.6 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -80.47 148.01 30.66 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.115 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.6 p -155.1 -168.76 2.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.981 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 m -131.71 145.29 51.55 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.06 160.79 37.23 Favored 'General case' 0 C--N 1.277 -2.585 0 O-C-N 123.569 0.543 . . . . 0.0 110.189 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.15 117.16 34.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.419 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 9.8 t90 -67.54 122.92 19.04 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -59.67 -23.57 63.2 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 24.9 mm-40 -84.83 -42.11 15.42 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -108.47 -18.45 13.74 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.69 6.93 89.07 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.679 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.8 m -94.42 161.91 14.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.19 128.26 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 O-C-N 123.904 0.753 . . . . 0.0 109.796 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.35 148.87 67.97 Favored Pre-proline 0 C--N 1.288 -2.104 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.665 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.16 129.94 15.78 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.404 2.07 . . . . 0.0 111.289 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.79 151.27 35.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.145 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.5 m -112.36 147.64 35.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.08 120.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.913 0.387 . . . . 0.0 111.133 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.59 -31.99 14.97 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.613 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.0 m -162.38 151.64 15.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.412 HG21 HD22 ' A' ' 138' ' ' LEU . 97.5 mt -127.6 135.87 62.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 122.712 0.405 . . . . 0.0 110.754 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.32 98.14 7.1 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -67.65 -23.84 65.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.017 0.437 . . . . 0.0 111.367 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -73.2 -36.4 66.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.473 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -90.61 -8.8 49.15 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 59.81 29.61 19.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.514 1.126 . . . . 0.0 108.645 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 72.0 p -122.06 162.18 21.67 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.869 -0.519 . . . . 0.0 110.088 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.706 ' SG ' HD12 ' A' ' 141' ' ' LEU . 5.6 p -148.69 153.74 38.66 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -97.37 130.44 46.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 26.6 m -119.06 146.02 24.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 90.6 t -109.69 118.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.8 119.31 13.83 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 123.731 0.645 . . . . 0.0 110.811 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -61.66 131.74 50.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.32 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.64 -23.22 17.27 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.271 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -101.73 -46.83 4.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.24 6.65 61.34 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.865 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -80.09 151.57 29.79 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.6 ppt_? -135.77 136.84 41.07 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.55 158.79 41.76 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -94.7 132.22 39.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.655 0.74 . . . . 0.0 110.253 -176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -127.3 165.31 19.94 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 126.037 1.735 . . . . 0.0 108.484 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.6 m-80 -87.51 145.29 26.31 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.441 HD21 ' SG ' ' A' ' 123' ' ' CYS . 78.7 mt -58.02 -38.44 76.2 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -75.28 -22.69 57.58 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.75 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.6 m-20 -89.5 -12.86 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.299 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.706 HD12 ' SG ' ' A' ' 123' ' ' CYS . 67.2 mt -68.55 146.61 52.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.317 0.58 . . . . 0.0 110.733 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.43 165.19 13.25 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.431 -1.376 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.167 179.612 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.5 m95 . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.511 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -130.2 158.72 38.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.75 127.85 23.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.19 11.67 48.16 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.48 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.511 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 18.2 m-20 -92.76 135.67 33.91 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -81.9 146.1 29.99 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 p -159.58 -172.78 3.83 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.636 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.6 m -129.02 144.19 51.11 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.12 161.09 36.32 Favored 'General case' 0 C--N 1.278 -2.537 0 O-C-N 123.798 0.686 . . . . 0.0 110.412 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.28 116.74 34.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -67.21 121.17 15.07 Favored 'General case' 0 C--O 1.193 -1.881 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.492 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 20.6 t -64.2 -17.2 63.31 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.146 0.43 . . . . 0.0 111.752 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -83.28 -41.95 17.72 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.335 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -112.75 -17.76 12.47 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.881 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.43 3.89 90.36 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.115 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 81.2 m -93.63 162.95 13.74 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.8 mm -77.66 130.34 36.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -139.77 151.52 66.08 Favored Pre-proline 0 C--N 1.303 -1.443 0 C-N-CA 123.455 0.702 . . . . 0.0 110.271 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.34 128.35 15.38 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.958 2.438 . . . . 0.0 111.789 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.57 149.67 31.98 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.121 0.486 . . . . 0.0 111.019 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 m -112.63 147.04 37.56 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 96' ' ' ASP . 67.6 mt -78.13 121.39 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.199 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.86 -35.7 13.22 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.578 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.1 m -159.52 149.78 18.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.424 HG21 HD22 ' A' ' 138' ' ' LEU . 94.5 mt -125.67 138.18 55.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.742 0.417 . . . . 0.0 110.777 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -112.97 98.32 7.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -65.27 -25.79 67.8 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.536 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -73.27 -38.6 65.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.214 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.45 -8.55 58.32 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.864 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 63.07 25.62 15.04 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 124.646 1.178 . . . . 0.0 108.772 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.2 p -124.76 163.99 20.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 111.072 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.695 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.8 p -148.63 153.41 38.28 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 122.693 0.397 . . . . 0.0 110.312 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.07 130.25 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.1 m -118.46 147.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.7 t -110.32 118.73 57.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.45 116.92 10.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.825 0.703 . . . . 0.0 110.468 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -65.04 131.47 46.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.96 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.76 -20.48 38.7 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -104.51 -47.65 4.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.978 0.418 . . . . 0.0 110.447 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.53 18.41 41.75 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.991 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -91.05 155.62 18.54 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.4 ppt_? -134.95 136.5 42.31 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.514 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.492 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.7 pt-20 -153.96 158.55 40.82 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -95.39 132.85 39.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.71 0.767 . . . . 0.0 111.228 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -125.44 164.64 20.0 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 125.84 1.656 . . . . 0.0 109.61 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.1 m-80 -88.11 143.67 26.93 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 116' ' ' ILE . 84.5 mt -58.03 -36.28 72.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.357 0.598 . . . . 0.0 110.683 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.6 m -75.16 -23.71 57.81 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.856 0.863 . . . . 0.0 111.459 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 2.5 m-20 -91.06 -11.54 38.42 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.806 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.695 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.7 mt -68.71 142.11 55.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.03 163.85 14.61 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.252 1.189 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.3 m95 . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.06 163.31 22.64 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.85 127.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.85 7.99 52.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.13 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.448 ' HB2' HD13 ' A' ' 113' ' ' ILE . 21.2 m-20 -91.35 135.42 33.83 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -74.44 146.4 42.88 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.368 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -160.04 -172.59 3.68 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.894 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.5 m -129.36 142.92 50.69 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.56 160.6 37.55 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.392 0.433 . . . . 0.0 110.699 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.41 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.0 t90 -65.61 119.53 11.3 Favored 'General case' 0 C--O 1.199 -1.585 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.499 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 6.4 t -66.95 -14.96 63.37 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.677 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.37 -42.39 17.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.602 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.41 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.8 t70 -109.49 -18.61 13.48 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.484 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.38 7.79 88.2 Favored Glycine 0 C--N 1.313 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.119 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.3 m -94.3 161.71 14.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.0 mm -79.14 129.33 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -137.52 150.85 69.73 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 127.84 14.98 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.566 2.178 . . . . 0.0 110.97 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.61 147.67 30.29 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.076 0.465 . . . . 0.0 110.465 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.4 m -112.53 147.16 37.19 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 96' ' ' ASP . 78.0 mt -75.47 126.21 35.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.919 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.41 12.13 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -159.34 148.32 18.18 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.439 HG21 HD22 ' A' ' 138' ' ' LEU . 87.0 mt -127.53 135.67 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.911 0.484 . . . . 0.0 110.025 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.09 96.36 5.99 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.15 -24.17 65.87 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.556 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -74.11 -34.08 63.81 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.69 -8.95 57.89 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.783 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 61.7 30.76 18.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.752 1.221 . . . . 0.0 108.624 -173.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 69.0 p -124.89 165.24 18.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.714 -0.616 . . . . 0.0 110.86 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' A' ' 141' ' ' LEU . 6.7 p -148.66 155.18 40.69 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.313 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.1 130.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -118.52 147.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.5 t -109.83 118.89 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -70.59 119.97 15.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.638 0.586 . . . . 0.0 110.72 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.8 m -64.56 131.45 47.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.096 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.07 -22.78 30.06 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -105.54 -41.81 5.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.16 0.505 . . . . 0.0 111.14 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.94 81.31 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -77.63 154.67 32.0 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -135.97 138.02 41.87 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.499 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.0 pt-20 -154.02 159.3 41.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -94.18 133.63 37.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.991 0.9 . . . . 0.0 111.57 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -128.87 164.85 22.21 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 125.75 1.62 . . . . 0.0 108.989 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.8 m-80 -89.92 145.82 24.85 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 116' ' ' ILE . 79.5 mt -59.39 -34.79 72.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.394 0.616 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -25.41 54.95 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.519 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.2 m-20 -89.2 -13.28 38.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.139 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.736 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.2 mt -66.77 145.5 55.45 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.048 0.451 . . . . 0.0 110.754 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.93 160.96 18.23 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.462 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 120.48 0.181 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.7 ptpp? -131.25 157.26 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.48 129.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.54 13.26 57.26 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.95 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.6 t0 -95.35 140.69 29.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -84.65 144.84 28.33 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -153.73 -170.06 3.47 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.1 m -130.81 141.25 50.33 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.94 160.62 37.14 Favored 'General case' 0 C--N 1.279 -2.458 0 O-C-N 123.624 0.578 . . . . 0.0 110.456 -174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.21 115.84 32.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 9.6 t90 -66.33 121.98 16.48 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 t -63.19 -21.65 66.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.301 0.572 . . . . 0.0 111.68 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.45 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 15.2 mm-40 -84.65 -33.36 23.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.416 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.4 t70 -117.04 -18.27 10.13 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.65 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.7 88.86 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.882 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.26 162.73 13.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.64 131.43 34.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.208 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.62 151.21 65.78 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.728 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.62 127.98 15.49 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 111.166 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.66 149.02 32.66 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.994 0.426 . . . . 0.0 109.971 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -111.92 147.81 35.05 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.0 mt -79.13 121.57 32.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.568 0.223 . . . . 0.0 111.069 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.95 -32.21 13.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.087 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 m -159.4 147.73 17.69 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 123' ' ' CYS . 89.7 mt -126.91 141.22 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.41 96.36 6.06 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 172.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -67.92 -24.02 65.15 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.761 0.315 . . . . 0.0 111.345 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.58 -39.31 64.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.293 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -90.63 -8.11 50.93 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.733 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 64.44 33.43 11.13 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.517 1.135 . . . . 0.0 109.245 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 81.5 p -123.79 164.83 18.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.935 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.703 ' SG ' HD12 ' A' ' 141' ' ' LEU . 6.3 p -149.91 157.28 43.01 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 123.013 0.525 . . . . 0.0 110.768 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.4 t -102.2 131.42 50.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.2 m -118.58 146.04 23.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 121.231 0.539 . . . . 0.0 109.831 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 92.3 t -111.09 118.61 57.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -71.19 119.84 15.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.696 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 m -67.2 130.67 43.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.727 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.71 -16.52 59.99 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.009 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -111.97 -35.09 5.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.76 4.0 90.25 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.492 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -78.18 157.2 29.46 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -141.41 136.42 31.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.453 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.8 pt-20 -152.95 158.41 42.05 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 29.7 tt0 -95.51 137.39 34.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.123 0.487 . . . . 0.0 111.185 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.453 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -137.94 159.0 43.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 124.402 1.081 . . . . 0.0 109.699 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 30.8 m-80 -81.39 147.67 29.69 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 116' ' ' ILE . 81.7 mt -60.81 -36.07 78.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.094 0.473 . . . . 0.0 111.414 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 t -80.89 -16.27 54.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.045 0.45 . . . . 0.0 110.418 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.424 ' O ' HD13 ' A' ' 142' ' ' LEU . 27.9 t70 -79.82 -32.26 40.67 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.703 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.5 mt -56.92 141.11 46.33 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.7 1.25 . . . . 0.0 111.718 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 140' ' ' ASP . 4.7 mp -114.2 159.92 19.57 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.561 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.309 -1.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.5 m95 . . . . . 0 N--CA 1.436 -1.126 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.572 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.0 ptpp? -130.84 160.15 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.69 128.16 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.61 13.35 41.29 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.196 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.572 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 13.2 m-20 -98.03 135.29 39.94 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -78.41 145.49 35.1 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.407 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -157.04 -169.23 2.88 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.817 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 m -133.6 146.14 50.68 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.21 161.64 36.32 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.356 0.41 . . . . 0.0 110.183 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.16 118.71 38.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.482 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 10.3 t90 -68.17 127.52 33.22 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.556 0.535 . . . . 0.0 109.954 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 m -56.36 -30.85 63.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -85.18 -41.12 15.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.482 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.3 t70 -109.19 -17.15 13.92 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.1 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.22 4.81 84.52 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.968 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.5 m -93.58 162.46 13.95 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -78.48 126.88 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.868 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.18 148.39 64.34 Favored Pre-proline 0 C--N 1.283 -2.288 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.832 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.58 128.67 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.659 2.239 . . . . 0.0 111.259 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.98 152.47 41.1 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -112.24 147.81 35.45 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 96' ' ' ASP . 74.5 mt -79.28 118.03 25.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 123.221 0.326 . . . . 0.0 110.937 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.78 -30.49 15.46 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.76 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.1 m -161.47 145.64 13.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.419 HG21 HD22 ' A' ' 138' ' ' LEU . 87.7 mt -123.39 134.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 120.852 0.358 . . . . 0.0 110.125 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 11.3 t70 -111.89 96.85 6.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -65.86 -23.71 66.72 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.112 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -71.52 -40.67 69.97 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' OD1' ' A' ' 117' ' ' ASP . 93.2 mtt180 -82.58 -9.45 59.39 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.466 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 62.91 29.61 16.54 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.195 1.398 . . . . 0.0 108.135 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.8 p -131.08 168.47 17.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.106 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.741 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.3 p -148.79 155.46 40.98 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.502 0.321 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.8 t -95.86 130.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.55 145.52 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 89.5 t -109.73 118.62 57.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.91 120.3 15.43 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 123.758 0.661 . . . . 0.0 111.576 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.462 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.42 -21.93 42.85 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.548 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -111.39 -43.14 3.74 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.612 0.244 . . . . 0.0 111.378 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 8.3 64.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.443 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.5 m-20 -80.39 153.33 28.38 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.76 -0.259 . . . . 0.0 110.419 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.0 ppt_? -137.69 135.24 36.29 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.057 0.456 . . . . 0.0 111.417 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.42 158.71 41.84 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.4 tt0 -94.44 135.11 36.23 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.174 0.511 . . . . 0.0 111.392 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.441 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -131.85 160.25 36.2 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.266 1.026 . . . . 0.0 110.478 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 26.1 m-80 -79.42 144.32 34.2 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 116' ' ' ILE . 75.3 mt -62.4 -33.2 74.3 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.945 0.879 . . . . 0.0 110.376 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.9 t -80.04 -21.46 43.45 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.71 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 23.1 t70 -83.6 -32.79 25.56 Favored 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.741 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.0 mt -51.07 134.48 26.51 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 125.046 1.466 . . . . 0.0 111.902 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.31 161.96 14.53 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.396 -3.157 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.686 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.2 m95 . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.525 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.6 ptpp? -129.76 162.61 28.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.68 127.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.06 15.05 40.25 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.491 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.525 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 22.5 m-20 -98.0 136.78 37.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 117.133 0.466 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -77.47 145.07 37.3 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.48 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.7 p -156.18 -165.87 2.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.499 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 m -139.42 149.44 44.07 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' HB2' ' NE2' ' A' ' 136' ' ' GLN . . . -140.32 161.53 37.47 Favored 'General case' 0 C--N 1.278 -2.502 0 O-C-N 123.877 0.735 . . . . 0.0 110.078 -173.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.82 120.05 40.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.446 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 10.1 t90 -69.65 125.89 28.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -58.93 -25.04 63.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 21.0 mm-40 -84.87 -37.73 20.3 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -174.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -117.41 -18.22 9.89 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.982 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.6 86.95 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.212 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.2 m -92.93 160.19 15.0 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.85 126.12 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 C-N-CA 123.848 0.859 . . . . 0.0 109.016 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -134.58 149.51 71.11 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.18 128.09 17.89 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.914 2.409 . . . . 0.0 110.902 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.88 149.52 34.42 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.843 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.3 m -113.85 147.76 37.84 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.416 HD13 ' HB2' ' A' ' 96' ' ' ASP . 75.8 mt -76.89 126.23 37.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.63 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -33.1 11.24 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 m -161.33 149.57 15.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.42 HG21 HD22 ' A' ' 138' ' ' LEU . 87.3 mt -128.82 140.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.513 0.725 . . . . 0.0 109.966 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -113.04 98.87 7.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.03 -23.76 67.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.447 -174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -73.42 -40.52 64.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -87.8 -8.32 56.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.026 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 61.4 28.29 17.73 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.856 0.862 . . . . 0.0 108.793 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 68.9 p -122.02 159.56 26.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 121.7 -0.625 . . . . 0.0 110.55 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.645 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.4 p -148.22 152.37 37.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.654 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 59.4 t -95.99 130.56 44.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.5 m -118.06 145.77 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.1 t -111.53 118.55 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.36 116.67 10.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 124.042 0.839 . . . . 0.0 110.503 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 m -62.93 131.13 47.69 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.072 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.79 -27.98 12.78 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -101.81 -42.97 5.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.938 0.399 . . . . 0.0 110.758 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.21 1.58 75.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -72.24 149.39 44.6 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.3 ppt_? -133.64 136.18 44.63 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.507 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.471 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 7.7 pt-20 -153.46 158.39 41.29 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.6 tt0 -95.95 134.53 38.84 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.471 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -134.05 157.51 45.93 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.374 1.069 . . . . 0.0 109.802 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 32.3 m-80 -79.43 147.26 32.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 116' ' ' ILE . 77.8 mt -58.28 -34.32 70.39 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.674 0.75 . . . . 0.0 110.078 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -76.59 -24.65 53.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.199 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.23 -12.87 45.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.176 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.645 HD12 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -70.29 143.09 52.17 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 123.479 0.487 . . . . 0.0 111.41 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.31 160.67 18.82 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.617 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.401 -2.89 0 C-N-CA 124.602 1.161 . . . . 0.0 110.327 178.408 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 C--O 1.244 0.78 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.8 m -91.63 91.73 8.15 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.66 -26.81 19.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.261 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 71.45 8.47 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.755 0.788 . . . . 0.0 111.467 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -124.53 13.31 8.74 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -107.81 34.83 3.36 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.456 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -79.95 132.9 36.15 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.27 -172.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -132.59 129.61 39.18 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.408 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 -128.29 163.36 24.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.4 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 25.4 pttm -131.15 154.32 48.48 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.97 135.56 27.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.139 0.576 . . . . 0.0 110.156 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.67 11.92 57.48 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.006 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 3.4 m-20 -99.68 143.56 29.78 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.871 0.367 . . . . 0.0 110.364 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.15 144.72 30.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.16 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.0 p -159.31 -169.89 2.78 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.6 m -132.95 146.05 51.44 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 160.94 37.23 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.722 0.639 . . . . 0.0 111.107 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.1 mm -91.92 117.1 34.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -67.96 126.99 31.21 Favored 'General case' 0 C--O 1.203 -1.357 0 O-C-N 123.571 0.544 . . . . 0.0 109.694 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -57.92 -28.65 64.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.46 -41.22 16.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -109.6 -17.75 13.65 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.702 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.87 7.5 88.46 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.625 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.59 161.76 14.23 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -77.35 127.77 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.713 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.02 151.24 73.38 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 123.453 0.701 . . . . 0.0 109.313 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.77 129.98 18.52 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.521 2.147 . . . . 0.0 111.685 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.37 151.96 36.2 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 120.889 0.376 . . . . 0.0 110.539 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.0 m -114.1 148.11 37.67 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -75.01 124.48 32.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.48 -36.62 10.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.268 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.5 p -159.19 149.56 19.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.423 HG21 HD22 ' A' ' 138' ' ' LEU . 98.2 mt -126.39 129.11 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.451 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 12.1 t70 -112.77 101.63 9.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 173.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -67.25 -24.23 65.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.89 -38.64 64.32 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.466 ' O ' HG21 ' A' ' 122' ' ' THR . 98.0 mtt180 -81.59 -9.48 59.67 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 61.56 25.26 15.22 Favored 'General case' 0 C--O 1.252 1.234 0 C-N-CA 125.274 1.429 . . . . 0.0 108.469 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 120' ' ' ARG . 68.1 p -129.38 168.82 15.72 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.435 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.681 ' SG ' HD12 ' A' ' 141' ' ' LEU . 5.7 p -148.5 151.27 34.85 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.31 132.64 40.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.9 m -119.6 149.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 133' ' ' ARG . 96.7 t -111.09 118.51 57.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.586 ' CD2' HC22 ' A' 1148 ' ' DA2 . 97.1 m-85 -69.19 118.12 11.68 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.827 0.705 . . . . 0.0 110.726 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 m -65.32 131.37 46.29 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.38 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.89 -19.42 53.08 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -111.74 -44.96 3.4 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.705 0.288 . . . . 0.0 111.511 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.33 0.98 67.02 Favored Glycine 0 C--N 1.311 -0.809 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.876 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -73.69 152.37 40.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.3 ppt_? -137.94 135.74 36.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 120.773 0.321 . . . . 0.0 110.864 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -151.94 159.53 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -93.8 131.63 38.99 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.099 0.952 . . . . 0.0 111.105 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.404 ' OE1' HG23 ' A' ' 125' ' ' VAL . 7.5 mp0 -123.39 165.07 17.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 125.572 1.549 . . . . 0.0 109.629 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 35.7 m-80 -89.72 142.92 27.24 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.448 HD21 ' SG ' ' A' ' 123' ' ' CYS . 63.4 mt -58.79 -36.64 74.77 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.43 0.692 . . . . 0.0 110.682 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 t -79.55 -16.63 55.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.477 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 4.1 t70 -89.62 -28.05 19.78 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.73 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.681 HD12 ' SG ' ' A' ' 123' ' ' CYS . 62.8 mt -54.87 134.81 48.4 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.983 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.71 167.03 10.45 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.479 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.0 t -62.47 142.75 96.35 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.61 -177.76 1.02 Allowed 'Trans proline' 0 C--O 1.241 0.648 0 C-N-CA 123.422 2.748 . . . . 0.0 113.718 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.6 pt -86.34 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.592 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.07 42.34 1.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.394 1.092 . . . . 0.0 111.442 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 . . . . . 0 C--N 1.252 -3.64 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.859 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.586 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 p -80.74 107.13 13.29 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.91 -56.41 2.57 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.853 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.16 81.62 1.94 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -144.9 24.01 1.51 Allowed 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.77 11.03 38.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.69 125.17 24.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.797 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -114.31 141.24 47.86 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -134.12 164.08 28.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 120.95 0.405 . . . . 0.0 111.271 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -130.96 159.34 37.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.08 132.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.49 10.55 57.98 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.834 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.13 141.3 29.68 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -81.15 144.09 31.92 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.37 0.605 . . . . 0.0 110.985 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -156.65 -171.57 3.73 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.16 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 142.21 50.82 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.6 160.62 37.92 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 123.493 0.496 . . . . 0.0 110.002 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.76 117.11 35.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 8.8 t90 -64.74 121.14 13.84 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.536 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 27.7 t -58.3 -24.38 59.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -83.25 -42.07 17.63 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.14 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.402 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.9 t70 -111.5 -18.04 12.94 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.563 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 7.09 88.88 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.663 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.0 m -92.94 158.4 15.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mm -77.87 130.78 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.774 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -138.67 148.73 59.71 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.94 127.46 12.95 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.115 1.877 . . . . 0.0 111.024 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.89 150.41 38.37 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.391 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.1 m -111.84 147.61 35.38 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.0 mt -76.13 124.89 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.631 0.253 . . . . 0.0 110.818 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.19 12.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.872 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -160.8 152.54 19.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 123' ' ' CYS . 82.0 mt -132.48 139.89 48.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 122.979 0.512 . . . . 0.0 110.817 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -111.91 97.48 6.71 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -68.19 -23.9 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.04 -39.14 63.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.774 0.321 . . . . 0.0 110.977 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.75 -7.56 56.04 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.251 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 63.07 33.74 14.37 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.303 1.002 . . . . 0.0 108.84 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 53.8 p -123.62 161.75 24.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 110.402 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.709 ' SG ' HD12 ' A' ' 141' ' ' LEU . 4.6 p -149.43 151.91 34.81 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.5 t -96.32 130.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.0 m -118.69 145.94 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.4 t -112.4 118.6 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.555 ' CD2' HC23 ' A' 1148 ' ' DA2 . 98.2 m-85 -70.82 118.84 14.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 123.802 0.689 . . . . 0.0 110.911 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.2 m -63.63 131.56 48.37 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.716 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.18 -29.85 8.9 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.824 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.92 -40.64 6.8 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.702 0.287 . . . . 0.0 111.321 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.54 74.79 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.078 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -80.37 153.87 28.08 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.1 ppt_? -136.0 137.9 41.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.536 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 6.8 pt-20 -154.23 158.92 40.98 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.8 tt0 -99.37 132.22 44.85 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.519 0.676 . . . . 0.0 111.526 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.484 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -132.2 163.46 28.52 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.653 1.181 . . . . 0.0 109.681 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 24.7 m-80 -85.06 146.7 27.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.409 HD22 HG21 ' A' ' 116' ' ' ILE . 84.3 mt -57.21 -35.57 69.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.738 0.78 . . . . 0.0 111.177 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.4 m -80.08 -20.28 45.5 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.097 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -13.89 39.86 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.709 HD12 ' SG ' ' A' ' 123' ' ' CYS . 63.8 mt -71.68 145.14 49.06 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.625 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -114.98 159.5 20.67 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.7 m -62.76 141.32 97.21 Favored Pre-proline 0 N--CA 1.39 -3.434 0 C-N-CA 123.755 0.822 . . . . 0.0 108.953 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.46 162.4 30.92 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 122.755 2.303 . . . . 0.0 113.805 -174.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 pt -113.44 161.6 12.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.803 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.4 m -71.83 121.45 19.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.285 0.564 . . . . 0.0 110.084 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--N 1.276 -2.616 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.881 -179.057 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.555 HC23 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.9 m -140.71 96.03 2.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 -34.34 15.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.256 0.551 . . . . 0.0 110.039 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.03 66.6 5.84 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.814 0.816 . . . . 0.0 110.842 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 90' ' ' GLN . 11.8 p -118.9 4.08 11.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.222 175.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -88.01 17.82 4.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.799 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 88' ' ' SER . 9.8 mm100 -65.91 129.12 38.7 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.709 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.59 110.97 15.09 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 82.7 m95 -112.82 161.22 17.18 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.249 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.552 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.7 ptpp? -131.21 161.34 32.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.7 t -63.84 127.71 24.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.89 13.91 38.57 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.15 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.552 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 28.2 m-20 -96.82 142.46 28.8 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -152.72 -170.58 3.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.509 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.3 m -127.27 143.55 51.22 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HB2' ' NE2' ' A' ' 136' ' ' GLN . . . -135.39 160.4 38.55 Favored 'General case' 0 C--N 1.278 -2.529 0 O-C-N 123.644 0.59 . . . . 0.0 110.005 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 mm -92.36 116.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -64.8 126.62 28.53 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 123.601 0.563 . . . . 0.0 109.904 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.1 m -58.27 -28.16 64.69 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.4 -41.82 15.09 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.077 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.91 -17.83 13.53 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.722 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.88 90.0 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.736 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.91 161.99 14.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.55 130.47 36.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.425 0.69 . . . . 0.0 109.657 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -139.29 151.0 66.28 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.679 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.7 127.78 14.3 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.664 2.242 . . . . 0.0 111.028 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.36 150.82 36.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 120.914 0.387 . . . . 0.0 110.557 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -111.88 147.59 35.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.422 HD13 ' HB2' ' A' ' 96' ' ' ASP . 69.3 mt -79.35 121.8 33.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.781 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.42 -35.32 12.39 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.785 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -159.14 144.65 16.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.433 HG21 HD22 ' A' ' 138' ' ' LEU . 99.0 mt -122.13 134.78 64.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.399 0.28 . . . . 0.0 110.416 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -113.13 96.64 6.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -64.39 -25.83 68.19 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HZ3' ' HB3' ' A' ' 119' ' ' LYS . 3.7 mmmp? -69.16 -37.35 78.16 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.03 -7.24 52.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.464 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 62.59 25.11 14.96 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 108.558 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 71.5 p -122.82 161.96 23.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.546 -0.721 . . . . 0.0 111.422 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.676 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.6 p -148.03 153.18 38.61 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 78.9 t -96.26 130.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.4 m -119.22 145.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-O 121.171 0.51 . . . . 0.0 109.88 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.0 t -110.41 118.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.543 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.551 ' CD1' HC13 ' A' 1148 ' ' DA2 . 99.6 m-85 -71.73 117.95 13.95 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -65.85 131.82 47.18 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.48 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.61 -17.16 55.9 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.69 -39.95 4.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.893 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.68 23.58 57.73 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.821 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -95.28 153.27 17.75 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.0 ppt_? -137.94 135.7 36.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.679 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.436 ' CD ' ' HH ' ' A' ' 127' ' ' TYR . 10.3 pt-20 -154.34 159.16 41.04 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -94.83 133.22 38.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.468 0.651 . . . . 0.0 111.855 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.486 ' NE2' ' HB2' ' A' ' 100' ' ' ALA . 5.7 mp0 -131.78 163.66 27.73 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.84 1.256 . . . . 0.0 110.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 26.8 m-80 -85.51 146.86 26.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 116' ' ' ILE . 67.0 mt -59.22 -37.4 77.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.548 0.69 . . . . 0.0 109.964 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.8 m -74.4 -22.14 59.31 Favored 'General case' 0 N--CA 1.405 -2.711 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.433 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 m-20 -91.32 -13.46 32.53 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.676 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.0 mt -71.19 144.13 50.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.089 0.471 . . . . 0.0 110.676 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.2 165.52 12.84 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.8 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.8 t -62.92 137.6 96.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.509 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 50.7 Cg_endo -67.16 166.26 23.78 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.317 2.011 . . . . 0.0 112.101 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.1 pt -116.29 174.19 3.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.808 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.4 p -72.8 159.94 32.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.285 0.366 . . . . 0.0 110.27 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--N 1.293 -1.854 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.177 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.551 HC13 ' CD1' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.55 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.3 m120 . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m -47.19 115.14 1.01 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.698 1.199 . . . . 0.0 112.7 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.07 8.23 5.32 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.431 1.492 . . . . 0.0 113.503 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.495 ' HB3' ' NE2' ' A' ' 90' ' ' GLN . . . -128.43 22.24 6.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.261 0.553 . . . . 0.0 112.275 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -89.58 20.68 3.83 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.665 0.745 . . . . 0.0 109.931 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -121.73 12.83 10.69 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.216 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.495 ' NE2' ' HB3' ' A' ' 87' ' ' ALA . 39.1 mt-30 -95.99 151.66 19.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.906 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -132.42 114.06 13.89 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.442 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 95.4 m95 -104.18 160.02 15.21 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.852 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 64.5 pttt -131.45 159.97 36.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 16.29 68.42 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.586 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 6.8 t0 -100.08 136.15 40.43 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -85.04 141.86 29.98 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.442 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -150.14 -167.87 2.95 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -130.13 143.61 50.88 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.58 160.56 38.1 Favored 'General case' 0 C--N 1.281 -2.408 0 O-C-N 123.439 0.462 . . . . 0.0 110.101 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.29 117.88 36.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -67.02 122.46 17.82 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.436 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 11.1 t -65.31 -16.26 63.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 118.052 0.387 . . . . 0.0 111.804 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -85.3 -38.44 18.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -115.16 -18.33 11.18 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.408 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 6.29 88.73 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.022 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.62 162.51 13.92 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.69 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.42 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.35 150.87 73.71 Favored Pre-proline 0 C--N 1.284 -2.244 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.358 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.15 127.46 13.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.988 1.792 . . . . 0.0 110.861 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.09 35.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 m -112.21 148.19 34.62 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 71.3 mt -77.18 121.63 30.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.857 0.36 . . . . 0.0 110.995 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.35 -39.76 12.5 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.713 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.2 m -158.5 149.8 20.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 138' ' ' LEU . 95.3 mt -125.11 136.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.98 0.419 . . . . 0.0 110.494 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -112.11 99.29 7.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.95 -23.46 65.06 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.894 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.17 -36.36 66.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.954 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.33 -8.91 54.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.485 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 59.98 28.69 18.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.209 1.004 . . . . 0.0 109.0 -172.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 76.1 p -122.84 162.86 21.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 121.405 -0.81 . . . . 0.0 110.671 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.649 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.5 p -148.69 152.35 36.51 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 122.617 0.367 . . . . 0.0 110.521 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.9 t -95.31 131.12 42.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.1 m -118.43 145.65 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 91.4 t -111.49 118.67 58.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.568 ' CD2' HC22 ' A' 1148 ' ' DA2 . 99.6 m-85 -69.14 121.9 17.7 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 123.734 0.646 . . . . 0.0 110.887 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.4 m -62.8 131.21 48.09 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.389 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.09 18.22 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.4 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.86 -42.14 5.94 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 122.508 -0.407 . . . . 0.0 111.566 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.35 61.99 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.822 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -89.4 152.66 21.38 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.8 ppt_? -133.98 140.22 46.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.496 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.3 pt-20 -153.68 158.04 40.46 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 21.9 tt0 -98.21 129.75 44.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.496 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.4 mp0 -126.56 163.16 24.03 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 124.333 1.053 . . . . 0.0 109.676 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.3 m-80 -82.88 146.98 28.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.428 HD22 HG21 ' A' ' 116' ' ' ILE . 57.3 mt -60.76 -34.34 74.31 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.316 1.055 . . . . 0.0 109.251 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 84' ' ' ASN . 7.5 t -80.11 -8.33 59.35 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.088 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -104.89 -15.67 15.09 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.529 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.649 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.2 mt -66.37 146.82 54.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.205 0.526 . . . . 0.0 111.166 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.29 161.76 18.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.709 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -63.04 136.38 96.66 Favored Pre-proline 0 N--CA 1.396 -3.132 0 C-N-CA 124.548 1.139 . . . . 0.0 110.303 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.18 173.92 13.21 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.922 2.414 . . . . 0.0 113.445 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.55 156.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 56.7 m -91.09 97.19 11.01 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.133 0.968 . . . . 0.0 110.537 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 . . . . . 0 C--N 1.261 -3.241 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.185 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.568 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.5 p -82.58 149.85 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.361 0.264 . . . . 0.0 111.196 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.22 -77.54 0.57 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.463 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.57 20.08 3.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.005 0.907 . . . . 0.0 111.359 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -78.11 7.68 5.88 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.274 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.433 HD13 HE21 ' A' ' 90' ' ' GLN . 1.2 pp -125.32 16.57 8.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.075 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.433 HE21 HD13 ' A' ' 89' ' ' LEU . 31.6 mm-40 -83.21 156.05 23.38 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.601 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -118.33 113.46 21.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.408 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 85.8 m95 -101.66 161.94 13.28 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.353 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.593 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -131.17 162.87 28.97 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.85 132.32 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.91 12.47 56.56 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.275 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 75.4 m-20 -97.26 149.42 22.07 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.402 0.62 . . . . 0.0 109.839 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -86.89 139.81 30.27 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.275 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -155.96 -172.38 4.09 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.114 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 13.6 m -131.2 146.89 52.5 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.18 37.42 Favored 'General case' 0 C--N 1.274 -2.701 0 O-C-N 123.69 0.619 . . . . 0.0 109.791 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.93 118.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -65.87 120.55 13.26 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.612 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 9.0 t -61.55 -19.58 62.31 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.065 0.228 . . . . 0.0 111.324 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.97 -42.07 15.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.85 -17.91 12.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.075 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.62 89.16 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.108 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.16 161.46 14.41 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.17 130.53 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.94 150.28 64.69 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 132.26 24.32 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.326 2.017 . . . . 0.0 111.156 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.5 149.65 32.02 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.024 0.44 . . . . 0.0 110.208 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -111.53 147.26 35.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.55 125.69 36.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.5 -35.43 10.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.02 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.2 m -158.65 148.04 19.15 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.407 HG21 HD22 ' A' ' 138' ' ' LEU . 88.7 mt -125.98 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 122.64 0.376 . . . . 0.0 110.051 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.95 98.81 7.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -24.03 66.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.288 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.77 -37.41 67.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.694 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.88 -8.87 57.77 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.376 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.01 28.87 18.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.534 1.134 . . . . 0.0 108.432 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 70.2 p -125.2 160.73 28.49 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.685 -0.634 . . . . 0.0 110.492 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.661 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.2 p -148.19 153.73 39.17 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 122.704 0.402 . . . . 0.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.5 t -95.52 130.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.51 145.72 24.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.0 t -111.36 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.554 ' CD2' HC23 ' A' 1148 ' ' DA2 . 98.9 m-85 -68.79 117.73 10.85 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.849 0.718 . . . . 0.0 111.111 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 m -60.77 131.14 49.74 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.531 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.62 -28.28 7.84 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.987 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -101.01 -42.9 6.22 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 122.508 -0.407 . . . . 0.0 111.494 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.52 14.6 63.33 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.422 -0.895 . . . . 0.0 111.891 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -86.78 151.35 23.45 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.92 135.77 39.92 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 123.131 0.269 . . . . 0.0 111.129 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.7 pt-20 -153.69 158.16 40.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.0 tt0 -96.35 131.4 42.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.482 0.658 . . . . 0.0 111.689 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.471 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.2 mp0 -128.16 163.64 24.23 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 125.27 1.428 . . . . 0.0 109.763 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 29.2 m-80 -82.67 147.55 28.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 116' ' ' ILE . 72.7 mt -59.37 -35.99 74.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.878 0.847 . . . . 0.0 110.06 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.0 m -76.82 -19.52 57.44 Favored 'General case' 0 N--CA 1.405 -2.69 0 C-N-CA 124.164 0.986 . . . . 0.0 111.63 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -93.25 -10.06 36.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.049 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.661 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -72.37 147.36 46.32 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.529 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.62 163.18 18.43 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.5 t -65.27 145.31 99.1 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.456 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 84.2 Cg_endo -76.9 -179.3 5.27 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.758 2.305 . . . . 0.0 112.325 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.1 pt -116.17 168.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.1 p -73.14 137.02 44.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 123.582 0.753 . . . . 0.0 110.115 -177.339 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.554 HC23 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 m -104.96 109.2 21.09 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 65.5 11.05 7.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.719 1.208 . . . . 0.0 113.03 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.19 79.96 1.72 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.445 0.641 . . . . 0.0 111.334 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -95.04 -13.46 25.18 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.065 0.936 . . . . 0.0 108.608 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.75 23.56 0.09 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.355 -1.293 . . . . 0.0 113.552 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -69.81 117.24 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.16 0.505 . . . . 0.0 110.327 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -107.31 128.44 54.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -125.12 160.24 29.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.946 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.8 pttm -131.98 160.82 34.72 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.57 129.21 26.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 13.97 39.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.591 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 71.6 m-20 -97.91 141.03 31.4 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -84.48 144.99 28.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.01 -169.37 3.05 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -130.35 144.21 51.25 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.55 161.0 37.08 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.116 0.26 . . . . 0.0 110.431 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -92.37 119.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.46 125.77 27.52 Favored 'General case' 0 C--O 1.205 -1.254 0 O-C-N 123.436 0.46 . . . . 0.0 109.795 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -57.96 -26.79 62.76 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -84.73 -41.83 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.248 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.89 -17.35 12.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.914 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.28 90.19 Favored Glycine 0 C--O 1.222 -0.644 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.177 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.9 m -93.15 162.05 14.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.9 mm -78.39 131.05 35.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.123 0.969 . . . . 0.0 109.605 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -140.26 151.42 64.44 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.636 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 129.7 16.76 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.433 2.088 . . . . 0.0 111.209 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.32 150.48 35.82 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.991 0.424 . . . . 0.0 110.661 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.9 m -111.94 147.58 35.56 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.446 HD13 ' HB2' ' A' ' 96' ' ' ASP . 75.5 mt -77.6 120.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.41 -33.84 13.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.836 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.8 m -162.05 146.82 12.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.4 mt -121.54 138.6 51.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.79 96.05 5.75 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -65.2 -24.04 67.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.359 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.06 -39.99 71.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.396 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -85.6 -9.02 57.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 61.54 30.72 18.85 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.877 1.271 . . . . 0.0 109.141 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.9 p -129.2 165.33 21.55 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.91 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.745 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.6 p -148.71 153.67 38.55 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 122.4 0.28 . . . . 0.0 110.965 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 46.9 t -95.92 130.1 45.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.94 146.06 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.661 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 90.8 t -110.4 118.84 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.564 ' CD2' HC22 ' A' 1148 ' ' DA2 . 96.8 m-85 -69.59 118.31 12.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.752 0.658 . . . . 0.0 110.96 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 m -64.94 130.93 45.23 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.53 -19.59 43.27 Favored Glycine 0 N--CA 1.428 -1.836 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.22 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -107.68 -43.37 4.51 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.808 0.337 . . . . 0.0 111.659 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.19 8.41 66.62 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.092 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -81.3 152.76 27.41 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.5 OUTLIER -139.47 136.42 34.57 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.932 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.477 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.36 158.48 41.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -94.6 133.84 37.81 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.351 0.596 . . . . 0.0 111.475 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.477 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.3 mp0 -128.88 163.29 25.59 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 124.832 1.253 . . . . 0.0 110.376 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 36.6 m-80 -81.24 148.47 29.46 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.61 -31.0 71.77 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.442 0.639 . . . . 0.0 110.763 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.2 t -80.29 -25.39 39.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.378 0.609 . . . . 0.0 109.758 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.48 ' O ' HD13 ' A' ' 142' ' ' LEU . 32.6 t70 -74.77 -31.25 61.71 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.568 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 ' SG ' ' A' ' 123' ' ' CYS . 54.1 mt -58.54 134.14 56.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.39 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 140' ' ' ASP . 5.1 mp -109.51 159.41 17.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.173 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.2 m -62.64 144.48 96.02 Favored Pre-proline 0 N--CA 1.392 -3.332 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.42 158.9 17.59 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.906 2.404 . . . . 0.0 114.676 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 pt -120.97 179.4 2.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.034 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 56.6 m -74.99 133.34 41.71 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-O 117.752 -1.118 . . . . 0.0 109.902 -178.192 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.564 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 111.296 0.109 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 87' ' ' ALA . 25.5 m -72.41 108.86 5.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 77.13 -40.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 110.811 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 85' ' ' THR . . . -99.22 90.48 4.59 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.331 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -135.92 20.33 3.26 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 pp -98.49 12.23 35.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.125 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.03 125.69 26.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.051 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -103.12 113.56 27.14 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -101.84 163.33 12.31 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.329 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.5 pttm -130.83 159.28 37.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.67 128.38 25.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.03 7.32 52.86 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.153 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' HB2' HD13 ' A' ' 113' ' ' ILE . 60.5 m-20 -91.13 137.17 32.57 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -80.71 141.11 35.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -154.14 -166.27 2.32 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 m -131.32 146.95 52.51 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.07 161.92 36.71 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 122.98 0.175 . . . . 0.0 110.687 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.5 mm -91.12 116.04 31.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 123.819 0.7 . . . . 0.0 109.814 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -65.74 119.39 11.11 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 t -65.79 -14.95 62.36 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 118.205 0.457 . . . . 0.0 112.013 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.19 -41.84 19.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.69 -0.404 . . . . 0.0 112.028 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.94 -16.99 12.58 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.26 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.0 8.5 87.59 Favored Glycine 0 C--N 1.307 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.705 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.7 m -93.83 160.61 14.67 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.4 mm -77.17 129.64 37.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.888 0.875 . . . . 0.0 109.553 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -138.6 150.08 64.77 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 123.087 0.555 . . . . 0.0 109.966 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.06 128.3 14.67 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.556 2.171 . . . . 0.0 110.8 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.66 150.4 34.29 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.422 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.0 m -111.51 147.82 34.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 96' ' ' ASP . 62.5 mt -78.06 121.91 31.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.12 -32.6 13.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -159.05 148.65 18.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 116' ' ' ILE . 91.2 mt -129.05 139.68 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 122.893 0.477 . . . . 0.0 109.977 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.68 99.1 7.89 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.55 -24.04 65.48 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.085 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -73.97 -41.61 61.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.636 0.255 . . . . 0.0 110.749 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -86.64 -8.89 57.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.029 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 61.56 32.85 18.59 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.327 1.017 . . . . 0.0 108.671 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 59.2 p -122.96 159.68 27.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.85 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.611 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.1 p -149.02 152.61 36.57 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 122.776 0.43 . . . . 0.0 111.039 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.3 t -96.37 131.22 43.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.8 m -119.45 145.3 25.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.5 t -110.18 118.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.569 ' CD2' HC23 ' A' 1148 ' ' DA2 . 99.8 m-85 -72.41 116.91 13.43 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 123.698 0.624 . . . . 0.0 110.564 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.7 m -63.76 131.61 48.38 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.24 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.19 -22.08 36.68 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.988 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.23 -40.07 5.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.38 78.51 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.065 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -73.92 149.26 41.53 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.94 135.82 39.92 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -152.58 158.13 42.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.6 tt0 -93.71 132.7 37.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.307 0.575 . . . . 0.0 110.923 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -133.55 163.67 28.88 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 125.097 1.359 . . . . 0.0 107.396 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 34.4 m-80 -83.74 151.42 25.24 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 116' ' ' ILE . 75.5 mt -62.26 -36.32 81.66 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.07 0.938 . . . . 0.0 108.963 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -33.16 74.46 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -15.56 45.45 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.439 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.611 HD12 ' SG ' ' A' ' 123' ' ' CYS . 58.9 mt -65.13 146.98 54.27 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.14 0.495 . . . . 0.0 111.862 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.84 161.16 20.18 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.57 136.99 96.28 Favored Pre-proline 0 N--CA 1.405 -2.725 0 C-N-CA 124.443 1.097 . . . . 0.0 110.568 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 175.83 8.11 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 123.211 2.607 . . . . 0.0 112.903 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.76 -176.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.969 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.5 p -74.74 133.51 42.0 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.445 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 C--O 1.252 1.226 0 O-C-N 124.728 1.268 . . . . 0.0 110.843 -179.591 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.569 HC23 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t30 . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.0 t -135.16 147.45 49.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.132 0.491 . . . . 0.0 111.175 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.79 -0.48 19.9 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.47 84.32 3.68 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.981 0.896 . . . . 0.0 109.827 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -145.19 32.62 1.1 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.6 14.71 12.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.163 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.28 125.43 30.33 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.396 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -111.65 109.1 18.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.417 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 79.5 m95 -101.85 163.06 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.613 -173.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.529 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.9 ptpp? -128.88 155.95 44.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -63.65 127.47 24.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.7 33.09 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.69 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.529 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 29.2 m-20 -96.2 141.3 29.73 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -82.14 143.51 31.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.417 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 27.0 p -155.23 -170.47 3.48 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 m -131.4 142.9 50.12 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.65 160.46 38.04 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.093 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.47 120.23 41.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -67.15 126.1 28.12 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.6 m -58.77 -27.16 64.72 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -85.21 -41.86 15.23 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.51 -16.36 13.68 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.318 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.77 89.89 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.06 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.5 160.47 15.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mm -78.44 128.28 38.4 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.347 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -136.14 151.24 73.18 Favored Pre-proline 0 C--N 1.287 -2.145 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.66 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.88 127.9 15.15 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.411 2.074 . . . . 0.0 110.797 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.05 150.17 36.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 120.849 0.356 . . . . 0.0 110.29 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -112.04 147.83 35.17 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 96' ' ' ASP . 70.9 mt -81.35 118.91 29.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-O 120.831 0.348 . . . . 0.0 110.746 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.87 15.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.077 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.6 m -161.43 146.62 13.67 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.409 HG21 HD22 ' A' ' 138' ' ' LEU . 94.3 mt -128.64 135.97 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 122.843 0.457 . . . . 0.0 110.534 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.59 102.7 10.76 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.67 -26.09 66.03 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.041 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -70.14 -40.42 74.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.304 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.45 -8.8 58.18 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.021 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 60.36 27.57 17.16 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.23 1.014 . . . . 0.0 109.12 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -124.85 160.17 29.4 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 121.143 -0.973 . . . . 0.0 110.871 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.705 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.4 p -148.3 153.83 39.19 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 50.7 t -95.91 130.42 44.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 86.4 t -111.57 119.05 59.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.595 ' CD2' HC23 ' A' 1148 ' ' DA2 . 98.6 m-85 -70.42 120.24 15.77 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.539 0.685 . . . . 0.0 111.068 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.1 m -64.59 132.09 48.82 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.156 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.68 -20.9 32.48 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.051 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -106.82 -50.3 3.14 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.914 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.05 3.42 59.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.489 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.4 154.49 34.81 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.7 ppt_? -137.12 139.35 41.15 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.6 pt-20 -153.51 158.28 41.07 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.72 129.69 44.75 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.504 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 5.9 mp0 -127.5 163.48 24.02 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 124.298 1.039 . . . . 0.0 110.037 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -82.14 148.4 28.53 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.409 HD22 HG21 ' A' ' 116' ' ' ILE . 67.8 mt -61.15 -31.62 71.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.084 0.945 . . . . 0.0 109.659 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.2 m -78.19 -24.09 47.28 Favored 'General case' 0 N--CA 1.392 -3.328 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.422 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.411 ' O ' HD13 ' A' ' 142' ' ' LEU . 26.1 t70 -81.82 -32.29 31.32 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.386 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.705 HD12 ' SG ' ' A' ' 123' ' ' CYS . 54.7 mt -56.01 141.55 39.44 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 124.587 1.179 . . . . 0.0 111.689 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 140' ' ' ASP . 5.4 mp -113.79 162.32 16.46 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.485 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 t -62.64 146.56 94.11 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.65 166.99 12.42 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.354 2.036 . . . . 0.0 112.448 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.18 159.26 15.16 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.187 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 54.9 m -96.68 126.75 42.07 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 C--N 1.287 -2.125 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.373 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.595 HC23 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.458 0.171 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -75.08 89.1 2.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.576 0.703 . . . . 0.0 111.638 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.28 2.63 26.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.813 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 89' ' ' LEU . . . 63.51 25.29 14.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.916 0.886 . . . . 0.0 111.246 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.4 m -78.52 20.47 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.891 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 87' ' ' ALA . 1.5 pp -133.91 23.5 3.91 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.449 0.643 . . . . 0.0 110.866 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -82.75 141.87 32.05 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.263 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -103.83 114.46 28.73 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 -106.27 161.49 14.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.637 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 24.6 pttm -131.77 161.59 32.53 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.29 130.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.17 23.3 38.22 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.986 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.2 t0 -101.43 139.91 36.44 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -83.3 141.57 31.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.38 -170.95 3.52 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -129.6 141.89 50.86 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.29 160.66 35.57 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.253 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mm -91.99 116.88 34.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -65.7 125.51 25.5 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -30.81 63.49 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 123.539 0.736 . . . . 0.0 112.821 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -85.2 -40.7 16.38 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.33 -17.81 13.91 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.383 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.69 89.95 Favored Glycine 0 CA--C 1.507 -0.449 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.035 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 95.0 m -93.55 162.77 13.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.74 128.47 37.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.682 0.614 . . . . 0.0 109.536 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -136.3 151.41 73.23 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.86 128.02 14.48 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.185 1.923 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.85 146.36 27.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.098 0.475 . . . . 0.0 110.108 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.5 m -111.84 147.95 34.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.8 mt -75.87 123.53 32.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.581 0.229 . . . . 0.0 110.651 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.9 -32.47 12.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.2 m -160.96 146.54 14.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.42 HG21 HD22 ' A' ' 138' ' ' LEU . 98.1 mt -124.47 135.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 0.0 111.049 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.16 100.9 8.94 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -67.78 -24.16 65.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.342 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.88 -37.43 70.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.879 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -87.86 -8.71 55.48 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.294 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 61.08 30.05 19.25 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.171 0.988 . . . . 0.0 108.435 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 78.2 p -126.16 163.66 22.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.635 -0.666 . . . . 0.0 111.407 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.4 p -148.74 153.32 38.03 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.1 0.56 . . . . 0.0 110.455 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.34 130.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.9 m -118.89 145.54 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.4 t -109.95 118.87 57.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.563 ' CD2' HC22 ' A' 1148 ' ' DA2 . 99.4 m-85 -71.58 121.2 18.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.801 0.688 . . . . 0.0 110.565 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -62.09 130.98 48.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.536 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.62 -16.59 39.83 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.538 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -104.56 -43.39 5.17 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.155 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.01 12.29 63.87 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.77 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.7 m-20 -85.28 151.64 23.9 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -137.72 135.26 36.25 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.06 158.03 39.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -99.75 127.52 45.89 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.491 0.663 . . . . 0.0 111.796 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -123.04 163.68 20.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.985 1.314 . . . . 0.0 110.007 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.0 m-80 -84.69 146.52 27.4 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 116' ' ' ILE . 58.8 mt -59.5 -32.69 70.51 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.215 1.007 . . . . 0.0 109.063 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -75.25 -22.54 57.77 Favored 'General case' 0 N--CA 1.394 -3.254 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.708 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 t70 -93.29 -19.35 21.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 123' ' ' CYS . 78.1 mt -61.34 141.22 57.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.919 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 140' ' ' ASP . 5.2 mp -114.61 162.94 16.11 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.822 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.9 t -62.56 141.17 96.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.33 160.77 18.62 Favored 'Trans proline' 0 CA--C 1.505 -0.945 0 C-N-CA 122.984 2.456 . . . . 0.0 113.291 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.94 -178.83 2.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.361 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 60.2 m -69.91 135.84 49.96 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.874 0.734 . . . . 0.0 110.378 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.287 -2.126 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.725 -179.555 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.563 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.7 m -68.52 115.84 8.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.177 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 74.13 -3.11 2.61 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.494 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.35 94.03 1.46 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.137 0.494 . . . . 0.0 110.904 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 t -118.49 -11.23 9.98 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.051 0.929 . . . . 0.0 109.628 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.8 20.51 15.16 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.299 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.82 127.26 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.894 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -111.33 111.65 22.85 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.604 0.716 . . . . 0.0 109.34 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 89.6 m95 -105.41 163.77 12.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.121 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.545 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.1 ptpp? -130.89 161.27 32.22 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.6 t -63.55 128.17 25.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.26 8.05 48.01 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.612 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.545 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.3 m-20 -97.1 150.01 21.32 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HD2' HG21 ' A' ' 112' ' ' THR . 27.1 mmmt -91.35 140.55 29.66 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.575 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.422 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.9 p -152.65 -169.38 3.32 Favored 'General case' 0 C--N 1.262 -3.228 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.852 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 8.7 m -130.77 146.09 52.13 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.07 160.48 38.5 Favored 'General case' 0 C--N 1.275 -2.66 0 O-C-N 123.83 0.706 . . . . 0.0 109.665 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mm -91.54 120.38 40.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.54 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 11.4 t90 -69.28 127.29 32.52 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 123.497 0.498 . . . . 0.0 109.955 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.9 m -57.79 -28.54 64.11 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.96 -42.81 14.59 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.58 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.03 -18.62 13.86 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.028 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.47 6.36 88.03 Favored Glycine 0 C--O 1.222 -0.615 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.793 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.83 163.0 13.69 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.2 mm -77.94 130.23 36.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.199 0.6 . . . . 0.0 109.385 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -137.79 149.35 64.24 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.304 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.49 128.65 14.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.268 1.979 . . . . 0.0 110.777 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.41 153.02 41.49 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.207 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.42 HG21 ' HD2' ' A' ' 97' ' ' LYS . 4.4 m -112.08 147.42 36.08 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.01 121.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 120.856 0.36 . . . . 0.0 110.604 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.83 -39.42 11.21 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -159.46 148.57 18.14 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.425 HG21 HD22 ' A' ' 138' ' ' LEU . 90.8 mt -126.13 134.73 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.281 0.363 . . . . 0.0 111.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -112.33 99.7 8.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -64.69 -28.18 69.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.325 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.7 -39.65 64.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.188 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -81.23 -8.59 59.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.042 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 62.02 26.41 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.938 1.295 . . . . 0.0 109.055 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 82.1 p -125.65 161.73 26.6 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 121.481 -0.762 . . . . 0.0 111.055 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.622 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.6 p -147.78 152.33 37.53 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.5 t -96.07 131.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.7 m -119.34 148.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 87.9 t -109.61 118.43 56.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.592 ' CD2' HC21 ' A' 1148 ' ' DA2 . 94.7 m-85 -71.34 120.84 17.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 109.496 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.432 HG22 ' OE1' ' A' ' 147' ' ' GLU . 44.2 m -66.27 131.99 47.39 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.548 -175.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.36 40.42 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.042 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.8 -43.49 4.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.015 0.436 . . . . 0.0 111.415 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.2 2.46 64.09 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.201 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.0 m-20 -74.92 150.11 39.22 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.3 ppt_? -135.12 135.42 41.14 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.5 159.62 41.09 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -93.77 136.43 34.05 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 121.865 0.84 . . . . 0.0 110.824 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -129.46 165.55 21.39 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 126.224 1.81 . . . . 0.0 108.772 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 31.2 m-80 -89.4 147.82 23.83 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 116' ' ' ILE . 74.7 mt -61.11 -34.14 74.48 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.758 0.79 . . . . 0.0 110.296 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -71.62 -29.99 65.29 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.656 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.53 -14.55 45.54 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.622 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.7 mt -67.74 147.45 52.6 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.259 0.552 . . . . 0.0 111.074 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.82 163.39 19.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.4 t -63.17 142.94 97.76 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.415 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 37.0 Cg_endo -64.49 157.64 53.88 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 113.084 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.28 -177.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.275 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.19 132.73 49.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.814 0.34 . . . . 0.0 110.797 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.432 ' OE1' HG22 ' A' ' 128' ' ' THR . 33.6 mt-10 . . . . . 0 C--O 1.256 1.417 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.592 HC21 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 . . . . . 0 CA--C 1.503 -0.835 0 CA-C-O 120.743 0.306 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.3 m -84.24 102.53 12.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.696 0.76 . . . . 0.0 110.132 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.53 -2.39 54.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.853 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.01 21.47 4.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.207 1.003 . . . . 0.0 110.257 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 p -82.54 14.43 3.09 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 pp -110.17 5.58 22.04 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.473 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -87.94 146.39 25.56 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.111 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -126.62 115.9 20.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.405 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 93.4 m95 -108.28 163.04 13.54 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.562 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 47.4 pttt -131.01 155.23 47.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.12 128.09 25.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.66 14.92 51.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.27 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 3.6 t0 -93.69 142.5 27.28 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -80.52 141.32 35.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.405 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.2 p -158.55 -171.36 3.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.8 m -130.61 146.45 52.12 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.8 161.09 36.92 Favored 'General case' 0 C--N 1.278 -2.539 0 O-C-N 123.26 0.35 . . . . 0.0 110.489 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mm -92.41 115.37 31.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -64.44 121.35 14.17 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.54 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 8.1 t -66.44 -15.27 63.2 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 118.216 0.462 . . . . 0.0 111.831 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -84.86 -41.93 15.55 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.992 0.425 . . . . 0.0 110.876 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -110.79 -18.0 13.22 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.662 0.744 . . . . 0.0 110.847 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.29 90.52 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.202 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.3 m -94.05 163.85 13.31 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mm -77.51 130.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 123.445 0.698 . . . . 0.0 110.109 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.29 150.61 64.91 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.327 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.84 129.92 18.35 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.53 2.153 . . . . 0.0 111.367 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.65 149.97 32.41 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.065 0.46 . . . . 0.0 110.851 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 m -112.17 147.95 35.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -76.16 128.01 37.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.637 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.96 -31.79 10.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.258 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -160.29 145.64 14.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.413 HG21 HD22 ' A' ' 138' ' ' LEU . 98.4 mt -124.09 134.35 66.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 122.85 0.46 . . . . 0.0 110.568 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.42 97.94 6.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -61.95 -25.47 67.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.63 -39.91 64.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.35 -9.17 58.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 60.96 24.83 14.88 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.953 1.301 . . . . 0.0 109.04 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.412 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 68.3 p -122.37 159.99 26.35 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.654 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.3 p -146.21 153.14 40.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.859 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 67.4 t -95.45 130.89 43.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.1 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 85.1 t -109.92 118.46 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.55 ' CD2' HC23 ' A' 1148 ' ' DA2 . 98.0 m-85 -70.01 118.45 12.87 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.801 0.688 . . . . 0.0 111.236 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 131.71 46.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.93 -17.23 56.17 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.079 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.85 -49.28 3.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.952 0.406 . . . . 0.0 110.711 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.63 4.78 59.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.314 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.81 154.93 33.45 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 122.178 0.191 . . . . 0.0 110.549 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.48 136.29 39.31 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.364 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.54 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.8 pt-20 -153.37 158.72 41.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 24.5 tt0 -96.55 129.12 43.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.598 0.713 . . . . 0.0 111.987 -175.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.484 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.9 mp0 -128.19 163.42 24.74 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.245 1.418 . . . . 0.0 110.007 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.0 m-80 -82.17 146.25 29.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 116' ' ' ILE . 67.7 mt -59.43 -34.72 72.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.09 0.948 . . . . 0.0 109.724 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -77.04 -20.34 56.02 Favored 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.424 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 6.2 t70 -90.01 -28.14 19.28 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -175.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.654 HD12 ' SG ' ' A' ' 123' ' ' CYS . 77.1 mt -52.2 137.48 28.17 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 124.695 1.247 . . . . 0.0 111.739 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.19 162.68 14.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.975 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.7 m -62.49 139.37 96.66 Favored Pre-proline 0 N--CA 1.399 -2.976 0 C-N-CA 123.796 0.838 . . . . 0.0 109.344 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.428 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 51.7 Cg_endo -68.1 169.59 16.27 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.627 2.218 . . . . 0.0 112.811 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.79 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.244 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.6 p -53.89 136.29 40.92 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 124.085 0.866 . . . . 0.0 110.87 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.727 1.211 . . . . 0.0 110.905 -177.917 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.55 HC23 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.508 -0.642 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.5 m -144.04 118.88 9.91 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.79 21.59 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.46 75.67 0.39 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.035 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -111.57 24.3 12.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.232 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.77 17.18 10.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.808 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.19 149.69 37.22 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.66 114.09 26.9 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -101.2 152.85 20.16 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.115 -173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 21.9 pttm -131.11 162.64 29.42 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.3 129.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.73 13.99 41.93 Favored Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.835 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' HD11 ' A' ' 113' ' ' ILE . 53.8 m-20 -96.43 140.06 31.64 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -84.89 139.91 31.51 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -151.96 -169.49 3.38 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 123.551 0.532 . . . . 0.0 109.573 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.4 m -130.03 144.23 51.22 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.504 ' HB2' ' NE2' ' A' ' 136' ' ' GLN . . . -134.5 160.24 38.62 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.949 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.67 114.64 31.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -61.71 126.9 28.98 Favored 'General case' 0 C--O 1.203 -1.348 0 O-C-N 124.03 0.831 . . . . 0.0 110.325 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.7 m -57.17 -29.9 64.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.24 -37.27 20.26 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.0 -17.07 10.45 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.509 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.8 8.23 87.71 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.257 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.4 160.07 15.27 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.97 131.22 35.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.89 149.47 59.11 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.03 128.04 16.09 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.602 2.201 . . . . 0.0 111.055 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.88 35.61 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.848 0.356 . . . . 0.0 110.379 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -111.8 147.49 35.59 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 96' ' ' ASP . 68.5 mt -78.9 120.17 29.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.71 -31.95 13.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.495 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -159.97 144.96 15.05 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 138' ' ' LEU . 83.6 mt -120.83 134.69 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 120' ' ' ARG . 12.3 t70 -113.35 98.52 7.15 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -67.72 -23.86 65.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.36 -40.43 85.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.875 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' OD2' ' A' ' 117' ' ' ASP . 95.6 mtt180 -87.95 -8.66 55.39 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.16 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 63.28 27.25 15.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.954 1.301 . . . . 0.0 108.585 -175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 60.9 p -125.76 166.74 16.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.9 p -148.38 151.95 36.19 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 122.911 0.484 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.0 t -95.81 129.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.5 145.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 121.133 0.492 . . . . 0.0 109.706 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 93.3 t -109.29 118.97 57.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.564 ' CD2' HC22 ' A' 1148 ' ' DA2 . 99.5 m-85 -71.28 121.09 17.82 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.313 0.577 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.0 m -69.03 131.4 44.98 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.034 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.03 57.29 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.665 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -111.12 -48.81 3.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 122.453 -0.439 . . . . 0.0 111.608 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.34 10.79 57.94 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -83.13 153.02 25.04 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.91 135.73 38.04 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.35 158.69 40.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -96.79 130.39 44.06 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.797 0.808 . . . . 0.0 112.229 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.504 ' NE2' ' HB2' ' A' ' 100' ' ' ALA . 6.2 mp0 -126.0 163.36 23.18 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.36 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.7 m-80 -84.28 144.9 28.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.428 HD22 HG21 ' A' ' 116' ' ' ILE . 70.4 mt -60.06 -35.39 75.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.535 0.683 . . . . 0.0 110.614 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -73.32 -29.34 62.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -82.51 -14.06 55.61 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.788 -177.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.639 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.1 mt -66.23 143.93 56.93 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.573 0.546 . . . . 0.0 111.517 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.05 158.83 23.51 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 t -63.25 144.97 97.33 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.462 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 46.4 Cg_endo -65.92 165.01 25.05 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.956 1.771 . . . . 0.0 112.531 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 pt -94.88 -177.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.285 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.85 137.89 52.11 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--N 1.306 -1.301 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.785 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.564 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 p -76.05 87.73 2.97 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.287 0.565 . . . . 0.0 110.33 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -170.79 -48.84 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.901 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.83 102.04 2.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.3 m -120.01 31.89 6.3 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.43 1.109 . . . . 0.0 108.312 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.65 18.25 10.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.335 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.435 ' HB3' ' NE1' ' A' ' 92' ' ' TRP . 24.2 mp0 -70.68 138.84 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -130.94 116.67 18.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.435 ' NE1' ' HB3' ' A' ' 90' ' ' GLN . 86.1 m95 -120.45 162.24 19.88 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.071 -175.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.9 ptpp? -131.57 161.53 32.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.91 128.23 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 15.22 33.67 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.739 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.432 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 72.7 m-20 -102.29 145.54 29.31 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -88.06 141.42 28.58 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.167 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.24 -171.52 3.94 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 123.892 0.745 . . . . 0.0 109.056 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 m -131.69 143.86 50.58 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 173.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB2' ' NE2' ' A' ' 136' ' ' GLN . . . -135.22 160.92 36.86 Favored 'General case' 0 C--N 1.273 -2.733 0 O-C-N 123.514 0.509 . . . . 0.0 110.211 -174.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 mm -92.21 118.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -67.46 124.81 24.22 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 m -59.0 -26.42 64.5 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -84.49 -41.84 16.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.998 -173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -111.38 -17.47 13.12 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.864 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 4.74 89.9 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.105 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.62 160.18 15.13 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -76.71 129.02 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 O-C-N 124.002 0.814 . . . . 0.0 109.442 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -137.97 148.04 58.78 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.17 127.72 16.35 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.62 2.214 . . . . 0.0 110.895 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.51 38.33 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.752 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -112.16 147.48 36.04 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 62.6 mt -77.46 121.86 30.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 123.076 0.235 . . . . 0.0 110.368 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.65 13.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.1 p -160.63 145.14 14.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.692 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.417 HG21 HD22 ' A' ' 138' ' ' LEU . 97.8 mt -124.42 135.24 64.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 110.784 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -112.9 101.81 9.85 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.63 -24.97 65.51 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.72 0.295 . . . . 0.0 111.198 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.25 -37.09 66.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.304 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -86.81 -8.95 56.86 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.841 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 60.35 28.98 18.63 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 122.634 1.207 . . . . 0.0 109.184 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.8 p -126.33 162.39 25.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.852 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.651 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.7 p -148.33 152.16 36.6 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.261 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 99.4 t -95.37 130.96 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.9 m -118.3 145.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.9 t -110.7 118.38 57.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.553 ' CD2' HC22 ' A' 1148 ' ' DA2 . 96.6 m-85 -68.42 119.13 12.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.694 0.621 . . . . 0.0 110.568 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.6 m -63.6 131.01 46.66 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.756 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.0 -18.0 47.41 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.269 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -108.33 -37.57 5.96 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 122.395 -0.474 . . . . 0.0 111.747 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 13.52 76.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.623 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -85.59 151.97 23.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.488 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 7.5 ppt_? -135.66 137.26 41.64 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.193 0.308 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.0 pt-20 -153.62 158.69 41.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 20.6 tt0 -97.91 129.75 44.82 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.537 0.684 . . . . 0.0 111.353 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.521 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.1 mp0 -126.53 163.58 23.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 124.494 1.118 . . . . 0.0 109.755 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.8 m-80 -82.14 145.48 30.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 116' ' ' ILE . 76.5 mt -57.95 -36.35 72.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.742 0.782 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -77.58 -19.54 55.47 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.4 t70 -84.96 -30.91 23.87 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.844 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.651 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.9 mt -51.9 132.12 31.7 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.655 1.222 . . . . 0.0 111.918 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.39 164.16 12.07 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.953 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.3 t -63.3 138.53 97.37 Favored Pre-proline 0 C--N 1.308 -1.215 0 O-C-N 124.172 0.92 . . . . 0.0 109.07 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.61 173.34 14.67 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 122.872 2.382 . . . . 0.0 113.191 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 pt -112.36 157.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.814 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.0 m -66.0 135.71 55.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.91 0.756 . . . . 0.0 109.499 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.656 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.553 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 m -125.31 80.72 1.91 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.07 -26.83 7.91 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.214 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.9 3.2 46.52 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.568 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.5 p -82.85 3.85 27.91 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.604 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.68 22.24 2.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.695 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.01 127.52 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.085 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -97.07 124.62 41.12 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.434 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 92.6 m95 -122.32 160.01 26.23 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.029 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.8 ptpp? -131.25 162.48 29.91 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.6 t -63.74 128.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.64 13.64 37.25 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.918 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.6 m-20 -100.64 141.5 33.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -83.02 143.62 30.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.97 -169.48 3.27 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 m -132.59 145.98 51.54 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.37 161.2 36.94 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 123.781 0.676 . . . . 0.0 110.08 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.0 119.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.27 125.14 25.78 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -58.77 -24.59 61.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -85.0 -41.74 15.53 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.933 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -111.51 -17.86 12.97 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 118.733 -1.187 . . . . 0.0 111.187 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.26 89.73 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.181 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.19 162.29 14.08 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -77.58 129.79 37.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.856 0.723 . . . . 0.0 109.687 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -137.8 151.4 70.41 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 123.639 0.776 . . . . 0.0 109.137 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.96 128.62 14.25 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.11 149.46 36.58 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.976 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -111.51 147.5 35.22 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 64.4 mt -77.12 122.09 30.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.505 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.89 -33.11 12.33 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.735 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.7 m -160.58 148.73 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.428 HG21 HD22 ' A' ' 138' ' ' LEU . 93.2 mt -126.44 135.72 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.91 99.86 8.44 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -66.43 -23.94 66.38 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.079 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.24 -37.65 69.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.235 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -87.79 -8.9 55.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.994 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 30.4 tt0 61.03 24.74 14.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p -122.77 161.08 24.64 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.625 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.0 p -146.53 151.9 38.1 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.427 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.7 t -95.37 130.21 44.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.04 145.68 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.7 t -111.0 118.67 57.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.588 ' CD2' HC22 ' A' 1148 ' ' DA2 . 99.0 m-85 -69.07 118.67 12.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 123.718 0.636 . . . . 0.0 110.21 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 53.1 m -63.66 131.02 46.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.403 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.39 -26.56 10.08 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.896 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -96.84 -47.27 5.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.967 0.413 . . . . 0.0 110.616 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.8 60.1 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.363 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -82.76 152.1 25.86 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -139.03 136.31 35.16 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.169 0.293 . . . . 0.0 110.77 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.5 pt-20 -153.07 158.07 41.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -95.8 133.21 40.2 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.455 0.645 . . . . 0.0 112.077 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.415 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 8.5 mp0 -131.98 163.78 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 125.157 1.383 . . . . 0.0 109.967 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.4 m-80 -81.15 148.2 29.69 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.428 HD22 HG21 ' A' ' 116' ' ' ILE . 65.2 mt -59.21 -36.11 74.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.261 1.029 . . . . 0.0 108.933 175.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.3 m -75.53 -18.09 59.9 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.992 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -98.06 -7.29 30.03 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.379 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.625 HD12 ' SG ' ' A' ' 123' ' ' CYS . 63.7 mt -72.97 139.89 47.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.417 0.627 . . . . 0.0 111.042 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.9 166.06 11.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.781 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.3 t -64.84 137.83 97.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.0 171.47 11.2 Favored 'Trans proline' 0 CA--C 1.508 -0.808 0 C-N-CA 123.04 2.493 . . . . 0.0 112.969 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.6 pt -79.79 162.67 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.7 m -92.46 133.13 36.2 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--N 1.285 -2.215 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -179.096 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.588 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.2 m 65.39 76.24 0.33 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.776 0.672 . . . . 0.0 111.672 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 63.07 17.36 10.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.654 1.182 . . . . 0.0 112.283 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . -105.71 22.91 14.74 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.467 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 p -81.22 24.53 0.53 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 123.645 0.778 . . . . 0.0 111.712 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 87' ' ' ALA . 1.2 pp -114.41 15.87 17.87 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 124.265 1.026 . . . . 0.0 111.385 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 85.6 mm-40 -71.84 136.49 47.02 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -122.41 135.29 54.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.45 ' NE1' ' HB3' ' A' ' 90' ' ' GLN . 87.8 m95 -133.96 164.31 27.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 63.5 pttt -126.36 157.95 37.16 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.72 131.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 18.71 54.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.737 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 4.7 t0 -100.8 133.21 45.6 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -80.47 148.01 30.66 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.115 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.6 p -155.1 -168.76 2.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.981 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 m -131.71 145.29 51.55 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.06 160.79 37.23 Favored 'General case' 0 C--N 1.277 -2.585 0 O-C-N 123.569 0.543 . . . . 0.0 110.189 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.15 117.16 34.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.419 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 9.8 t90 -67.54 122.92 19.04 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -59.67 -23.57 63.2 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 24.9 mm-40 -84.83 -42.11 15.42 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -108.47 -18.45 13.74 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.69 6.93 89.07 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.679 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.8 m -94.42 161.91 14.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.19 128.26 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 O-C-N 123.904 0.753 . . . . 0.0 109.796 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.35 148.87 67.97 Favored Pre-proline 0 C--N 1.288 -2.104 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.665 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.16 129.94 15.78 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.404 2.07 . . . . 0.0 111.289 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.79 151.27 35.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.145 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.5 m -112.36 147.64 35.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.08 120.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.913 0.387 . . . . 0.0 111.133 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.59 -31.99 14.97 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.613 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.0 m -162.38 151.64 15.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.412 HG21 HD22 ' A' ' 138' ' ' LEU . 97.5 mt -127.6 135.87 62.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 122.712 0.405 . . . . 0.0 110.754 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.32 98.14 7.1 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -67.65 -23.84 65.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.017 0.437 . . . . 0.0 111.367 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -73.2 -36.4 66.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.473 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -90.61 -8.8 49.15 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 59.81 29.61 19.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.514 1.126 . . . . 0.0 108.645 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 72.0 p -122.06 162.18 21.67 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.869 -0.519 . . . . 0.0 110.088 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.706 ' SG ' HD12 ' A' ' 141' ' ' LEU . 5.6 p -148.69 153.74 38.66 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -97.37 130.44 46.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 26.6 m -119.06 146.02 24.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 90.6 t -109.69 118.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.591 ' CD2' HC23 ' A' 1148 ' ' DA2 . 98.2 m-85 -69.8 119.31 13.83 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 123.731 0.645 . . . . 0.0 110.811 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -61.66 131.74 50.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.32 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.64 -23.22 17.27 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.271 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -101.73 -46.83 4.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.24 6.65 61.34 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.865 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -80.09 151.57 29.79 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.6 ppt_? -135.77 136.84 41.07 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.55 158.79 41.76 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -94.7 132.22 39.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.655 0.74 . . . . 0.0 110.253 -176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -127.3 165.31 19.94 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 126.037 1.735 . . . . 0.0 108.484 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.6 m-80 -87.51 145.29 26.31 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.441 HD21 ' SG ' ' A' ' 123' ' ' CYS . 78.7 mt -58.02 -38.44 76.2 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -75.28 -22.69 57.58 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.75 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.6 m-20 -89.5 -12.86 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.299 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.706 HD12 ' SG ' ' A' ' 123' ' ' CYS . 67.2 mt -68.55 146.61 52.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.317 0.58 . . . . 0.0 110.733 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.43 165.19 13.25 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.1 t -64.51 139.08 97.64 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.167 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.24 173.17 12.67 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.198 2.598 . . . . 0.0 112.418 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.06 157.34 3.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.879 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 m -74.19 132.61 42.35 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--N 1.292 -1.93 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.793 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.591 HC23 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.51 -0.575 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.1 m -80.01 113.04 17.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.64 -59.99 3.1 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.506 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.61 147.56 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -130.38 22.95 5.16 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.895 0.855 . . . . 0.0 110.032 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.07 38.02 2.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.136 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -62.12 132.52 53.1 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.704 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -127.5 131.74 50.07 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -129.64 163.75 25.4 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.037 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.511 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -130.2 158.72 38.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.75 127.85 23.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.19 11.67 48.16 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.48 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.511 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 18.2 m-20 -92.76 135.67 33.91 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -81.9 146.1 29.99 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 p -159.58 -172.78 3.83 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.636 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.6 m -129.02 144.19 51.11 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.12 161.09 36.32 Favored 'General case' 0 C--N 1.278 -2.537 0 O-C-N 123.798 0.686 . . . . 0.0 110.412 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.28 116.74 34.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -67.21 121.17 15.07 Favored 'General case' 0 C--O 1.193 -1.881 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.492 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 20.6 t -64.2 -17.2 63.31 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.146 0.43 . . . . 0.0 111.752 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -83.28 -41.95 17.72 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.335 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -112.75 -17.76 12.47 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.881 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.43 3.89 90.36 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.115 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 81.2 m -93.63 162.95 13.74 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.8 mm -77.66 130.34 36.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.403 ' CG ' HC12 ' A' 1148 ' ' DA2 . 89.1 m-85 -139.77 151.52 66.08 Favored Pre-proline 0 C--N 1.303 -1.443 0 C-N-CA 123.455 0.702 . . . . 0.0 110.271 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.34 128.35 15.38 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.958 2.438 . . . . 0.0 111.789 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.57 149.67 31.98 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.121 0.486 . . . . 0.0 111.019 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 m -112.63 147.04 37.56 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 96' ' ' ASP . 67.6 mt -78.13 121.39 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.199 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.86 -35.7 13.22 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.578 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.1 m -159.52 149.78 18.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.424 HG21 HD22 ' A' ' 138' ' ' LEU . 94.5 mt -125.67 138.18 55.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.742 0.417 . . . . 0.0 110.777 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -112.97 98.32 7.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -65.27 -25.79 67.8 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.536 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -73.27 -38.6 65.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.214 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.45 -8.55 58.32 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.864 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 63.07 25.62 15.04 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 124.646 1.178 . . . . 0.0 108.772 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.2 p -124.76 163.99 20.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 111.072 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.695 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.8 p -148.63 153.41 38.28 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 122.693 0.397 . . . . 0.0 110.312 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.07 130.25 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.1 m -118.46 147.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.7 t -110.32 118.73 57.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.557 ' CD1' HC13 ' A' 1148 ' ' DA2 . 98.9 m-85 -69.45 116.92 10.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.825 0.703 . . . . 0.0 110.468 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -65.04 131.47 46.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.96 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.76 -20.48 38.7 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -104.51 -47.65 4.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.978 0.418 . . . . 0.0 110.447 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.53 18.41 41.75 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.991 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -91.05 155.62 18.54 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.4 ppt_? -134.95 136.5 42.31 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.514 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.492 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.7 pt-20 -153.96 158.55 40.82 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -95.39 132.85 39.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.71 0.767 . . . . 0.0 111.228 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -125.44 164.64 20.0 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 125.84 1.656 . . . . 0.0 109.61 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.1 m-80 -88.11 143.67 26.93 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 116' ' ' ILE . 84.5 mt -58.03 -36.28 72.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.357 0.598 . . . . 0.0 110.683 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.6 m -75.16 -23.71 57.81 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.856 0.863 . . . . 0.0 111.459 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 2.5 m-20 -91.06 -11.54 38.42 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.806 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.695 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.7 mt -68.71 142.11 55.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.03 163.85 14.61 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.3 t -63.17 143.43 97.65 Favored Pre-proline 0 C--O 1.252 1.189 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.38 160.79 12.88 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 123.499 2.799 . . . . 0.0 114.071 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.79 -173.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.343 -175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 61.0 m -57.37 139.1 53.98 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.8 0.688 . . . . 0.0 111.045 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--N 1.3 -1.55 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.605 -176.05 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.557 HC13 ' CD1' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.1 m -84.89 82.44 8.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 122.054 0.931 . . . . 0.0 110.118 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 177.87 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 29.43 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.136 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 m -83.73 2.51 37.52 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.851 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.71 4.55 24.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.915 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -83.56 141.77 31.35 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.96 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -132.18 121.78 24.24 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -116.47 160.66 20.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.639 -171.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.06 163.31 22.64 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.85 127.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.85 7.99 52.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.13 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.448 ' HB2' HD13 ' A' ' 113' ' ' ILE . 21.2 m-20 -91.35 135.42 33.83 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -74.44 146.4 42.88 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.368 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -160.04 -172.59 3.68 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.894 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.5 m -129.36 142.92 50.69 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.56 160.6 37.55 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.392 0.433 . . . . 0.0 110.699 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.41 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.0 t90 -65.61 119.53 11.3 Favored 'General case' 0 C--O 1.199 -1.585 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.499 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 6.4 t -66.95 -14.96 63.37 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.677 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.37 -42.39 17.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.602 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.41 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.8 t70 -109.49 -18.61 13.48 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.484 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.38 7.79 88.2 Favored Glycine 0 C--N 1.313 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.119 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.3 m -94.3 161.71 14.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.0 mm -79.14 129.33 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -137.52 150.85 69.73 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 127.84 14.98 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.566 2.178 . . . . 0.0 110.97 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.61 147.67 30.29 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.076 0.465 . . . . 0.0 110.465 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.4 m -112.53 147.16 37.19 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 96' ' ' ASP . 78.0 mt -75.47 126.21 35.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.919 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.41 12.13 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -159.34 148.32 18.18 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.439 HG21 HD22 ' A' ' 138' ' ' LEU . 87.0 mt -127.53 135.67 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.911 0.484 . . . . 0.0 110.025 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.09 96.36 5.99 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.15 -24.17 65.87 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.556 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -74.11 -34.08 63.81 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.69 -8.95 57.89 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.783 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 61.7 30.76 18.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.752 1.221 . . . . 0.0 108.624 -173.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 69.0 p -124.89 165.24 18.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.714 -0.616 . . . . 0.0 110.86 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' A' ' 141' ' ' LEU . 6.7 p -148.66 155.18 40.69 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.313 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.1 130.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -118.52 147.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.5 t -109.83 118.89 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.555 ' CD2' HC21 ' A' 1148 ' ' DA2 . 99.4 m-85 -70.59 119.97 15.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.638 0.586 . . . . 0.0 110.72 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.8 m -64.56 131.45 47.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.096 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.07 -22.78 30.06 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -105.54 -41.81 5.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.16 0.505 . . . . 0.0 111.14 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.94 81.31 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -77.63 154.67 32.0 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -135.97 138.02 41.87 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.499 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.0 pt-20 -154.02 159.3 41.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -94.18 133.63 37.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.991 0.9 . . . . 0.0 111.57 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -128.87 164.85 22.21 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 125.75 1.62 . . . . 0.0 108.989 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.8 m-80 -89.92 145.82 24.85 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 116' ' ' ILE . 79.5 mt -59.39 -34.79 72.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.394 0.616 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -25.41 54.95 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.519 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.2 m-20 -89.2 -13.28 38.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.139 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.736 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.2 mt -66.77 145.5 55.45 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.048 0.451 . . . . 0.0 110.754 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.93 160.96 18.23 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 t -67.53 145.71 98.39 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.33 170.39 9.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.828 2.352 . . . . 0.0 113.131 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.0 pt -103.93 175.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 35.3 t -84.3 144.33 28.94 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.863 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.051 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.555 HC21 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.501 -0.926 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.5 m 60.41 90.13 0.06 Allowed 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.247 1.019 . . . . 0.0 111.97 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.45 -19.28 39.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.136 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.4 38.94 0.95 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.652 0.381 . . . . 0.0 110.969 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 90' ' ' GLN . 18.6 p -69.79 -3.51 15.91 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.525 0.678 . . . . 0.0 112.091 -177.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.11 31.45 0.1 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.204 1.401 . . . . 0.0 112.483 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 88' ' ' SER . 32.8 mm-40 -66.26 138.53 57.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.304 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.37 139.0 49.24 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -125.73 161.5 27.18 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.48 0.181 . . . . 0.0 111.421 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.7 ptpp? -131.25 157.26 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.48 129.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.54 13.26 57.26 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.95 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.6 t0 -95.35 140.69 29.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -84.65 144.84 28.33 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -153.73 -170.06 3.47 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.1 m -130.81 141.25 50.33 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.94 160.62 37.14 Favored 'General case' 0 C--N 1.279 -2.458 0 O-C-N 123.624 0.578 . . . . 0.0 110.456 -174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.21 115.84 32.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 9.6 t90 -66.33 121.98 16.48 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 t -63.19 -21.65 66.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.301 0.572 . . . . 0.0 111.68 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.45 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 15.2 mm-40 -84.65 -33.36 23.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.416 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.4 t70 -117.04 -18.27 10.13 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.65 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.7 88.86 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.882 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.26 162.73 13.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.64 131.43 34.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.208 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.62 151.21 65.78 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.728 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.62 127.98 15.49 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 111.166 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.66 149.02 32.66 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.994 0.426 . . . . 0.0 109.971 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -111.92 147.81 35.05 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.0 mt -79.13 121.57 32.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.568 0.223 . . . . 0.0 111.069 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.95 -32.21 13.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.087 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 m -159.4 147.73 17.69 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 123' ' ' CYS . 89.7 mt -126.91 141.22 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.41 96.36 6.06 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 172.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -67.92 -24.02 65.15 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.761 0.315 . . . . 0.0 111.345 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.58 -39.31 64.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.293 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -90.63 -8.11 50.93 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.733 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 64.44 33.43 11.13 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.517 1.135 . . . . 0.0 109.245 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 81.5 p -123.79 164.83 18.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.935 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.703 ' SG ' HD12 ' A' ' 141' ' ' LEU . 6.3 p -149.91 157.28 43.01 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 123.013 0.525 . . . . 0.0 110.768 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.4 t -102.2 131.42 50.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.2 m -118.58 146.04 23.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 121.231 0.539 . . . . 0.0 109.831 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 92.3 t -111.09 118.61 57.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.598 ' CD2' HC22 ' A' 1148 ' ' DA2 . 97.8 m-85 -71.19 119.84 15.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.696 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 m -67.2 130.67 43.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.727 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.71 -16.52 59.99 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.009 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -111.97 -35.09 5.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.76 4.0 90.25 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.492 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -78.18 157.2 29.46 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -141.41 136.42 31.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.453 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.8 pt-20 -152.95 158.41 42.05 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 29.7 tt0 -95.51 137.39 34.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.123 0.487 . . . . 0.0 111.185 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.453 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -137.94 159.0 43.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 124.402 1.081 . . . . 0.0 109.699 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 30.8 m-80 -81.39 147.67 29.69 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 116' ' ' ILE . 81.7 mt -60.81 -36.07 78.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.094 0.473 . . . . 0.0 111.414 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 t -80.89 -16.27 54.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.045 0.45 . . . . 0.0 110.418 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.424 ' O ' HD13 ' A' ' 142' ' ' LEU . 27.9 t70 -79.82 -32.26 40.67 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.703 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.5 mt -56.92 141.11 46.33 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.7 1.25 . . . . 0.0 111.718 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 140' ' ' ASP . 4.7 mp -114.2 159.92 19.57 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.561 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.8 t -63.11 141.9 97.73 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.86 161.46 43.89 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.263 1.975 . . . . 0.0 113.274 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 pt -104.88 177.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.714 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 39.1 t -77.42 142.41 39.24 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 121.158 0.504 . . . . 0.0 109.812 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.379 -178.974 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.598 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 m -73.51 101.5 3.56 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.46 -33.15 1.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 90' ' ' GLN . . . -124.99 23.55 7.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.567 0.698 . . . . 0.0 111.158 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -87.66 9.86 20.02 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.449 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -107.89 7.23 27.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.391 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 87' ' ' ALA . 46.3 mt-30 -87.83 122.79 31.9 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.415 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.0 129.44 55.45 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.5 m95 -115.78 162.33 17.44 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.524 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.572 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.0 ptpp? -130.84 160.15 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.69 128.16 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.61 13.35 41.29 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.196 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.572 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 13.2 m-20 -98.03 135.29 39.94 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -78.41 145.49 35.1 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.407 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -157.04 -169.23 2.88 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.817 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 m -133.6 146.14 50.68 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.21 161.64 36.32 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.356 0.41 . . . . 0.0 110.183 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.16 118.71 38.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.482 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 10.3 t90 -68.17 127.52 33.22 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.556 0.535 . . . . 0.0 109.954 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 m -56.36 -30.85 63.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -85.18 -41.12 15.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.482 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.3 t70 -109.19 -17.15 13.92 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.1 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.22 4.81 84.52 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.968 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.5 m -93.58 162.46 13.95 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -78.48 126.88 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.868 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.18 148.39 64.34 Favored Pre-proline 0 C--N 1.283 -2.288 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.832 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.58 128.67 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.659 2.239 . . . . 0.0 111.259 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.98 152.47 41.1 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -112.24 147.81 35.45 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 96' ' ' ASP . 74.5 mt -79.28 118.03 25.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 123.221 0.326 . . . . 0.0 110.937 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.78 -30.49 15.46 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.76 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.1 m -161.47 145.64 13.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.419 HG21 HD22 ' A' ' 138' ' ' LEU . 87.7 mt -123.39 134.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 120.852 0.358 . . . . 0.0 110.125 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 11.3 t70 -111.89 96.85 6.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -65.86 -23.71 66.72 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.112 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -71.52 -40.67 69.97 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' OD1' ' A' ' 117' ' ' ASP . 93.2 mtt180 -82.58 -9.45 59.39 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.466 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 62.91 29.61 16.54 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.195 1.398 . . . . 0.0 108.135 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.8 p -131.08 168.47 17.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.106 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.741 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.3 p -148.79 155.46 40.98 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.502 0.321 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.8 t -95.86 130.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.55 145.52 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 89.5 t -109.73 118.62 57.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.573 ' CD2' HC21 ' A' 1148 ' ' DA2 . 96.9 m-85 -69.91 120.3 15.43 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 123.758 0.661 . . . . 0.0 111.576 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.462 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.42 -21.93 42.85 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.548 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -111.39 -43.14 3.74 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.612 0.244 . . . . 0.0 111.378 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 8.3 64.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.443 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.5 m-20 -80.39 153.33 28.38 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.76 -0.259 . . . . 0.0 110.419 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.0 ppt_? -137.69 135.24 36.29 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.057 0.456 . . . . 0.0 111.417 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.42 158.71 41.84 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.4 tt0 -94.44 135.11 36.23 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.174 0.511 . . . . 0.0 111.392 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.441 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -131.85 160.25 36.2 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.266 1.026 . . . . 0.0 110.478 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 26.1 m-80 -79.42 144.32 34.2 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.419 HD22 HG21 ' A' ' 116' ' ' ILE . 75.3 mt -62.4 -33.2 74.3 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.945 0.879 . . . . 0.0 110.376 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.9 t -80.04 -21.46 43.45 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.71 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 23.1 t70 -83.6 -32.79 25.56 Favored 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.741 HD12 ' SG ' ' A' ' 123' ' ' CYS . 69.0 mt -51.07 134.48 26.51 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 125.046 1.466 . . . . 0.0 111.902 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.31 161.96 14.53 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.6 m -63.03 146.87 95.31 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.51 174.34 7.52 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 113.661 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.08 160.92 5.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.784 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.9 m -83.44 127.69 33.91 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.359 -179.267 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.573 HC21 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m 61.94 77.57 0.32 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.732 0.813 . . . . 0.0 109.963 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.89 -42.75 63.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.312 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.44 112.31 16.12 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -98.32 13.67 30.66 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.409 0.623 . . . . 0.0 110.289 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -103.23 16.48 26.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.142 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -71.26 137.81 48.91 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -136.23 136.89 40.27 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -116.27 157.17 25.36 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.37 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.525 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.6 ptpp? -129.76 162.61 28.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.68 127.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.06 15.05 40.25 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.491 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 22.5 m-20 -98.0 136.78 37.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 117.133 0.466 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -77.47 145.07 37.3 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.48 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.7 p -156.18 -165.87 2.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.499 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 m -139.42 149.44 44.07 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' HB2' ' NE2' ' A' ' 136' ' ' GLN . . . -140.32 161.53 37.47 Favored 'General case' 0 C--N 1.278 -2.502 0 O-C-N 123.877 0.735 . . . . 0.0 110.078 -173.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.82 120.05 40.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.446 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 10.1 t90 -69.65 125.89 28.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -58.93 -25.04 63.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 21.0 mm-40 -84.87 -37.73 20.3 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -174.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -117.41 -18.22 9.89 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.982 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.6 86.95 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.212 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.2 m -92.93 160.19 15.0 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.85 126.12 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 C-N-CA 123.848 0.859 . . . . 0.0 109.016 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -134.58 149.51 71.11 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.18 128.09 17.89 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.914 2.409 . . . . 0.0 110.902 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.88 149.52 34.42 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.843 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.3 m -113.85 147.76 37.84 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.416 HD13 ' HB2' ' A' ' 96' ' ' ASP . 75.8 mt -76.89 126.23 37.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.63 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -33.1 11.24 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 m -161.33 149.57 15.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.42 HG21 HD22 ' A' ' 138' ' ' LEU . 87.3 mt -128.82 140.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.513 0.725 . . . . 0.0 109.966 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -113.04 98.87 7.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.03 -23.76 67.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.447 -174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -73.42 -40.52 64.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -87.8 -8.32 56.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.026 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 61.4 28.29 17.73 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.856 0.862 . . . . 0.0 108.793 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 68.9 p -122.02 159.56 26.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 121.7 -0.625 . . . . 0.0 110.55 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.645 ' SG ' HD12 ' A' ' 141' ' ' LEU . 7.4 p -148.22 152.37 37.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.654 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 59.4 t -95.99 130.56 44.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.5 m -118.06 145.77 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.1 t -111.53 118.55 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.6 ' CD2' HC22 ' A' 1148 ' ' DA2 . 96.7 m-85 -69.36 116.67 10.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 124.042 0.839 . . . . 0.0 110.503 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 m -62.93 131.13 47.69 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.072 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.79 -27.98 12.78 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -101.81 -42.97 5.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.938 0.399 . . . . 0.0 110.758 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.21 1.58 75.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -72.24 149.39 44.6 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.3 ppt_? -133.64 136.18 44.63 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.507 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.471 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 7.7 pt-20 -153.46 158.39 41.29 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.6 tt0 -95.95 134.53 38.84 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.471 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -134.05 157.51 45.93 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.374 1.069 . . . . 0.0 109.802 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 32.3 m-80 -79.43 147.26 32.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 116' ' ' ILE . 77.8 mt -58.28 -34.32 70.39 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.674 0.75 . . . . 0.0 110.078 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -76.59 -24.65 53.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.199 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.23 -12.87 45.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.176 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.645 HD12 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -70.29 143.09 52.17 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 123.479 0.487 . . . . 0.0 111.41 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.31 160.67 18.82 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.617 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -63.15 140.88 97.73 Favored Pre-proline 0 N--CA 1.401 -2.89 0 C-N-CA 124.602 1.161 . . . . 0.0 110.327 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.39 179.18 5.76 Favored 'Trans proline' 0 C--O 1.252 1.197 0 C-N-CA 122.714 2.276 . . . . 0.0 112.807 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.3 pt -124.27 173.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.451 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.22 132.9 35.23 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.649 0.738 . . . . 0.0 109.022 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 C--N 1.272 -2.769 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.666 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1148 ' ' DA2 . . . . . 0.6 HC22 ' CD2' ' A' ' 127' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.436 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 . . . . . 0 C--O 1.243 0.712 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 25.4 pttm -131.15 154.32 48.48 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.97 135.56 27.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.139 0.576 . . . . 0.0 110.156 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.67 11.92 57.48 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.006 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 3.4 m-20 -99.68 143.56 29.78 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.871 0.367 . . . . 0.0 110.364 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.15 144.72 30.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.16 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.436 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.0 p -159.31 -169.89 2.78 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.6 m -132.95 146.05 51.44 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 160.94 37.23 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.722 0.639 . . . . 0.0 111.107 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.1 mm -91.92 117.1 34.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -67.96 126.99 31.21 Favored 'General case' 0 C--O 1.203 -1.357 0 O-C-N 123.571 0.544 . . . . 0.0 109.694 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -57.92 -28.65 64.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.46 -41.22 16.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -109.6 -17.75 13.65 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.702 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.87 7.5 88.46 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.625 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.59 161.76 14.23 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -77.35 127.77 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.713 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.02 151.24 73.38 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 123.453 0.701 . . . . 0.0 109.313 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.77 129.98 18.52 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.521 2.147 . . . . 0.0 111.685 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -148.37 151.96 36.2 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 120.889 0.376 . . . . 0.0 110.539 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.0 m -114.1 148.11 37.67 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -75.01 124.48 32.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -96.48 -36.62 10.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.5 p -159.19 149.56 19.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.627 HG23 HD21 ' A' ' 138' ' ' LEU . 98.2 mt -126.39 129.11 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 12.1 t70 -112.77 101.63 9.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 173.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -67.25 -24.23 65.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.89 -38.64 64.32 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 122' ' ' THR . 98.0 mtt180 -81.59 -9.48 59.67 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 61.56 25.26 15.22 Favored 'General case' 0 C--O 1.252 1.234 0 C-N-CA 125.274 1.429 . . . . 0.0 108.469 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 120' ' ' ARG . 68.1 p -129.38 168.82 15.72 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.435 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.691 ' SG ' HD11 ' A' ' 141' ' ' LEU . 5.7 p -148.5 151.27 34.85 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 65.9 t -96.31 132.64 40.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.9 m -119.6 149.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 133' ' ' ARG . 96.7 t -111.09 118.51 57.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.19 118.12 11.68 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.827 0.705 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 m -65.32 131.37 46.29 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.38 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.89 -19.42 53.08 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -111.74 -44.96 3.4 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.705 0.288 . . . . 0.0 111.511 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.33 0.98 67.02 Favored Glycine 0 C--N 1.311 -0.809 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.876 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -73.69 152.37 40.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.3 ppt_? -137.94 135.74 36.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 120.773 0.321 . . . . 0.0 110.864 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -151.94 159.53 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.7 tt0 -93.8 131.63 38.99 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.099 0.952 . . . . 0.0 111.105 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 125' ' ' VAL . 7.5 mp0 -123.39 165.07 17.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 125.572 1.549 . . . . 0.0 109.629 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 35.7 m-80 -89.72 142.92 27.24 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.627 HD21 HG23 ' A' ' 116' ' ' ILE . 63.4 mt -58.79 -36.64 74.77 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.43 0.692 . . . . 0.0 110.682 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 t -79.55 -16.63 55.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.477 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 4.1 t70 -89.62 -28.05 19.78 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.73 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.691 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.8 mt -54.87 134.81 48.4 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.983 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.71 167.03 10.45 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.479 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.316 -0.89 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.058 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-O 120.95 0.405 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -130.96 159.34 37.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.08 132.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.49 10.55 57.98 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.834 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.13 141.3 29.68 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -81.15 144.09 31.92 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.37 0.605 . . . . 0.0 110.985 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -156.65 -171.57 3.73 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.16 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 142.21 50.82 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.6 160.62 37.92 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 123.493 0.496 . . . . 0.0 110.002 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.76 117.11 35.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 8.8 t90 -64.74 121.14 13.84 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.553 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 27.7 t -58.3 -24.38 59.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -83.25 -42.07 17.63 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.14 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.429 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.9 t70 -111.5 -18.04 12.94 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.563 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 7.09 88.88 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.663 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.0 m -92.94 158.4 15.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mm -77.87 130.78 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.774 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -138.67 148.73 59.71 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.94 127.46 12.95 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.115 1.877 . . . . 0.0 111.024 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.89 150.41 38.37 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.391 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.1 m -111.84 147.61 35.38 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.0 mt -76.13 124.89 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.631 0.253 . . . . 0.0 110.818 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.19 12.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.872 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -160.8 152.54 19.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.575 HG23 HD21 ' A' ' 138' ' ' LEU . 82.0 mt -132.48 139.89 48.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 122.979 0.512 . . . . 0.0 110.817 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -111.91 97.48 6.71 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -68.19 -23.9 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.04 -39.14 63.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.774 0.321 . . . . 0.0 110.977 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.75 -7.56 56.04 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.251 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 63.07 33.74 14.37 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.303 1.002 . . . . 0.0 108.84 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 53.8 p -123.62 161.75 24.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 110.402 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.713 ' SG ' HD11 ' A' ' 141' ' ' LEU . 4.6 p -149.43 151.91 34.81 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.5 t -96.32 130.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.0 m -118.69 145.94 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.4 t -112.4 118.6 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.82 118.84 14.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 123.802 0.689 . . . . 0.0 110.911 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.2 m -63.63 131.56 48.37 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.716 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.18 -29.85 8.9 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.824 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.92 -40.64 6.8 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.702 0.287 . . . . 0.0 111.321 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.54 74.79 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.078 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -80.37 153.87 28.08 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.1 ppt_? -136.0 137.9 41.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 6.8 pt-20 -154.23 158.92 40.98 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.8 tt0 -99.37 132.22 44.85 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.519 0.676 . . . . 0.0 111.526 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.529 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -132.2 163.46 28.52 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.653 1.181 . . . . 0.0 109.681 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 24.7 m-80 -85.06 146.7 27.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.575 HD21 HG23 ' A' ' 116' ' ' ILE . 84.3 mt -57.21 -35.57 69.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.738 0.78 . . . . 0.0 111.177 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.4 m -80.08 -20.28 45.5 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.097 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -13.89 39.86 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.713 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.8 mt -71.68 145.14 49.06 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.625 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -114.98 159.5 20.67 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.39 -3.434 0 C-N-CA 123.755 0.822 . . . . 0.0 108.953 178.25 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.7 m95 . . . . . 0 N--CA 1.423 -1.816 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.7 ptpp? -131.21 161.34 32.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.7 t -63.84 127.71 24.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.89 13.91 38.57 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.15 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.555 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 28.2 m-20 -96.82 142.46 28.8 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -152.72 -170.58 3.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 143.55 51.22 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -135.39 160.4 38.55 Favored 'General case' 0 C--N 1.278 -2.529 0 O-C-N 123.644 0.59 . . . . 0.0 110.005 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 mm -92.36 116.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -64.8 126.62 28.53 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 123.601 0.563 . . . . 0.0 109.904 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.1 m -58.27 -28.16 64.69 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.4 -41.82 15.09 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.077 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.91 -17.83 13.53 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.722 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.88 90.0 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.736 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.91 161.99 14.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.55 130.47 36.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.425 0.69 . . . . 0.0 109.657 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -139.29 151.0 66.28 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.679 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.7 127.78 14.3 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.664 2.242 . . . . 0.0 111.028 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.36 150.82 36.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 120.914 0.387 . . . . 0.0 110.557 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -111.88 147.59 35.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 96' ' ' ASP . 69.3 mt -79.35 121.8 33.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.781 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.42 -35.32 12.39 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.785 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -159.14 144.65 16.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.601 HG23 HD21 ' A' ' 138' ' ' LEU . 99.0 mt -122.13 134.78 64.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.399 0.28 . . . . 0.0 110.416 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -113.13 96.64 6.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -64.39 -25.83 68.19 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -69.16 -37.35 78.16 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.03 -7.24 52.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.464 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 62.59 25.11 14.96 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 108.558 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 71.5 p -122.82 161.96 23.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.546 -0.721 . . . . 0.0 111.422 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.691 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.6 p -148.03 153.18 38.61 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 78.9 t -96.26 130.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.4 m -119.22 145.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-O 121.171 0.51 . . . . 0.0 109.88 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.0 t -110.41 118.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.543 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -71.73 117.95 13.95 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -65.85 131.82 47.18 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.48 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.61 -17.16 55.9 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.69 -39.95 4.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.893 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.68 23.58 57.73 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.821 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -95.28 153.27 17.75 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.0 ppt_? -137.94 135.7 36.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.679 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.34 159.16 41.04 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -94.83 133.22 38.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.468 0.651 . . . . 0.0 111.855 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.496 ' NE2' ' HB1' ' A' ' 100' ' ' ALA . 5.7 mp0 -131.78 163.66 27.73 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.84 1.256 . . . . 0.0 110.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 26.8 m-80 -85.51 146.86 26.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.601 HD21 HG23 ' A' ' 116' ' ' ILE . 67.0 mt -59.22 -37.4 77.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.548 0.69 . . . . 0.0 109.964 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.8 m -74.4 -22.14 59.31 Favored 'General case' 0 N--CA 1.405 -2.711 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.433 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 m-20 -91.32 -13.46 32.53 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.691 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.0 mt -71.19 144.13 50.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.089 0.471 . . . . 0.0 110.676 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.2 165.52 12.84 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.8 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.31 -1.123 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.833 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.47 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 95.4 m95 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 110.852 -0.055 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 64.5 pttt -131.45 159.97 36.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 16.29 68.42 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.586 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 6.8 t0 -100.08 136.15 40.43 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -85.04 141.86 29.98 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.47 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -150.14 -167.87 2.95 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -130.13 143.61 50.88 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.58 160.56 38.1 Favored 'General case' 0 C--N 1.281 -2.408 0 O-C-N 123.439 0.462 . . . . 0.0 110.101 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.29 117.88 36.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -67.02 122.46 17.82 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 11.1 t -65.31 -16.26 63.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 118.052 0.387 . . . . 0.0 111.804 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -85.3 -38.44 18.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -115.16 -18.33 11.18 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.408 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 6.29 88.73 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.022 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.62 162.51 13.92 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.69 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.42 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.35 150.87 73.71 Favored Pre-proline 0 C--N 1.284 -2.244 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.358 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.15 127.46 13.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.988 1.792 . . . . 0.0 110.861 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.09 35.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 m -112.21 148.19 34.62 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 96' ' ' ASP . 71.3 mt -77.18 121.63 30.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.857 0.36 . . . . 0.0 110.995 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -90.35 -39.76 12.5 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.2 m -158.5 149.8 20.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.585 HG23 HD21 ' A' ' 138' ' ' LEU . 95.3 mt -125.11 136.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.98 0.419 . . . . 0.0 110.494 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -112.11 99.29 7.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.95 -23.46 65.06 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.894 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.17 -36.36 66.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.954 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.33 -8.91 54.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.485 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 59.98 28.69 18.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.209 1.004 . . . . 0.0 109.0 -172.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 76.1 p -122.84 162.86 21.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 121.405 -0.81 . . . . 0.0 110.671 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.5 p -148.69 152.35 36.51 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 122.617 0.367 . . . . 0.0 110.521 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.9 t -95.31 131.12 42.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.1 m -118.43 145.65 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 91.4 t -111.49 118.67 58.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -69.14 121.9 17.7 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 123.734 0.646 . . . . 0.0 110.887 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.4 m -62.8 131.21 48.09 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.389 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.09 18.22 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.4 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.86 -42.14 5.94 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 122.508 -0.407 . . . . 0.0 111.566 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.35 61.99 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.822 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -89.4 152.66 21.38 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.8 ppt_? -133.98 140.22 46.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.554 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.3 pt-20 -153.68 158.04 40.46 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 21.9 tt0 -98.21 129.75 44.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.554 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.4 mp0 -126.56 163.16 24.03 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 124.333 1.053 . . . . 0.0 109.676 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.3 m-80 -82.88 146.98 28.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.585 HD21 HG23 ' A' ' 116' ' ' ILE . 57.3 mt -60.76 -34.34 74.31 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.316 1.055 . . . . 0.0 109.251 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.5 t -80.11 -8.33 59.35 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.088 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -104.89 -15.67 15.09 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.529 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.657 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.2 mt -66.37 146.82 54.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.205 0.526 . . . . 0.0 111.166 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.29 161.76 18.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.709 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.396 -3.132 0 C-N-CA 124.548 1.139 . . . . 0.0 110.303 -179.196 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 85.8 m95 . . . . . 0 C--O 1.248 1.01 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.599 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -131.17 162.87 28.97 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.85 132.32 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.91 12.47 56.56 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.275 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 75.4 m-20 -97.26 149.42 22.07 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.402 0.62 . . . . 0.0 109.839 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -86.89 139.81 30.27 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.275 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -155.96 -172.38 4.09 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.114 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -131.2 146.89 52.5 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.18 37.42 Favored 'General case' 0 C--N 1.274 -2.701 0 O-C-N 123.69 0.619 . . . . 0.0 109.791 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.93 118.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -65.87 120.55 13.26 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.628 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 9.0 t -61.55 -19.58 62.31 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.065 0.228 . . . . 0.0 111.324 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.97 -42.07 15.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.85 -17.91 12.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.075 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.62 89.16 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.108 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.16 161.46 14.41 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.17 130.53 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.94 150.28 64.69 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 132.26 24.32 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.326 2.017 . . . . 0.0 111.156 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.5 149.65 32.02 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.024 0.44 . . . . 0.0 110.208 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -111.53 147.26 35.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.55 125.69 36.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.5 -35.43 10.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.02 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.2 m -158.65 148.04 19.15 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 138' ' ' LEU . 88.7 mt -125.98 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 122.64 0.376 . . . . 0.0 110.051 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.95 98.81 7.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -24.03 66.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.288 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.77 -37.41 67.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.694 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.88 -8.87 57.77 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.376 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.01 28.87 18.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.534 1.134 . . . . 0.0 108.432 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 70.2 p -125.2 160.73 28.49 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.685 -0.634 . . . . 0.0 110.492 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.2 p -148.19 153.73 39.17 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 122.704 0.402 . . . . 0.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.5 t -95.52 130.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.51 145.72 24.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.0 t -111.36 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -68.79 117.73 10.85 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.849 0.718 . . . . 0.0 111.111 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 m -60.77 131.14 49.74 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.531 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.62 -28.28 7.84 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.987 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -101.01 -42.9 6.22 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 122.508 -0.407 . . . . 0.0 111.494 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.52 14.6 63.33 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.422 -0.895 . . . . 0.0 111.891 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -86.78 151.35 23.45 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.92 135.77 39.92 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 123.131 0.269 . . . . 0.0 111.129 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.628 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.7 pt-20 -153.69 158.16 40.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.0 tt0 -96.35 131.4 42.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.482 0.658 . . . . 0.0 111.689 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.536 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.2 mp0 -128.16 163.64 24.23 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 125.27 1.428 . . . . 0.0 109.763 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 29.2 m-80 -82.67 147.55 28.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 116' ' ' ILE . 72.7 mt -59.37 -35.99 74.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.878 0.847 . . . . 0.0 110.06 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.0 m -76.82 -19.52 57.44 Favored 'General case' 0 N--CA 1.405 -2.69 0 C-N-CA 124.164 0.986 . . . . 0.0 111.63 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -93.25 -10.06 36.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.049 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -72.37 147.36 46.32 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.529 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.62 163.18 18.43 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.308 -1.204 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.927 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.428 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.1 m95 . . . . . 0 C--O 1.255 1.36 0 CA-C-O 120.56 0.219 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.8 pttm -131.98 160.82 34.72 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.57 129.21 26.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 13.97 39.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.591 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HB2' HD12 ' A' ' 113' ' ' ILE . 71.6 m-20 -97.91 141.03 31.4 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -84.48 144.99 28.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.428 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.01 -169.37 3.05 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -130.35 144.21 51.25 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -136.55 161.0 37.08 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.116 0.26 . . . . 0.0 110.431 -175.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -92.37 119.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.46 125.77 27.52 Favored 'General case' 0 C--O 1.205 -1.254 0 O-C-N 123.436 0.46 . . . . 0.0 109.795 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -57.96 -26.79 62.76 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -84.73 -41.83 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.248 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.89 -17.35 12.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.914 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.28 90.19 Favored Glycine 0 C--O 1.222 -0.644 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.177 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.9 m -93.15 162.05 14.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.9 mm -78.39 131.05 35.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.123 0.969 . . . . 0.0 109.605 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -140.26 151.42 64.44 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.636 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 129.7 16.76 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.433 2.088 . . . . 0.0 111.209 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.32 150.48 35.82 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.991 0.424 . . . . 0.0 110.661 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.9 m -111.94 147.58 35.56 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' A' ' 96' ' ' ASP . 75.5 mt -77.6 120.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -93.41 -33.84 13.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.836 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.8 m -162.05 146.82 12.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.538 HG23 HD21 ' A' ' 138' ' ' LEU . 84.4 mt -121.54 138.6 51.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.79 96.05 5.75 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -65.2 -24.04 67.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.359 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.06 -39.99 71.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.396 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -85.6 -9.02 57.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 61.54 30.72 18.85 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.877 1.271 . . . . 0.0 109.141 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.9 p -129.2 165.33 21.55 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.91 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -148.71 153.67 38.55 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 122.4 0.28 . . . . 0.0 110.965 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 46.9 t -95.92 130.1 45.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.94 146.06 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.661 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 114' ' ' ALA . 90.8 t -110.4 118.84 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -69.59 118.31 12.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.752 0.658 . . . . 0.0 110.96 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 m -64.94 130.93 45.23 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.53 -19.59 43.27 Favored Glycine 0 N--CA 1.428 -1.836 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.22 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -107.68 -43.37 4.51 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.808 0.337 . . . . 0.0 111.659 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.19 8.41 66.62 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.092 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -81.3 152.76 27.41 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.5 OUTLIER -139.47 136.42 34.57 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.932 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.553 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.36 158.48 41.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -94.6 133.84 37.81 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.351 0.596 . . . . 0.0 111.475 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.553 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.3 mp0 -128.88 163.29 25.59 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 124.832 1.253 . . . . 0.0 110.376 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -81.24 148.47 29.46 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 116' ' ' ILE . 57.5 mt -62.61 -31.0 71.77 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.442 0.639 . . . . 0.0 110.763 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.2 t -80.29 -25.39 39.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.378 0.609 . . . . 0.0 109.758 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 142' ' ' LEU . 32.6 t70 -74.77 -31.25 61.71 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.568 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.76 HD11 ' SG ' ' A' ' 123' ' ' CYS . 54.1 mt -58.54 134.14 56.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.39 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 140' ' ' ASP . 5.1 mp -109.51 159.41 17.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.173 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.392 -3.332 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.59 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.416 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.0 m95 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.5 pttm -130.83 159.28 37.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.67 128.38 25.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.03 7.32 52.86 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.153 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.508 ' HB2' HD12 ' A' ' 113' ' ' ILE . 60.5 m-20 -91.13 137.17 32.57 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -80.71 141.11 35.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.416 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -154.14 -166.27 2.32 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 m -131.32 146.95 52.51 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.07 161.92 36.71 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 122.98 0.175 . . . . 0.0 110.687 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.5 mm -91.12 116.04 31.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 123.819 0.7 . . . . 0.0 109.814 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -65.74 119.39 11.11 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 t -65.79 -14.95 62.36 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 118.205 0.457 . . . . 0.0 112.013 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.19 -41.84 19.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.69 -0.404 . . . . 0.0 112.028 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.94 -16.99 12.58 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.26 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.0 8.5 87.59 Favored Glycine 0 C--N 1.307 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.705 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.7 m -93.83 160.61 14.67 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.427 HD12 HD22 ' A' ' 142' ' ' LEU . 26.4 mm -77.17 129.64 37.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.888 0.875 . . . . 0.0 109.553 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -138.6 150.08 64.77 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 123.087 0.555 . . . . 0.0 109.966 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.06 128.3 14.67 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.556 2.171 . . . . 0.0 110.8 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.66 150.4 34.29 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.422 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.0 m -111.51 147.82 34.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 96' ' ' ASP . 62.5 mt -78.06 121.91 31.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.456 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -95.12 -32.6 13.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -159.05 148.65 18.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.568 HG23 HD21 ' A' ' 138' ' ' LEU . 91.2 mt -129.05 139.68 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 122.893 0.477 . . . . 0.0 109.977 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.68 99.1 7.89 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.55 -24.04 65.48 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.085 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -73.97 -41.61 61.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.636 0.255 . . . . 0.0 110.749 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -86.64 -8.89 57.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.029 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 61.56 32.85 18.59 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.327 1.017 . . . . 0.0 108.671 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 59.2 p -122.96 159.68 27.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.85 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.1 p -149.02 152.61 36.57 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 122.776 0.43 . . . . 0.0 111.039 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.3 t -96.37 131.22 43.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.8 m -119.45 145.3 25.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 133' ' ' ARG . 59.5 t -110.18 118.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -72.41 116.91 13.43 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 123.698 0.624 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.7 m -63.76 131.61 48.38 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.24 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.19 -22.08 36.68 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.988 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.23 -40.07 5.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.38 78.51 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.065 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -73.92 149.26 41.53 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.94 135.82 39.92 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -152.58 158.13 42.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.6 tt0 -93.71 132.7 37.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.307 0.575 . . . . 0.0 110.923 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.55 163.67 28.88 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 125.097 1.359 . . . . 0.0 107.396 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 34.4 m-80 -83.74 151.42 25.24 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 116' ' ' ILE . 75.5 mt -62.26 -36.32 81.66 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.07 0.938 . . . . 0.0 108.963 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -33.16 74.46 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -15.56 45.45 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.439 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.627 HD11 ' SG ' ' A' ' 123' ' ' CYS . 58.9 mt -65.13 146.98 54.27 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.14 0.495 . . . . 0.0 111.862 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 108' ' ' ILE . 5.3 mp -117.84 161.16 20.18 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.405 -2.725 0 C-N-CA 124.443 1.097 . . . . 0.0 110.568 -178.972 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 79.5 m95 . . . . . 0 N--CA 1.438 -1.043 0 CA-C-O 120.627 0.251 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.536 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.9 ptpp? -128.88 155.95 44.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -63.65 127.47 24.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.7 33.09 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.69 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 29.2 m-20 -96.2 141.3 29.73 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -82.14 143.51 31.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.445 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 27.0 p -155.23 -170.47 3.48 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 m -131.4 142.9 50.12 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.65 160.46 38.04 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.093 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.47 120.23 41.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -67.15 126.1 28.12 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.6 m -58.77 -27.16 64.72 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -85.21 -41.86 15.23 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.51 -16.36 13.68 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.318 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.77 89.89 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.06 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.5 160.47 15.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mm -78.44 128.28 38.4 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.347 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -136.14 151.24 73.18 Favored Pre-proline 0 C--N 1.287 -2.145 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.66 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.88 127.9 15.15 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.411 2.074 . . . . 0.0 110.797 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.05 150.17 36.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 120.849 0.356 . . . . 0.0 110.29 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -112.04 147.83 35.17 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 96' ' ' ASP . 70.9 mt -81.35 118.91 29.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-O 120.831 0.348 . . . . 0.0 110.746 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.87 15.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.077 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.6 m -161.43 146.62 13.67 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.566 HG23 HD21 ' A' ' 138' ' ' LEU . 94.3 mt -128.64 135.97 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 122.843 0.457 . . . . 0.0 110.534 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.59 102.7 10.76 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.67 -26.09 66.03 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.041 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -70.14 -40.42 74.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.304 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.45 -8.8 58.18 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.021 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 60.36 27.57 17.16 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.23 1.014 . . . . 0.0 109.12 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -124.85 160.17 29.4 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 121.143 -0.973 . . . . 0.0 110.871 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.712 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.4 p -148.3 153.83 39.19 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 50.7 t -95.91 130.42 44.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 86.4 t -111.57 119.05 59.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -70.42 120.24 15.77 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.539 0.685 . . . . 0.0 111.068 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.1 m -64.59 132.09 48.82 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.156 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.68 -20.9 32.48 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.051 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -106.82 -50.3 3.14 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.914 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.05 3.42 59.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.489 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.4 154.49 34.81 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.7 ppt_? -137.12 139.35 41.15 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.564 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.6 pt-20 -153.51 158.28 41.07 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.9 tt0 -97.72 129.69 44.75 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.564 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 5.9 mp0 -127.5 163.48 24.02 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 124.298 1.039 . . . . 0.0 110.037 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -82.14 148.4 28.53 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 116' ' ' ILE . 67.8 mt -61.15 -31.62 71.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.084 0.945 . . . . 0.0 109.659 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.2 m -78.19 -24.09 47.28 Favored 'General case' 0 N--CA 1.392 -3.328 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.422 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.82 -32.29 31.32 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.386 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.712 HD11 ' SG ' ' A' ' 123' ' ' CYS . 54.7 mt -56.01 141.55 39.44 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 124.587 1.179 . . . . 0.0 111.689 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.79 162.32 16.46 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.485 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.639 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.463 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 24.6 pttm -131.77 161.59 32.53 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.29 130.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.17 23.3 38.22 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.986 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.2 t0 -101.43 139.91 36.44 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -83.3 141.57 31.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.38 -170.95 3.52 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -129.6 141.89 50.86 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -132.29 160.66 35.57 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.253 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mm -91.99 116.88 34.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -65.7 125.51 25.5 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -30.81 63.49 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 123.539 0.736 . . . . 0.0 112.821 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -85.2 -40.7 16.38 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.33 -17.81 13.91 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.383 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.69 89.95 Favored Glycine 0 CA--C 1.507 -0.449 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.035 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 95.0 m -93.55 162.77 13.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.74 128.47 37.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.682 0.614 . . . . 0.0 109.536 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -136.3 151.41 73.23 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.86 128.02 14.48 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.185 1.923 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.85 146.36 27.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.098 0.475 . . . . 0.0 110.108 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.5 m -111.84 147.95 34.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 67.8 mt -75.87 123.53 32.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.581 0.229 . . . . 0.0 110.651 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -96.9 -32.47 12.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.2 m -160.96 146.54 14.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.582 HG23 HD21 ' A' ' 138' ' ' LEU . 98.1 mt -124.47 135.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 0.0 111.049 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.16 100.9 8.94 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -67.78 -24.16 65.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.342 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.88 -37.43 70.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.879 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -87.86 -8.71 55.48 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.294 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 61.08 30.05 19.25 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.171 0.988 . . . . 0.0 108.435 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 78.2 p -126.16 163.66 22.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.635 -0.666 . . . . 0.0 111.407 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.747 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.4 p -148.74 153.32 38.03 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.1 0.56 . . . . 0.0 110.455 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.4 t -95.34 130.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.9 m -118.89 145.54 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.4 t -109.95 118.87 57.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -71.58 121.2 18.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.801 0.688 . . . . 0.0 110.565 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -62.09 130.98 48.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.536 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.62 -16.59 39.83 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.538 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -104.56 -43.39 5.17 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.155 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.01 12.29 63.87 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.77 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.7 m-20 -85.28 151.64 23.9 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -137.72 135.26 36.25 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 15.1 pt-20 -154.06 158.03 39.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 19.5 tt0 -99.75 127.52 45.89 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.491 0.663 . . . . 0.0 111.796 -172.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.465 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 3.4 mp0 -123.04 163.68 20.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.985 1.314 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.0 m-80 -84.69 146.52 27.4 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.582 HD21 HG23 ' A' ' 116' ' ' ILE . 58.8 mt -59.5 -32.69 70.51 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.215 1.007 . . . . 0.0 109.063 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -75.25 -22.54 57.77 Favored 'General case' 0 N--CA 1.394 -3.254 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.708 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 t70 -93.29 -19.35 21.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.747 HD11 ' SG ' ' A' ' 123' ' ' CYS . 78.1 mt -61.34 141.22 57.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.919 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.61 162.94 16.11 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.822 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--N 1.314 -0.952 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.449 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 89.6 m95 . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.554 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.1 ptpp? -130.89 161.27 32.22 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.6 t -63.55 128.17 25.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.26 8.05 48.01 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.612 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.554 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.3 m-20 -97.1 150.01 21.32 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HD2' HG23 ' A' ' 112' ' ' THR . 27.1 mmmt -91.35 140.55 29.66 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.575 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.449 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.9 p -152.65 -169.38 3.32 Favored 'General case' 0 C--N 1.262 -3.228 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.852 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 m -130.77 146.09 52.13 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.07 160.48 38.5 Favored 'General case' 0 C--N 1.275 -2.66 0 O-C-N 123.83 0.706 . . . . 0.0 109.665 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mm -91.54 120.38 40.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.563 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 11.4 t90 -69.28 127.29 32.52 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 123.497 0.498 . . . . 0.0 109.955 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.9 m -57.79 -28.54 64.11 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.96 -42.81 14.59 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.58 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.419 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.6 t70 -107.03 -18.62 13.86 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.028 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.47 6.36 88.03 Favored Glycine 0 C--O 1.222 -0.615 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.793 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.83 163.0 13.69 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.2 mm -77.94 130.23 36.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.199 0.6 . . . . 0.0 109.385 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -137.79 149.35 64.24 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.304 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.49 128.65 14.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.268 1.979 . . . . 0.0 110.777 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.431 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.41 153.02 41.49 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.207 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 97' ' ' LYS . 4.4 m -112.08 147.42 36.08 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.01 121.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 120.856 0.36 . . . . 0.0 110.604 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.83 -39.42 11.21 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -159.46 148.57 18.14 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.634 HG23 HD21 ' A' ' 138' ' ' LEU . 90.8 mt -126.13 134.73 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.281 0.363 . . . . 0.0 111.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -112.33 99.7 8.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -64.69 -28.18 69.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.325 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.7 -39.65 64.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.188 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 122' ' ' THR . 93.3 mtt180 -81.23 -8.59 59.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.042 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 62.02 26.41 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.938 1.295 . . . . 0.0 109.055 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 120' ' ' ARG . 82.1 p -125.65 161.73 26.6 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 121.481 -0.762 . . . . 0.0 111.055 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.6 p -147.78 152.33 37.53 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 66.5 t -96.07 131.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.7 m -119.34 148.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 87.9 t -109.61 118.43 56.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 102' ' ' TRP . 94.7 m-85 -71.34 120.84 17.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 109.496 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.2 m -66.27 131.99 47.39 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.548 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.36 40.42 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.042 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.8 -43.49 4.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.015 0.436 . . . . 0.0 111.415 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.2 2.46 64.09 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.201 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.0 m-20 -74.92 150.11 39.22 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.3 ppt_? -135.12 135.42 41.14 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.5 159.62 41.09 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 22.3 tt0 -93.77 136.43 34.05 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 121.865 0.84 . . . . 0.0 110.824 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -129.46 165.55 21.39 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 126.224 1.81 . . . . 0.0 108.772 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 31.2 m-80 -89.4 147.82 23.83 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.634 HD21 HG23 ' A' ' 116' ' ' ILE . 74.7 mt -61.11 -34.14 74.48 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.758 0.79 . . . . 0.0 110.296 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -71.62 -29.99 65.29 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.656 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.53 -14.55 45.54 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.643 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.7 mt -67.74 147.45 52.6 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.259 0.552 . . . . 0.0 111.074 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.82 163.39 19.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.096 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 93.4 m95 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 120.727 0.298 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 47.4 pttt -131.01 155.23 47.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.12 128.09 25.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.66 14.92 51.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.27 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 3.6 t0 -93.69 142.5 27.28 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -80.52 141.32 35.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.2 p -158.55 -171.36 3.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 m -130.61 146.45 52.12 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.8 161.09 36.92 Favored 'General case' 0 C--N 1.278 -2.539 0 O-C-N 123.26 0.35 . . . . 0.0 110.489 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mm -92.41 115.37 31.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -64.44 121.35 14.17 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.557 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 8.1 t -66.44 -15.27 63.2 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 118.216 0.462 . . . . 0.0 111.831 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -84.86 -41.93 15.55 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.992 0.425 . . . . 0.0 110.876 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -110.79 -18.0 13.22 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.662 0.744 . . . . 0.0 110.847 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.29 90.52 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.202 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.3 m -94.05 163.85 13.31 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mm -77.51 130.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 123.445 0.698 . . . . 0.0 110.109 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.29 150.61 64.91 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.327 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.84 129.92 18.35 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.53 2.153 . . . . 0.0 111.367 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.65 149.97 32.41 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.065 0.46 . . . . 0.0 110.851 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 m -112.17 147.95 35.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -76.16 128.01 37.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.637 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.96 -31.79 10.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.258 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -160.29 145.64 14.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.571 HG23 HD21 ' A' ' 138' ' ' LEU . 98.4 mt -124.09 134.35 66.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 122.85 0.46 . . . . 0.0 110.568 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.42 97.94 6.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -61.95 -25.47 67.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.63 -39.91 64.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.35 -9.17 58.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 60.96 24.83 14.88 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.953 1.301 . . . . 0.0 109.04 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 68.3 p -122.37 159.99 26.35 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -146.21 153.14 40.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.859 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 67.4 t -95.45 130.89 43.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.1 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 85.1 t -109.92 118.46 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.01 118.45 12.87 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.801 0.688 . . . . 0.0 111.236 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 131.71 46.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.93 -17.23 56.17 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.079 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.85 -49.28 3.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.952 0.406 . . . . 0.0 110.711 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.63 4.78 59.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.314 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.81 154.93 33.45 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 122.178 0.191 . . . . 0.0 110.549 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.48 136.29 39.31 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.364 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.557 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.8 pt-20 -153.37 158.72 41.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 24.5 tt0 -96.55 129.12 43.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.598 0.713 . . . . 0.0 111.987 -175.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.533 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.9 mp0 -128.19 163.42 24.74 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.245 1.418 . . . . 0.0 110.007 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.0 m-80 -82.17 146.25 29.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.571 HD21 HG23 ' A' ' 116' ' ' ILE . 67.7 mt -59.43 -34.72 72.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.09 0.948 . . . . 0.0 109.724 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -77.04 -20.34 56.02 Favored 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.424 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 6.2 t70 -90.01 -28.14 19.28 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -175.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.669 HD11 ' SG ' ' A' ' 123' ' ' CYS . 77.1 mt -52.2 137.48 28.17 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 124.695 1.247 . . . . 0.0 111.739 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.19 162.68 14.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.975 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.399 -2.976 0 C-N-CA 123.796 0.838 . . . . 0.0 109.344 177.876 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.404 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 83.5 m95 . . . . . 0 N--CA 1.424 -1.734 0 CA-C-O 120.823 0.344 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 21.9 pttm -131.11 162.64 29.42 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.3 129.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.73 13.99 41.93 Favored Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.835 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.544 ' HB2' HD12 ' A' ' 113' ' ' ILE . 53.8 m-20 -96.43 140.06 31.64 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -84.89 139.91 31.51 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.404 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -151.96 -169.49 3.38 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 123.551 0.532 . . . . 0.0 109.573 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.4 m -130.03 144.23 51.22 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.517 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -134.5 160.24 38.62 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.949 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.67 114.64 31.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -61.71 126.9 28.98 Favored 'General case' 0 C--O 1.203 -1.348 0 O-C-N 124.03 0.831 . . . . 0.0 110.325 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.7 m -57.17 -29.9 64.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.24 -37.27 20.26 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.0 -17.07 10.45 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.509 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.8 8.23 87.71 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.257 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.4 160.07 15.27 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.97 131.22 35.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.89 149.47 59.11 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.03 128.04 16.09 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.602 2.201 . . . . 0.0 111.055 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.88 35.61 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.848 0.356 . . . . 0.0 110.379 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -111.8 147.49 35.59 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 96' ' ' ASP . 68.5 mt -78.9 120.17 29.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.71 -31.95 13.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.495 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -159.97 144.96 15.05 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 138' ' ' LEU . 83.6 mt -120.83 134.69 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -113.35 98.52 7.15 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -67.72 -23.86 65.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.36 -40.43 85.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.875 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.95 -8.66 55.39 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.16 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 63.28 27.25 15.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.954 1.301 . . . . 0.0 108.585 -175.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 60.9 p -125.76 166.74 16.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.9 p -148.38 151.95 36.19 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 122.911 0.484 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.0 t -95.81 129.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.5 145.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 121.133 0.492 . . . . 0.0 109.706 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 93.3 t -109.29 118.97 57.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -71.28 121.09 17.82 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.313 0.577 . . . . 0.0 110.857 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.0 m -69.03 131.4 44.98 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.034 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.03 57.29 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.665 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -111.12 -48.81 3.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 122.453 -0.439 . . . . 0.0 111.608 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.34 10.79 57.94 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -83.13 153.02 25.04 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.91 135.73 38.04 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.35 158.69 40.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -96.79 130.39 44.06 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.797 0.808 . . . . 0.0 112.229 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.517 ' NE2' ' HB1' ' A' ' 100' ' ' ALA . 6.2 mp0 -126.0 163.36 23.18 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.36 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.7 m-80 -84.28 144.9 28.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.576 HD21 HG23 ' A' ' 116' ' ' ILE . 70.4 mt -60.06 -35.39 75.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.535 0.683 . . . . 0.0 110.614 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -73.32 -29.34 62.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -82.51 -14.06 55.61 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.788 -177.085 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.658 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.1 mt -66.23 143.93 56.93 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.573 0.546 . . . . 0.0 111.517 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.05 158.83 23.51 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.945 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.443 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.1 m95 . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 111.071 0.026 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.9 ptpp? -131.57 161.53 32.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.91 128.23 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 15.22 33.67 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.739 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 72.7 m-20 -102.29 145.54 29.31 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 18.8 mmmt -88.06 141.42 28.58 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.167 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.443 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.24 -171.52 3.94 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 123.892 0.745 . . . . 0.0 109.056 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 m -131.69 143.86 50.58 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 173.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -135.22 160.92 36.86 Favored 'General case' 0 C--N 1.273 -2.733 0 O-C-N 123.514 0.509 . . . . 0.0 110.211 -174.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 mm -92.21 118.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -67.46 124.81 24.22 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 m -59.0 -26.42 64.5 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -84.49 -41.84 16.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.998 -173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -111.38 -17.47 13.12 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.864 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 4.74 89.9 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.105 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.62 160.18 15.13 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -76.71 129.02 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 O-C-N 124.002 0.814 . . . . 0.0 109.442 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -137.97 148.04 58.78 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.17 127.72 16.35 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.62 2.214 . . . . 0.0 110.895 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.51 38.33 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.752 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -112.16 147.48 36.04 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 96' ' ' ASP . 62.6 mt -77.46 121.86 30.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 123.076 0.235 . . . . 0.0 110.368 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.65 13.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.1 p -160.63 145.14 14.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.692 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.579 HG23 HD21 ' A' ' 138' ' ' LEU . 97.8 mt -124.42 135.24 64.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 110.784 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -112.9 101.81 9.85 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.63 -24.97 65.51 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.72 0.295 . . . . 0.0 111.198 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.25 -37.09 66.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.304 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -86.81 -8.95 56.86 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.841 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 60.35 28.98 18.63 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 122.634 1.207 . . . . 0.0 109.184 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.403 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 70.8 p -126.33 162.39 25.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.852 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.67 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.7 p -148.33 152.16 36.6 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.261 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 99.4 t -95.37 130.96 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.9 m -118.3 145.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.9 t -110.7 118.38 57.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -68.42 119.13 12.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.694 0.621 . . . . 0.0 110.568 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.6 m -63.6 131.01 46.66 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.756 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.0 -18.0 47.41 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.269 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -108.33 -37.57 5.96 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 122.395 -0.474 . . . . 0.0 111.747 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 13.52 76.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.623 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -85.59 151.97 23.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.5 ppt_? -135.66 137.26 41.64 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.193 0.308 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.0 pt-20 -153.62 158.69 41.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 20.6 tt0 -97.91 129.75 44.82 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.537 0.684 . . . . 0.0 111.353 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.571 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.1 mp0 -126.53 163.58 23.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 124.494 1.118 . . . . 0.0 109.755 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.8 m-80 -82.14 145.48 30.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.579 HD21 HG23 ' A' ' 116' ' ' ILE . 76.5 mt -57.95 -36.35 72.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.742 0.782 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -77.58 -19.54 55.47 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.4 t70 -84.96 -30.91 23.87 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.844 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.67 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.9 mt -51.9 132.12 31.7 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.655 1.222 . . . . 0.0 111.918 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.39 164.16 12.07 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.953 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.308 -1.215 0 O-C-N 124.172 0.92 . . . . 0.0 109.07 -179.741 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 92.6 m95 . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.622 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.8 ptpp? -131.25 162.48 29.91 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.6 t -63.74 128.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.64 13.64 37.25 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.918 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.622 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.6 m-20 -100.64 141.5 33.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -83.02 143.62 30.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.97 -169.48 3.27 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 m -132.59 145.98 51.54 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.37 161.2 36.94 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 123.781 0.676 . . . . 0.0 110.08 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.0 119.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.27 125.14 25.78 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -58.77 -24.59 61.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -85.0 -41.74 15.53 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.933 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -111.51 -17.86 12.97 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 118.733 -1.187 . . . . 0.0 111.187 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.26 89.73 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.181 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.19 162.29 14.08 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -77.58 129.79 37.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.856 0.723 . . . . 0.0 109.687 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -137.8 151.4 70.41 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 123.639 0.776 . . . . 0.0 109.137 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.96 128.62 14.25 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.11 149.46 36.58 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.976 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -111.51 147.5 35.22 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 64.4 mt -77.12 122.09 30.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.505 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -95.89 -33.11 12.33 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.735 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.7 m -160.58 148.73 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.595 HG23 HD21 ' A' ' 138' ' ' LEU . 93.2 mt -126.44 135.72 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.91 99.86 8.44 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -66.43 -23.94 66.38 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.079 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.24 -37.65 69.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.235 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -87.79 -8.9 55.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.994 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 30.4 tt0 61.03 24.74 14.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p -122.77 161.08 24.64 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.0 p -146.53 151.9 38.1 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.427 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.7 t -95.37 130.21 44.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.04 145.68 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.7 t -111.0 118.67 57.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -69.07 118.67 12.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 123.718 0.636 . . . . 0.0 110.21 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 53.1 m -63.66 131.02 46.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.403 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.39 -26.56 10.08 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.896 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -96.84 -47.27 5.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.967 0.413 . . . . 0.0 110.616 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.8 60.1 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.363 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -82.76 152.1 25.86 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -139.03 136.31 35.16 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.169 0.293 . . . . 0.0 110.77 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.5 pt-20 -153.07 158.07 41.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -95.8 133.21 40.2 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.455 0.645 . . . . 0.0 112.077 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.478 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 8.5 mp0 -131.98 163.78 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 125.157 1.383 . . . . 0.0 109.967 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.4 m-80 -81.15 148.2 29.69 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 116' ' ' ILE . 65.2 mt -59.21 -36.11 74.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.261 1.029 . . . . 0.0 108.933 175.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.3 m -75.53 -18.09 59.9 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.992 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -98.06 -7.29 30.03 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.379 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.64 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.7 mt -72.97 139.89 47.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.417 0.627 . . . . 0.0 111.042 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.9 166.06 11.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.781 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--N 1.31 -1.119 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.519 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 87.8 m95 . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 63.5 pttt -126.36 157.95 37.16 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.72 131.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 18.71 54.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.737 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 4.7 t0 -100.8 133.21 45.6 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG2' HG23 ' A' ' 112' ' ' THR . 68.0 mttt -80.47 148.01 30.66 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.115 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.6 p -155.1 -168.76 2.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.981 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 m -131.71 145.29 51.55 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.06 160.79 37.23 Favored 'General case' 0 C--N 1.277 -2.585 0 O-C-N 123.569 0.543 . . . . 0.0 110.189 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.15 117.16 34.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.422 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 9.8 t90 -67.54 122.92 19.04 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -59.67 -23.57 63.2 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 24.9 mm-40 -84.83 -42.11 15.42 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -108.47 -18.45 13.74 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.69 6.93 89.07 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.679 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.8 m -94.42 161.91 14.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.19 128.26 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 O-C-N 123.904 0.753 . . . . 0.0 109.796 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.35 148.87 67.97 Favored Pre-proline 0 C--N 1.288 -2.104 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.665 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.16 129.94 15.78 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.404 2.07 . . . . 0.0 111.289 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.79 151.27 35.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.145 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.421 HG23 ' HG2' ' A' ' 97' ' ' LYS . 12.5 m -112.36 147.64 35.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 96' ' ' ASP . 71.3 mt -77.08 120.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.913 0.387 . . . . 0.0 111.133 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -92.59 -31.99 14.97 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.613 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.0 m -162.38 151.64 15.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.606 HG23 HD21 ' A' ' 138' ' ' LEU . 97.5 mt -127.6 135.87 62.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 122.712 0.405 . . . . 0.0 110.754 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.32 98.14 7.1 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -67.65 -23.84 65.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.017 0.437 . . . . 0.0 111.367 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -73.2 -36.4 66.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.473 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -90.61 -8.8 49.15 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 59.81 29.61 19.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.514 1.126 . . . . 0.0 108.645 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 72.0 p -122.06 162.18 21.67 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.869 -0.519 . . . . 0.0 110.088 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 141' ' ' LEU . 5.6 p -148.69 153.74 38.66 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -97.37 130.44 46.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 26.6 m -119.06 146.02 24.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 90.6 t -109.69 118.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.8 119.31 13.83 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 123.731 0.645 . . . . 0.0 110.811 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -61.66 131.74 50.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.32 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.64 -23.22 17.27 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.271 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -101.73 -46.83 4.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.24 6.65 61.34 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.865 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -80.09 151.57 29.79 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.6 ppt_? -135.77 136.84 41.07 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.55 158.79 41.76 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 20.3 tt0 -94.7 132.22 39.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.655 0.74 . . . . 0.0 110.253 -176.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -127.3 165.31 19.94 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 126.037 1.735 . . . . 0.0 108.484 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.6 m-80 -87.51 145.29 26.31 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 116' ' ' ILE . 78.7 mt -58.02 -38.44 76.2 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -75.28 -22.69 57.58 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.75 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.6 m-20 -89.5 -12.86 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.299 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.7 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.2 mt -68.55 146.61 52.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.317 0.58 . . . . 0.0 110.733 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.43 165.19 13.25 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.431 -1.376 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.167 179.612 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 87.5 m95 . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -130.2 158.72 38.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.75 127.85 23.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.19 11.67 48.16 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.48 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.547 ' HB2' HD12 ' A' ' 113' ' ' ILE . 18.2 m-20 -92.76 135.67 33.91 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -81.9 146.1 29.99 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.411 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.5 p -159.58 -172.78 3.83 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.636 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.6 m -129.02 144.19 51.11 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.12 161.09 36.32 Favored 'General case' 0 C--N 1.278 -2.537 0 O-C-N 123.798 0.686 . . . . 0.0 110.412 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.28 116.74 34.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -67.21 121.17 15.07 Favored 'General case' 0 C--O 1.193 -1.881 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.508 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 20.6 t -64.2 -17.2 63.31 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.146 0.43 . . . . 0.0 111.752 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -83.28 -41.95 17.72 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.335 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -112.75 -17.76 12.47 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.881 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.43 3.89 90.36 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.115 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 81.2 m -93.63 162.95 13.74 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.8 mm -77.66 130.34 36.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -139.77 151.52 66.08 Favored Pre-proline 0 C--N 1.303 -1.443 0 C-N-CA 123.455 0.702 . . . . 0.0 110.271 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.34 128.35 15.38 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.958 2.438 . . . . 0.0 111.789 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.57 149.67 31.98 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.121 0.486 . . . . 0.0 111.019 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 m -112.63 147.04 37.56 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 96' ' ' ASP . 67.6 mt -78.13 121.39 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.199 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.86 -35.7 13.22 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.578 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.1 m -159.52 149.78 18.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.564 HG23 HD21 ' A' ' 138' ' ' LEU . 94.5 mt -125.67 138.18 55.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.742 0.417 . . . . 0.0 110.777 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -112.97 98.32 7.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -65.27 -25.79 67.8 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.536 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -73.27 -38.6 65.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.214 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.45 -8.55 58.32 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.864 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 63.07 25.62 15.04 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 124.646 1.178 . . . . 0.0 108.772 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 74.2 p -124.76 163.99 20.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 111.072 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.8 p -148.63 153.41 38.28 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 122.693 0.397 . . . . 0.0 110.312 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.07 130.25 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.1 m -118.46 147.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.7 t -110.32 118.73 57.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.45 116.92 10.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.825 0.703 . . . . 0.0 110.468 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -65.04 131.47 46.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.96 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.76 -20.48 38.7 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -104.51 -47.65 4.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.978 0.418 . . . . 0.0 110.447 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.53 18.41 41.75 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.991 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -91.05 155.62 18.54 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.4 ppt_? -134.95 136.5 42.31 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.514 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.7 pt-20 -153.96 158.55 40.82 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 17.4 tt0 -95.39 132.85 39.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.71 0.767 . . . . 0.0 111.228 -176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.408 ' OE1' HG22 ' A' ' 125' ' ' VAL . 9.0 mp0 -125.44 164.64 20.0 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 125.84 1.656 . . . . 0.0 109.61 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.1 m-80 -88.11 143.67 26.93 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.564 HD21 HG23 ' A' ' 116' ' ' ILE . 84.5 mt -58.03 -36.28 72.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.357 0.598 . . . . 0.0 110.683 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.6 m -75.16 -23.71 57.81 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.856 0.863 . . . . 0.0 111.459 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 2.5 m-20 -91.06 -11.54 38.42 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.806 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.706 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.7 mt -68.71 142.11 55.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.03 163.85 14.61 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.252 1.189 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.992 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.3 m95 . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.06 163.31 22.64 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.85 127.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.85 7.99 52.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.13 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 113' ' ' ILE . 21.2 m-20 -91.35 135.42 33.83 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -74.44 146.4 42.88 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.368 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -160.04 -172.59 3.68 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.894 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.5 m -129.36 142.92 50.69 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.56 160.6 37.55 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.392 0.433 . . . . 0.0 110.699 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.435 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.0 t90 -65.61 119.53 11.3 Favored 'General case' 0 C--O 1.199 -1.585 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.504 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 6.4 t -66.95 -14.96 63.37 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.677 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.37 -42.39 17.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.602 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.435 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.8 t70 -109.49 -18.61 13.48 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.484 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.38 7.79 88.2 Favored Glycine 0 C--N 1.313 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.119 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.3 m -94.3 161.71 14.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.0 mm -79.14 129.33 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -137.52 150.85 69.73 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 127.84 14.98 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.566 2.178 . . . . 0.0 110.97 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.61 147.67 30.29 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.076 0.465 . . . . 0.0 110.465 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.4 m -112.53 147.16 37.19 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 96' ' ' ASP . 78.0 mt -75.47 126.21 35.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.919 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.41 12.13 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -159.34 148.32 18.18 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 138' ' ' LEU . 87.0 mt -127.53 135.67 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.911 0.484 . . . . 0.0 110.025 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.09 96.36 5.99 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.15 -24.17 65.87 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.556 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -74.11 -34.08 63.81 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.69 -8.95 57.89 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.783 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 61.7 30.76 18.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.752 1.221 . . . . 0.0 108.624 -173.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 69.0 p -124.89 165.24 18.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.714 -0.616 . . . . 0.0 110.86 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.737 ' SG ' HD11 ' A' ' 141' ' ' LEU . 6.7 p -148.66 155.18 40.69 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.313 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.1 130.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -118.52 147.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.5 t -109.83 118.89 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -70.59 119.97 15.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.638 0.586 . . . . 0.0 110.72 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.8 m -64.56 131.45 47.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.096 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.07 -22.78 30.06 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -105.54 -41.81 5.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.16 0.505 . . . . 0.0 111.14 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.94 81.31 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -77.63 154.67 32.0 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -135.97 138.02 41.87 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.0 pt-20 -154.02 159.3 41.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -94.18 133.63 37.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.991 0.9 . . . . 0.0 111.57 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 125' ' ' VAL . 10.3 mp0 -128.87 164.85 22.21 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 125.75 1.62 . . . . 0.0 108.989 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 25.8 m-80 -89.92 145.82 24.85 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 116' ' ' ILE . 79.5 mt -59.39 -34.79 72.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.394 0.616 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -25.41 54.95 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.519 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.2 -13.28 38.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.139 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.737 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.2 mt -66.77 145.5 55.45 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.048 0.451 . . . . 0.0 110.754 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.93 160.96 18.23 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.462 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 92.8 m95 . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 120.48 0.181 . . . . 0.0 111.421 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.7 ptpp? -131.25 157.26 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.48 129.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.54 13.26 57.26 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.95 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.6 t0 -95.35 140.69 29.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -84.65 144.84 28.33 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.1 p -153.73 -170.06 3.47 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.1 m -130.81 141.25 50.33 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.94 160.62 37.14 Favored 'General case' 0 C--N 1.279 -2.458 0 O-C-N 123.624 0.578 . . . . 0.0 110.456 -174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.21 115.84 32.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.6 t90 -66.33 121.98 16.48 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 t -63.19 -21.65 66.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.301 0.572 . . . . 0.0 111.68 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 15.2 mm-40 -84.65 -33.36 23.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.4 t70 -117.04 -18.27 10.13 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.65 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.7 88.86 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.882 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.26 162.73 13.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.64 131.43 34.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.208 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.62 151.21 65.78 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.728 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.62 127.98 15.49 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 111.166 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.66 149.02 32.66 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.994 0.426 . . . . 0.0 109.971 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -111.92 147.81 35.05 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.0 mt -79.13 121.57 32.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.568 0.223 . . . . 0.0 111.069 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.95 -32.21 13.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.087 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 m -159.4 147.73 17.69 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.552 HG23 HD21 ' A' ' 138' ' ' LEU . 89.7 mt -126.91 141.22 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.41 96.36 6.06 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 172.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -67.92 -24.02 65.15 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.761 0.315 . . . . 0.0 111.345 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.58 -39.31 64.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.293 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -90.63 -8.11 50.93 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.733 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 64.44 33.43 11.13 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.517 1.135 . . . . 0.0 109.245 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 81.5 p -123.79 164.83 18.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.935 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.716 ' SG ' HD11 ' A' ' 141' ' ' LEU . 6.3 p -149.91 157.28 43.01 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 123.013 0.525 . . . . 0.0 110.768 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.4 t -102.2 131.42 50.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.2 m -118.58 146.04 23.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 121.231 0.539 . . . . 0.0 109.831 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 92.3 t -111.09 118.61 57.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -71.19 119.84 15.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.696 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 m -67.2 130.67 43.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.727 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.71 -16.52 59.99 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.009 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -111.97 -35.09 5.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.76 4.0 90.25 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.492 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -78.18 157.2 29.46 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -141.41 136.42 31.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.501 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.8 pt-20 -152.95 158.41 42.05 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 29.7 tt0 -95.51 137.39 34.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.123 0.487 . . . . 0.0 111.185 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.501 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -137.94 159.0 43.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 124.402 1.081 . . . . 0.0 109.699 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 30.8 m-80 -81.39 147.67 29.69 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.552 HD21 HG23 ' A' ' 116' ' ' ILE . 81.7 mt -60.81 -36.07 78.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.094 0.473 . . . . 0.0 111.414 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 t -80.89 -16.27 54.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.045 0.45 . . . . 0.0 110.418 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.82 -32.26 40.67 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.716 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.5 mt -56.92 141.11 46.33 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.7 1.25 . . . . 0.0 111.718 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.2 159.92 19.57 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.561 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.309 -1.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.586 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.5 m95 . . . . . 0 N--CA 1.436 -1.126 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.579 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.0 ptpp? -130.84 160.15 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.69 128.16 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.61 13.35 41.29 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.196 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.579 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 13.2 m-20 -98.03 135.29 39.94 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -78.41 145.49 35.1 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.407 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.454 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -157.04 -169.23 2.88 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.817 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 m -133.6 146.14 50.68 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -138.21 161.64 36.32 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.356 0.41 . . . . 0.0 110.183 -174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.16 118.71 38.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 10.3 t90 -68.17 127.52 33.22 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.556 0.535 . . . . 0.0 109.954 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 m -56.36 -30.85 63.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -85.18 -41.12 15.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.529 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.3 t70 -109.19 -17.15 13.92 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.1 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.22 4.81 84.52 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.968 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.5 m -93.58 162.46 13.95 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -78.48 126.88 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.868 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.18 148.39 64.34 Favored Pre-proline 0 C--N 1.283 -2.288 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.832 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.58 128.67 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.659 2.239 . . . . 0.0 111.259 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.98 152.47 41.1 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -112.24 147.81 35.45 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 96' ' ' ASP . 74.5 mt -79.28 118.03 25.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 123.221 0.326 . . . . 0.0 110.937 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.78 -30.49 15.46 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.76 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.1 m -161.47 145.64 13.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.586 HG23 HD21 ' A' ' 138' ' ' LEU . 87.7 mt -123.39 134.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 120.852 0.358 . . . . 0.0 110.125 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 11.3 t70 -111.89 96.85 6.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -65.86 -23.71 66.72 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.112 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -71.52 -40.67 69.97 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' OD1' ' A' ' 117' ' ' ASP . 93.2 mtt180 -82.58 -9.45 59.39 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.466 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 62.91 29.61 16.54 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.195 1.398 . . . . 0.0 108.135 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 137' ' ' ASN . 74.8 p -131.08 168.47 17.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.106 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.751 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -148.79 155.46 40.98 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.502 0.321 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.8 t -95.86 130.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.55 145.52 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 133' ' ' ARG . 89.5 t -109.73 118.62 57.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.91 120.3 15.43 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 123.758 0.661 . . . . 0.0 111.576 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.462 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.42 -21.93 42.85 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.548 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -111.39 -43.14 3.74 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.612 0.244 . . . . 0.0 111.378 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 8.3 64.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.443 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.5 m-20 -80.39 153.33 28.38 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.76 -0.259 . . . . 0.0 110.419 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.0 ppt_? -137.69 135.24 36.29 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.057 0.456 . . . . 0.0 111.417 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.42 158.71 41.84 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.4 tt0 -94.44 135.11 36.23 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.174 0.511 . . . . 0.0 111.392 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.504 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -131.85 160.25 36.2 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.266 1.026 . . . . 0.0 110.478 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 26.1 m-80 -79.42 144.32 34.2 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 116' ' ' ILE . 75.3 mt -62.4 -33.2 74.3 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.945 0.879 . . . . 0.0 110.376 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.9 t -80.04 -21.46 43.45 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.71 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 23.1 t70 -83.6 -32.79 25.56 Favored 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.751 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.0 mt -51.07 134.48 26.51 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 125.046 1.466 . . . . 0.0 111.902 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.31 161.96 14.53 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.396 -3.157 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.686 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.42 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.2 m95 . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.6 ptpp? -129.76 162.61 28.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.68 127.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.06 15.05 40.25 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.491 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 22.5 m-20 -98.0 136.78 37.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 117.133 0.466 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -77.47 145.07 37.3 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.48 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.7 p -156.18 -165.87 2.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.499 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 m -139.42 149.44 44.07 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -140.32 161.53 37.47 Favored 'General case' 0 C--N 1.278 -2.502 0 O-C-N 123.877 0.735 . . . . 0.0 110.078 -173.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.82 120.05 40.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.446 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 10.1 t90 -69.65 125.89 28.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -58.93 -25.04 63.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 21.0 mm-40 -84.87 -37.73 20.3 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -174.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -117.41 -18.22 9.89 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.982 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.6 86.95 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.212 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.2 m -92.93 160.19 15.0 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.85 126.12 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 C-N-CA 123.848 0.859 . . . . 0.0 109.016 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -134.58 149.51 71.11 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.18 128.09 17.89 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.914 2.409 . . . . 0.0 110.902 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.88 149.52 34.42 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.843 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.3 m -113.85 147.76 37.84 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.461 HD12 ' HB2' ' A' ' 96' ' ' ASP . 75.8 mt -76.89 126.23 37.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.63 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -33.1 11.24 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 m -161.33 149.57 15.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.579 HG23 HD21 ' A' ' 138' ' ' LEU . 87.3 mt -128.82 140.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.513 0.725 . . . . 0.0 109.966 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -113.04 98.87 7.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.03 -23.76 67.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.447 -174.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -73.42 -40.52 64.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -87.8 -8.32 56.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.026 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 61.4 28.29 17.73 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.856 0.862 . . . . 0.0 108.793 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 68.9 p -122.02 159.56 26.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 121.7 -0.625 . . . . 0.0 110.55 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.66 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.4 p -148.22 152.37 37.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.654 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 59.4 t -95.99 130.56 44.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.5 m -118.06 145.77 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.1 t -111.53 118.55 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.36 116.67 10.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 124.042 0.839 . . . . 0.0 110.503 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 m -62.93 131.13 47.69 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.072 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.79 -27.98 12.78 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -101.81 -42.97 5.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.938 0.399 . . . . 0.0 110.758 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.21 1.58 75.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -72.24 149.39 44.6 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.3 ppt_? -133.64 136.18 44.63 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.507 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 7.7 pt-20 -153.46 158.39 41.29 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.6 tt0 -95.95 134.53 38.84 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.528 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -134.05 157.51 45.93 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.374 1.069 . . . . 0.0 109.802 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 32.3 m-80 -79.43 147.26 32.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.579 HD21 HG23 ' A' ' 116' ' ' ILE . 77.8 mt -58.28 -34.32 70.39 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.674 0.75 . . . . 0.0 110.078 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -76.59 -24.65 53.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.199 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.23 -12.87 45.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.176 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.66 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -70.29 143.09 52.17 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 123.479 0.487 . . . . 0.0 111.41 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.31 160.67 18.82 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.617 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.401 -2.89 0 C-N-CA 124.602 1.161 . . . . 0.0 110.327 178.408 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 C--O 1.244 0.78 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.8 m -91.63 91.73 8.15 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.66 -26.81 19.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.261 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 71.45 8.47 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.755 0.788 . . . . 0.0 111.467 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -124.53 13.31 8.74 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -107.81 34.83 3.36 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.456 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.421 ' HB3' ' NE1' ' A' ' 92' ' ' TRP . 9.8 mm100 -79.95 132.9 36.15 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.27 -172.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -132.59 129.61 39.18 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.436 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 -128.29 163.36 24.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 25.4 pttm -131.15 154.32 48.48 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.97 135.56 27.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.139 0.576 . . . . 0.0 110.156 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.67 11.92 57.48 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.006 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 3.4 m-20 -99.68 143.56 29.78 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.871 0.367 . . . . 0.0 110.364 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.15 144.72 30.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.16 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.436 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.0 p -159.31 -169.89 2.78 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.6 m -132.95 146.05 51.44 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 160.94 37.23 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.722 0.639 . . . . 0.0 111.107 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.1 mm -91.92 117.1 34.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -67.96 126.99 31.21 Favored 'General case' 0 C--O 1.203 -1.357 0 O-C-N 123.571 0.544 . . . . 0.0 109.694 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -57.92 -28.65 64.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.46 -41.22 16.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -109.6 -17.75 13.65 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.702 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.87 7.5 88.46 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.625 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.59 161.76 14.23 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -77.35 127.77 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.713 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.02 151.24 73.38 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 123.453 0.701 . . . . 0.0 109.313 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.77 129.98 18.52 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.521 2.147 . . . . 0.0 111.685 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -148.37 151.96 36.2 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 120.889 0.376 . . . . 0.0 110.539 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.0 m -114.1 148.11 37.67 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -75.01 124.48 32.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -96.48 -36.62 10.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.5 p -159.19 149.56 19.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.627 HG23 HD21 ' A' ' 138' ' ' LEU . 98.2 mt -126.39 129.11 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 12.1 t70 -112.77 101.63 9.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 173.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -67.25 -24.23 65.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.89 -38.64 64.32 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 122' ' ' THR . 98.0 mtt180 -81.59 -9.48 59.67 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 61.56 25.26 15.22 Favored 'General case' 0 C--O 1.252 1.234 0 C-N-CA 125.274 1.429 . . . . 0.0 108.469 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 120' ' ' ARG . 68.1 p -129.38 168.82 15.72 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.435 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.691 ' SG ' HD11 ' A' ' 141' ' ' LEU . 5.7 p -148.5 151.27 34.85 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 65.9 t -96.31 132.64 40.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.9 m -119.6 149.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 133' ' ' ARG . 96.7 t -111.09 118.51 57.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.19 118.12 11.68 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.827 0.705 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 m -65.32 131.37 46.29 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.38 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.89 -19.42 53.08 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -111.74 -44.96 3.4 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.705 0.288 . . . . 0.0 111.511 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.33 0.98 67.02 Favored Glycine 0 C--N 1.311 -0.809 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.876 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -73.69 152.37 40.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.3 ppt_? -137.94 135.74 36.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 120.773 0.321 . . . . 0.0 110.864 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -151.94 159.53 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.7 tt0 -93.8 131.63 38.99 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.099 0.952 . . . . 0.0 111.105 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 125' ' ' VAL . 7.5 mp0 -123.39 165.07 17.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 125.572 1.549 . . . . 0.0 109.629 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 35.7 m-80 -89.72 142.92 27.24 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.627 HD21 HG23 ' A' ' 116' ' ' ILE . 63.4 mt -58.79 -36.64 74.77 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.43 0.692 . . . . 0.0 110.682 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 t -79.55 -16.63 55.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.477 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 4.1 t70 -89.62 -28.05 19.78 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.73 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.691 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.8 mt -54.87 134.81 48.4 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.983 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.71 167.03 10.45 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.479 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.0 t -62.47 142.75 96.35 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.61 -177.76 1.02 Allowed 'Trans proline' 0 C--O 1.241 0.648 0 C-N-CA 123.422 2.748 . . . . 0.0 113.718 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.6 pt -86.34 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.592 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.07 42.34 1.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.394 1.092 . . . . 0.0 111.442 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 . . . . . 0 C--N 1.252 -3.64 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.859 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 p -80.74 107.13 13.29 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.91 -56.41 2.57 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.853 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.16 81.62 1.94 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -144.9 24.01 1.51 Allowed 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.77 11.03 38.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.69 125.17 24.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.797 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -114.31 141.24 47.86 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -134.12 164.08 28.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 120.95 0.405 . . . . 0.0 111.271 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -130.96 159.34 37.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.08 132.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.49 10.55 57.98 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.834 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.13 141.3 29.68 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -81.15 144.09 31.92 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.37 0.605 . . . . 0.0 110.985 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -156.65 -171.57 3.73 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.16 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 142.21 50.82 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.6 160.62 37.92 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 123.493 0.496 . . . . 0.0 110.002 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.76 117.11 35.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 8.8 t90 -64.74 121.14 13.84 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.553 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 27.7 t -58.3 -24.38 59.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -83.25 -42.07 17.63 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.14 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.429 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.9 t70 -111.5 -18.04 12.94 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.563 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 7.09 88.88 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.663 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.0 m -92.94 158.4 15.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mm -77.87 130.78 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.774 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.442 ' CD2' HC11 ' A' 1148 ' ' DA2 . 85.9 m-85 -138.67 148.73 59.71 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.94 127.46 12.95 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.115 1.877 . . . . 0.0 111.024 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.89 150.41 38.37 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.391 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.1 m -111.84 147.61 35.38 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.0 mt -76.13 124.89 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.631 0.253 . . . . 0.0 110.818 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.19 12.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.872 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -160.8 152.54 19.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.575 HG23 HD21 ' A' ' 138' ' ' LEU . 82.0 mt -132.48 139.89 48.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 122.979 0.512 . . . . 0.0 110.817 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -111.91 97.48 6.71 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -68.19 -23.9 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.04 -39.14 63.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.774 0.321 . . . . 0.0 110.977 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.75 -7.56 56.04 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.251 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 63.07 33.74 14.37 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.303 1.002 . . . . 0.0 108.84 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 53.8 p -123.62 161.75 24.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 110.402 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.713 ' SG ' HD11 ' A' ' 141' ' ' LEU . 4.6 p -149.43 151.91 34.81 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.5 t -96.32 130.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.0 m -118.69 145.94 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.4 t -112.4 118.6 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.82 118.84 14.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 123.802 0.689 . . . . 0.0 110.911 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.2 m -63.63 131.56 48.37 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.716 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.18 -29.85 8.9 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.824 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.92 -40.64 6.8 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.702 0.287 . . . . 0.0 111.321 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.54 74.79 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.078 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -80.37 153.87 28.08 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.1 ppt_? -136.0 137.9 41.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 6.8 pt-20 -154.23 158.92 40.98 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.8 tt0 -99.37 132.22 44.85 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.519 0.676 . . . . 0.0 111.526 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.529 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -132.2 163.46 28.52 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.653 1.181 . . . . 0.0 109.681 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 24.7 m-80 -85.06 146.7 27.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.575 HD21 HG23 ' A' ' 116' ' ' ILE . 84.3 mt -57.21 -35.57 69.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.738 0.78 . . . . 0.0 111.177 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.4 m -80.08 -20.28 45.5 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.097 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -13.89 39.86 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.713 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.8 mt -71.68 145.14 49.06 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.625 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -114.98 159.5 20.67 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.7 m -62.76 141.32 97.21 Favored Pre-proline 0 N--CA 1.39 -3.434 0 C-N-CA 123.755 0.822 . . . . 0.0 108.953 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.46 162.4 30.92 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 122.755 2.303 . . . . 0.0 113.805 -174.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 pt -113.44 161.6 12.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.803 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.4 m -71.83 121.45 19.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.285 0.564 . . . . 0.0 110.084 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--N 1.276 -2.616 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.881 -179.057 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.442 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.513 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.9 m -140.71 96.03 2.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 -34.34 15.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.256 0.551 . . . . 0.0 110.039 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.03 66.6 5.84 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.814 0.816 . . . . 0.0 110.842 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 p -118.9 4.08 11.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.222 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -88.01 17.82 4.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.799 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.428 ' HB3' ' NE1' ' A' ' 92' ' ' TRP . 9.8 mm100 -65.91 129.12 38.7 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.709 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.59 110.97 15.09 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.7 m95 -112.82 161.22 17.18 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.249 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.7 ptpp? -131.21 161.34 32.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.7 t -63.84 127.71 24.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.89 13.91 38.57 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.15 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.555 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 28.2 m-20 -96.82 142.46 28.8 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -152.72 -170.58 3.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.3 m -127.27 143.55 51.22 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -135.39 160.4 38.55 Favored 'General case' 0 C--N 1.278 -2.529 0 O-C-N 123.644 0.59 . . . . 0.0 110.005 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 mm -92.36 116.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -64.8 126.62 28.53 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 123.601 0.563 . . . . 0.0 109.904 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.1 m -58.27 -28.16 64.69 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.4 -41.82 15.09 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.077 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.91 -17.83 13.53 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.722 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.88 90.0 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.736 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.91 161.99 14.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.55 130.47 36.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.425 0.69 . . . . 0.0 109.657 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CG ' HC11 ' A' 1148 ' ' DA2 . 91.9 m-85 -139.29 151.0 66.28 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.679 176.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.7 127.78 14.3 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.664 2.242 . . . . 0.0 111.028 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.36 150.82 36.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 120.914 0.387 . . . . 0.0 110.557 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -111.88 147.59 35.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 96' ' ' ASP . 69.3 mt -79.35 121.8 33.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.781 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.42 -35.32 12.39 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.785 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -159.14 144.65 16.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.601 HG23 HD21 ' A' ' 138' ' ' LEU . 99.0 mt -122.13 134.78 64.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.399 0.28 . . . . 0.0 110.416 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -113.13 96.64 6.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -64.39 -25.83 68.19 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -69.16 -37.35 78.16 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.03 -7.24 52.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.464 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 62.59 25.11 14.96 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 108.558 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 71.5 p -122.82 161.96 23.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.546 -0.721 . . . . 0.0 111.422 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.691 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.6 p -148.03 153.18 38.61 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 78.9 t -96.26 130.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.4 m -119.22 145.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-O 121.171 0.51 . . . . 0.0 109.88 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.0 t -110.41 118.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.543 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -71.73 117.95 13.95 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -65.85 131.82 47.18 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.48 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.61 -17.16 55.9 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.69 -39.95 4.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.893 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.68 23.58 57.73 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.821 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -95.28 153.27 17.75 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.0 ppt_? -137.94 135.7 36.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.679 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.34 159.16 41.04 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -94.83 133.22 38.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.468 0.651 . . . . 0.0 111.855 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.496 ' NE2' ' HB1' ' A' ' 100' ' ' ALA . 5.7 mp0 -131.78 163.66 27.73 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.84 1.256 . . . . 0.0 110.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 26.8 m-80 -85.51 146.86 26.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.601 HD21 HG23 ' A' ' 116' ' ' ILE . 67.0 mt -59.22 -37.4 77.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.548 0.69 . . . . 0.0 109.964 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.8 m -74.4 -22.14 59.31 Favored 'General case' 0 N--CA 1.405 -2.711 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.433 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 m-20 -91.32 -13.46 32.53 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.691 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.0 mt -71.19 144.13 50.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.089 0.471 . . . . 0.0 110.676 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.2 165.52 12.84 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.8 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.8 t -62.92 137.6 96.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.552 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 50.7 Cg_endo -67.16 166.26 23.78 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.317 2.011 . . . . 0.0 112.101 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.1 pt -116.29 174.19 3.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.808 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.4 p -72.8 159.94 32.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.285 0.366 . . . . 0.0 110.27 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--N 1.293 -1.854 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.177 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.419 HC21 ' HNE' ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.544 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.3 m120 . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m -47.19 115.14 1.01 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.698 1.199 . . . . 0.0 112.7 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.07 8.23 5.32 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.431 1.492 . . . . 0.0 113.503 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.506 ' HB1' ' NE2' ' A' ' 90' ' ' GLN . . . -128.43 22.24 6.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.261 0.553 . . . . 0.0 112.275 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -89.58 20.68 3.83 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.665 0.745 . . . . 0.0 109.931 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -121.73 12.83 10.69 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.216 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.506 ' NE2' ' HB1' ' A' ' 87' ' ' ALA . 39.1 mt-30 -95.99 151.66 19.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.906 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -132.42 114.06 13.89 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.47 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 95.4 m95 -104.18 160.02 15.21 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.852 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 64.5 pttt -131.45 159.97 36.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 16.29 68.42 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.586 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 6.8 t0 -100.08 136.15 40.43 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -85.04 141.86 29.98 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.47 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -150.14 -167.87 2.95 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -130.13 143.61 50.88 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.58 160.56 38.1 Favored 'General case' 0 C--N 1.281 -2.408 0 O-C-N 123.439 0.462 . . . . 0.0 110.101 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.29 117.88 36.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -67.02 122.46 17.82 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 11.1 t -65.31 -16.26 63.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 118.052 0.387 . . . . 0.0 111.804 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -85.3 -38.44 18.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -115.16 -18.33 11.18 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.408 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 6.29 88.73 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.022 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.62 162.51 13.92 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.69 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.42 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.35 150.87 73.71 Favored Pre-proline 0 C--N 1.284 -2.244 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.358 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.15 127.46 13.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.988 1.792 . . . . 0.0 110.861 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.09 35.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 m -112.21 148.19 34.62 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 96' ' ' ASP . 71.3 mt -77.18 121.63 30.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.857 0.36 . . . . 0.0 110.995 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -90.35 -39.76 12.5 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.2 m -158.5 149.8 20.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.585 HG23 HD21 ' A' ' 138' ' ' LEU . 95.3 mt -125.11 136.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.98 0.419 . . . . 0.0 110.494 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -112.11 99.29 7.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.95 -23.46 65.06 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.894 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.17 -36.36 66.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.954 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.33 -8.91 54.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.485 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 59.98 28.69 18.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.209 1.004 . . . . 0.0 109.0 -172.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 76.1 p -122.84 162.86 21.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 121.405 -0.81 . . . . 0.0 110.671 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.5 p -148.69 152.35 36.51 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 122.617 0.367 . . . . 0.0 110.521 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.9 t -95.31 131.12 42.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.1 m -118.43 145.65 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 91.4 t -111.49 118.67 58.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -69.14 121.9 17.7 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 123.734 0.646 . . . . 0.0 110.887 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.4 m -62.8 131.21 48.09 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.389 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.09 18.22 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.4 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.86 -42.14 5.94 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 122.508 -0.407 . . . . 0.0 111.566 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.35 61.99 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.822 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -89.4 152.66 21.38 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.8 ppt_? -133.98 140.22 46.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.554 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.3 pt-20 -153.68 158.04 40.46 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 21.9 tt0 -98.21 129.75 44.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.554 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.4 mp0 -126.56 163.16 24.03 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 124.333 1.053 . . . . 0.0 109.676 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.3 m-80 -82.88 146.98 28.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.585 HD21 HG23 ' A' ' 116' ' ' ILE . 57.3 mt -60.76 -34.34 74.31 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.316 1.055 . . . . 0.0 109.251 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.544 ' OG ' ' HA ' ' A' ' 84' ' ' ASN . 7.5 t -80.11 -8.33 59.35 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.088 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -104.89 -15.67 15.09 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.529 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.657 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.2 mt -66.37 146.82 54.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.205 0.526 . . . . 0.0 111.166 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.29 161.76 18.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.709 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -63.04 136.38 96.66 Favored Pre-proline 0 N--CA 1.396 -3.132 0 C-N-CA 124.548 1.139 . . . . 0.0 110.303 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.18 173.92 13.21 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.922 2.414 . . . . 0.0 113.445 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.55 156.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 56.7 m -91.09 97.19 11.01 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.133 0.968 . . . . 0.0 110.537 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 . . . . . 0 C--N 1.261 -3.241 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.185 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.5 p -82.58 149.85 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.361 0.264 . . . . 0.0 111.196 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.22 -77.54 0.57 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.463 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.57 20.08 3.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.005 0.907 . . . . 0.0 111.359 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -78.11 7.68 5.88 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.274 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 pp -125.32 16.57 8.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.075 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -83.21 156.05 23.38 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.601 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -118.33 113.46 21.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 85.8 m95 -101.66 161.94 13.28 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.353 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.599 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -131.17 162.87 28.97 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.85 132.32 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.91 12.47 56.56 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.275 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 75.4 m-20 -97.26 149.42 22.07 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.402 0.62 . . . . 0.0 109.839 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -86.89 139.81 30.27 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.275 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -155.96 -172.38 4.09 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.114 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 13.6 m -131.2 146.89 52.5 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.18 37.42 Favored 'General case' 0 C--N 1.274 -2.701 0 O-C-N 123.69 0.619 . . . . 0.0 109.791 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.93 118.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -65.87 120.55 13.26 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.628 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 9.0 t -61.55 -19.58 62.31 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.065 0.228 . . . . 0.0 111.324 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.97 -42.07 15.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.85 -17.91 12.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.075 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.62 89.16 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.108 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.16 161.46 14.41 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.17 130.53 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.427 ' CD2' HC11 ' A' 1148 ' ' DA2 . 86.9 m-85 -138.94 150.28 64.69 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 132.26 24.32 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.326 2.017 . . . . 0.0 111.156 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.5 149.65 32.02 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.024 0.44 . . . . 0.0 110.208 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -111.53 147.26 35.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.55 125.69 36.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.5 -35.43 10.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.02 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.2 m -158.65 148.04 19.15 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 138' ' ' LEU . 88.7 mt -125.98 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 122.64 0.376 . . . . 0.0 110.051 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.95 98.81 7.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -24.03 66.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.288 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.77 -37.41 67.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.694 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.88 -8.87 57.77 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.376 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.01 28.87 18.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.534 1.134 . . . . 0.0 108.432 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 70.2 p -125.2 160.73 28.49 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.685 -0.634 . . . . 0.0 110.492 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.2 p -148.19 153.73 39.17 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 122.704 0.402 . . . . 0.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.5 t -95.52 130.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.51 145.72 24.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.0 t -111.36 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -68.79 117.73 10.85 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.849 0.718 . . . . 0.0 111.111 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 m -60.77 131.14 49.74 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.531 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.62 -28.28 7.84 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.987 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -101.01 -42.9 6.22 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 122.508 -0.407 . . . . 0.0 111.494 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.52 14.6 63.33 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.422 -0.895 . . . . 0.0 111.891 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -86.78 151.35 23.45 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.92 135.77 39.92 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 123.131 0.269 . . . . 0.0 111.129 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.628 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.7 pt-20 -153.69 158.16 40.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.0 tt0 -96.35 131.4 42.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.482 0.658 . . . . 0.0 111.689 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.536 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.2 mp0 -128.16 163.64 24.23 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 125.27 1.428 . . . . 0.0 109.763 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 29.2 m-80 -82.67 147.55 28.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 116' ' ' ILE . 72.7 mt -59.37 -35.99 74.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.878 0.847 . . . . 0.0 110.06 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.0 m -76.82 -19.52 57.44 Favored 'General case' 0 N--CA 1.405 -2.69 0 C-N-CA 124.164 0.986 . . . . 0.0 111.63 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -93.25 -10.06 36.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.049 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -72.37 147.36 46.32 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.529 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.62 163.18 18.43 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.5 t -65.27 145.31 99.1 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.503 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 84.2 Cg_endo -76.9 -179.3 5.27 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.758 2.305 . . . . 0.0 112.325 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.1 pt -116.17 168.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.1 p -73.14 137.02 44.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 123.582 0.753 . . . . 0.0 110.115 -177.339 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.427 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 m -104.96 109.2 21.09 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 65.5 11.05 7.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.719 1.208 . . . . 0.0 113.03 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.19 79.96 1.72 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.445 0.641 . . . . 0.0 111.334 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -95.04 -13.46 25.18 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.065 0.936 . . . . 0.0 108.608 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.75 23.56 0.09 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.355 -1.293 . . . . 0.0 113.552 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -69.81 117.24 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.16 0.505 . . . . 0.0 110.327 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -107.31 128.44 54.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.428 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.1 m95 -125.12 160.24 29.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.946 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.8 pttm -131.98 160.82 34.72 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.57 129.21 26.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 13.97 39.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.591 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HB2' HD12 ' A' ' 113' ' ' ILE . 71.6 m-20 -97.91 141.03 31.4 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -84.48 144.99 28.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.428 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.01 -169.37 3.05 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -130.35 144.21 51.25 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -136.55 161.0 37.08 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.116 0.26 . . . . 0.0 110.431 -175.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -92.37 119.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.46 125.77 27.52 Favored 'General case' 0 C--O 1.205 -1.254 0 O-C-N 123.436 0.46 . . . . 0.0 109.795 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -57.96 -26.79 62.76 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -84.73 -41.83 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.248 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.89 -17.35 12.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.914 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.28 90.19 Favored Glycine 0 C--O 1.222 -0.644 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.177 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.9 m -93.15 162.05 14.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.9 mm -78.39 131.05 35.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.123 0.969 . . . . 0.0 109.605 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CD2' HC11 ' A' 1148 ' ' DA2 . 91.0 m-85 -140.26 151.42 64.44 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.636 175.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.411 ' HD3' HD11 ' A' ' 145' ' ' ILE . 55.8 Cg_endo -70.92 129.7 16.76 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.433 2.088 . . . . 0.0 111.209 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.32 150.48 35.82 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.991 0.424 . . . . 0.0 110.661 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.9 m -111.94 147.58 35.56 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' A' ' 96' ' ' ASP . 75.5 mt -77.6 120.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -93.41 -33.84 13.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.836 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.8 m -162.05 146.82 12.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.538 HG23 HD21 ' A' ' 138' ' ' LEU . 84.4 mt -121.54 138.6 51.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.79 96.05 5.75 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -65.2 -24.04 67.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.359 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.06 -39.99 71.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.396 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -85.6 -9.02 57.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 61.54 30.72 18.85 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.877 1.271 . . . . 0.0 109.141 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.9 p -129.2 165.33 21.55 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.91 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -148.71 153.67 38.55 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 122.4 0.28 . . . . 0.0 110.965 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 46.9 t -95.92 130.1 45.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.94 146.06 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.661 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 114' ' ' ALA . 90.8 t -110.4 118.84 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -69.59 118.31 12.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.752 0.658 . . . . 0.0 110.96 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 m -64.94 130.93 45.23 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.53 -19.59 43.27 Favored Glycine 0 N--CA 1.428 -1.836 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.22 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -107.68 -43.37 4.51 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.808 0.337 . . . . 0.0 111.659 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.19 8.41 66.62 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.092 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -81.3 152.76 27.41 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.5 OUTLIER -139.47 136.42 34.57 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.932 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.553 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.36 158.48 41.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -94.6 133.84 37.81 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.351 0.596 . . . . 0.0 111.475 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.553 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.3 mp0 -128.88 163.29 25.59 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 124.832 1.253 . . . . 0.0 110.376 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -81.24 148.47 29.46 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 116' ' ' ILE . 57.5 mt -62.61 -31.0 71.77 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.442 0.639 . . . . 0.0 110.763 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.2 t -80.29 -25.39 39.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.378 0.609 . . . . 0.0 109.758 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 142' ' ' LEU . 32.6 t70 -74.77 -31.25 61.71 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.568 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.76 HD11 ' SG ' ' A' ' 123' ' ' CYS . 54.1 mt -58.54 134.14 56.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.39 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 140' ' ' ASP . 5.1 mp -109.51 159.41 17.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.173 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.2 m -62.64 144.48 96.02 Favored Pre-proline 0 N--CA 1.392 -3.332 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.42 158.9 17.59 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.906 2.404 . . . . 0.0 114.676 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.411 HD11 ' HD3' ' A' ' 110' ' ' PRO . 23.8 pt -120.97 179.4 2.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.034 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 56.6 m -74.99 133.34 41.71 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-O 117.752 -1.118 . . . . 0.0 109.902 -178.192 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.461 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 111.296 0.109 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 m -72.41 108.86 5.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 77.13 -40.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 110.811 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.22 90.48 4.59 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.331 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -135.92 20.33 3.26 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 pp -98.49 12.23 35.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.125 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.03 125.69 26.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.051 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -103.12 113.56 27.14 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.416 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.0 m95 -101.84 163.33 12.31 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.329 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.5 pttm -130.83 159.28 37.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.67 128.38 25.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.03 7.32 52.86 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.153 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.508 ' HB2' HD12 ' A' ' 113' ' ' ILE . 60.5 m-20 -91.13 137.17 32.57 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -80.71 141.11 35.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.416 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -154.14 -166.27 2.32 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 m -131.32 146.95 52.51 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.07 161.92 36.71 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 122.98 0.175 . . . . 0.0 110.687 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.5 mm -91.12 116.04 31.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 123.819 0.7 . . . . 0.0 109.814 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -65.74 119.39 11.11 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 t -65.79 -14.95 62.36 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 118.205 0.457 . . . . 0.0 112.013 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.19 -41.84 19.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.69 -0.404 . . . . 0.0 112.028 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.94 -16.99 12.58 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.26 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.0 8.5 87.59 Favored Glycine 0 C--N 1.307 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.705 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.7 m -93.83 160.61 14.67 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.427 HD12 HD22 ' A' ' 142' ' ' LEU . 26.4 mm -77.17 129.64 37.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.888 0.875 . . . . 0.0 109.553 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -138.6 150.08 64.77 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 123.087 0.555 . . . . 0.0 109.966 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.06 128.3 14.67 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.556 2.171 . . . . 0.0 110.8 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.66 150.4 34.29 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.422 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.0 m -111.51 147.82 34.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 96' ' ' ASP . 62.5 mt -78.06 121.91 31.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.456 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -95.12 -32.6 13.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -159.05 148.65 18.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.568 HG23 HD21 ' A' ' 138' ' ' LEU . 91.2 mt -129.05 139.68 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 122.893 0.477 . . . . 0.0 109.977 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.68 99.1 7.89 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.55 -24.04 65.48 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.085 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -73.97 -41.61 61.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.636 0.255 . . . . 0.0 110.749 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -86.64 -8.89 57.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.029 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 61.56 32.85 18.59 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.327 1.017 . . . . 0.0 108.671 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 59.2 p -122.96 159.68 27.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.85 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.1 p -149.02 152.61 36.57 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 122.776 0.43 . . . . 0.0 111.039 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.3 t -96.37 131.22 43.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.8 m -119.45 145.3 25.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 133' ' ' ARG . 59.5 t -110.18 118.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -72.41 116.91 13.43 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 123.698 0.624 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.7 m -63.76 131.61 48.38 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.24 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.19 -22.08 36.68 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.988 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.23 -40.07 5.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.38 78.51 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.065 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -73.92 149.26 41.53 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.94 135.82 39.92 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -152.58 158.13 42.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.6 tt0 -93.71 132.7 37.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.307 0.575 . . . . 0.0 110.923 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.55 163.67 28.88 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 125.097 1.359 . . . . 0.0 107.396 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 34.4 m-80 -83.74 151.42 25.24 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 116' ' ' ILE . 75.5 mt -62.26 -36.32 81.66 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.07 0.938 . . . . 0.0 108.963 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -33.16 74.46 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -15.56 45.45 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.439 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.627 HD11 ' SG ' ' A' ' 123' ' ' CYS . 58.9 mt -65.13 146.98 54.27 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.14 0.495 . . . . 0.0 111.862 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 108' ' ' ILE . 5.3 mp -117.84 161.16 20.18 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.57 136.99 96.28 Favored Pre-proline 0 N--CA 1.405 -2.725 0 C-N-CA 124.443 1.097 . . . . 0.0 110.568 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 175.83 8.11 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 123.211 2.607 . . . . 0.0 112.903 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.76 -176.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.969 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.5 p -74.74 133.51 42.0 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.445 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 C--O 1.252 1.226 0 O-C-N 124.728 1.268 . . . . 0.0 110.843 -179.591 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.444 HC21 ' HNE' ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t30 . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.0 t -135.16 147.45 49.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.132 0.491 . . . . 0.0 111.175 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.79 -0.48 19.9 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.47 84.32 3.68 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.981 0.896 . . . . 0.0 109.827 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -145.19 32.62 1.1 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.6 14.71 12.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.163 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.28 125.43 30.33 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.396 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -111.65 109.1 18.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 79.5 m95 -101.85 163.06 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.613 -173.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.536 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.9 ptpp? -128.88 155.95 44.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -63.65 127.47 24.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.7 33.09 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.69 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 29.2 m-20 -96.2 141.3 29.73 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -82.14 143.51 31.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.445 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 27.0 p -155.23 -170.47 3.48 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 m -131.4 142.9 50.12 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.65 160.46 38.04 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.093 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.47 120.23 41.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -67.15 126.1 28.12 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.6 m -58.77 -27.16 64.72 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -85.21 -41.86 15.23 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.51 -16.36 13.68 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.318 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.77 89.89 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.06 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.5 160.47 15.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mm -78.44 128.28 38.4 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.347 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.431 ' CD2' HC11 ' A' 1148 ' ' DA2 . 86.4 m-85 -136.14 151.24 73.18 Favored Pre-proline 0 C--N 1.287 -2.145 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.66 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.88 127.9 15.15 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.411 2.074 . . . . 0.0 110.797 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.05 150.17 36.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 120.849 0.356 . . . . 0.0 110.29 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -112.04 147.83 35.17 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 96' ' ' ASP . 70.9 mt -81.35 118.91 29.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-O 120.831 0.348 . . . . 0.0 110.746 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.87 15.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.077 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.6 m -161.43 146.62 13.67 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.566 HG23 HD21 ' A' ' 138' ' ' LEU . 94.3 mt -128.64 135.97 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 122.843 0.457 . . . . 0.0 110.534 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.59 102.7 10.76 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.67 -26.09 66.03 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.041 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -70.14 -40.42 74.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.304 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.45 -8.8 58.18 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.021 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 60.36 27.57 17.16 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.23 1.014 . . . . 0.0 109.12 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -124.85 160.17 29.4 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 121.143 -0.973 . . . . 0.0 110.871 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.712 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.4 p -148.3 153.83 39.19 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 50.7 t -95.91 130.42 44.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 86.4 t -111.57 119.05 59.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -70.42 120.24 15.77 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.539 0.685 . . . . 0.0 111.068 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.1 m -64.59 132.09 48.82 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.156 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.68 -20.9 32.48 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.051 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -106.82 -50.3 3.14 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.914 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.05 3.42 59.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.489 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.4 154.49 34.81 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.7 ppt_? -137.12 139.35 41.15 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.564 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.6 pt-20 -153.51 158.28 41.07 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.9 tt0 -97.72 129.69 44.75 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.564 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 5.9 mp0 -127.5 163.48 24.02 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 124.298 1.039 . . . . 0.0 110.037 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -82.14 148.4 28.53 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 116' ' ' ILE . 67.8 mt -61.15 -31.62 71.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.084 0.945 . . . . 0.0 109.659 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.2 m -78.19 -24.09 47.28 Favored 'General case' 0 N--CA 1.392 -3.328 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.422 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.82 -32.29 31.32 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.386 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.712 HD11 ' SG ' ' A' ' 123' ' ' CYS . 54.7 mt -56.01 141.55 39.44 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 124.587 1.179 . . . . 0.0 111.689 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.79 162.32 16.46 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.485 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 t -62.64 146.56 94.11 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.65 166.99 12.42 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.354 2.036 . . . . 0.0 112.448 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.18 159.26 15.16 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.187 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 54.9 m -96.68 126.75 42.07 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 C--N 1.287 -2.125 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.373 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.431 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.458 0.171 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -75.08 89.1 2.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.576 0.703 . . . . 0.0 111.638 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.28 2.63 26.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.813 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.51 25.29 14.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.916 0.886 . . . . 0.0 111.246 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.4 m -78.52 20.47 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.891 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 pp -133.91 23.5 3.91 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.449 0.643 . . . . 0.0 110.866 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -82.75 141.87 32.05 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.263 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -103.83 114.46 28.73 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.463 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 -106.27 161.49 14.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.637 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 24.6 pttm -131.77 161.59 32.53 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.29 130.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.17 23.3 38.22 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.986 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.2 t0 -101.43 139.91 36.44 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -83.3 141.57 31.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.38 -170.95 3.52 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -129.6 141.89 50.86 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -132.29 160.66 35.57 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.253 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mm -91.99 116.88 34.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -65.7 125.51 25.5 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -30.81 63.49 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 123.539 0.736 . . . . 0.0 112.821 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -85.2 -40.7 16.38 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.33 -17.81 13.91 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.383 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.69 89.95 Favored Glycine 0 CA--C 1.507 -0.449 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.035 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 95.0 m -93.55 162.77 13.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.74 128.47 37.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.682 0.614 . . . . 0.0 109.536 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -136.3 151.41 73.23 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.86 128.02 14.48 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.185 1.923 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.85 146.36 27.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.098 0.475 . . . . 0.0 110.108 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.5 m -111.84 147.95 34.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 67.8 mt -75.87 123.53 32.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.581 0.229 . . . . 0.0 110.651 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -96.9 -32.47 12.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.2 m -160.96 146.54 14.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.582 HG23 HD21 ' A' ' 138' ' ' LEU . 98.1 mt -124.47 135.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 0.0 111.049 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.16 100.9 8.94 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -67.78 -24.16 65.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.342 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.88 -37.43 70.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.879 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -87.86 -8.71 55.48 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.294 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 61.08 30.05 19.25 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.171 0.988 . . . . 0.0 108.435 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 78.2 p -126.16 163.66 22.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.635 -0.666 . . . . 0.0 111.407 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.747 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.4 p -148.74 153.32 38.03 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.1 0.56 . . . . 0.0 110.455 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.4 t -95.34 130.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.9 m -118.89 145.54 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.4 t -109.95 118.87 57.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -71.58 121.2 18.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.801 0.688 . . . . 0.0 110.565 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -62.09 130.98 48.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.536 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.62 -16.59 39.83 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.538 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -104.56 -43.39 5.17 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.155 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.01 12.29 63.87 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.77 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.7 m-20 -85.28 151.64 23.9 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -137.72 135.26 36.25 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 15.1 pt-20 -154.06 158.03 39.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 19.5 tt0 -99.75 127.52 45.89 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.491 0.663 . . . . 0.0 111.796 -172.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.465 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 3.4 mp0 -123.04 163.68 20.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.985 1.314 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.0 m-80 -84.69 146.52 27.4 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.582 HD21 HG23 ' A' ' 116' ' ' ILE . 58.8 mt -59.5 -32.69 70.51 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.215 1.007 . . . . 0.0 109.063 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -75.25 -22.54 57.77 Favored 'General case' 0 N--CA 1.394 -3.254 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.708 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 t70 -93.29 -19.35 21.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.747 HD11 ' SG ' ' A' ' 123' ' ' CYS . 78.1 mt -61.34 141.22 57.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.919 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.61 162.94 16.11 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.822 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.9 t -62.56 141.17 96.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.33 160.77 18.62 Favored 'Trans proline' 0 CA--C 1.505 -0.945 0 C-N-CA 122.984 2.456 . . . . 0.0 113.291 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.94 -178.83 2.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.361 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 60.2 m -69.91 135.84 49.96 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.874 0.734 . . . . 0.0 110.378 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.287 -2.126 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.725 -179.555 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.7 m -68.52 115.84 8.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.177 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 74.13 -3.11 2.61 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.494 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.35 94.03 1.46 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.137 0.494 . . . . 0.0 110.904 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 t -118.49 -11.23 9.98 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.051 0.929 . . . . 0.0 109.628 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.8 20.51 15.16 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.299 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.82 127.26 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.894 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -111.33 111.65 22.85 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.604 0.716 . . . . 0.0 109.34 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.449 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 89.6 m95 -105.41 163.77 12.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.121 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.554 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.1 ptpp? -130.89 161.27 32.22 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.6 t -63.55 128.17 25.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.26 8.05 48.01 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.612 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.554 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.3 m-20 -97.1 150.01 21.32 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HD2' HG23 ' A' ' 112' ' ' THR . 27.1 mmmt -91.35 140.55 29.66 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.575 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.449 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.9 p -152.65 -169.38 3.32 Favored 'General case' 0 C--N 1.262 -3.228 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.852 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.478 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 8.7 m -130.77 146.09 52.13 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.07 160.48 38.5 Favored 'General case' 0 C--N 1.275 -2.66 0 O-C-N 123.83 0.706 . . . . 0.0 109.665 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mm -91.54 120.38 40.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.563 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 11.4 t90 -69.28 127.29 32.52 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 123.497 0.498 . . . . 0.0 109.955 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.9 m -57.79 -28.54 64.11 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.96 -42.81 14.59 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.58 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.419 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.6 t70 -107.03 -18.62 13.86 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.028 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.47 6.36 88.03 Favored Glycine 0 C--O 1.222 -0.615 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.793 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.83 163.0 13.69 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.2 mm -77.94 130.23 36.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.199 0.6 . . . . 0.0 109.385 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -137.79 149.35 64.24 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.304 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.49 128.65 14.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.268 1.979 . . . . 0.0 110.777 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.431 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.41 153.02 41.49 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.207 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 97' ' ' LYS . 4.4 m -112.08 147.42 36.08 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.01 121.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 120.856 0.36 . . . . 0.0 110.604 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.83 -39.42 11.21 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -159.46 148.57 18.14 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.634 HG23 HD21 ' A' ' 138' ' ' LEU . 90.8 mt -126.13 134.73 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.281 0.363 . . . . 0.0 111.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -112.33 99.7 8.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -64.69 -28.18 69.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.325 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.7 -39.65 64.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.188 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 122' ' ' THR . 93.3 mtt180 -81.23 -8.59 59.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.042 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 62.02 26.41 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.938 1.295 . . . . 0.0 109.055 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 120' ' ' ARG . 82.1 p -125.65 161.73 26.6 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 121.481 -0.762 . . . . 0.0 111.055 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.6 p -147.78 152.33 37.53 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 66.5 t -96.07 131.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.7 m -119.34 148.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 87.9 t -109.61 118.43 56.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 102' ' ' TRP . 94.7 m-85 -71.34 120.84 17.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 109.496 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.445 HG21 ' OE1' ' A' ' 147' ' ' GLU . 44.2 m -66.27 131.99 47.39 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.548 -175.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.36 40.42 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.042 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.8 -43.49 4.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.015 0.436 . . . . 0.0 111.415 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.2 2.46 64.09 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.201 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.0 m-20 -74.92 150.11 39.22 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.3 ppt_? -135.12 135.42 41.14 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.5 159.62 41.09 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 22.3 tt0 -93.77 136.43 34.05 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 121.865 0.84 . . . . 0.0 110.824 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -129.46 165.55 21.39 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 126.224 1.81 . . . . 0.0 108.772 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 31.2 m-80 -89.4 147.82 23.83 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.634 HD21 HG23 ' A' ' 116' ' ' ILE . 74.7 mt -61.11 -34.14 74.48 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.758 0.79 . . . . 0.0 110.296 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -71.62 -29.99 65.29 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.656 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.53 -14.55 45.54 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.643 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.7 mt -67.74 147.45 52.6 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.259 0.552 . . . . 0.0 111.074 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.82 163.39 19.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.4 t -63.17 142.94 97.76 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.478 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 37.0 Cg_endo -64.49 157.64 53.88 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 113.084 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.28 -177.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.275 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.19 132.73 49.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.814 0.34 . . . . 0.0 110.797 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 128' ' ' THR . 33.6 mt-10 . . . . . 0 C--O 1.256 1.417 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 . . . . . 0 CA--C 1.503 -0.835 0 CA-C-O 120.743 0.306 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.3 m -84.24 102.53 12.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.696 0.76 . . . . 0.0 110.132 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.53 -2.39 54.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.853 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.01 21.47 4.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.207 1.003 . . . . 0.0 110.257 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 p -82.54 14.43 3.09 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 pp -110.17 5.58 22.04 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.473 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -87.94 146.39 25.56 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.111 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -126.62 115.9 20.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 93.4 m95 -108.28 163.04 13.54 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.562 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 47.4 pttt -131.01 155.23 47.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.12 128.09 25.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.66 14.92 51.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.27 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 3.6 t0 -93.69 142.5 27.28 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -80.52 141.32 35.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.2 p -158.55 -171.36 3.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.8 m -130.61 146.45 52.12 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.8 161.09 36.92 Favored 'General case' 0 C--N 1.278 -2.539 0 O-C-N 123.26 0.35 . . . . 0.0 110.489 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mm -92.41 115.37 31.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -64.44 121.35 14.17 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.557 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 8.1 t -66.44 -15.27 63.2 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 118.216 0.462 . . . . 0.0 111.831 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -84.86 -41.93 15.55 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.992 0.425 . . . . 0.0 110.876 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -110.79 -18.0 13.22 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.662 0.744 . . . . 0.0 110.847 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.29 90.52 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.202 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.3 m -94.05 163.85 13.31 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mm -77.51 130.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 123.445 0.698 . . . . 0.0 110.109 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.29 150.61 64.91 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.327 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.84 129.92 18.35 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.53 2.153 . . . . 0.0 111.367 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.65 149.97 32.41 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.065 0.46 . . . . 0.0 110.851 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 m -112.17 147.95 35.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -76.16 128.01 37.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.637 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.96 -31.79 10.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.258 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -160.29 145.64 14.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.571 HG23 HD21 ' A' ' 138' ' ' LEU . 98.4 mt -124.09 134.35 66.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 122.85 0.46 . . . . 0.0 110.568 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.42 97.94 6.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -61.95 -25.47 67.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.63 -39.91 64.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.35 -9.17 58.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 60.96 24.83 14.88 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.953 1.301 . . . . 0.0 109.04 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 68.3 p -122.37 159.99 26.35 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -146.21 153.14 40.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.859 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 67.4 t -95.45 130.89 43.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.1 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 85.1 t -109.92 118.46 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.01 118.45 12.87 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.801 0.688 . . . . 0.0 111.236 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 131.71 46.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.93 -17.23 56.17 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.079 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.85 -49.28 3.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.952 0.406 . . . . 0.0 110.711 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.63 4.78 59.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.314 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.81 154.93 33.45 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 122.178 0.191 . . . . 0.0 110.549 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.48 136.29 39.31 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.364 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.557 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.8 pt-20 -153.37 158.72 41.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 24.5 tt0 -96.55 129.12 43.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.598 0.713 . . . . 0.0 111.987 -175.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.533 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.9 mp0 -128.19 163.42 24.74 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.245 1.418 . . . . 0.0 110.007 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.0 m-80 -82.17 146.25 29.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.571 HD21 HG23 ' A' ' 116' ' ' ILE . 67.7 mt -59.43 -34.72 72.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.09 0.948 . . . . 0.0 109.724 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -77.04 -20.34 56.02 Favored 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.424 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 6.2 t70 -90.01 -28.14 19.28 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -175.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.669 HD11 ' SG ' ' A' ' 123' ' ' CYS . 77.1 mt -52.2 137.48 28.17 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 124.695 1.247 . . . . 0.0 111.739 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.19 162.68 14.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.975 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.7 m -62.49 139.37 96.66 Favored Pre-proline 0 N--CA 1.399 -2.976 0 C-N-CA 123.796 0.838 . . . . 0.0 109.344 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.471 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 51.7 Cg_endo -68.1 169.59 16.27 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.627 2.218 . . . . 0.0 112.811 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.79 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.244 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.6 p -53.89 136.29 40.92 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 124.085 0.866 . . . . 0.0 110.87 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.727 1.211 . . . . 0.0 110.905 -177.917 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.508 -0.642 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.5 m -144.04 118.88 9.91 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.79 21.59 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.46 75.67 0.39 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.035 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -111.57 24.3 12.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.232 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.77 17.18 10.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.808 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.19 149.69 37.22 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.66 114.09 26.9 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.404 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 83.5 m95 -101.2 152.85 20.16 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.115 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 21.9 pttm -131.11 162.64 29.42 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.3 129.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.73 13.99 41.93 Favored Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.835 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.544 ' HB2' HD12 ' A' ' 113' ' ' ILE . 53.8 m-20 -96.43 140.06 31.64 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -84.89 139.91 31.51 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.404 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -151.96 -169.49 3.38 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 123.551 0.532 . . . . 0.0 109.573 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.4 m -130.03 144.23 51.22 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.517 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -134.5 160.24 38.62 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.949 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.67 114.64 31.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -61.71 126.9 28.98 Favored 'General case' 0 C--O 1.203 -1.348 0 O-C-N 124.03 0.831 . . . . 0.0 110.325 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.7 m -57.17 -29.9 64.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.24 -37.27 20.26 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.0 -17.07 10.45 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.509 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.8 8.23 87.71 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.257 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.4 160.07 15.27 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.97 131.22 35.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.425 ' CD2' HC11 ' A' 1148 ' ' DA2 . 90.7 m-85 -139.89 149.47 59.11 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.03 128.04 16.09 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.602 2.201 . . . . 0.0 111.055 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.88 35.61 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.848 0.356 . . . . 0.0 110.379 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -111.8 147.49 35.59 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 96' ' ' ASP . 68.5 mt -78.9 120.17 29.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.71 -31.95 13.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.495 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -159.97 144.96 15.05 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 138' ' ' LEU . 83.6 mt -120.83 134.69 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -113.35 98.52 7.15 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -67.72 -23.86 65.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.36 -40.43 85.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.875 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.95 -8.66 55.39 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.16 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 63.28 27.25 15.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.954 1.301 . . . . 0.0 108.585 -175.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 60.9 p -125.76 166.74 16.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.9 p -148.38 151.95 36.19 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 122.911 0.484 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.0 t -95.81 129.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.5 145.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 121.133 0.492 . . . . 0.0 109.706 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 93.3 t -109.29 118.97 57.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -71.28 121.09 17.82 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.313 0.577 . . . . 0.0 110.857 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.0 m -69.03 131.4 44.98 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.034 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.03 57.29 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.665 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -111.12 -48.81 3.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 122.453 -0.439 . . . . 0.0 111.608 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.34 10.79 57.94 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -83.13 153.02 25.04 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.91 135.73 38.04 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.35 158.69 40.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -96.79 130.39 44.06 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.797 0.808 . . . . 0.0 112.229 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.517 ' NE2' ' HB1' ' A' ' 100' ' ' ALA . 6.2 mp0 -126.0 163.36 23.18 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.36 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.7 m-80 -84.28 144.9 28.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.576 HD21 HG23 ' A' ' 116' ' ' ILE . 70.4 mt -60.06 -35.39 75.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.535 0.683 . . . . 0.0 110.614 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -73.32 -29.34 62.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -82.51 -14.06 55.61 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.788 -177.085 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.658 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.1 mt -66.23 143.93 56.93 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.573 0.546 . . . . 0.0 111.517 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.05 158.83 23.51 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 t -63.25 144.97 97.33 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.513 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 46.4 Cg_endo -65.92 165.01 25.05 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.956 1.771 . . . . 0.0 112.531 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 pt -94.88 -177.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.285 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.85 137.89 52.11 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--N 1.306 -1.301 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.785 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.425 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.436 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 p -76.05 87.73 2.97 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.287 0.565 . . . . 0.0 110.33 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -170.79 -48.84 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.901 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.83 102.04 2.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.3 m -120.01 31.89 6.3 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.43 1.109 . . . . 0.0 108.312 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.65 18.25 10.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.335 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.446 ' HB3' ' NE1' ' A' ' 92' ' ' TRP . 24.2 mp0 -70.68 138.84 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -130.94 116.67 18.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.446 ' NE1' ' HB3' ' A' ' 90' ' ' GLN . 86.1 m95 -120.45 162.24 19.88 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.071 -175.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.9 ptpp? -131.57 161.53 32.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.91 128.23 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 15.22 33.67 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.739 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 72.7 m-20 -102.29 145.54 29.31 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 18.8 mmmt -88.06 141.42 28.58 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.167 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.443 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.24 -171.52 3.94 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 123.892 0.745 . . . . 0.0 109.056 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 m -131.69 143.86 50.58 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 173.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -135.22 160.92 36.86 Favored 'General case' 0 C--N 1.273 -2.733 0 O-C-N 123.514 0.509 . . . . 0.0 110.211 -174.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 mm -92.21 118.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -67.46 124.81 24.22 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 m -59.0 -26.42 64.5 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -84.49 -41.84 16.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.998 -173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -111.38 -17.47 13.12 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.864 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 4.74 89.9 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.105 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.62 160.18 15.13 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -76.71 129.02 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 O-C-N 124.002 0.814 . . . . 0.0 109.442 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.435 ' CD2' HC11 ' A' 1148 ' ' DA2 . 93.5 m-85 -137.97 148.04 58.78 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.17 127.72 16.35 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.62 2.214 . . . . 0.0 110.895 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.51 38.33 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.752 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -112.16 147.48 36.04 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 96' ' ' ASP . 62.6 mt -77.46 121.86 30.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 123.076 0.235 . . . . 0.0 110.368 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.65 13.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.1 p -160.63 145.14 14.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.692 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.579 HG23 HD21 ' A' ' 138' ' ' LEU . 97.8 mt -124.42 135.24 64.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 110.784 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -112.9 101.81 9.85 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.63 -24.97 65.51 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.72 0.295 . . . . 0.0 111.198 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.25 -37.09 66.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.304 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -86.81 -8.95 56.86 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.841 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 60.35 28.98 18.63 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 122.634 1.207 . . . . 0.0 109.184 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.403 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 70.8 p -126.33 162.39 25.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.852 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.67 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.7 p -148.33 152.16 36.6 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.261 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 99.4 t -95.37 130.96 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.9 m -118.3 145.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.9 t -110.7 118.38 57.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -68.42 119.13 12.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.694 0.621 . . . . 0.0 110.568 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.6 m -63.6 131.01 46.66 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.756 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.0 -18.0 47.41 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.269 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -108.33 -37.57 5.96 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 122.395 -0.474 . . . . 0.0 111.747 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 13.52 76.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.623 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -85.59 151.97 23.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.5 ppt_? -135.66 137.26 41.64 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.193 0.308 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.0 pt-20 -153.62 158.69 41.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 20.6 tt0 -97.91 129.75 44.82 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.537 0.684 . . . . 0.0 111.353 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.571 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.1 mp0 -126.53 163.58 23.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 124.494 1.118 . . . . 0.0 109.755 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.8 m-80 -82.14 145.48 30.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.579 HD21 HG23 ' A' ' 116' ' ' ILE . 76.5 mt -57.95 -36.35 72.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.742 0.782 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -77.58 -19.54 55.47 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.4 t70 -84.96 -30.91 23.87 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.844 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.67 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.9 mt -51.9 132.12 31.7 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.655 1.222 . . . . 0.0 111.918 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.39 164.16 12.07 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.953 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.3 t -63.3 138.53 97.37 Favored Pre-proline 0 C--N 1.308 -1.215 0 O-C-N 124.172 0.92 . . . . 0.0 109.07 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.61 173.34 14.67 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 122.872 2.382 . . . . 0.0 113.191 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 pt -112.36 157.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.814 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.0 m -66.0 135.71 55.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.91 0.756 . . . . 0.0 109.499 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.656 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.452 HC21 ' HNE' ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.404 HG22 ' OG ' ' A' ' 88' ' ' SER . 7.6 m -125.31 80.72 1.91 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.07 -26.83 7.91 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.214 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . . . -86.9 3.2 46.52 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.568 -176.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 139' ' ' SER . 16.5 p -82.85 3.85 27.91 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.604 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.68 22.24 2.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.695 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.435 ' HG2' ' HA ' ' A' ' 87' ' ' ALA . 29.9 mm-40 -69.01 127.52 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.085 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -97.07 124.62 41.12 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 92.6 m95 -122.32 160.01 26.23 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.029 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.622 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.8 ptpp? -131.25 162.48 29.91 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.6 t -63.74 128.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.64 13.64 37.25 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.918 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.622 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.6 m-20 -100.64 141.5 33.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -83.02 143.62 30.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.97 -169.48 3.27 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 m -132.59 145.98 51.54 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.37 161.2 36.94 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 123.781 0.676 . . . . 0.0 110.08 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.0 119.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.27 125.14 25.78 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -58.77 -24.59 61.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -85.0 -41.74 15.53 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.933 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -111.51 -17.86 12.97 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 118.733 -1.187 . . . . 0.0 111.187 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.26 89.73 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.181 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.19 162.29 14.08 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -77.58 129.79 37.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.856 0.723 . . . . 0.0 109.687 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -137.8 151.4 70.41 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 123.639 0.776 . . . . 0.0 109.137 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.96 128.62 14.25 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.11 149.46 36.58 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.976 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -111.51 147.5 35.22 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 64.4 mt -77.12 122.09 30.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.505 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -95.89 -33.11 12.33 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.735 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.7 m -160.58 148.73 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.595 HG23 HD21 ' A' ' 138' ' ' LEU . 93.2 mt -126.44 135.72 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.91 99.86 8.44 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -66.43 -23.94 66.38 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.079 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.24 -37.65 69.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.235 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -87.79 -8.9 55.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.994 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 30.4 tt0 61.03 24.74 14.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p -122.77 161.08 24.64 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.0 p -146.53 151.9 38.1 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.427 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.7 t -95.37 130.21 44.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.04 145.68 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.7 t -111.0 118.67 57.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -69.07 118.67 12.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 123.718 0.636 . . . . 0.0 110.21 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 53.1 m -63.66 131.02 46.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.403 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.39 -26.56 10.08 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.896 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -96.84 -47.27 5.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.967 0.413 . . . . 0.0 110.616 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.8 60.1 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.363 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -82.76 152.1 25.86 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -139.03 136.31 35.16 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.169 0.293 . . . . 0.0 110.77 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.5 pt-20 -153.07 158.07 41.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -95.8 133.21 40.2 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.455 0.645 . . . . 0.0 112.077 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.478 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 8.5 mp0 -131.98 163.78 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 125.157 1.383 . . . . 0.0 109.967 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.4 m-80 -81.15 148.2 29.69 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 116' ' ' ILE . 65.2 mt -59.21 -36.11 74.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.261 1.029 . . . . 0.0 108.933 175.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.429 ' HB3' ' HA ' ' A' ' 88' ' ' SER . 42.3 m -75.53 -18.09 59.9 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.992 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -98.06 -7.29 30.03 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.379 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.64 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.7 mt -72.97 139.89 47.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.417 0.627 . . . . 0.0 111.042 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.9 166.06 11.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.781 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.3 t -64.84 137.83 97.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.0 171.47 11.2 Favored 'Trans proline' 0 CA--C 1.508 -0.808 0 C-N-CA 123.04 2.493 . . . . 0.0 112.969 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.6 pt -79.79 162.67 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.7 m -92.46 133.13 36.2 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--N 1.285 -2.215 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -179.096 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.2 m 65.39 76.24 0.33 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.776 0.672 . . . . 0.0 111.672 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 63.07 17.36 10.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.654 1.182 . . . . 0.0 112.283 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . -105.71 22.91 14.74 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.467 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 p -81.22 24.53 0.53 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 123.645 0.778 . . . . 0.0 111.712 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 pp -114.41 15.87 17.87 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 124.265 1.026 . . . . 0.0 111.385 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 85.6 mm-40 -71.84 136.49 47.02 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -122.41 135.29 54.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.469 ' NE1' ' HB3' ' A' ' 90' ' ' GLN . 87.8 m95 -133.96 164.31 27.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 63.5 pttt -126.36 157.95 37.16 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.72 131.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 18.71 54.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.737 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 4.7 t0 -100.8 133.21 45.6 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG2' HG23 ' A' ' 112' ' ' THR . 68.0 mttt -80.47 148.01 30.66 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.115 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.6 p -155.1 -168.76 2.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.981 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 m -131.71 145.29 51.55 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.06 160.79 37.23 Favored 'General case' 0 C--N 1.277 -2.585 0 O-C-N 123.569 0.543 . . . . 0.0 110.189 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.15 117.16 34.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.422 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 9.8 t90 -67.54 122.92 19.04 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -59.67 -23.57 63.2 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 24.9 mm-40 -84.83 -42.11 15.42 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -108.47 -18.45 13.74 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.69 6.93 89.07 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.679 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.8 m -94.42 161.91 14.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.19 128.26 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 O-C-N 123.904 0.753 . . . . 0.0 109.796 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.35 148.87 67.97 Favored Pre-proline 0 C--N 1.288 -2.104 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.665 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.16 129.94 15.78 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.404 2.07 . . . . 0.0 111.289 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.79 151.27 35.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.145 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.421 HG23 ' HG2' ' A' ' 97' ' ' LYS . 12.5 m -112.36 147.64 35.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 96' ' ' ASP . 71.3 mt -77.08 120.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.913 0.387 . . . . 0.0 111.133 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -92.59 -31.99 14.97 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.613 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.0 m -162.38 151.64 15.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.606 HG23 HD21 ' A' ' 138' ' ' LEU . 97.5 mt -127.6 135.87 62.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 122.712 0.405 . . . . 0.0 110.754 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.32 98.14 7.1 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -67.65 -23.84 65.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.017 0.437 . . . . 0.0 111.367 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -73.2 -36.4 66.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.473 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -90.61 -8.8 49.15 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 59.81 29.61 19.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.514 1.126 . . . . 0.0 108.645 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 72.0 p -122.06 162.18 21.67 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.869 -0.519 . . . . 0.0 110.088 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 141' ' ' LEU . 5.6 p -148.69 153.74 38.66 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -97.37 130.44 46.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 26.6 m -119.06 146.02 24.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 90.6 t -109.69 118.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.8 119.31 13.83 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 123.731 0.645 . . . . 0.0 110.811 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -61.66 131.74 50.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.32 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.64 -23.22 17.27 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.271 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -101.73 -46.83 4.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.24 6.65 61.34 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.865 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -80.09 151.57 29.79 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.6 ppt_? -135.77 136.84 41.07 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.55 158.79 41.76 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 20.3 tt0 -94.7 132.22 39.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.655 0.74 . . . . 0.0 110.253 -176.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -127.3 165.31 19.94 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 126.037 1.735 . . . . 0.0 108.484 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.6 m-80 -87.51 145.29 26.31 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 116' ' ' ILE . 78.7 mt -58.02 -38.44 76.2 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -75.28 -22.69 57.58 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.75 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.6 m-20 -89.5 -12.86 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.299 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.7 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.2 mt -68.55 146.61 52.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.317 0.58 . . . . 0.0 110.733 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.43 165.19 13.25 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.1 t -64.51 139.08 97.64 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.167 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.24 173.17 12.67 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.198 2.598 . . . . 0.0 112.418 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.06 157.34 3.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.879 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 m -74.19 132.61 42.35 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--N 1.292 -1.93 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.793 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.51 -0.575 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.1 m -80.01 113.04 17.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.64 -59.99 3.1 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.506 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.61 147.56 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -130.38 22.95 5.16 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.895 0.855 . . . . 0.0 110.032 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.07 38.02 2.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.136 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -62.12 132.52 53.1 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.704 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -127.5 131.74 50.07 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 87.5 m95 -129.64 163.75 25.4 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.037 -174.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -130.2 158.72 38.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.75 127.85 23.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.19 11.67 48.16 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.48 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.547 ' HB2' HD12 ' A' ' 113' ' ' ILE . 18.2 m-20 -92.76 135.67 33.91 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -81.9 146.1 29.99 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.411 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.5 p -159.58 -172.78 3.83 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.636 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.6 m -129.02 144.19 51.11 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.12 161.09 36.32 Favored 'General case' 0 C--N 1.278 -2.537 0 O-C-N 123.798 0.686 . . . . 0.0 110.412 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.28 116.74 34.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -67.21 121.17 15.07 Favored 'General case' 0 C--O 1.193 -1.881 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.508 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 20.6 t -64.2 -17.2 63.31 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.146 0.43 . . . . 0.0 111.752 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -83.28 -41.95 17.72 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.335 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -112.75 -17.76 12.47 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.881 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.43 3.89 90.36 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.115 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 81.2 m -93.63 162.95 13.74 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.8 mm -77.66 130.34 36.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.431 ' CG ' HC11 ' A' 1148 ' ' DA2 . 89.1 m-85 -139.77 151.52 66.08 Favored Pre-proline 0 C--N 1.303 -1.443 0 C-N-CA 123.455 0.702 . . . . 0.0 110.271 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.34 128.35 15.38 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.958 2.438 . . . . 0.0 111.789 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.57 149.67 31.98 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.121 0.486 . . . . 0.0 111.019 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 m -112.63 147.04 37.56 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 96' ' ' ASP . 67.6 mt -78.13 121.39 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.199 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.86 -35.7 13.22 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.578 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.1 m -159.52 149.78 18.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.564 HG23 HD21 ' A' ' 138' ' ' LEU . 94.5 mt -125.67 138.18 55.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.742 0.417 . . . . 0.0 110.777 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -112.97 98.32 7.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -65.27 -25.79 67.8 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.536 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -73.27 -38.6 65.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.214 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.45 -8.55 58.32 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.864 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 63.07 25.62 15.04 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 124.646 1.178 . . . . 0.0 108.772 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 74.2 p -124.76 163.99 20.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 111.072 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.8 p -148.63 153.41 38.28 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 122.693 0.397 . . . . 0.0 110.312 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.07 130.25 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.1 m -118.46 147.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.7 t -110.32 118.73 57.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.45 116.92 10.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.825 0.703 . . . . 0.0 110.468 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -65.04 131.47 46.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.96 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.76 -20.48 38.7 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -104.51 -47.65 4.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.978 0.418 . . . . 0.0 110.447 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.53 18.41 41.75 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.991 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -91.05 155.62 18.54 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.4 ppt_? -134.95 136.5 42.31 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.514 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.7 pt-20 -153.96 158.55 40.82 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 17.4 tt0 -95.39 132.85 39.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.71 0.767 . . . . 0.0 111.228 -176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.408 ' OE1' HG22 ' A' ' 125' ' ' VAL . 9.0 mp0 -125.44 164.64 20.0 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 125.84 1.656 . . . . 0.0 109.61 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.1 m-80 -88.11 143.67 26.93 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.564 HD21 HG23 ' A' ' 116' ' ' ILE . 84.5 mt -58.03 -36.28 72.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.357 0.598 . . . . 0.0 110.683 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.6 m -75.16 -23.71 57.81 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.856 0.863 . . . . 0.0 111.459 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 2.5 m-20 -91.06 -11.54 38.42 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.806 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.706 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.7 mt -68.71 142.11 55.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.03 163.85 14.61 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.3 t -63.17 143.43 97.65 Favored Pre-proline 0 C--O 1.252 1.189 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.38 160.79 12.88 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 123.499 2.799 . . . . 0.0 114.071 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.79 -173.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.343 -175.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 61.0 m -57.37 139.1 53.98 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.8 0.688 . . . . 0.0 111.045 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--N 1.3 -1.55 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.605 -176.05 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.431 HC11 ' CG ' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.1 m -84.89 82.44 8.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 122.054 0.931 . . . . 0.0 110.118 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 177.87 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 29.43 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.136 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 m -83.73 2.51 37.52 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.851 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.71 4.55 24.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.915 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -83.56 141.77 31.35 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.96 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -132.18 121.78 24.24 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -116.47 160.66 20.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.639 -171.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.06 163.31 22.64 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.85 127.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.85 7.99 52.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.13 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 113' ' ' ILE . 21.2 m-20 -91.35 135.42 33.83 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -74.44 146.4 42.88 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.368 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -160.04 -172.59 3.68 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.894 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.5 m -129.36 142.92 50.69 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.56 160.6 37.55 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.392 0.433 . . . . 0.0 110.699 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.435 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.0 t90 -65.61 119.53 11.3 Favored 'General case' 0 C--O 1.199 -1.585 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.504 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 6.4 t -66.95 -14.96 63.37 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.677 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.37 -42.39 17.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.602 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.435 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.8 t70 -109.49 -18.61 13.48 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.484 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.38 7.79 88.2 Favored Glycine 0 C--N 1.313 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.119 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.3 m -94.3 161.71 14.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.0 mm -79.14 129.33 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -137.52 150.85 69.73 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 127.84 14.98 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.566 2.178 . . . . 0.0 110.97 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.61 147.67 30.29 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.076 0.465 . . . . 0.0 110.465 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.4 m -112.53 147.16 37.19 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 96' ' ' ASP . 78.0 mt -75.47 126.21 35.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.919 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.41 12.13 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -159.34 148.32 18.18 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 138' ' ' LEU . 87.0 mt -127.53 135.67 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.911 0.484 . . . . 0.0 110.025 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.09 96.36 5.99 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.15 -24.17 65.87 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.556 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -74.11 -34.08 63.81 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.69 -8.95 57.89 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.783 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 61.7 30.76 18.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.752 1.221 . . . . 0.0 108.624 -173.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 69.0 p -124.89 165.24 18.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.714 -0.616 . . . . 0.0 110.86 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.737 ' SG ' HD11 ' A' ' 141' ' ' LEU . 6.7 p -148.66 155.18 40.69 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.313 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.1 130.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -118.52 147.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.5 t -109.83 118.89 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -70.59 119.97 15.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.638 0.586 . . . . 0.0 110.72 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.8 m -64.56 131.45 47.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.096 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.07 -22.78 30.06 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -105.54 -41.81 5.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.16 0.505 . . . . 0.0 111.14 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.94 81.31 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -77.63 154.67 32.0 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -135.97 138.02 41.87 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.0 pt-20 -154.02 159.3 41.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -94.18 133.63 37.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.991 0.9 . . . . 0.0 111.57 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 125' ' ' VAL . 10.3 mp0 -128.87 164.85 22.21 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 125.75 1.62 . . . . 0.0 108.989 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 25.8 m-80 -89.92 145.82 24.85 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 116' ' ' ILE . 79.5 mt -59.39 -34.79 72.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.394 0.616 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -25.41 54.95 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.519 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.2 -13.28 38.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.139 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.737 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.2 mt -66.77 145.5 55.45 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.048 0.451 . . . . 0.0 110.754 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.93 160.96 18.23 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 t -67.53 145.71 98.39 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.33 170.39 9.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.828 2.352 . . . . 0.0 113.131 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.0 pt -103.93 175.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 35.3 t -84.3 144.33 28.94 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.863 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.051 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.441 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.8 OUTLIER . . . . . 0 CA--C 1.501 -0.926 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.5 m 60.41 90.13 0.06 Allowed 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.247 1.019 . . . . 0.0 111.97 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.45 -19.28 39.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.136 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.4 38.94 0.95 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.652 0.381 . . . . 0.0 110.969 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.6 p -69.79 -3.51 15.91 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.525 0.678 . . . . 0.0 112.091 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.11 31.45 0.1 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.204 1.401 . . . . 0.0 112.483 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -66.26 138.53 57.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.304 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.37 139.0 49.24 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 92.8 m95 -125.73 161.5 27.18 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.48 0.181 . . . . 0.0 111.421 -174.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.7 ptpp? -131.25 157.26 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.48 129.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.54 13.26 57.26 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.95 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.6 t0 -95.35 140.69 29.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -84.65 144.84 28.33 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.1 p -153.73 -170.06 3.47 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.1 m -130.81 141.25 50.33 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.94 160.62 37.14 Favored 'General case' 0 C--N 1.279 -2.458 0 O-C-N 123.624 0.578 . . . . 0.0 110.456 -174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.21 115.84 32.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.6 t90 -66.33 121.98 16.48 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 t -63.19 -21.65 66.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.301 0.572 . . . . 0.0 111.68 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 15.2 mm-40 -84.65 -33.36 23.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.4 t70 -117.04 -18.27 10.13 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.65 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.7 88.86 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.882 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.26 162.73 13.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.64 131.43 34.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.208 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.425 ' CD2' HC11 ' A' 1148 ' ' DA2 . 92.6 m-85 -139.62 151.21 65.78 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.728 175.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.62 127.98 15.49 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 111.166 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.66 149.02 32.66 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.994 0.426 . . . . 0.0 109.971 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -111.92 147.81 35.05 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.0 mt -79.13 121.57 32.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.568 0.223 . . . . 0.0 111.069 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.95 -32.21 13.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.087 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 m -159.4 147.73 17.69 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.552 HG23 HD21 ' A' ' 138' ' ' LEU . 89.7 mt -126.91 141.22 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.41 96.36 6.06 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 172.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -67.92 -24.02 65.15 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.761 0.315 . . . . 0.0 111.345 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.58 -39.31 64.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.293 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -90.63 -8.11 50.93 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.733 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 64.44 33.43 11.13 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.517 1.135 . . . . 0.0 109.245 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 81.5 p -123.79 164.83 18.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.935 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.716 ' SG ' HD11 ' A' ' 141' ' ' LEU . 6.3 p -149.91 157.28 43.01 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 123.013 0.525 . . . . 0.0 110.768 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.4 t -102.2 131.42 50.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.2 m -118.58 146.04 23.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 121.231 0.539 . . . . 0.0 109.831 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 92.3 t -111.09 118.61 57.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -71.19 119.84 15.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.696 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 m -67.2 130.67 43.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.727 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.71 -16.52 59.99 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.009 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -111.97 -35.09 5.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.76 4.0 90.25 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.492 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -78.18 157.2 29.46 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -141.41 136.42 31.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.8 pt-20 -152.95 158.41 42.05 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 29.7 tt0 -95.51 137.39 34.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.123 0.487 . . . . 0.0 111.185 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.501 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -137.94 159.0 43.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 124.402 1.081 . . . . 0.0 109.699 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 30.8 m-80 -81.39 147.67 29.69 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.552 HD21 HG23 ' A' ' 116' ' ' ILE . 81.7 mt -60.81 -36.07 78.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.094 0.473 . . . . 0.0 111.414 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 t -80.89 -16.27 54.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.045 0.45 . . . . 0.0 110.418 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.82 -32.26 40.67 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.716 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.5 mt -56.92 141.11 46.33 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.7 1.25 . . . . 0.0 111.718 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.2 159.92 19.57 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.561 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.8 t -63.11 141.9 97.73 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.86 161.46 43.89 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.263 1.975 . . . . 0.0 113.274 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 pt -104.88 177.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.714 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 39.1 t -77.42 142.41 39.24 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 121.158 0.504 . . . . 0.0 109.812 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.379 -178.974 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.427 HC21 ' HNE' ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 m -73.51 101.5 3.56 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.46 -33.15 1.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.461 ' HB1' ' NE2' ' A' ' 90' ' ' GLN . . . -124.99 23.55 7.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.567 0.698 . . . . 0.0 111.158 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -87.66 9.86 20.02 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.449 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -107.89 7.23 27.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.391 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.461 ' NE2' ' HB1' ' A' ' 87' ' ' ALA . 46.3 mt-30 -87.83 122.79 31.9 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.415 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.0 129.44 55.45 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.5 m95 -115.78 162.33 17.44 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.524 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.579 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.0 ptpp? -130.84 160.15 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.69 128.16 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.61 13.35 41.29 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.196 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.579 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 13.2 m-20 -98.03 135.29 39.94 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -78.41 145.49 35.1 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.407 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.454 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -157.04 -169.23 2.88 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.817 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 m -133.6 146.14 50.68 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -138.21 161.64 36.32 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.356 0.41 . . . . 0.0 110.183 -174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.16 118.71 38.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 10.3 t90 -68.17 127.52 33.22 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.556 0.535 . . . . 0.0 109.954 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 m -56.36 -30.85 63.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -85.18 -41.12 15.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.3 t70 -109.19 -17.15 13.92 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.1 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.22 4.81 84.52 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.968 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.5 m -93.58 162.46 13.95 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -78.48 126.88 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.868 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.415 ' CD2' HC11 ' A' 1148 ' ' DA2 . 94.8 m-85 -136.18 148.39 64.34 Favored Pre-proline 0 C--N 1.283 -2.288 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.832 175.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.58 128.67 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.659 2.239 . . . . 0.0 111.259 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.98 152.47 41.1 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -112.24 147.81 35.45 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 96' ' ' ASP . 74.5 mt -79.28 118.03 25.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 123.221 0.326 . . . . 0.0 110.937 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.78 -30.49 15.46 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.76 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.1 m -161.47 145.64 13.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.586 HG23 HD21 ' A' ' 138' ' ' LEU . 87.7 mt -123.39 134.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 120.852 0.358 . . . . 0.0 110.125 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 11.3 t70 -111.89 96.85 6.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -65.86 -23.71 66.72 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.112 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -71.52 -40.67 69.97 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' OD1' ' A' ' 117' ' ' ASP . 93.2 mtt180 -82.58 -9.45 59.39 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.466 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 62.91 29.61 16.54 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.195 1.398 . . . . 0.0 108.135 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 137' ' ' ASN . 74.8 p -131.08 168.47 17.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.106 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.751 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -148.79 155.46 40.98 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.502 0.321 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.8 t -95.86 130.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.55 145.52 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 133' ' ' ARG . 89.5 t -109.73 118.62 57.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.91 120.3 15.43 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 123.758 0.661 . . . . 0.0 111.576 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.462 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.42 -21.93 42.85 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.548 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -111.39 -43.14 3.74 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.612 0.244 . . . . 0.0 111.378 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 8.3 64.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.443 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.5 m-20 -80.39 153.33 28.38 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.76 -0.259 . . . . 0.0 110.419 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.0 ppt_? -137.69 135.24 36.29 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.057 0.456 . . . . 0.0 111.417 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.42 158.71 41.84 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.4 tt0 -94.44 135.11 36.23 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.174 0.511 . . . . 0.0 111.392 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.504 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -131.85 160.25 36.2 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.266 1.026 . . . . 0.0 110.478 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 26.1 m-80 -79.42 144.32 34.2 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 116' ' ' ILE . 75.3 mt -62.4 -33.2 74.3 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.945 0.879 . . . . 0.0 110.376 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.9 t -80.04 -21.46 43.45 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.71 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 23.1 t70 -83.6 -32.79 25.56 Favored 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.751 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.0 mt -51.07 134.48 26.51 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 125.046 1.466 . . . . 0.0 111.902 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.31 161.96 14.53 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.6 m -63.03 146.87 95.31 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.51 174.34 7.52 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 113.661 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.08 160.92 5.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.784 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.9 m -83.44 127.69 33.91 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.359 -179.267 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.429 HC21 ' HNE' ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.424 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m 61.94 77.57 0.32 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.732 0.813 . . . . 0.0 109.963 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.89 -42.75 63.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.312 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.44 112.31 16.12 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -98.32 13.67 30.66 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.409 0.623 . . . . 0.0 110.289 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -103.23 16.48 26.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.142 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -71.26 137.81 48.91 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -136.23 136.89 40.27 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.42 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.2 m95 -116.27 157.17 25.36 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.37 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.6 ptpp? -129.76 162.61 28.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.68 127.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.06 15.05 40.25 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.491 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 22.5 m-20 -98.0 136.78 37.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 117.133 0.466 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -77.47 145.07 37.3 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.48 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.7 p -156.18 -165.87 2.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.499 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 m -139.42 149.44 44.07 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -140.32 161.53 37.47 Favored 'General case' 0 C--N 1.278 -2.502 0 O-C-N 123.877 0.735 . . . . 0.0 110.078 -173.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.82 120.05 40.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.446 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 10.1 t90 -69.65 125.89 28.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -58.93 -25.04 63.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 21.0 mm-40 -84.87 -37.73 20.3 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -174.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -117.41 -18.22 9.89 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.982 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.6 86.95 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.212 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.2 m -92.93 160.19 15.0 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.85 126.12 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 C-N-CA 123.848 0.859 . . . . 0.0 109.016 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.439 ' CD2' HC11 ' A' 1148 ' ' DA2 . 86.2 m-85 -134.58 149.51 71.11 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.18 128.09 17.89 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.914 2.409 . . . . 0.0 110.902 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.88 149.52 34.42 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.843 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.3 m -113.85 147.76 37.84 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.461 HD12 ' HB2' ' A' ' 96' ' ' ASP . 75.8 mt -76.89 126.23 37.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.63 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -33.1 11.24 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 m -161.33 149.57 15.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.579 HG23 HD21 ' A' ' 138' ' ' LEU . 87.3 mt -128.82 140.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.513 0.725 . . . . 0.0 109.966 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -113.04 98.87 7.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.03 -23.76 67.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.447 -174.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -73.42 -40.52 64.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -87.8 -8.32 56.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.026 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 61.4 28.29 17.73 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.856 0.862 . . . . 0.0 108.793 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 68.9 p -122.02 159.56 26.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 121.7 -0.625 . . . . 0.0 110.55 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.66 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.4 p -148.22 152.37 37.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.654 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 59.4 t -95.99 130.56 44.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.5 m -118.06 145.77 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.1 t -111.53 118.55 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.36 116.67 10.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 124.042 0.839 . . . . 0.0 110.503 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 m -62.93 131.13 47.69 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.072 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.79 -27.98 12.78 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -101.81 -42.97 5.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.938 0.399 . . . . 0.0 110.758 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.21 1.58 75.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -72.24 149.39 44.6 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.3 ppt_? -133.64 136.18 44.63 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.507 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 7.7 pt-20 -153.46 158.39 41.29 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.6 tt0 -95.95 134.53 38.84 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.528 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -134.05 157.51 45.93 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.374 1.069 . . . . 0.0 109.802 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 32.3 m-80 -79.43 147.26 32.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.579 HD21 HG23 ' A' ' 116' ' ' ILE . 77.8 mt -58.28 -34.32 70.39 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.674 0.75 . . . . 0.0 110.078 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -76.59 -24.65 53.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.199 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.23 -12.87 45.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.176 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.66 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -70.29 143.09 52.17 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 123.479 0.487 . . . . 0.0 111.41 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.31 160.67 18.82 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.617 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -63.15 140.88 97.73 Favored Pre-proline 0 N--CA 1.401 -2.89 0 C-N-CA 124.602 1.161 . . . . 0.0 110.327 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.39 179.18 5.76 Favored 'Trans proline' 0 C--O 1.252 1.197 0 C-N-CA 122.714 2.276 . . . . 0.0 112.807 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.3 pt -124.27 173.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.451 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.22 132.9 35.23 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.649 0.738 . . . . 0.0 109.022 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 C--N 1.272 -2.769 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.666 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1148 ' ' DA2 . . . . . 0.439 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.436 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 . . . . . 0 C--O 1.243 0.712 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 25.4 pttm -131.15 154.32 48.48 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.97 135.56 27.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.139 0.576 . . . . 0.0 110.156 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.67 11.92 57.48 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.006 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 3.4 m-20 -99.68 143.56 29.78 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.871 0.367 . . . . 0.0 110.364 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.15 144.72 30.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.16 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.436 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.0 p -159.31 -169.89 2.78 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.6 m -132.95 146.05 51.44 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 160.94 37.23 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.722 0.639 . . . . 0.0 111.107 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.1 mm -91.92 117.1 34.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -67.96 126.99 31.21 Favored 'General case' 0 C--O 1.203 -1.357 0 O-C-N 123.571 0.544 . . . . 0.0 109.694 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -57.92 -28.65 64.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.46 -41.22 16.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -109.6 -17.75 13.65 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.702 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.87 7.5 88.46 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.625 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.59 161.76 14.23 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -77.35 127.77 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.713 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.02 151.24 73.38 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 123.453 0.701 . . . . 0.0 109.313 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.77 129.98 18.52 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.521 2.147 . . . . 0.0 111.685 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -148.37 151.96 36.2 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 120.889 0.376 . . . . 0.0 110.539 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.0 m -114.1 148.11 37.67 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -75.01 124.48 32.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -96.48 -36.62 10.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.5 p -159.19 149.56 19.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.627 HG23 HD21 ' A' ' 138' ' ' LEU . 98.2 mt -126.39 129.11 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 12.1 t70 -112.77 101.63 9.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 173.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -67.25 -24.23 65.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.89 -38.64 64.32 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 122' ' ' THR . 98.0 mtt180 -81.59 -9.48 59.67 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 61.56 25.26 15.22 Favored 'General case' 0 C--O 1.252 1.234 0 C-N-CA 125.274 1.429 . . . . 0.0 108.469 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 120' ' ' ARG . 68.1 p -129.38 168.82 15.72 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.435 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.691 ' SG ' HD11 ' A' ' 141' ' ' LEU . 5.7 p -148.5 151.27 34.85 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 65.9 t -96.31 132.64 40.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.9 m -119.6 149.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 133' ' ' ARG . 96.7 t -111.09 118.51 57.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.19 118.12 11.68 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.827 0.705 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 m -65.32 131.37 46.29 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.38 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.89 -19.42 53.08 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -111.74 -44.96 3.4 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.705 0.288 . . . . 0.0 111.511 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.33 0.98 67.02 Favored Glycine 0 C--N 1.311 -0.809 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.876 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -73.69 152.37 40.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.3 ppt_? -137.94 135.74 36.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 120.773 0.321 . . . . 0.0 110.864 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -151.94 159.53 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.7 tt0 -93.8 131.63 38.99 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.099 0.952 . . . . 0.0 111.105 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 125' ' ' VAL . 7.5 mp0 -123.39 165.07 17.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 125.572 1.549 . . . . 0.0 109.629 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 35.7 m-80 -89.72 142.92 27.24 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.627 HD21 HG23 ' A' ' 116' ' ' ILE . 63.4 mt -58.79 -36.64 74.77 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.43 0.692 . . . . 0.0 110.682 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 t -79.55 -16.63 55.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.477 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 4.1 t70 -89.62 -28.05 19.78 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.73 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.691 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.8 mt -54.87 134.81 48.4 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.983 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.71 167.03 10.45 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.479 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.316 -0.89 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.058 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 N--CA 1.441 -0.889 0 CA-C-O 120.95 0.405 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -130.96 159.34 37.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.08 132.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.49 10.55 57.98 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.834 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.13 141.3 29.68 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -81.15 144.09 31.92 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.37 0.605 . . . . 0.0 110.985 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -156.65 -171.57 3.73 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.16 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 142.21 50.82 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.6 160.62 37.92 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 123.493 0.496 . . . . 0.0 110.002 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.76 117.11 35.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 8.8 t90 -64.74 121.14 13.84 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.553 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 27.7 t -58.3 -24.38 59.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -83.25 -42.07 17.63 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.14 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.429 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.9 t70 -111.5 -18.04 12.94 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.563 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 7.09 88.88 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.663 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.0 m -92.94 158.4 15.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mm -77.87 130.78 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.774 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -138.67 148.73 59.71 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.94 127.46 12.95 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.115 1.877 . . . . 0.0 111.024 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.89 150.41 38.37 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.391 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.1 m -111.84 147.61 35.38 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.0 mt -76.13 124.89 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.631 0.253 . . . . 0.0 110.818 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.19 12.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.872 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -160.8 152.54 19.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.575 HG23 HD21 ' A' ' 138' ' ' LEU . 82.0 mt -132.48 139.89 48.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 122.979 0.512 . . . . 0.0 110.817 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -111.91 97.48 6.71 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -68.19 -23.9 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.04 -39.14 63.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.774 0.321 . . . . 0.0 110.977 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.75 -7.56 56.04 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.251 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 63.07 33.74 14.37 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.303 1.002 . . . . 0.0 108.84 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 53.8 p -123.62 161.75 24.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 110.402 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.713 ' SG ' HD11 ' A' ' 141' ' ' LEU . 4.6 p -149.43 151.91 34.81 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.5 t -96.32 130.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.0 m -118.69 145.94 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.4 t -112.4 118.6 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.82 118.84 14.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 123.802 0.689 . . . . 0.0 110.911 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.2 m -63.63 131.56 48.37 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.716 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.18 -29.85 8.9 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.824 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.92 -40.64 6.8 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.702 0.287 . . . . 0.0 111.321 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.54 74.79 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.078 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -80.37 153.87 28.08 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.1 ppt_? -136.0 137.9 41.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 6.8 pt-20 -154.23 158.92 40.98 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.8 tt0 -99.37 132.22 44.85 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.519 0.676 . . . . 0.0 111.526 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.529 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -132.2 163.46 28.52 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.653 1.181 . . . . 0.0 109.681 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 24.7 m-80 -85.06 146.7 27.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.575 HD21 HG23 ' A' ' 116' ' ' ILE . 84.3 mt -57.21 -35.57 69.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.738 0.78 . . . . 0.0 111.177 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.4 m -80.08 -20.28 45.5 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.097 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -13.89 39.86 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.713 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.8 mt -71.68 145.14 49.06 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.625 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -114.98 159.5 20.67 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.39 -3.434 0 C-N-CA 123.755 0.822 . . . . 0.0 108.953 178.25 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.7 m95 . . . . . 0 N--CA 1.423 -1.816 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.7 ptpp? -131.21 161.34 32.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.7 t -63.84 127.71 24.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.89 13.91 38.57 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.15 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.555 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 28.2 m-20 -96.82 142.46 28.8 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -152.72 -170.58 3.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 143.55 51.22 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -135.39 160.4 38.55 Favored 'General case' 0 C--N 1.278 -2.529 0 O-C-N 123.644 0.59 . . . . 0.0 110.005 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 mm -92.36 116.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -64.8 126.62 28.53 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 123.601 0.563 . . . . 0.0 109.904 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.1 m -58.27 -28.16 64.69 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.4 -41.82 15.09 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.077 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.91 -17.83 13.53 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.722 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.88 90.0 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.736 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.91 161.99 14.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.55 130.47 36.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.425 0.69 . . . . 0.0 109.657 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -139.29 151.0 66.28 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.679 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.7 127.78 14.3 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.664 2.242 . . . . 0.0 111.028 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.36 150.82 36.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 120.914 0.387 . . . . 0.0 110.557 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -111.88 147.59 35.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 96' ' ' ASP . 69.3 mt -79.35 121.8 33.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.781 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.42 -35.32 12.39 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.785 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -159.14 144.65 16.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.601 HG23 HD21 ' A' ' 138' ' ' LEU . 99.0 mt -122.13 134.78 64.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.399 0.28 . . . . 0.0 110.416 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -113.13 96.64 6.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -64.39 -25.83 68.19 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -69.16 -37.35 78.16 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.03 -7.24 52.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.464 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 62.59 25.11 14.96 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 108.558 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 71.5 p -122.82 161.96 23.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.546 -0.721 . . . . 0.0 111.422 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.691 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.6 p -148.03 153.18 38.61 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 78.9 t -96.26 130.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.4 m -119.22 145.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-O 121.171 0.51 . . . . 0.0 109.88 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.0 t -110.41 118.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.543 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -71.73 117.95 13.95 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -65.85 131.82 47.18 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.48 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.61 -17.16 55.9 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.69 -39.95 4.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.893 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.68 23.58 57.73 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.821 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -95.28 153.27 17.75 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.0 ppt_? -137.94 135.7 36.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.679 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.34 159.16 41.04 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -94.83 133.22 38.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.468 0.651 . . . . 0.0 111.855 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.496 ' NE2' ' HB1' ' A' ' 100' ' ' ALA . 5.7 mp0 -131.78 163.66 27.73 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.84 1.256 . . . . 0.0 110.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 26.8 m-80 -85.51 146.86 26.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.601 HD21 HG23 ' A' ' 116' ' ' ILE . 67.0 mt -59.22 -37.4 77.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.548 0.69 . . . . 0.0 109.964 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.8 m -74.4 -22.14 59.31 Favored 'General case' 0 N--CA 1.405 -2.711 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.433 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 m-20 -91.32 -13.46 32.53 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.691 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.0 mt -71.19 144.13 50.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.089 0.471 . . . . 0.0 110.676 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.2 165.52 12.84 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.8 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.31 -1.123 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.833 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.47 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 95.4 m95 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 110.852 -0.055 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 64.5 pttt -131.45 159.97 36.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 16.29 68.42 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.586 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 6.8 t0 -100.08 136.15 40.43 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -85.04 141.86 29.98 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.47 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -150.14 -167.87 2.95 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -130.13 143.61 50.88 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.58 160.56 38.1 Favored 'General case' 0 C--N 1.281 -2.408 0 O-C-N 123.439 0.462 . . . . 0.0 110.101 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.29 117.88 36.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -67.02 122.46 17.82 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 11.1 t -65.31 -16.26 63.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 118.052 0.387 . . . . 0.0 111.804 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -85.3 -38.44 18.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -115.16 -18.33 11.18 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.408 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 6.29 88.73 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.022 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.62 162.51 13.92 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.69 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.42 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.35 150.87 73.71 Favored Pre-proline 0 C--N 1.284 -2.244 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.358 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.15 127.46 13.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.988 1.792 . . . . 0.0 110.861 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.09 35.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 m -112.21 148.19 34.62 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 96' ' ' ASP . 71.3 mt -77.18 121.63 30.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.857 0.36 . . . . 0.0 110.995 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -90.35 -39.76 12.5 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.2 m -158.5 149.8 20.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.585 HG23 HD21 ' A' ' 138' ' ' LEU . 95.3 mt -125.11 136.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.98 0.419 . . . . 0.0 110.494 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -112.11 99.29 7.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.95 -23.46 65.06 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.894 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.17 -36.36 66.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.954 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.33 -8.91 54.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.485 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 59.98 28.69 18.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.209 1.004 . . . . 0.0 109.0 -172.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 76.1 p -122.84 162.86 21.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 121.405 -0.81 . . . . 0.0 110.671 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.5 p -148.69 152.35 36.51 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 122.617 0.367 . . . . 0.0 110.521 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.9 t -95.31 131.12 42.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.1 m -118.43 145.65 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 91.4 t -111.49 118.67 58.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -69.14 121.9 17.7 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 123.734 0.646 . . . . 0.0 110.887 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.4 m -62.8 131.21 48.09 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.389 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.09 18.22 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.4 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.86 -42.14 5.94 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 122.508 -0.407 . . . . 0.0 111.566 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.35 61.99 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.822 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -89.4 152.66 21.38 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.8 ppt_? -133.98 140.22 46.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.554 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.3 pt-20 -153.68 158.04 40.46 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 21.9 tt0 -98.21 129.75 44.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.554 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.4 mp0 -126.56 163.16 24.03 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 124.333 1.053 . . . . 0.0 109.676 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.3 m-80 -82.88 146.98 28.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.585 HD21 HG23 ' A' ' 116' ' ' ILE . 57.3 mt -60.76 -34.34 74.31 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.316 1.055 . . . . 0.0 109.251 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.5 t -80.11 -8.33 59.35 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.088 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -104.89 -15.67 15.09 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.529 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.657 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.2 mt -66.37 146.82 54.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.205 0.526 . . . . 0.0 111.166 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.29 161.76 18.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.709 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.396 -3.132 0 C-N-CA 124.548 1.139 . . . . 0.0 110.303 -179.196 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 85.8 m95 . . . . . 0 C--O 1.248 1.01 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.599 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -131.17 162.87 28.97 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.85 132.32 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.91 12.47 56.56 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.275 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 75.4 m-20 -97.26 149.42 22.07 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.402 0.62 . . . . 0.0 109.839 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -86.89 139.81 30.27 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.275 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -155.96 -172.38 4.09 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.114 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -131.2 146.89 52.5 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.18 37.42 Favored 'General case' 0 C--N 1.274 -2.701 0 O-C-N 123.69 0.619 . . . . 0.0 109.791 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.93 118.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -65.87 120.55 13.26 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.628 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 9.0 t -61.55 -19.58 62.31 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.065 0.228 . . . . 0.0 111.324 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.97 -42.07 15.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.85 -17.91 12.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.075 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.62 89.16 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.108 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.16 161.46 14.41 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.17 130.53 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.94 150.28 64.69 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 132.26 24.32 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.326 2.017 . . . . 0.0 111.156 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.5 149.65 32.02 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.024 0.44 . . . . 0.0 110.208 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -111.53 147.26 35.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.55 125.69 36.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.5 -35.43 10.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.02 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.2 m -158.65 148.04 19.15 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 138' ' ' LEU . 88.7 mt -125.98 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 122.64 0.376 . . . . 0.0 110.051 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.95 98.81 7.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -24.03 66.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.288 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.77 -37.41 67.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.694 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.88 -8.87 57.77 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.376 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.01 28.87 18.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.534 1.134 . . . . 0.0 108.432 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 70.2 p -125.2 160.73 28.49 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.685 -0.634 . . . . 0.0 110.492 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.2 p -148.19 153.73 39.17 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 122.704 0.402 . . . . 0.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.5 t -95.52 130.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.51 145.72 24.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.0 t -111.36 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -68.79 117.73 10.85 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.849 0.718 . . . . 0.0 111.111 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 m -60.77 131.14 49.74 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.531 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.62 -28.28 7.84 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.987 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -101.01 -42.9 6.22 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 122.508 -0.407 . . . . 0.0 111.494 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.52 14.6 63.33 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.422 -0.895 . . . . 0.0 111.891 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -86.78 151.35 23.45 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.92 135.77 39.92 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 123.131 0.269 . . . . 0.0 111.129 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.628 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.7 pt-20 -153.69 158.16 40.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.0 tt0 -96.35 131.4 42.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.482 0.658 . . . . 0.0 111.689 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.536 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.2 mp0 -128.16 163.64 24.23 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 125.27 1.428 . . . . 0.0 109.763 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 29.2 m-80 -82.67 147.55 28.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 116' ' ' ILE . 72.7 mt -59.37 -35.99 74.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.878 0.847 . . . . 0.0 110.06 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.0 m -76.82 -19.52 57.44 Favored 'General case' 0 N--CA 1.405 -2.69 0 C-N-CA 124.164 0.986 . . . . 0.0 111.63 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -93.25 -10.06 36.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.049 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -72.37 147.36 46.32 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.529 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.62 163.18 18.43 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.308 -1.204 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.428 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.1 m95 . . . . . 0 C--O 1.255 1.36 0 CA-C-O 120.56 0.219 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.8 pttm -131.98 160.82 34.72 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.57 129.21 26.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 13.97 39.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.591 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HB2' HD12 ' A' ' 113' ' ' ILE . 71.6 m-20 -97.91 141.03 31.4 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -84.48 144.99 28.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.428 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.01 -169.37 3.05 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -130.35 144.21 51.25 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -136.55 161.0 37.08 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.116 0.26 . . . . 0.0 110.431 -175.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -92.37 119.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.46 125.77 27.52 Favored 'General case' 0 C--O 1.205 -1.254 0 O-C-N 123.436 0.46 . . . . 0.0 109.795 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -57.96 -26.79 62.76 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -84.73 -41.83 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.248 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.89 -17.35 12.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.914 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.28 90.19 Favored Glycine 0 C--O 1.222 -0.644 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.177 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.9 m -93.15 162.05 14.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.9 mm -78.39 131.05 35.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.123 0.969 . . . . 0.0 109.605 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -140.26 151.42 64.44 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.636 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 129.7 16.76 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.433 2.088 . . . . 0.0 111.209 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.32 150.48 35.82 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.991 0.424 . . . . 0.0 110.661 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.9 m -111.94 147.58 35.56 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' A' ' 96' ' ' ASP . 75.5 mt -77.6 120.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -93.41 -33.84 13.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.836 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.8 m -162.05 146.82 12.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.538 HG23 HD21 ' A' ' 138' ' ' LEU . 84.4 mt -121.54 138.6 51.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.79 96.05 5.75 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -65.2 -24.04 67.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.359 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.06 -39.99 71.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.396 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -85.6 -9.02 57.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 61.54 30.72 18.85 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.877 1.271 . . . . 0.0 109.141 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.9 p -129.2 165.33 21.55 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.91 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -148.71 153.67 38.55 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 122.4 0.28 . . . . 0.0 110.965 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 46.9 t -95.92 130.1 45.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.94 146.06 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.661 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 114' ' ' ALA . 90.8 t -110.4 118.84 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -69.59 118.31 12.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.752 0.658 . . . . 0.0 110.96 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 m -64.94 130.93 45.23 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.53 -19.59 43.27 Favored Glycine 0 N--CA 1.428 -1.836 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.22 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -107.68 -43.37 4.51 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.808 0.337 . . . . 0.0 111.659 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.19 8.41 66.62 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.092 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -81.3 152.76 27.41 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.5 OUTLIER -139.47 136.42 34.57 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.932 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.553 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.36 158.48 41.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -94.6 133.84 37.81 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.351 0.596 . . . . 0.0 111.475 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.553 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.3 mp0 -128.88 163.29 25.59 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 124.832 1.253 . . . . 0.0 110.376 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -81.24 148.47 29.46 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 116' ' ' ILE . 57.5 mt -62.61 -31.0 71.77 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.442 0.639 . . . . 0.0 110.763 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.2 t -80.29 -25.39 39.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.378 0.609 . . . . 0.0 109.758 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 142' ' ' LEU . 32.6 t70 -74.77 -31.25 61.71 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.568 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.76 HD11 ' SG ' ' A' ' 123' ' ' CYS . 54.1 mt -58.54 134.14 56.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.39 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 140' ' ' ASP . 5.1 mp -109.51 159.41 17.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.173 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.392 -3.332 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.59 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.416 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.0 m95 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.5 pttm -130.83 159.28 37.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.67 128.38 25.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.03 7.32 52.86 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.153 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.508 ' HB2' HD12 ' A' ' 113' ' ' ILE . 60.5 m-20 -91.13 137.17 32.57 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -80.71 141.11 35.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.416 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -154.14 -166.27 2.32 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 m -131.32 146.95 52.51 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB1' HE21 ' A' ' 136' ' ' GLN . . . -141.07 161.92 36.71 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 122.98 0.175 . . . . 0.0 110.687 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.5 mm -91.12 116.04 31.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 123.819 0.7 . . . . 0.0 109.814 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -65.74 119.39 11.11 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 t -65.79 -14.95 62.36 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 118.205 0.457 . . . . 0.0 112.013 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.19 -41.84 19.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.69 -0.404 . . . . 0.0 112.028 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.94 -16.99 12.58 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.26 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.0 8.5 87.59 Favored Glycine 0 C--N 1.307 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.705 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.7 m -93.83 160.61 14.67 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.427 HD12 HD22 ' A' ' 142' ' ' LEU . 26.4 mm -77.17 129.64 37.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.888 0.875 . . . . 0.0 109.553 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -138.6 150.08 64.77 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 123.087 0.555 . . . . 0.0 109.966 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.06 128.3 14.67 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.556 2.171 . . . . 0.0 110.8 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.66 150.4 34.29 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.422 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.0 m -111.51 147.82 34.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 96' ' ' ASP . 62.5 mt -78.06 121.91 31.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.456 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -95.12 -32.6 13.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -159.05 148.65 18.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.568 HG23 HD21 ' A' ' 138' ' ' LEU . 91.2 mt -129.05 139.68 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 122.893 0.477 . . . . 0.0 109.977 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.68 99.1 7.89 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.55 -24.04 65.48 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.085 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -73.97 -41.61 61.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.636 0.255 . . . . 0.0 110.749 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -86.64 -8.89 57.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.029 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 61.56 32.85 18.59 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.327 1.017 . . . . 0.0 108.671 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 59.2 p -122.96 159.68 27.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.85 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.1 p -149.02 152.61 36.57 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 122.776 0.43 . . . . 0.0 111.039 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.3 t -96.37 131.22 43.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.8 m -119.45 145.3 25.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 133' ' ' ARG . 59.5 t -110.18 118.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -72.41 116.91 13.43 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 123.698 0.624 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.7 m -63.76 131.61 48.38 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.24 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.19 -22.08 36.68 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.988 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.23 -40.07 5.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.38 78.51 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.065 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -73.92 149.26 41.53 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.94 135.82 39.92 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -152.58 158.13 42.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.6 tt0 -93.71 132.7 37.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.307 0.575 . . . . 0.0 110.923 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.508 HE21 ' HB1' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -133.55 163.67 28.88 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 125.097 1.359 . . . . 0.0 107.396 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 34.4 m-80 -83.74 151.42 25.24 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 116' ' ' ILE . 75.5 mt -62.26 -36.32 81.66 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.07 0.938 . . . . 0.0 108.963 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -33.16 74.46 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -15.56 45.45 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.439 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.627 HD11 ' SG ' ' A' ' 123' ' ' CYS . 58.9 mt -65.13 146.98 54.27 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.14 0.495 . . . . 0.0 111.862 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 108' ' ' ILE . 5.3 mp -117.84 161.16 20.18 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.405 -2.725 0 C-N-CA 124.443 1.097 . . . . 0.0 110.568 -178.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 79.5 m95 . . . . . 0 N--CA 1.438 -1.043 0 CA-C-O 120.627 0.251 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.536 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.9 ptpp? -128.88 155.95 44.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -63.65 127.47 24.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.7 33.09 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.69 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 29.2 m-20 -96.2 141.3 29.73 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -82.14 143.51 31.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.445 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 27.0 p -155.23 -170.47 3.48 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 m -131.4 142.9 50.12 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.65 160.46 38.04 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.093 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.47 120.23 41.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -67.15 126.1 28.12 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.6 m -58.77 -27.16 64.72 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -85.21 -41.86 15.23 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.51 -16.36 13.68 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.318 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.77 89.89 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.06 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.5 160.47 15.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mm -78.44 128.28 38.4 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.347 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -136.14 151.24 73.18 Favored Pre-proline 0 C--N 1.287 -2.145 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.66 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.88 127.9 15.15 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.411 2.074 . . . . 0.0 110.797 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.05 150.17 36.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 120.849 0.356 . . . . 0.0 110.29 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -112.04 147.83 35.17 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 96' ' ' ASP . 70.9 mt -81.35 118.91 29.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-O 120.831 0.348 . . . . 0.0 110.746 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.87 15.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.077 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.6 m -161.43 146.62 13.67 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.566 HG23 HD21 ' A' ' 138' ' ' LEU . 94.3 mt -128.64 135.97 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 122.843 0.457 . . . . 0.0 110.534 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.59 102.7 10.76 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.67 -26.09 66.03 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.041 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -70.14 -40.42 74.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.304 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.45 -8.8 58.18 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.021 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 60.36 27.57 17.16 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.23 1.014 . . . . 0.0 109.12 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -124.85 160.17 29.4 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 121.143 -0.973 . . . . 0.0 110.871 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.712 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.4 p -148.3 153.83 39.19 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 50.7 t -95.91 130.42 44.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 86.4 t -111.57 119.05 59.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -70.42 120.24 15.77 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.539 0.685 . . . . 0.0 111.068 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.1 m -64.59 132.09 48.82 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.156 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.68 -20.9 32.48 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.051 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -106.82 -50.3 3.14 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.914 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.05 3.42 59.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.489 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.4 154.49 34.81 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.7 ppt_? -137.12 139.35 41.15 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.564 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.6 pt-20 -153.51 158.28 41.07 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.9 tt0 -97.72 129.69 44.75 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.564 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 5.9 mp0 -127.5 163.48 24.02 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 124.298 1.039 . . . . 0.0 110.037 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -82.14 148.4 28.53 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 116' ' ' ILE . 67.8 mt -61.15 -31.62 71.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.084 0.945 . . . . 0.0 109.659 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.2 m -78.19 -24.09 47.28 Favored 'General case' 0 N--CA 1.392 -3.328 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.422 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.82 -32.29 31.32 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.386 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.712 HD11 ' SG ' ' A' ' 123' ' ' CYS . 54.7 mt -56.01 141.55 39.44 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 124.587 1.179 . . . . 0.0 111.689 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.79 162.32 16.46 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.485 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.639 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.463 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 . . . . . 0 N--CA 1.424 -1.749 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 24.6 pttm -131.77 161.59 32.53 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.29 130.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.17 23.3 38.22 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.986 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.2 t0 -101.43 139.91 36.44 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -83.3 141.57 31.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.38 -170.95 3.52 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -129.6 141.89 50.86 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -132.29 160.66 35.57 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.253 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mm -91.99 116.88 34.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -65.7 125.51 25.5 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -30.81 63.49 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 123.539 0.736 . . . . 0.0 112.821 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -85.2 -40.7 16.38 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.33 -17.81 13.91 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.383 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.69 89.95 Favored Glycine 0 CA--C 1.507 -0.449 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.035 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 95.0 m -93.55 162.77 13.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.74 128.47 37.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.682 0.614 . . . . 0.0 109.536 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -136.3 151.41 73.23 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.86 128.02 14.48 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.185 1.923 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.85 146.36 27.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.098 0.475 . . . . 0.0 110.108 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.5 m -111.84 147.95 34.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 67.8 mt -75.87 123.53 32.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.581 0.229 . . . . 0.0 110.651 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -96.9 -32.47 12.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.2 m -160.96 146.54 14.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.582 HG23 HD21 ' A' ' 138' ' ' LEU . 98.1 mt -124.47 135.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 0.0 111.049 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.16 100.9 8.94 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -67.78 -24.16 65.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.342 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.88 -37.43 70.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.879 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -87.86 -8.71 55.48 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.294 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 61.08 30.05 19.25 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.171 0.988 . . . . 0.0 108.435 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 78.2 p -126.16 163.66 22.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.635 -0.666 . . . . 0.0 111.407 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.747 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.4 p -148.74 153.32 38.03 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.1 0.56 . . . . 0.0 110.455 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.4 t -95.34 130.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.9 m -118.89 145.54 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.4 t -109.95 118.87 57.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -71.58 121.2 18.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.801 0.688 . . . . 0.0 110.565 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -62.09 130.98 48.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.536 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.62 -16.59 39.83 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.538 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -104.56 -43.39 5.17 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.155 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.01 12.29 63.87 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.77 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.7 m-20 -85.28 151.64 23.9 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -137.72 135.26 36.25 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 15.1 pt-20 -154.06 158.03 39.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 19.5 tt0 -99.75 127.52 45.89 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.491 0.663 . . . . 0.0 111.796 -172.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.465 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 3.4 mp0 -123.04 163.68 20.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.985 1.314 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.0 m-80 -84.69 146.52 27.4 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.582 HD21 HG23 ' A' ' 116' ' ' ILE . 58.8 mt -59.5 -32.69 70.51 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.215 1.007 . . . . 0.0 109.063 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -75.25 -22.54 57.77 Favored 'General case' 0 N--CA 1.394 -3.254 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.708 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 t70 -93.29 -19.35 21.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.747 HD11 ' SG ' ' A' ' 123' ' ' CYS . 78.1 mt -61.34 141.22 57.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.919 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.61 162.94 16.11 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.822 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 C--N 1.314 -0.952 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.449 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 89.6 m95 . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.554 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.1 ptpp? -130.89 161.27 32.22 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.6 t -63.55 128.17 25.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.26 8.05 48.01 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.612 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.554 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.3 m-20 -97.1 150.01 21.32 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HD2' HG23 ' A' ' 112' ' ' THR . 27.1 mmmt -91.35 140.55 29.66 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.575 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.449 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.9 p -152.65 -169.38 3.32 Favored 'General case' 0 C--N 1.262 -3.228 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.852 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 m -130.77 146.09 52.13 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.07 160.48 38.5 Favored 'General case' 0 C--N 1.275 -2.66 0 O-C-N 123.83 0.706 . . . . 0.0 109.665 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mm -91.54 120.38 40.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.563 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 11.4 t90 -69.28 127.29 32.52 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 123.497 0.498 . . . . 0.0 109.955 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.9 m -57.79 -28.54 64.11 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.96 -42.81 14.59 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.58 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.419 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.6 t70 -107.03 -18.62 13.86 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.028 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.47 6.36 88.03 Favored Glycine 0 C--O 1.222 -0.615 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.793 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.83 163.0 13.69 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.2 mm -77.94 130.23 36.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.199 0.6 . . . . 0.0 109.385 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -137.79 149.35 64.24 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.304 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.49 128.65 14.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.268 1.979 . . . . 0.0 110.777 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.431 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.41 153.02 41.49 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.207 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 97' ' ' LYS . 4.4 m -112.08 147.42 36.08 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.01 121.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 120.856 0.36 . . . . 0.0 110.604 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.83 -39.42 11.21 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -159.46 148.57 18.14 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.634 HG23 HD21 ' A' ' 138' ' ' LEU . 90.8 mt -126.13 134.73 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.281 0.363 . . . . 0.0 111.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -112.33 99.7 8.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -64.69 -28.18 69.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.325 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.7 -39.65 64.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.188 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 122' ' ' THR . 93.3 mtt180 -81.23 -8.59 59.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.042 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 62.02 26.41 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.938 1.295 . . . . 0.0 109.055 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 120' ' ' ARG . 82.1 p -125.65 161.73 26.6 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 121.481 -0.762 . . . . 0.0 111.055 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.6 p -147.78 152.33 37.53 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 66.5 t -96.07 131.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.7 m -119.34 148.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 87.9 t -109.61 118.43 56.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 102' ' ' TRP . 94.7 m-85 -71.34 120.84 17.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 109.496 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.2 m -66.27 131.99 47.39 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.548 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.36 40.42 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.042 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.8 -43.49 4.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.015 0.436 . . . . 0.0 111.415 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.2 2.46 64.09 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.201 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.0 m-20 -74.92 150.11 39.22 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.3 ppt_? -135.12 135.42 41.14 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.5 159.62 41.09 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 22.3 tt0 -93.77 136.43 34.05 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 121.865 0.84 . . . . 0.0 110.824 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -129.46 165.55 21.39 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 126.224 1.81 . . . . 0.0 108.772 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 31.2 m-80 -89.4 147.82 23.83 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.634 HD21 HG23 ' A' ' 116' ' ' ILE . 74.7 mt -61.11 -34.14 74.48 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.758 0.79 . . . . 0.0 110.296 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -71.62 -29.99 65.29 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.656 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.53 -14.55 45.54 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.643 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.7 mt -67.74 147.45 52.6 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.259 0.552 . . . . 0.0 111.074 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.82 163.39 19.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.096 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 93.4 m95 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 120.727 0.298 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 47.4 pttt -131.01 155.23 47.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.12 128.09 25.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.66 14.92 51.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.27 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 3.6 t0 -93.69 142.5 27.28 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -80.52 141.32 35.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.2 p -158.55 -171.36 3.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.8 m -130.61 146.45 52.12 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.8 161.09 36.92 Favored 'General case' 0 C--N 1.278 -2.539 0 O-C-N 123.26 0.35 . . . . 0.0 110.489 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mm -92.41 115.37 31.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -64.44 121.35 14.17 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.557 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 8.1 t -66.44 -15.27 63.2 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 118.216 0.462 . . . . 0.0 111.831 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -84.86 -41.93 15.55 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.992 0.425 . . . . 0.0 110.876 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -110.79 -18.0 13.22 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.662 0.744 . . . . 0.0 110.847 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.29 90.52 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.202 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.3 m -94.05 163.85 13.31 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mm -77.51 130.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 123.445 0.698 . . . . 0.0 110.109 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.29 150.61 64.91 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.327 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.84 129.92 18.35 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.53 2.153 . . . . 0.0 111.367 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.65 149.97 32.41 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.065 0.46 . . . . 0.0 110.851 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 m -112.17 147.95 35.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -76.16 128.01 37.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.637 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.96 -31.79 10.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.258 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -160.29 145.64 14.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.571 HG23 HD21 ' A' ' 138' ' ' LEU . 98.4 mt -124.09 134.35 66.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 122.85 0.46 . . . . 0.0 110.568 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.42 97.94 6.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -61.95 -25.47 67.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.63 -39.91 64.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.35 -9.17 58.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 60.96 24.83 14.88 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.953 1.301 . . . . 0.0 109.04 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 68.3 p -122.37 159.99 26.35 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -146.21 153.14 40.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.859 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 67.4 t -95.45 130.89 43.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.1 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 85.1 t -109.92 118.46 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.01 118.45 12.87 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.801 0.688 . . . . 0.0 111.236 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 131.71 46.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.93 -17.23 56.17 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.079 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.85 -49.28 3.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.952 0.406 . . . . 0.0 110.711 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.63 4.78 59.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.314 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.81 154.93 33.45 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 122.178 0.191 . . . . 0.0 110.549 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.48 136.29 39.31 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.364 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.557 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.8 pt-20 -153.37 158.72 41.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 24.5 tt0 -96.55 129.12 43.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.598 0.713 . . . . 0.0 111.987 -175.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.533 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.9 mp0 -128.19 163.42 24.74 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.245 1.418 . . . . 0.0 110.007 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.0 m-80 -82.17 146.25 29.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.571 HD21 HG23 ' A' ' 116' ' ' ILE . 67.7 mt -59.43 -34.72 72.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.09 0.948 . . . . 0.0 109.724 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -77.04 -20.34 56.02 Favored 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.424 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 6.2 t70 -90.01 -28.14 19.28 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -175.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.669 HD11 ' SG ' ' A' ' 123' ' ' CYS . 77.1 mt -52.2 137.48 28.17 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 124.695 1.247 . . . . 0.0 111.739 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.19 162.68 14.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.975 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.399 -2.976 0 C-N-CA 123.796 0.838 . . . . 0.0 109.344 177.876 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.404 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 83.5 m95 . . . . . 0 N--CA 1.424 -1.734 0 CA-C-O 120.823 0.344 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 21.9 pttm -131.11 162.64 29.42 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.3 129.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.73 13.99 41.93 Favored Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.835 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.544 ' HB2' HD12 ' A' ' 113' ' ' ILE . 53.8 m-20 -96.43 140.06 31.64 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -84.89 139.91 31.51 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.404 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -151.96 -169.49 3.38 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 123.551 0.532 . . . . 0.0 109.573 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.4 m -130.03 144.23 51.22 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.517 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -134.5 160.24 38.62 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.949 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.67 114.64 31.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -61.71 126.9 28.98 Favored 'General case' 0 C--O 1.203 -1.348 0 O-C-N 124.03 0.831 . . . . 0.0 110.325 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.7 m -57.17 -29.9 64.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.24 -37.27 20.26 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.0 -17.07 10.45 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.509 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.8 8.23 87.71 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.257 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.4 160.07 15.27 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.97 131.22 35.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -139.89 149.47 59.11 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.03 128.04 16.09 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.602 2.201 . . . . 0.0 111.055 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.88 35.61 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.848 0.356 . . . . 0.0 110.379 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -111.8 147.49 35.59 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 96' ' ' ASP . 68.5 mt -78.9 120.17 29.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.71 -31.95 13.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.495 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -159.97 144.96 15.05 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 138' ' ' LEU . 83.6 mt -120.83 134.69 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -113.35 98.52 7.15 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -67.72 -23.86 65.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.36 -40.43 85.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.875 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.95 -8.66 55.39 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.16 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 63.28 27.25 15.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.954 1.301 . . . . 0.0 108.585 -175.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 60.9 p -125.76 166.74 16.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.9 p -148.38 151.95 36.19 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 122.911 0.484 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.0 t -95.81 129.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.5 145.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 121.133 0.492 . . . . 0.0 109.706 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 93.3 t -109.29 118.97 57.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -71.28 121.09 17.82 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.313 0.577 . . . . 0.0 110.857 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.0 m -69.03 131.4 44.98 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.034 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.03 57.29 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.665 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -111.12 -48.81 3.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 122.453 -0.439 . . . . 0.0 111.608 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.34 10.79 57.94 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -83.13 153.02 25.04 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.91 135.73 38.04 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.35 158.69 40.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -96.79 130.39 44.06 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.797 0.808 . . . . 0.0 112.229 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.517 ' NE2' ' HB1' ' A' ' 100' ' ' ALA . 6.2 mp0 -126.0 163.36 23.18 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.36 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.7 m-80 -84.28 144.9 28.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.576 HD21 HG23 ' A' ' 116' ' ' ILE . 70.4 mt -60.06 -35.39 75.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.535 0.683 . . . . 0.0 110.614 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -73.32 -29.34 62.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -82.51 -14.06 55.61 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.788 -177.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.658 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.1 mt -66.23 143.93 56.93 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.573 0.546 . . . . 0.0 111.517 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.05 158.83 23.51 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.443 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.1 m95 . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 111.071 0.026 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.9 ptpp? -131.57 161.53 32.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.91 128.23 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 15.22 33.67 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.739 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 72.7 m-20 -102.29 145.54 29.31 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 18.8 mmmt -88.06 141.42 28.58 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.167 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.443 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.24 -171.52 3.94 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 123.892 0.745 . . . . 0.0 109.056 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 m -131.69 143.86 50.58 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 173.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -135.22 160.92 36.86 Favored 'General case' 0 C--N 1.273 -2.733 0 O-C-N 123.514 0.509 . . . . 0.0 110.211 -174.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 mm -92.21 118.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -67.46 124.81 24.22 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 m -59.0 -26.42 64.5 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -84.49 -41.84 16.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.998 -173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -111.38 -17.47 13.12 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.864 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 4.74 89.9 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.105 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.62 160.18 15.13 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -76.71 129.02 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 O-C-N 124.002 0.814 . . . . 0.0 109.442 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -137.97 148.04 58.78 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.17 127.72 16.35 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.62 2.214 . . . . 0.0 110.895 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.51 38.33 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.752 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -112.16 147.48 36.04 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 96' ' ' ASP . 62.6 mt -77.46 121.86 30.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 123.076 0.235 . . . . 0.0 110.368 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.65 13.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.1 p -160.63 145.14 14.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.692 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.579 HG23 HD21 ' A' ' 138' ' ' LEU . 97.8 mt -124.42 135.24 64.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 110.784 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -112.9 101.81 9.85 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.63 -24.97 65.51 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.72 0.295 . . . . 0.0 111.198 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.25 -37.09 66.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.304 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -86.81 -8.95 56.86 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.841 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 60.35 28.98 18.63 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 122.634 1.207 . . . . 0.0 109.184 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.403 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 70.8 p -126.33 162.39 25.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.852 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.67 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.7 p -148.33 152.16 36.6 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.261 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 99.4 t -95.37 130.96 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.9 m -118.3 145.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.9 t -110.7 118.38 57.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -68.42 119.13 12.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.694 0.621 . . . . 0.0 110.568 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.6 m -63.6 131.01 46.66 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.756 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.0 -18.0 47.41 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.269 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -108.33 -37.57 5.96 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 122.395 -0.474 . . . . 0.0 111.747 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 13.52 76.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.623 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -85.59 151.97 23.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.5 ppt_? -135.66 137.26 41.64 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.193 0.308 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.0 pt-20 -153.62 158.69 41.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 20.6 tt0 -97.91 129.75 44.82 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.537 0.684 . . . . 0.0 111.353 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.571 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.1 mp0 -126.53 163.58 23.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 124.494 1.118 . . . . 0.0 109.755 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.8 m-80 -82.14 145.48 30.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.579 HD21 HG23 ' A' ' 116' ' ' ILE . 76.5 mt -57.95 -36.35 72.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.742 0.782 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -77.58 -19.54 55.47 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.4 t70 -84.96 -30.91 23.87 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.844 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.67 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.9 mt -51.9 132.12 31.7 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.655 1.222 . . . . 0.0 111.918 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.39 164.16 12.07 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.953 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.308 -1.215 0 O-C-N 124.172 0.92 . . . . 0.0 109.07 -179.741 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 92.6 m95 . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.622 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.8 ptpp? -131.25 162.48 29.91 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.6 t -63.74 128.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.64 13.64 37.25 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.918 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.622 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.6 m-20 -100.64 141.5 33.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -83.02 143.62 30.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.97 -169.48 3.27 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 m -132.59 145.98 51.54 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.37 161.2 36.94 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 123.781 0.676 . . . . 0.0 110.08 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.0 119.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.27 125.14 25.78 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -58.77 -24.59 61.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -85.0 -41.74 15.53 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.933 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -111.51 -17.86 12.97 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 118.733 -1.187 . . . . 0.0 111.187 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.26 89.73 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.181 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.19 162.29 14.08 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -77.58 129.79 37.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.856 0.723 . . . . 0.0 109.687 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -137.8 151.4 70.41 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 123.639 0.776 . . . . 0.0 109.137 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.96 128.62 14.25 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.11 149.46 36.58 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.976 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -111.51 147.5 35.22 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 96' ' ' ASP . 64.4 mt -77.12 122.09 30.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.505 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -95.89 -33.11 12.33 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.735 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.7 m -160.58 148.73 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.595 HG23 HD21 ' A' ' 138' ' ' LEU . 93.2 mt -126.44 135.72 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.91 99.86 8.44 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -66.43 -23.94 66.38 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.079 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.24 -37.65 69.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.235 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -87.79 -8.9 55.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.994 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 30.4 tt0 61.03 24.74 14.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p -122.77 161.08 24.64 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.0 p -146.53 151.9 38.1 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.427 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.7 t -95.37 130.21 44.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.04 145.68 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.7 t -111.0 118.67 57.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -69.07 118.67 12.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 123.718 0.636 . . . . 0.0 110.21 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 53.1 m -63.66 131.02 46.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.403 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.39 -26.56 10.08 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.896 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -96.84 -47.27 5.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.967 0.413 . . . . 0.0 110.616 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.8 60.1 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.363 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -82.76 152.1 25.86 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -139.03 136.31 35.16 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.169 0.293 . . . . 0.0 110.77 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.5 pt-20 -153.07 158.07 41.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -95.8 133.21 40.2 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.455 0.645 . . . . 0.0 112.077 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.478 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 8.5 mp0 -131.98 163.78 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 125.157 1.383 . . . . 0.0 109.967 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.4 m-80 -81.15 148.2 29.69 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 116' ' ' ILE . 65.2 mt -59.21 -36.11 74.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.261 1.029 . . . . 0.0 108.933 175.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.3 m -75.53 -18.09 59.9 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.992 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -98.06 -7.29 30.03 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.379 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.64 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.7 mt -72.97 139.89 47.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.417 0.627 . . . . 0.0 111.042 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.9 166.06 11.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.781 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--N 1.31 -1.119 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.519 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 87.8 m95 . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 63.5 pttt -126.36 157.95 37.16 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.72 131.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 18.71 54.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.737 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 4.7 t0 -100.8 133.21 45.6 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG2' HG23 ' A' ' 112' ' ' THR . 68.0 mttt -80.47 148.01 30.66 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.115 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.6 p -155.1 -168.76 2.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.981 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 m -131.71 145.29 51.55 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.06 160.79 37.23 Favored 'General case' 0 C--N 1.277 -2.585 0 O-C-N 123.569 0.543 . . . . 0.0 110.189 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.15 117.16 34.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.422 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 9.8 t90 -67.54 122.92 19.04 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -59.67 -23.57 63.2 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 24.9 mm-40 -84.83 -42.11 15.42 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -108.47 -18.45 13.74 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.69 6.93 89.07 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.679 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.8 m -94.42 161.91 14.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.19 128.26 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 O-C-N 123.904 0.753 . . . . 0.0 109.796 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.35 148.87 67.97 Favored Pre-proline 0 C--N 1.288 -2.104 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.665 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.16 129.94 15.78 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.404 2.07 . . . . 0.0 111.289 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.79 151.27 35.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.145 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.421 HG23 ' HG2' ' A' ' 97' ' ' LYS . 12.5 m -112.36 147.64 35.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 96' ' ' ASP . 71.3 mt -77.08 120.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.913 0.387 . . . . 0.0 111.133 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -92.59 -31.99 14.97 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.613 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.0 m -162.38 151.64 15.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.606 HG23 HD21 ' A' ' 138' ' ' LEU . 97.5 mt -127.6 135.87 62.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 122.712 0.405 . . . . 0.0 110.754 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.32 98.14 7.1 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -67.65 -23.84 65.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.017 0.437 . . . . 0.0 111.367 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -73.2 -36.4 66.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.473 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -90.61 -8.8 49.15 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 59.81 29.61 19.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.514 1.126 . . . . 0.0 108.645 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 72.0 p -122.06 162.18 21.67 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.869 -0.519 . . . . 0.0 110.088 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 141' ' ' LEU . 5.6 p -148.69 153.74 38.66 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -97.37 130.44 46.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 26.6 m -119.06 146.02 24.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 90.6 t -109.69 118.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.8 119.31 13.83 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 123.731 0.645 . . . . 0.0 110.811 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -61.66 131.74 50.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.32 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.64 -23.22 17.27 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.271 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -101.73 -46.83 4.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.24 6.65 61.34 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.865 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -80.09 151.57 29.79 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.6 ppt_? -135.77 136.84 41.07 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.55 158.79 41.76 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 20.3 tt0 -94.7 132.22 39.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.655 0.74 . . . . 0.0 110.253 -176.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -127.3 165.31 19.94 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 126.037 1.735 . . . . 0.0 108.484 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.6 m-80 -87.51 145.29 26.31 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 116' ' ' ILE . 78.7 mt -58.02 -38.44 76.2 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -75.28 -22.69 57.58 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.75 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.6 m-20 -89.5 -12.86 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.299 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.7 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.2 mt -68.55 146.61 52.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.317 0.58 . . . . 0.0 110.733 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.43 165.19 13.25 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.431 -1.376 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.167 179.612 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 87.5 m95 . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -130.2 158.72 38.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.75 127.85 23.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.19 11.67 48.16 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.48 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.547 ' HB2' HD12 ' A' ' 113' ' ' ILE . 18.2 m-20 -92.76 135.67 33.91 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -81.9 146.1 29.99 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.411 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.5 p -159.58 -172.78 3.83 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.636 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.6 m -129.02 144.19 51.11 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.12 161.09 36.32 Favored 'General case' 0 C--N 1.278 -2.537 0 O-C-N 123.798 0.686 . . . . 0.0 110.412 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.28 116.74 34.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -67.21 121.17 15.07 Favored 'General case' 0 C--O 1.193 -1.881 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.508 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 20.6 t -64.2 -17.2 63.31 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.146 0.43 . . . . 0.0 111.752 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -83.28 -41.95 17.72 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.335 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -112.75 -17.76 12.47 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.881 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.43 3.89 90.36 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.115 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 81.2 m -93.63 162.95 13.74 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.8 mm -77.66 130.34 36.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -139.77 151.52 66.08 Favored Pre-proline 0 C--N 1.303 -1.443 0 C-N-CA 123.455 0.702 . . . . 0.0 110.271 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.34 128.35 15.38 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.958 2.438 . . . . 0.0 111.789 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.57 149.67 31.98 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.121 0.486 . . . . 0.0 111.019 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 m -112.63 147.04 37.56 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 96' ' ' ASP . 67.6 mt -78.13 121.39 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.199 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.86 -35.7 13.22 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.578 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.1 m -159.52 149.78 18.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.564 HG23 HD21 ' A' ' 138' ' ' LEU . 94.5 mt -125.67 138.18 55.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.742 0.417 . . . . 0.0 110.777 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -112.97 98.32 7.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -65.27 -25.79 67.8 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.536 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -73.27 -38.6 65.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.214 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.45 -8.55 58.32 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.864 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 63.07 25.62 15.04 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 124.646 1.178 . . . . 0.0 108.772 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 74.2 p -124.76 163.99 20.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 111.072 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.8 p -148.63 153.41 38.28 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 122.693 0.397 . . . . 0.0 110.312 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.07 130.25 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.1 m -118.46 147.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.7 t -110.32 118.73 57.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.45 116.92 10.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.825 0.703 . . . . 0.0 110.468 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -65.04 131.47 46.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.96 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.76 -20.48 38.7 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -104.51 -47.65 4.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.978 0.418 . . . . 0.0 110.447 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.53 18.41 41.75 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.991 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -91.05 155.62 18.54 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.4 ppt_? -134.95 136.5 42.31 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.514 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.7 pt-20 -153.96 158.55 40.82 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 17.4 tt0 -95.39 132.85 39.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.71 0.767 . . . . 0.0 111.228 -176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.408 ' OE1' HG22 ' A' ' 125' ' ' VAL . 9.0 mp0 -125.44 164.64 20.0 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 125.84 1.656 . . . . 0.0 109.61 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.1 m-80 -88.11 143.67 26.93 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.564 HD21 HG23 ' A' ' 116' ' ' ILE . 84.5 mt -58.03 -36.28 72.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.357 0.598 . . . . 0.0 110.683 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.6 m -75.16 -23.71 57.81 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.856 0.863 . . . . 0.0 111.459 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 2.5 m-20 -91.06 -11.54 38.42 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.806 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.706 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.7 mt -68.71 142.11 55.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.03 163.85 14.61 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.252 1.189 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.3 m95 . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.06 163.31 22.64 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.85 127.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.85 7.99 52.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.13 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 113' ' ' ILE . 21.2 m-20 -91.35 135.42 33.83 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -74.44 146.4 42.88 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.368 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -160.04 -172.59 3.68 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.894 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.5 m -129.36 142.92 50.69 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.56 160.6 37.55 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.392 0.433 . . . . 0.0 110.699 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.435 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.0 t90 -65.61 119.53 11.3 Favored 'General case' 0 C--O 1.199 -1.585 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.504 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 6.4 t -66.95 -14.96 63.37 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.677 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.37 -42.39 17.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.602 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.435 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.8 t70 -109.49 -18.61 13.48 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.484 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.38 7.79 88.2 Favored Glycine 0 C--N 1.313 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.119 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.3 m -94.3 161.71 14.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.0 mm -79.14 129.33 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -137.52 150.85 69.73 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 127.84 14.98 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.566 2.178 . . . . 0.0 110.97 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.61 147.67 30.29 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.076 0.465 . . . . 0.0 110.465 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.4 m -112.53 147.16 37.19 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 96' ' ' ASP . 78.0 mt -75.47 126.21 35.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.919 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.41 12.13 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -159.34 148.32 18.18 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 138' ' ' LEU . 87.0 mt -127.53 135.67 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.911 0.484 . . . . 0.0 110.025 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.09 96.36 5.99 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.15 -24.17 65.87 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.556 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -74.11 -34.08 63.81 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.69 -8.95 57.89 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.783 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 61.7 30.76 18.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.752 1.221 . . . . 0.0 108.624 -173.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 69.0 p -124.89 165.24 18.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.714 -0.616 . . . . 0.0 110.86 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.737 ' SG ' HD11 ' A' ' 141' ' ' LEU . 6.7 p -148.66 155.18 40.69 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.313 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.1 130.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -118.52 147.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.5 t -109.83 118.89 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -70.59 119.97 15.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.638 0.586 . . . . 0.0 110.72 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.8 m -64.56 131.45 47.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.096 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.07 -22.78 30.06 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -105.54 -41.81 5.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.16 0.505 . . . . 0.0 111.14 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.94 81.31 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -77.63 154.67 32.0 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -135.97 138.02 41.87 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.0 pt-20 -154.02 159.3 41.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -94.18 133.63 37.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.991 0.9 . . . . 0.0 111.57 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 125' ' ' VAL . 10.3 mp0 -128.87 164.85 22.21 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 125.75 1.62 . . . . 0.0 108.989 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 25.8 m-80 -89.92 145.82 24.85 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 116' ' ' ILE . 79.5 mt -59.39 -34.79 72.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.394 0.616 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -25.41 54.95 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.519 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.2 -13.28 38.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.139 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.737 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.2 mt -66.77 145.5 55.45 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.048 0.451 . . . . 0.0 110.754 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.93 160.96 18.23 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.462 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 92.8 m95 . . . . . 0 N--CA 1.44 -0.958 0 CA-C-O 120.48 0.181 . . . . 0.0 111.421 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.7 ptpp? -131.25 157.26 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.48 129.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.54 13.26 57.26 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.95 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.6 t0 -95.35 140.69 29.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -84.65 144.84 28.33 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.1 p -153.73 -170.06 3.47 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.1 m -130.81 141.25 50.33 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.94 160.62 37.14 Favored 'General case' 0 C--N 1.279 -2.458 0 O-C-N 123.624 0.578 . . . . 0.0 110.456 -174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.21 115.84 32.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.6 t90 -66.33 121.98 16.48 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 t -63.19 -21.65 66.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.301 0.572 . . . . 0.0 111.68 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 15.2 mm-40 -84.65 -33.36 23.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.4 t70 -117.04 -18.27 10.13 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.65 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.7 88.86 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.882 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.26 162.73 13.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.64 131.43 34.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.208 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -139.62 151.21 65.78 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.728 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.62 127.98 15.49 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 111.166 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.66 149.02 32.66 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.994 0.426 . . . . 0.0 109.971 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -111.92 147.81 35.05 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.0 mt -79.13 121.57 32.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.568 0.223 . . . . 0.0 111.069 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.95 -32.21 13.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.087 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 m -159.4 147.73 17.69 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.552 HG23 HD21 ' A' ' 138' ' ' LEU . 89.7 mt -126.91 141.22 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.41 96.36 6.06 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 172.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -67.92 -24.02 65.15 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.761 0.315 . . . . 0.0 111.345 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.58 -39.31 64.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.293 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -90.63 -8.11 50.93 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.733 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 64.44 33.43 11.13 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.517 1.135 . . . . 0.0 109.245 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 81.5 p -123.79 164.83 18.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.935 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.716 ' SG ' HD11 ' A' ' 141' ' ' LEU . 6.3 p -149.91 157.28 43.01 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 123.013 0.525 . . . . 0.0 110.768 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.4 t -102.2 131.42 50.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.2 m -118.58 146.04 23.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 121.231 0.539 . . . . 0.0 109.831 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 92.3 t -111.09 118.61 57.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -71.19 119.84 15.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.696 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 m -67.2 130.67 43.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.727 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.71 -16.52 59.99 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.009 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -111.97 -35.09 5.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.76 4.0 90.25 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.492 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -78.18 157.2 29.46 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -141.41 136.42 31.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.501 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.8 pt-20 -152.95 158.41 42.05 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 29.7 tt0 -95.51 137.39 34.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.123 0.487 . . . . 0.0 111.185 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.501 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -137.94 159.0 43.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 124.402 1.081 . . . . 0.0 109.699 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 30.8 m-80 -81.39 147.67 29.69 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.552 HD21 HG23 ' A' ' 116' ' ' ILE . 81.7 mt -60.81 -36.07 78.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.094 0.473 . . . . 0.0 111.414 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 t -80.89 -16.27 54.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.045 0.45 . . . . 0.0 110.418 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.82 -32.26 40.67 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.716 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.5 mt -56.92 141.11 46.33 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.7 1.25 . . . . 0.0 111.718 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.2 159.92 19.57 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.561 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.309 -1.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.5 m95 . . . . . 0 N--CA 1.436 -1.126 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.579 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.0 ptpp? -130.84 160.15 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.69 128.16 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.61 13.35 41.29 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.196 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.579 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 13.2 m-20 -98.03 135.29 39.94 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -78.41 145.49 35.1 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.407 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.454 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -157.04 -169.23 2.88 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.817 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 m -133.6 146.14 50.68 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -138.21 161.64 36.32 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.356 0.41 . . . . 0.0 110.183 -174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.16 118.71 38.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 10.3 t90 -68.17 127.52 33.22 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.556 0.535 . . . . 0.0 109.954 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 m -56.36 -30.85 63.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -85.18 -41.12 15.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.529 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.3 t70 -109.19 -17.15 13.92 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.1 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.22 4.81 84.52 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.968 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.5 m -93.58 162.46 13.95 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -78.48 126.88 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.868 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.18 148.39 64.34 Favored Pre-proline 0 C--N 1.283 -2.288 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.832 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.58 128.67 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.659 2.239 . . . . 0.0 111.259 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.98 152.47 41.1 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -112.24 147.81 35.45 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 96' ' ' ASP . 74.5 mt -79.28 118.03 25.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 123.221 0.326 . . . . 0.0 110.937 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.78 -30.49 15.46 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.76 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.1 m -161.47 145.64 13.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.586 HG23 HD21 ' A' ' 138' ' ' LEU . 87.7 mt -123.39 134.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 120.852 0.358 . . . . 0.0 110.125 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 11.3 t70 -111.89 96.85 6.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -65.86 -23.71 66.72 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.112 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -71.52 -40.67 69.97 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' OD1' ' A' ' 117' ' ' ASP . 93.2 mtt180 -82.58 -9.45 59.39 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.466 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 62.91 29.61 16.54 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.195 1.398 . . . . 0.0 108.135 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 137' ' ' ASN . 74.8 p -131.08 168.47 17.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.106 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.751 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -148.79 155.46 40.98 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.502 0.321 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.8 t -95.86 130.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.55 145.52 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 133' ' ' ARG . 89.5 t -109.73 118.62 57.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.91 120.3 15.43 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 123.758 0.661 . . . . 0.0 111.576 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.462 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.42 -21.93 42.85 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.548 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -111.39 -43.14 3.74 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.612 0.244 . . . . 0.0 111.378 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 8.3 64.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.443 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.5 m-20 -80.39 153.33 28.38 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.76 -0.259 . . . . 0.0 110.419 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.0 ppt_? -137.69 135.24 36.29 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.057 0.456 . . . . 0.0 111.417 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.42 158.71 41.84 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.4 tt0 -94.44 135.11 36.23 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.174 0.511 . . . . 0.0 111.392 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.504 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -131.85 160.25 36.2 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.266 1.026 . . . . 0.0 110.478 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 26.1 m-80 -79.42 144.32 34.2 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 116' ' ' ILE . 75.3 mt -62.4 -33.2 74.3 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.945 0.879 . . . . 0.0 110.376 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.9 t -80.04 -21.46 43.45 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.71 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 23.1 t70 -83.6 -32.79 25.56 Favored 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.751 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.0 mt -51.07 134.48 26.51 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 125.046 1.466 . . . . 0.0 111.902 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.31 161.96 14.53 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.396 -3.157 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.686 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.42 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.2 m95 . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.6 ptpp? -129.76 162.61 28.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.68 127.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.06 15.05 40.25 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.491 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.526 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 22.5 m-20 -98.0 136.78 37.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 117.133 0.466 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -77.47 145.07 37.3 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.48 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.7 p -156.18 -165.87 2.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.499 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 m -139.42 149.44 44.07 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -140.32 161.53 37.47 Favored 'General case' 0 C--N 1.278 -2.502 0 O-C-N 123.877 0.735 . . . . 0.0 110.078 -173.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.82 120.05 40.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.446 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 10.1 t90 -69.65 125.89 28.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -58.93 -25.04 63.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 21.0 mm-40 -84.87 -37.73 20.3 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -174.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -117.41 -18.22 9.89 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.982 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.6 86.95 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.212 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.2 m -92.93 160.19 15.0 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.85 126.12 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 C-N-CA 123.848 0.859 . . . . 0.0 109.016 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -134.58 149.51 71.11 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.18 128.09 17.89 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.914 2.409 . . . . 0.0 110.902 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.88 149.52 34.42 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.843 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.3 m -113.85 147.76 37.84 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.461 HD12 ' HB2' ' A' ' 96' ' ' ASP . 75.8 mt -76.89 126.23 37.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.63 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -33.1 11.24 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 m -161.33 149.57 15.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.579 HG23 HD21 ' A' ' 138' ' ' LEU . 87.3 mt -128.82 140.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.513 0.725 . . . . 0.0 109.966 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -113.04 98.87 7.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.03 -23.76 67.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.447 -174.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -73.42 -40.52 64.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -87.8 -8.32 56.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.026 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 61.4 28.29 17.73 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.856 0.862 . . . . 0.0 108.793 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 68.9 p -122.02 159.56 26.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 121.7 -0.625 . . . . 0.0 110.55 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.66 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.4 p -148.22 152.37 37.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.654 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 59.4 t -95.99 130.56 44.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.5 m -118.06 145.77 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.1 t -111.53 118.55 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.36 116.67 10.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 124.042 0.839 . . . . 0.0 110.503 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 m -62.93 131.13 47.69 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.072 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.79 -27.98 12.78 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -101.81 -42.97 5.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.938 0.399 . . . . 0.0 110.758 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.21 1.58 75.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -72.24 149.39 44.6 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.3 ppt_? -133.64 136.18 44.63 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.507 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 7.7 pt-20 -153.46 158.39 41.29 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.6 tt0 -95.95 134.53 38.84 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.528 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -134.05 157.51 45.93 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.374 1.069 . . . . 0.0 109.802 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 32.3 m-80 -79.43 147.26 32.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.579 HD21 HG23 ' A' ' 116' ' ' ILE . 77.8 mt -58.28 -34.32 70.39 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.674 0.75 . . . . 0.0 110.078 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -76.59 -24.65 53.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.199 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.23 -12.87 45.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.176 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.66 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -70.29 143.09 52.17 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 123.479 0.487 . . . . 0.0 111.41 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.31 160.67 18.82 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.617 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.401 -2.89 0 C-N-CA 124.602 1.161 . . . . 0.0 110.327 178.408 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 C--O 1.244 0.78 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.8 m -91.63 91.73 8.15 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.66 -26.81 19.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.261 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 71.45 8.47 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.755 0.788 . . . . 0.0 111.467 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.8 t -124.53 13.31 8.74 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -107.81 34.83 3.36 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.456 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.421 ' HB3' ' NE1' ' A' ' 92' ' ' TRP . 9.8 mm100 -79.95 132.9 36.15 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.27 -172.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -132.59 129.61 39.18 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.436 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 -128.29 163.36 24.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -170.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 25.4 pttm -131.15 154.32 48.48 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.97 135.56 27.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.139 0.576 . . . . 0.0 110.156 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.67 11.92 57.48 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.006 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 3.4 m-20 -99.68 143.56 29.78 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-O 120.871 0.367 . . . . 0.0 110.364 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.15 144.72 30.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.16 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.436 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.0 p -159.31 -169.89 2.78 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.6 m -132.95 146.05 51.44 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 160.94 37.23 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.722 0.639 . . . . 0.0 111.107 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.1 mm -91.92 117.1 34.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -67.96 126.99 31.21 Favored 'General case' 0 C--O 1.203 -1.357 0 O-C-N 123.571 0.544 . . . . 0.0 109.694 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -57.92 -28.65 64.46 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -84.46 -41.22 16.82 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -109.6 -17.75 13.65 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.702 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.87 7.5 88.46 Favored Glycine 0 C--N 1.311 -0.835 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.625 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.59 161.76 14.23 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -77.35 127.77 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.713 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.02 151.24 73.38 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 123.453 0.701 . . . . 0.0 109.313 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.77 129.98 18.52 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.521 2.147 . . . . 0.0 111.685 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -148.37 151.96 36.2 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 120.889 0.376 . . . . 0.0 110.539 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.0 m -114.1 148.11 37.67 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -75.01 124.48 32.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.882 0.372 . . . . 0.0 111.229 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -96.48 -36.62 10.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.268 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.5 p -159.19 149.56 19.38 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.627 HG23 HD21 ' A' ' 138' ' ' LEU . 98.2 mt -126.39 129.11 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 12.1 t70 -112.77 101.63 9.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 173.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -67.25 -24.23 65.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.266 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.89 -38.64 64.32 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 122' ' ' THR . 98.0 mtt180 -81.59 -9.48 59.67 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 61.56 25.26 15.22 Favored 'General case' 0 C--O 1.252 1.234 0 C-N-CA 125.274 1.429 . . . . 0.0 108.469 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 120' ' ' ARG . 68.1 p -129.38 168.82 15.72 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.435 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.691 ' SG ' HD11 ' A' ' 141' ' ' LEU . 5.7 p -148.5 151.27 34.85 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 65.9 t -96.31 132.64 40.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.9 m -119.6 149.41 22.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 133' ' ' ARG . 96.7 t -111.09 118.51 57.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.19 118.12 11.68 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.827 0.705 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.3 m -65.32 131.37 46.29 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.38 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.89 -19.42 53.08 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -111.74 -44.96 3.4 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.705 0.288 . . . . 0.0 111.511 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.33 0.98 67.02 Favored Glycine 0 C--N 1.311 -0.809 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.876 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -73.69 152.37 40.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.3 ppt_? -137.94 135.74 36.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 120.773 0.321 . . . . 0.0 110.864 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -151.94 159.53 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.7 tt0 -93.8 131.63 38.99 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.099 0.952 . . . . 0.0 111.105 -176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 125' ' ' VAL . 7.5 mp0 -123.39 165.07 17.65 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 125.572 1.549 . . . . 0.0 109.629 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 35.7 m-80 -89.72 142.92 27.24 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.627 HD21 HG23 ' A' ' 116' ' ' ILE . 63.4 mt -58.79 -36.64 74.77 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.43 0.692 . . . . 0.0 110.682 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 t -79.55 -16.63 55.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.477 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 4.1 t70 -89.62 -28.05 19.78 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.73 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.691 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.8 mt -54.87 134.81 48.4 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.983 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.71 167.03 10.45 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.479 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.0 t -62.47 142.75 96.35 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.61 -177.76 1.02 Allowed 'Trans proline' 0 C--O 1.241 0.648 0 C-N-CA 123.422 2.748 . . . . 0.0 113.718 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.6 pt -86.34 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.592 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.07 42.34 1.08 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.394 1.092 . . . . 0.0 111.442 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 . . . . . 0 C--N 1.252 -3.64 0 CA-C-N 113.622 -1.626 . . . . 0.0 108.859 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 p -80.74 107.13 13.29 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.91 -56.41 2.57 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.853 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.16 81.62 1.94 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 m -144.9 24.01 1.51 Allowed 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.77 11.03 38.58 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.69 125.17 24.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.797 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -114.31 141.24 47.86 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -134.12 164.08 28.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 120.95 0.405 . . . . 0.0 111.271 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -130.96 159.34 37.73 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.08 132.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.49 10.55 57.98 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.834 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.13 141.3 29.68 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -81.15 144.09 31.92 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.37 0.605 . . . . 0.0 110.985 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -156.65 -171.57 3.73 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.16 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 142.21 50.82 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.6 160.62 37.92 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 123.493 0.496 . . . . 0.0 110.002 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.6 mm -92.76 117.11 35.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 8.8 t90 -64.74 121.14 13.84 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.553 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 27.7 t -58.3 -24.38 59.36 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.023 0.44 . . . . 0.0 111.597 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -83.25 -42.07 17.63 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.14 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.429 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.9 t70 -111.5 -18.04 12.94 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.563 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 7.09 88.88 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.663 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.0 m -92.94 158.4 15.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mm -77.87 130.78 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.774 175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.442 ' CD2' HC11 ' A' 1148 ' ' DA2 . 85.9 m-85 -138.67 148.73 59.71 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.94 127.46 12.95 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.115 1.877 . . . . 0.0 111.024 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.89 150.41 38.37 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.391 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.1 m -111.84 147.61 35.38 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 75.0 mt -76.13 124.89 35.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.631 0.253 . . . . 0.0 110.818 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.19 12.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.872 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.4 m -160.8 152.54 19.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.575 HG23 HD21 ' A' ' 138' ' ' LEU . 82.0 mt -132.48 139.89 48.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 122.979 0.512 . . . . 0.0 110.817 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -111.91 97.48 6.71 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -68.19 -23.9 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.04 -39.14 63.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.774 0.321 . . . . 0.0 110.977 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.75 -7.56 56.04 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.251 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 63.07 33.74 14.37 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.303 1.002 . . . . 0.0 108.84 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 53.8 p -123.62 161.75 24.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.506 -0.746 . . . . 0.0 110.402 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.713 ' SG ' HD11 ' A' ' 141' ' ' LEU . 4.6 p -149.43 151.91 34.81 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.5 t -96.32 130.98 44.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.0 m -118.69 145.94 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.4 t -112.4 118.6 58.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.82 118.84 14.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 123.802 0.689 . . . . 0.0 110.911 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.2 m -63.63 131.56 48.37 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.716 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.18 -29.85 8.9 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.824 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.92 -40.64 6.8 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.702 0.287 . . . . 0.0 111.321 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.23 8.54 74.79 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.078 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -80.37 153.87 28.08 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.1 ppt_? -136.0 137.9 41.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 6.8 pt-20 -154.23 158.92 40.98 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.8 tt0 -99.37 132.22 44.85 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.519 0.676 . . . . 0.0 111.526 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.529 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -132.2 163.46 28.52 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.653 1.181 . . . . 0.0 109.681 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 24.7 m-80 -85.06 146.7 27.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.575 HD21 HG23 ' A' ' 116' ' ' ILE . 84.3 mt -57.21 -35.57 69.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.738 0.78 . . . . 0.0 111.177 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.4 m -80.08 -20.28 45.5 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.097 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -13.89 39.86 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.713 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.8 mt -71.68 145.14 49.06 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.625 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -114.98 159.5 20.67 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.7 m -62.76 141.32 97.21 Favored Pre-proline 0 N--CA 1.39 -3.434 0 C-N-CA 123.755 0.822 . . . . 0.0 108.953 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.46 162.4 30.92 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 122.755 2.303 . . . . 0.0 113.805 -174.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 pt -113.44 161.6 12.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.803 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.4 m -71.83 121.45 19.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.285 0.564 . . . . 0.0 110.084 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--N 1.276 -2.616 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.881 -179.057 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.442 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.9 m -140.71 96.03 2.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 -34.34 15.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.256 0.551 . . . . 0.0 110.039 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.03 66.6 5.84 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.814 0.816 . . . . 0.0 110.842 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 p -118.9 4.08 11.5 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.222 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -88.01 17.82 4.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.799 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.428 ' HB3' ' NE1' ' A' ' 92' ' ' TRP . 9.8 mm100 -65.91 129.12 38.7 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.709 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.59 110.97 15.09 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.7 m95 -112.82 161.22 17.18 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.249 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.7 ptpp? -131.21 161.34 32.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 173.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.7 t -63.84 127.71 24.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.89 13.91 38.57 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.15 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.555 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 28.2 m-20 -96.82 142.46 28.8 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -87.39 141.41 28.65 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -152.72 -170.58 3.67 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.3 m -127.27 143.55 51.22 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -135.39 160.4 38.55 Favored 'General case' 0 C--N 1.278 -2.529 0 O-C-N 123.644 0.59 . . . . 0.0 110.005 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 mm -92.36 116.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -64.8 126.62 28.53 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 123.601 0.563 . . . . 0.0 109.904 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.1 m -58.27 -28.16 64.69 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.4 -41.82 15.09 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.077 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.91 -17.83 13.53 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.722 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.88 90.0 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.736 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.91 161.99 14.26 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.55 130.47 36.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.425 0.69 . . . . 0.0 109.657 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CG ' HC11 ' A' 1148 ' ' DA2 . 91.9 m-85 -139.29 151.0 66.28 Favored Pre-proline 0 C--N 1.295 -1.786 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.679 176.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.7 127.78 14.3 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 122.664 2.242 . . . . 0.0 111.028 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.36 150.82 36.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-O 120.914 0.387 . . . . 0.0 110.557 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -111.88 147.59 35.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 96' ' ' ASP . 69.3 mt -79.35 121.8 33.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.781 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.42 -35.32 12.39 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.785 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -159.14 144.65 16.15 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.601 HG23 HD21 ' A' ' 138' ' ' LEU . 99.0 mt -122.13 134.78 64.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.399 0.28 . . . . 0.0 110.416 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -113.13 96.64 6.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -64.39 -25.83 68.19 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.961 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -69.16 -37.35 78.16 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -91.03 -7.24 52.46 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.464 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 62.59 25.11 14.96 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 108.558 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 71.5 p -122.82 161.96 23.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 121.546 -0.721 . . . . 0.0 111.422 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.691 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.6 p -148.03 153.18 38.61 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.105 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 78.9 t -96.26 130.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.4 m -119.22 145.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-O 121.171 0.51 . . . . 0.0 109.88 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.0 t -110.41 118.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.543 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -71.73 117.95 13.95 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.2 m -65.85 131.82 47.18 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.48 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.61 -17.16 55.9 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -109.69 -39.95 4.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.893 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.68 23.58 57.73 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.821 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -95.28 153.27 17.75 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.0 ppt_? -137.94 135.7 36.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.679 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.34 159.16 41.04 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -94.83 133.22 38.77 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.468 0.651 . . . . 0.0 111.855 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.496 ' NE2' ' HB1' ' A' ' 100' ' ' ALA . 5.7 mp0 -131.78 163.66 27.73 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.84 1.256 . . . . 0.0 110.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 26.8 m-80 -85.51 146.86 26.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.601 HD21 HG23 ' A' ' 116' ' ' ILE . 67.0 mt -59.22 -37.4 77.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.548 0.69 . . . . 0.0 109.964 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.8 m -74.4 -22.14 59.31 Favored 'General case' 0 N--CA 1.405 -2.711 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.433 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 m-20 -91.32 -13.46 32.53 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.691 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.0 mt -71.19 144.13 50.26 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.089 0.471 . . . . 0.0 110.676 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.2 165.52 12.84 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.8 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.8 t -62.92 137.6 96.98 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.552 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 50.7 Cg_endo -67.16 166.26 23.78 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.317 2.011 . . . . 0.0 112.101 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.1 pt -116.29 174.19 3.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.808 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.4 p -72.8 159.94 32.97 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.285 0.366 . . . . 0.0 110.27 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--N 1.293 -1.854 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.177 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.419 ' HNE' HC21 ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.544 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.3 m120 . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m -47.19 115.14 1.01 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.698 1.199 . . . . 0.0 112.7 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.07 8.23 5.32 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.431 1.492 . . . . 0.0 113.503 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.506 ' HB1' ' NE2' ' A' ' 90' ' ' GLN . . . -128.43 22.24 6.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.261 0.553 . . . . 0.0 112.275 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -89.58 20.68 3.83 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.665 0.745 . . . . 0.0 109.931 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -121.73 12.83 10.69 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.216 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.506 ' NE2' ' HB1' ' A' ' 87' ' ' ALA . 39.1 mt-30 -95.99 151.66 19.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.906 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -132.42 114.06 13.89 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 174.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.47 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 95.4 m95 -104.18 160.02 15.21 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.852 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 64.5 pttt -131.45 159.97 36.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 16.29 68.42 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.586 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 6.8 t0 -100.08 136.15 40.43 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -85.04 141.86 29.98 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.47 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -150.14 -167.87 2.95 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -130.13 143.61 50.88 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.58 160.56 38.1 Favored 'General case' 0 C--N 1.281 -2.408 0 O-C-N 123.439 0.462 . . . . 0.0 110.101 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.29 117.88 36.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -67.02 122.46 17.82 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 11.1 t -65.31 -16.26 63.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 118.052 0.387 . . . . 0.0 111.804 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -85.3 -38.44 18.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -115.16 -18.33 11.18 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.408 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 6.29 88.73 Favored Glycine 0 C--N 1.31 -0.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.022 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.62 162.51 13.92 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mm -78.69 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.42 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.35 150.87 73.71 Favored Pre-proline 0 C--N 1.284 -2.244 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.358 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.15 127.46 13.53 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.988 1.792 . . . . 0.0 110.861 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.09 35.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 m -112.21 148.19 34.62 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 96' ' ' ASP . 71.3 mt -77.18 121.63 30.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.857 0.36 . . . . 0.0 110.995 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -90.35 -39.76 12.5 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.713 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.2 m -158.5 149.8 20.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.585 HG23 HD21 ' A' ' 138' ' ' LEU . 95.3 mt -125.11 136.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.98 0.419 . . . . 0.0 110.494 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -112.11 99.29 7.94 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.95 -23.46 65.06 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.894 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.17 -36.36 66.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.954 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.33 -8.91 54.37 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.485 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 59.98 28.69 18.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.209 1.004 . . . . 0.0 109.0 -172.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 76.1 p -122.84 162.86 21.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 121.405 -0.81 . . . . 0.0 110.671 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.5 p -148.69 152.35 36.51 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 122.617 0.367 . . . . 0.0 110.521 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.9 t -95.31 131.12 42.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.1 m -118.43 145.65 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 91.4 t -111.49 118.67 58.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -69.14 121.9 17.7 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 123.734 0.646 . . . . 0.0 110.887 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.4 m -62.8 131.21 48.09 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.389 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.09 18.22 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.4 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.86 -42.14 5.94 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 122.508 -0.407 . . . . 0.0 111.566 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.35 61.99 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.822 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -89.4 152.66 21.38 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.8 ppt_? -133.98 140.22 46.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.554 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.3 pt-20 -153.68 158.04 40.46 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 21.9 tt0 -98.21 129.75 44.96 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 110.891 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.554 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.4 mp0 -126.56 163.16 24.03 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 124.333 1.053 . . . . 0.0 109.676 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.3 m-80 -82.88 146.98 28.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.585 HD21 HG23 ' A' ' 116' ' ' ILE . 57.3 mt -60.76 -34.34 74.31 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.316 1.055 . . . . 0.0 109.251 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.544 ' OG ' ' HA ' ' A' ' 84' ' ' ASN . 7.5 t -80.11 -8.33 59.35 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.088 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -104.89 -15.67 15.09 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.529 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.657 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.2 mt -66.37 146.82 54.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.205 0.526 . . . . 0.0 111.166 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.29 161.76 18.52 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.709 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.4 m -63.04 136.38 96.66 Favored Pre-proline 0 N--CA 1.396 -3.132 0 C-N-CA 124.548 1.139 . . . . 0.0 110.303 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.18 173.92 13.21 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.922 2.414 . . . . 0.0 113.445 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.55 156.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 56.7 m -91.09 97.19 11.01 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.133 0.968 . . . . 0.0 110.537 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 . . . . . 0 C--N 1.261 -3.241 0 CA-C-N 113.934 -1.485 . . . . 0.0 108.185 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.5 p -82.58 149.85 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.361 0.264 . . . . 0.0 111.196 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -118.22 -77.54 0.57 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.463 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.57 20.08 3.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.005 0.907 . . . . 0.0 111.359 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -78.11 7.68 5.88 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.274 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.496 HD12 HE21 ' A' ' 90' ' ' GLN . 1.2 pp -125.32 16.57 8.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.075 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.496 HE21 HD12 ' A' ' 89' ' ' LEU . 31.6 mm-40 -83.21 156.05 23.38 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.601 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -118.33 113.46 21.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 85.8 m95 -101.66 161.94 13.28 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.353 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.599 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -131.17 162.87 28.97 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.85 132.32 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.91 12.47 56.56 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.275 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 75.4 m-20 -97.26 149.42 22.07 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.402 0.62 . . . . 0.0 109.839 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -86.89 139.81 30.27 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.275 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -155.96 -172.38 4.09 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.114 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 13.6 m -131.2 146.89 52.5 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.18 37.42 Favored 'General case' 0 C--N 1.274 -2.701 0 O-C-N 123.69 0.619 . . . . 0.0 109.791 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.0 mm -91.93 118.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -65.87 120.55 13.26 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.628 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 9.0 t -61.55 -19.58 62.31 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.065 0.228 . . . . 0.0 111.324 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.97 -42.07 15.26 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.85 -17.91 12.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.075 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.94 5.62 89.16 Favored Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.108 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.16 161.46 14.41 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.1 mm -79.17 130.53 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.427 ' CD2' HC11 ' A' 1148 ' ' DA2 . 86.9 m-85 -138.94 150.28 64.69 Favored Pre-proline 0 C--N 1.286 -2.19 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.91 132.26 24.32 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.326 2.017 . . . . 0.0 111.156 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.5 149.65 32.02 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.024 0.44 . . . . 0.0 110.208 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -111.53 147.26 35.76 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.0 mt -76.55 125.69 36.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.5 -35.43 10.25 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.02 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.2 m -158.65 148.04 19.15 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 138' ' ' LEU . 88.7 mt -125.98 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 122.64 0.376 . . . . 0.0 110.051 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.95 98.81 7.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -24.03 66.5 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.288 -174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.77 -37.41 67.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.694 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -85.88 -8.87 57.77 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.376 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.01 28.87 18.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.534 1.134 . . . . 0.0 108.432 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 70.2 p -125.2 160.73 28.49 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.685 -0.634 . . . . 0.0 110.492 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.2 p -148.19 153.73 39.17 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 122.704 0.402 . . . . 0.0 110.393 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.5 t -95.52 130.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.51 145.72 24.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.0 t -111.36 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -68.79 117.73 10.85 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.849 0.718 . . . . 0.0 111.111 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 m -60.77 131.14 49.74 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.531 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.62 -28.28 7.84 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.987 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -101.01 -42.9 6.22 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 122.508 -0.407 . . . . 0.0 111.494 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.52 14.6 63.33 Favored Glycine 0 C--N 1.309 -0.95 0 C-N-CA 120.422 -0.895 . . . . 0.0 111.891 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.1 m-20 -86.78 151.35 23.45 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.92 135.77 39.92 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 123.131 0.269 . . . . 0.0 111.129 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.628 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.7 pt-20 -153.69 158.16 40.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.0 tt0 -96.35 131.4 42.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.482 0.658 . . . . 0.0 111.689 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.536 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.2 mp0 -128.16 163.64 24.23 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 125.27 1.428 . . . . 0.0 109.763 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 29.2 m-80 -82.67 147.55 28.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 116' ' ' ILE . 72.7 mt -59.37 -35.99 74.93 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.878 0.847 . . . . 0.0 110.06 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.0 m -76.82 -19.52 57.44 Favored 'General case' 0 N--CA 1.405 -2.69 0 C-N-CA 124.164 0.986 . . . . 0.0 111.63 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -93.25 -10.06 36.93 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.049 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -72.37 147.36 46.32 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.529 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.62 163.18 18.43 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.5 t -65.27 145.31 99.1 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.503 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 84.2 Cg_endo -76.9 -179.3 5.27 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.758 2.305 . . . . 0.0 112.325 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.1 pt -116.17 168.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.1 p -73.14 137.02 44.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 123.582 0.753 . . . . 0.0 110.115 -177.339 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.427 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 m -104.96 109.2 21.09 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 65.5 11.05 7.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.719 1.208 . . . . 0.0 113.03 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.19 79.96 1.72 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.445 0.641 . . . . 0.0 111.334 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.7 t -95.04 -13.46 25.18 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.065 0.936 . . . . 0.0 108.608 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.75 23.56 0.09 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.355 -1.293 . . . . 0.0 113.552 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -69.81 117.24 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.16 0.505 . . . . 0.0 110.327 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -107.31 128.44 54.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.428 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.1 m95 -125.12 160.24 29.56 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.946 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.8 pttm -131.98 160.82 34.72 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.57 129.21 26.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 13.97 39.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.591 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.497 ' HB2' HD12 ' A' ' 113' ' ' ILE . 71.6 m-20 -97.91 141.03 31.4 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -84.48 144.99 28.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.428 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.01 -169.37 3.05 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 m -130.35 144.21 51.25 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -136.55 161.0 37.08 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.116 0.26 . . . . 0.0 110.431 -175.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -92.37 119.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.46 125.77 27.52 Favored 'General case' 0 C--O 1.205 -1.254 0 O-C-N 123.436 0.46 . . . . 0.0 109.795 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -57.96 -26.79 62.76 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -84.73 -41.83 15.82 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.248 -172.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.89 -17.35 12.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.914 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.52 4.28 90.19 Favored Glycine 0 C--O 1.222 -0.644 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.177 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.9 m -93.15 162.05 14.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.9 mm -78.39 131.05 35.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.123 0.969 . . . . 0.0 109.605 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CD2' HC11 ' A' 1148 ' ' DA2 . 91.0 m-85 -140.26 151.42 64.44 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.636 175.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.411 ' HD3' HD11 ' A' ' 145' ' ' ILE . 55.8 Cg_endo -70.92 129.7 16.76 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.433 2.088 . . . . 0.0 111.209 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.32 150.48 35.82 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.991 0.424 . . . . 0.0 110.661 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.9 m -111.94 147.58 35.56 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' A' ' 96' ' ' ASP . 75.5 mt -77.6 120.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -93.41 -33.84 13.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.836 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.8 m -162.05 146.82 12.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.538 HG23 HD21 ' A' ' 138' ' ' LEU . 84.4 mt -121.54 138.6 51.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.79 96.05 5.75 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -65.2 -24.04 67.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.359 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.06 -39.99 71.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.396 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -85.6 -9.02 57.92 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 61.54 30.72 18.85 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.877 1.271 . . . . 0.0 109.141 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.9 p -129.2 165.33 21.55 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.91 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -148.71 153.67 38.55 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 122.4 0.28 . . . . 0.0 110.965 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 46.9 t -95.92 130.1 45.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.94 146.06 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.661 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 114' ' ' ALA . 90.8 t -110.4 118.84 58.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -69.59 118.31 12.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.752 0.658 . . . . 0.0 110.96 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 m -64.94 130.93 45.23 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.556 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.53 -19.59 43.27 Favored Glycine 0 N--CA 1.428 -1.836 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.22 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -107.68 -43.37 4.51 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.808 0.337 . . . . 0.0 111.659 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.19 8.41 66.62 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.092 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.2 m-20 -81.3 152.76 27.41 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.5 OUTLIER -139.47 136.42 34.57 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.932 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.553 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.36 158.48 41.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -94.6 133.84 37.81 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.351 0.596 . . . . 0.0 111.475 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.553 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.3 mp0 -128.88 163.29 25.59 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 124.832 1.253 . . . . 0.0 110.376 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -81.24 148.47 29.46 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 116' ' ' ILE . 57.5 mt -62.61 -31.0 71.77 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.442 0.639 . . . . 0.0 110.763 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.2 t -80.29 -25.39 39.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.378 0.609 . . . . 0.0 109.758 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 142' ' ' LEU . 32.6 t70 -74.77 -31.25 61.71 Favored 'General case' 0 CA--C 1.469 -2.152 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.568 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.76 HD11 ' SG ' ' A' ' 123' ' ' CYS . 54.1 mt -58.54 134.14 56.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.39 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 140' ' ' ASP . 5.1 mp -109.51 159.41 17.08 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.173 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.2 m -62.64 144.48 96.02 Favored Pre-proline 0 N--CA 1.392 -3.332 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.42 158.9 17.59 Favored 'Trans proline' 0 C--O 1.253 1.26 0 C-N-CA 122.906 2.404 . . . . 0.0 114.676 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.411 HD11 ' HD3' ' A' ' 110' ' ' PRO . 23.8 pt -120.97 179.4 2.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.034 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 56.6 m -74.99 133.34 41.71 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-O 117.752 -1.118 . . . . 0.0 109.902 -178.192 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.461 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 111.296 0.109 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 m -72.41 108.86 5.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 77.13 -40.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.307 1.843 . . . . 0.0 110.811 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.22 90.48 4.59 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.331 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -135.92 20.33 3.26 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 pp -98.49 12.23 35.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.125 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.03 125.69 26.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.051 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -103.12 113.56 27.14 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.416 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.0 m95 -101.84 163.33 12.31 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.329 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 24.5 pttm -130.83 159.28 37.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.67 128.38 25.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.03 7.32 52.86 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.153 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.508 ' HB2' HD12 ' A' ' 113' ' ' ILE . 60.5 m-20 -91.13 137.17 32.57 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -80.71 141.11 35.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.416 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -154.14 -166.27 2.32 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 m -131.32 146.95 52.51 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB1' HE21 ' A' ' 136' ' ' GLN . . . -141.07 161.92 36.71 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 122.98 0.175 . . . . 0.0 110.687 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.5 mm -91.12 116.04 31.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 O-C-N 123.819 0.7 . . . . 0.0 109.814 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -65.74 119.39 11.11 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 t -65.79 -14.95 62.36 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 118.205 0.457 . . . . 0.0 112.013 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.19 -41.84 19.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.69 -0.404 . . . . 0.0 112.028 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.94 -16.99 12.58 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.26 -175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.0 8.5 87.59 Favored Glycine 0 C--N 1.307 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.705 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.7 m -93.83 160.61 14.67 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.427 HD12 HD22 ' A' ' 142' ' ' LEU . 26.4 mm -77.17 129.64 37.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.888 0.875 . . . . 0.0 109.553 176.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -138.6 150.08 64.77 Favored Pre-proline 0 C--N 1.29 -2.016 0 C-N-CA 123.087 0.555 . . . . 0.0 109.966 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.06 128.3 14.67 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.556 2.171 . . . . 0.0 110.8 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.66 150.4 34.29 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.422 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.0 m -111.51 147.82 34.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 96' ' ' ASP . 62.5 mt -78.06 121.91 31.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.791 -177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.456 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -95.12 -32.6 13.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -159.05 148.65 18.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.568 HG23 HD21 ' A' ' 138' ' ' LEU . 91.2 mt -129.05 139.68 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 122.893 0.477 . . . . 0.0 109.977 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.68 99.1 7.89 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -67.55 -24.04 65.48 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.085 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -73.97 -41.61 61.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.636 0.255 . . . . 0.0 110.749 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.8 mtm180 -86.64 -8.89 57.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.029 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 61.56 32.85 18.59 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.327 1.017 . . . . 0.0 108.671 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 59.2 p -122.96 159.68 27.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.85 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.1 p -149.02 152.61 36.57 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 122.776 0.43 . . . . 0.0 111.039 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.3 t -96.37 131.22 43.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.8 m -119.45 145.3 25.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 133' ' ' ARG . 59.5 t -110.18 118.73 57.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -72.41 116.91 13.43 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 123.698 0.624 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.7 m -63.76 131.61 48.38 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.24 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.19 -22.08 36.68 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.988 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -109.23 -40.07 5.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.38 78.51 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.065 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -73.92 149.26 41.53 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -135.94 135.82 39.92 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -152.58 158.13 42.03 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.6 tt0 -93.71 132.7 37.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.307 0.575 . . . . 0.0 110.923 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.508 HE21 ' HB1' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -133.55 163.67 28.88 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 125.097 1.359 . . . . 0.0 107.396 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 34.4 m-80 -83.74 151.42 25.24 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 116' ' ' ILE . 75.5 mt -62.26 -36.32 81.66 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.07 0.938 . . . . 0.0 108.963 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -33.16 74.46 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.682 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.52 -15.56 45.45 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.439 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.627 HD11 ' SG ' ' A' ' 123' ' ' CYS . 58.9 mt -65.13 146.98 54.27 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.14 0.495 . . . . 0.0 111.862 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 108' ' ' ILE . 5.3 mp -117.84 161.16 20.18 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.329 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 m -62.57 136.99 96.28 Favored Pre-proline 0 N--CA 1.405 -2.725 0 C-N-CA 124.443 1.097 . . . . 0.0 110.568 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 175.83 8.11 Favored 'Trans proline' 0 C--O 1.251 1.157 0 C-N-CA 123.211 2.607 . . . . 0.0 112.903 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.76 -176.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.969 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.5 p -74.74 133.51 42.0 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.445 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 C--O 1.252 1.226 0 O-C-N 124.728 1.268 . . . . 0.0 110.843 -179.591 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.444 HC21 ' HNE' ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t30 . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.0 t -135.16 147.45 49.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.132 0.491 . . . . 0.0 111.175 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.79 -0.48 19.9 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.47 84.32 3.68 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.981 0.896 . . . . 0.0 109.827 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -145.19 32.62 1.1 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.6 14.71 12.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.163 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.28 125.43 30.33 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.396 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -111.65 109.1 18.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 79.5 m95 -101.85 163.06 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.613 -173.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.536 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.9 ptpp? -128.88 155.95 44.45 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.8 t -63.65 127.47 24.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.7 33.09 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.69 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 29.2 m-20 -96.2 141.3 29.73 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -82.14 143.51 31.4 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.445 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 27.0 p -155.23 -170.47 3.48 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.9 m -131.4 142.9 50.12 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.65 160.46 38.04 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.093 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.47 120.23 41.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -67.15 126.1 28.12 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.6 m -58.77 -27.16 64.72 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -85.21 -41.86 15.23 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -110.51 -16.36 13.68 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.318 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.77 89.89 Favored Glycine 0 C--N 1.306 -1.116 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.06 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.5 160.47 15.04 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mm -78.44 128.28 38.4 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.347 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.431 ' CD2' HC11 ' A' 1148 ' ' DA2 . 86.4 m-85 -136.14 151.24 73.18 Favored Pre-proline 0 C--N 1.287 -2.145 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.66 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.88 127.9 15.15 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.411 2.074 . . . . 0.0 110.797 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.05 150.17 36.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 120.849 0.356 . . . . 0.0 110.29 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 m -112.04 147.83 35.17 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 96' ' ' ASP . 70.9 mt -81.35 118.91 29.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-O 120.831 0.348 . . . . 0.0 110.746 -177.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.87 15.39 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.077 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.6 m -161.43 146.62 13.67 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.566 HG23 HD21 ' A' ' 138' ' ' LEU . 94.3 mt -128.64 135.97 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 122.843 0.457 . . . . 0.0 110.534 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.59 102.7 10.76 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.67 -26.09 66.03 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.041 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -70.14 -40.42 74.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.304 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.45 -8.8 58.18 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.021 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 60.36 27.57 17.16 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.23 1.014 . . . . 0.0 109.12 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p -124.85 160.17 29.4 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 121.143 -0.973 . . . . 0.0 110.871 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.712 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.4 p -148.3 153.83 39.19 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 50.7 t -95.91 130.42 44.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 86.4 t -111.57 119.05 59.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -70.42 120.24 15.77 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.539 0.685 . . . . 0.0 111.068 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.1 m -64.59 132.09 48.82 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.156 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.68 -20.9 32.48 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.051 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -106.82 -50.3 3.14 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.914 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.05 3.42 59.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.489 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.4 154.49 34.81 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.7 ppt_? -137.12 139.35 41.15 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.564 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.6 pt-20 -153.51 158.28 41.07 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.9 tt0 -97.72 129.69 44.75 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.564 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 5.9 mp0 -127.5 163.48 24.02 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 124.298 1.039 . . . . 0.0 110.037 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -82.14 148.4 28.53 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 116' ' ' ILE . 67.8 mt -61.15 -31.62 71.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.084 0.945 . . . . 0.0 109.659 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.2 m -78.19 -24.09 47.28 Favored 'General case' 0 N--CA 1.392 -3.328 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.422 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.82 -32.29 31.32 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.386 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.712 HD11 ' SG ' ' A' ' 123' ' ' CYS . 54.7 mt -56.01 141.55 39.44 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 124.587 1.179 . . . . 0.0 111.689 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.79 162.32 16.46 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.485 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 t -62.64 146.56 94.11 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.65 166.99 12.42 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.354 2.036 . . . . 0.0 112.448 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.18 159.26 15.16 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.187 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 54.9 m -96.68 126.75 42.07 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 C--N 1.287 -2.125 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.373 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.431 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.458 0.171 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -75.08 89.1 2.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.576 0.703 . . . . 0.0 111.638 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -106.28 2.63 26.89 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.813 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.51 25.29 14.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.916 0.886 . . . . 0.0 111.246 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.4 m -78.52 20.47 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.891 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.411 HD12 HE21 ' A' ' 90' ' ' GLN . 1.5 pp -133.91 23.5 3.91 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.449 0.643 . . . . 0.0 110.866 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.411 HE21 HD12 ' A' ' 89' ' ' LEU . 30.2 mm-40 -82.75 141.87 32.05 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.263 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -103.83 114.46 28.73 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.463 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 91.5 m95 -106.27 161.49 14.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.637 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 24.6 pttm -131.77 161.59 32.53 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.29 130.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.17 23.3 38.22 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.986 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.2 t0 -101.43 139.91 36.44 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -83.3 141.57 31.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -156.38 -170.95 3.52 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -129.6 141.89 50.86 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 173.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -132.29 160.66 35.57 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.253 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mm -91.99 116.88 34.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -65.7 125.51 25.5 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -30.81 63.49 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 123.539 0.736 . . . . 0.0 112.821 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -85.2 -40.7 16.38 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.33 -17.81 13.91 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.383 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.4 3.69 89.95 Favored Glycine 0 CA--C 1.507 -0.449 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.035 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 95.0 m -93.55 162.77 13.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.74 128.47 37.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 O-C-N 123.682 0.614 . . . . 0.0 109.536 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -136.3 151.41 73.23 Favored Pre-proline 0 C--N 1.29 -2.0 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.86 128.02 14.48 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.185 1.923 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.85 146.36 27.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.098 0.475 . . . . 0.0 110.108 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.5 m -111.84 147.95 34.66 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 67.8 mt -75.87 123.53 32.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.581 0.229 . . . . 0.0 110.651 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -96.9 -32.47 12.05 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.2 m -160.96 146.54 14.42 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.582 HG23 HD21 ' A' ' 138' ' ' LEU . 98.1 mt -124.47 135.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 0.0 111.049 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.16 100.9 8.94 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -67.78 -24.16 65.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.342 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.88 -37.43 70.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.879 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -87.86 -8.71 55.48 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.294 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 61.08 30.05 19.25 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.171 0.988 . . . . 0.0 108.435 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 78.2 p -126.16 163.66 22.63 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.635 -0.666 . . . . 0.0 111.407 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.747 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.4 p -148.74 153.32 38.03 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.1 0.56 . . . . 0.0 110.455 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.4 t -95.34 130.73 43.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.9 m -118.89 145.54 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.4 t -109.95 118.87 57.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -71.58 121.2 18.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.801 0.688 . . . . 0.0 110.565 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -62.09 130.98 48.03 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.536 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.62 -16.59 39.83 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.538 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -104.56 -43.39 5.17 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.155 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.01 12.29 63.87 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.77 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.7 m-20 -85.28 151.64 23.9 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -137.72 135.26 36.25 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 15.1 pt-20 -154.06 158.03 39.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 19.5 tt0 -99.75 127.52 45.89 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.491 0.663 . . . . 0.0 111.796 -172.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.465 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 3.4 mp0 -123.04 163.68 20.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 124.985 1.314 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.0 m-80 -84.69 146.52 27.4 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.582 HD21 HG23 ' A' ' 116' ' ' ILE . 58.8 mt -59.5 -32.69 70.51 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.215 1.007 . . . . 0.0 109.063 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.3 m -75.25 -22.54 57.77 Favored 'General case' 0 N--CA 1.394 -3.254 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.708 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.4 t70 -93.29 -19.35 21.46 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.887 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.747 HD11 ' SG ' ' A' ' 123' ' ' CYS . 78.1 mt -61.34 141.22 57.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.919 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.61 162.94 16.11 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.822 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.9 t -62.56 141.17 96.83 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.33 160.77 18.62 Favored 'Trans proline' 0 CA--C 1.505 -0.945 0 C-N-CA 122.984 2.456 . . . . 0.0 113.291 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.94 -178.83 2.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.361 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 60.2 m -69.91 135.84 49.96 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 123.874 0.734 . . . . 0.0 110.378 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.287 -2.126 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.725 -179.555 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.7 m -68.52 115.84 8.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.177 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 74.13 -3.11 2.61 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.787 1.635 . . . . 0.0 112.494 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.35 94.03 1.46 Allowed 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.137 0.494 . . . . 0.0 110.904 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 t -118.49 -11.23 9.98 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.051 0.929 . . . . 0.0 109.628 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pp -100.8 20.51 15.16 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.299 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.82 127.26 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.894 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -111.33 111.65 22.85 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.604 0.716 . . . . 0.0 109.34 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.449 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 89.6 m95 -105.41 163.77 12.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.121 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.554 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.1 ptpp? -130.89 161.27 32.22 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.6 t -63.55 128.17 25.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.26 8.05 48.01 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.612 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.554 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.3 m-20 -97.1 150.01 21.32 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HD2' HG23 ' A' ' 112' ' ' THR . 27.1 mmmt -91.35 140.55 29.66 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.575 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.449 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.9 p -152.65 -169.38 3.32 Favored 'General case' 0 C--N 1.262 -3.228 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.852 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.478 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 8.7 m -130.77 146.09 52.13 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.07 160.48 38.5 Favored 'General case' 0 C--N 1.275 -2.66 0 O-C-N 123.83 0.706 . . . . 0.0 109.665 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mm -91.54 120.38 40.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.563 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 11.4 t90 -69.28 127.29 32.52 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 123.497 0.498 . . . . 0.0 109.955 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.9 m -57.79 -28.54 64.11 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.96 -42.81 14.59 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.58 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.419 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.6 t70 -107.03 -18.62 13.86 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.028 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.47 6.36 88.03 Favored Glycine 0 C--O 1.222 -0.615 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.793 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 92.0 m -93.83 163.0 13.69 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.2 mm -77.94 130.23 36.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.199 0.6 . . . . 0.0 109.385 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -137.79 149.35 64.24 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.304 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.49 128.65 14.72 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.268 1.979 . . . . 0.0 110.777 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.431 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.41 153.02 41.49 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.207 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 97' ' ' LYS . 4.4 m -112.08 147.42 36.08 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.01 121.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 120.856 0.36 . . . . 0.0 110.604 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.83 -39.42 11.21 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.6 m -159.46 148.57 18.14 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.634 HG23 HD21 ' A' ' 138' ' ' LEU . 90.8 mt -126.13 134.73 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.281 0.363 . . . . 0.0 111.029 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -112.33 99.7 8.22 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -64.69 -28.18 69.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.325 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.7 -39.65 64.2 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.188 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 122' ' ' THR . 93.3 mtt180 -81.23 -8.59 59.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.042 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 62.02 26.41 15.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.938 1.295 . . . . 0.0 109.055 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 120' ' ' ARG . 82.1 p -125.65 161.73 26.6 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 121.481 -0.762 . . . . 0.0 111.055 -176.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.6 p -147.78 152.33 37.53 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 66.5 t -96.07 131.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.7 m -119.34 148.32 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 87.9 t -109.61 118.43 56.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 102' ' ' TRP . 94.7 m-85 -71.34 120.84 17.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.329 0.585 . . . . 0.0 109.496 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.445 HG21 ' OE1' ' A' ' 147' ' ' GLU . 44.2 m -66.27 131.99 47.39 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.548 -175.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.36 40.42 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.042 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.8 -43.49 4.45 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.015 0.436 . . . . 0.0 111.415 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.2 2.46 64.09 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.201 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.0 m-20 -74.92 150.11 39.22 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.3 ppt_? -135.12 135.42 41.14 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.5 159.62 41.09 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 22.3 tt0 -93.77 136.43 34.05 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 121.865 0.84 . . . . 0.0 110.824 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -129.46 165.55 21.39 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 126.224 1.81 . . . . 0.0 108.772 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 31.2 m-80 -89.4 147.82 23.83 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.634 HD21 HG23 ' A' ' 116' ' ' ILE . 74.7 mt -61.11 -34.14 74.48 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.758 0.79 . . . . 0.0 110.296 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.0 m -71.62 -29.99 65.29 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.656 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.53 -14.55 45.54 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.643 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.7 mt -67.74 147.45 52.6 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.259 0.552 . . . . 0.0 111.074 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 mp -121.82 163.39 19.25 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.4 t -63.17 142.94 97.76 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.478 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 37.0 Cg_endo -64.49 157.64 53.88 Favored 'Trans proline' 0 CA--C 1.505 -0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 113.084 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 pt -117.28 -177.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.275 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.19 132.73 49.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.814 0.34 . . . . 0.0 110.797 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.445 ' OE1' HG21 ' A' ' 128' ' ' THR . 33.6 mt-10 . . . . . 0 C--O 1.256 1.417 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 . . . . . 0 CA--C 1.503 -0.835 0 CA-C-O 120.743 0.306 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.3 m -84.24 102.53 12.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.696 0.76 . . . . 0.0 110.132 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.53 -2.39 54.36 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.853 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.01 21.47 4.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.207 1.003 . . . . 0.0 110.257 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 p -82.54 14.43 3.09 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 pp -110.17 5.58 22.04 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.473 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -87.94 146.39 25.56 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.111 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -126.62 115.9 20.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 93.4 m95 -108.28 163.04 13.54 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.562 -176.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 47.4 pttt -131.01 155.23 47.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.12 128.09 25.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.66 14.92 51.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.27 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 3.6 t0 -93.69 142.5 27.28 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -80.52 141.32 35.26 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.2 p -158.55 -171.36 3.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.8 m -130.61 146.45 52.12 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.8 161.09 36.92 Favored 'General case' 0 C--N 1.278 -2.539 0 O-C-N 123.26 0.35 . . . . 0.0 110.489 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mm -92.41 115.37 31.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -64.44 121.35 14.17 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.557 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 8.1 t -66.44 -15.27 63.2 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 118.216 0.462 . . . . 0.0 111.831 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -84.86 -41.93 15.55 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.992 0.425 . . . . 0.0 110.876 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -110.79 -18.0 13.22 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.662 0.744 . . . . 0.0 110.847 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.29 90.52 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.202 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.3 m -94.05 163.85 13.31 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mm -77.51 130.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 123.445 0.698 . . . . 0.0 110.109 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.29 150.61 64.91 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.327 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.84 129.92 18.35 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.53 2.153 . . . . 0.0 111.367 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.65 149.97 32.41 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.065 0.46 . . . . 0.0 110.851 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 m -112.17 147.95 35.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.4 mt -76.16 128.01 37.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.637 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.96 -31.79 10.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.258 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -160.29 145.64 14.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.571 HG23 HD21 ' A' ' 138' ' ' LEU . 98.4 mt -124.09 134.35 66.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 122.85 0.46 . . . . 0.0 110.568 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.42 97.94 6.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 172.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -61.95 -25.47 67.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.63 -39.91 64.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.35 -9.17 58.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 60.96 24.83 14.88 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.953 1.301 . . . . 0.0 109.04 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 68.3 p -122.37 159.99 26.35 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -146.21 153.14 40.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.859 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 67.4 t -95.45 130.89 43.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 35.1 m -118.51 145.61 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 85.1 t -109.92 118.46 56.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.01 118.45 12.87 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.801 0.688 . . . . 0.0 111.236 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 131.71 46.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.93 -17.23 56.17 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.079 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.85 -49.28 3.05 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.952 0.406 . . . . 0.0 110.711 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.63 4.78 59.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.314 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.3 m-20 -76.81 154.93 33.45 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 122.178 0.191 . . . . 0.0 110.549 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.48 136.29 39.31 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.364 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.557 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 5.8 pt-20 -153.37 158.72 41.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 24.5 tt0 -96.55 129.12 43.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.598 0.713 . . . . 0.0 111.987 -175.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.533 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.9 mp0 -128.19 163.42 24.74 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.245 1.418 . . . . 0.0 110.007 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 28.0 m-80 -82.17 146.25 29.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.571 HD21 HG23 ' A' ' 116' ' ' ILE . 67.7 mt -59.43 -34.72 72.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.09 0.948 . . . . 0.0 109.724 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -77.04 -20.34 56.02 Favored 'General case' 0 N--CA 1.394 -3.261 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.424 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 6.2 t70 -90.01 -28.14 19.28 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -175.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.669 HD11 ' SG ' ' A' ' 123' ' ' CYS . 77.1 mt -52.2 137.48 28.17 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 124.695 1.247 . . . . 0.0 111.739 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.19 162.68 14.7 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.975 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.7 m -62.49 139.37 96.66 Favored Pre-proline 0 N--CA 1.399 -2.976 0 C-N-CA 123.796 0.838 . . . . 0.0 109.344 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.471 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 51.7 Cg_endo -68.1 169.59 16.27 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.627 2.218 . . . . 0.0 112.811 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.79 -167.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.244 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.6 p -53.89 136.29 40.92 Favored 'General case' 0 C--O 1.256 1.401 0 O-C-N 124.085 0.866 . . . . 0.0 110.87 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.727 1.211 . . . . 0.0 110.905 -177.917 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.508 -0.642 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.5 m -144.04 118.88 9.91 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.79 21.59 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.46 75.67 0.39 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.035 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.3 m -111.57 24.3 12.93 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.232 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -92.77 17.18 10.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.808 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.19 149.69 37.22 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.66 114.09 26.9 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.404 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 83.5 m95 -101.2 152.85 20.16 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.115 -173.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 21.9 pttm -131.11 162.64 29.42 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.3 129.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.73 13.99 41.93 Favored Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.835 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.544 ' HB2' HD12 ' A' ' 113' ' ' ILE . 53.8 m-20 -96.43 140.06 31.64 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -84.89 139.91 31.51 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.404 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.3 p -151.96 -169.49 3.38 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 123.551 0.532 . . . . 0.0 109.573 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 144' ' ' PRO . 7.4 m -130.03 144.23 51.22 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.517 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -134.5 160.24 38.62 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.949 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.67 114.64 31.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -61.71 126.9 28.98 Favored 'General case' 0 C--O 1.203 -1.348 0 O-C-N 124.03 0.831 . . . . 0.0 110.325 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.7 m -57.17 -29.9 64.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.24 -37.27 20.26 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -117.0 -17.07 10.45 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.509 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.8 8.23 87.71 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.257 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.4 160.07 15.27 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.97 131.22 35.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.425 ' CD2' HC11 ' A' 1148 ' ' DA2 . 90.7 m-85 -139.89 149.47 59.11 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.03 128.04 16.09 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.602 2.201 . . . . 0.0 111.055 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.33 149.88 35.61 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.848 0.356 . . . . 0.0 110.379 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -111.8 147.49 35.59 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 96' ' ' ASP . 68.5 mt -78.9 120.17 29.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.753 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.71 -31.95 13.57 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.495 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -159.97 144.96 15.05 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 138' ' ' LEU . 83.6 mt -120.83 134.69 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -113.35 98.52 7.15 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -67.72 -23.86 65.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.101 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.36 -40.43 85.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.875 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.95 -8.66 55.39 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.16 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 63.28 27.25 15.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.954 1.301 . . . . 0.0 108.585 -175.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 60.9 p -125.76 166.74 16.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.9 p -148.38 151.95 36.19 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 122.911 0.484 . . . . 0.0 110.231 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 58.0 t -95.81 129.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.6 m -118.5 145.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 121.133 0.492 . . . . 0.0 109.706 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 93.3 t -109.29 118.97 57.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -71.28 121.09 17.82 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.313 0.577 . . . . 0.0 110.857 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.0 m -69.03 131.4 44.98 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.034 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.56 -18.03 57.29 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.665 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -111.12 -48.81 3.07 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 122.453 -0.439 . . . . 0.0 111.608 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.34 10.79 57.94 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.44 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.9 m-20 -83.13 153.02 25.04 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.2 ppt_? -136.91 135.73 38.04 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.35 158.69 40.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -96.79 130.39 44.06 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.797 0.808 . . . . 0.0 112.229 -174.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.517 ' NE2' ' HB1' ' A' ' 100' ' ' ALA . 6.2 mp0 -126.0 163.36 23.18 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.36 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.7 m-80 -84.28 144.9 28.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.576 HD21 HG23 ' A' ' 116' ' ' ILE . 70.4 mt -60.06 -35.39 75.03 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.535 0.683 . . . . 0.0 110.614 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -73.32 -29.34 62.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -82.51 -14.06 55.61 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.788 -177.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.658 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.1 mt -66.23 143.93 56.93 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.573 0.546 . . . . 0.0 111.517 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.05 158.83 23.51 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 t -63.25 144.97 97.33 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.513 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 46.4 Cg_endo -65.92 165.01 25.05 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.956 1.771 . . . . 0.0 112.531 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 pt -94.88 -177.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.285 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.85 137.89 52.11 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--N 1.306 -1.301 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.785 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.425 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 p -76.05 87.73 2.97 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.287 0.565 . . . . 0.0 110.33 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -170.79 -48.84 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.901 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.83 102.04 2.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.3 m -120.01 31.89 6.3 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.43 1.109 . . . . 0.0 108.312 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.65 18.25 10.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.335 -176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.446 ' HB3' ' NE1' ' A' ' 92' ' ' TRP . 24.2 mp0 -70.68 138.84 50.98 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -130.94 116.67 18.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.446 ' NE1' ' HB3' ' A' ' 90' ' ' GLN . 86.1 m95 -120.45 162.24 19.88 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.071 -175.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.436 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.9 ptpp? -131.57 161.53 32.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.91 128.23 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 15.22 33.67 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.07 -1.062 . . . . 0.0 112.739 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 72.7 m-20 -102.29 145.54 29.31 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 18.8 mmmt -88.06 141.42 28.58 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.167 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.443 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.24 -171.52 3.94 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 123.892 0.745 . . . . 0.0 109.056 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 m -131.69 143.86 50.58 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 173.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -135.22 160.92 36.86 Favored 'General case' 0 C--N 1.273 -2.733 0 O-C-N 123.514 0.509 . . . . 0.0 110.211 -174.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 mm -92.21 118.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -67.46 124.81 24.22 Favored 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 m -59.0 -26.42 64.5 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -84.49 -41.84 16.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.998 -173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -111.38 -17.47 13.12 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.864 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 4.74 89.9 Favored Glycine 0 C--N 1.312 -0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.105 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -92.62 160.18 15.13 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.3 mm -76.71 129.02 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 O-C-N 124.002 0.814 . . . . 0.0 109.442 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.435 ' CD2' HC11 ' A' 1148 ' ' DA2 . 93.5 m-85 -137.97 148.04 58.78 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.17 127.72 16.35 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.62 2.214 . . . . 0.0 110.895 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.51 38.33 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.752 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 m -112.16 147.48 36.04 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 96' ' ' ASP . 62.6 mt -77.46 121.86 30.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 123.076 0.235 . . . . 0.0 110.368 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.65 13.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.1 p -160.63 145.14 14.11 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.692 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.579 HG23 HD21 ' A' ' 138' ' ' LEU . 97.8 mt -124.42 135.24 64.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 110.784 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -112.9 101.81 9.85 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.63 -24.97 65.51 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.72 0.295 . . . . 0.0 111.198 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -73.25 -37.09 66.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.304 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -86.81 -8.95 56.86 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.841 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 60.35 28.98 18.63 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 122.634 1.207 . . . . 0.0 109.184 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.403 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 70.8 p -126.33 162.39 25.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.852 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.67 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.7 p -148.33 152.16 36.6 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.261 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 99.4 t -95.37 130.96 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.9 m -118.3 145.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 83.9 t -110.7 118.38 57.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -68.42 119.13 12.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.694 0.621 . . . . 0.0 110.568 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.6 m -63.6 131.01 46.66 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.756 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.0 -18.0 47.41 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.269 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -108.33 -37.57 5.96 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 122.395 -0.474 . . . . 0.0 111.747 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.22 13.52 76.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.623 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -85.59 151.97 23.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.5 ppt_? -135.66 137.26 41.64 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 123.193 0.308 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.0 pt-20 -153.62 158.69 41.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 20.6 tt0 -97.91 129.75 44.82 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.537 0.684 . . . . 0.0 111.353 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.571 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 6.1 mp0 -126.53 163.58 23.06 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 124.494 1.118 . . . . 0.0 109.755 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.8 m-80 -82.14 145.48 30.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.579 HD21 HG23 ' A' ' 116' ' ' ILE . 76.5 mt -57.95 -36.35 72.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.742 0.782 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -77.58 -19.54 55.47 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.259 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.4 t70 -84.96 -30.91 23.87 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.844 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.67 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.9 mt -51.9 132.12 31.7 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.655 1.222 . . . . 0.0 111.918 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.39 164.16 12.07 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.953 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.3 t -63.3 138.53 97.37 Favored Pre-proline 0 C--N 1.308 -1.215 0 O-C-N 124.172 0.92 . . . . 0.0 109.07 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.61 173.34 14.67 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 122.872 2.382 . . . . 0.0 113.191 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 pt -112.36 157.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.814 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.0 m -66.0 135.71 55.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.91 0.756 . . . . 0.0 109.499 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.656 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.452 ' HNE' HC21 ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 CA--C 1.505 -0.769 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.404 HG22 ' OG ' ' A' ' 88' ' ' SER . 7.6 m -125.31 80.72 1.91 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.07 -26.83 7.91 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.214 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . . . -86.9 3.2 46.52 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.568 -176.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 139' ' ' SER . 16.5 p -82.85 3.85 27.91 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.604 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 pp -141.68 22.24 2.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.695 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.435 ' HG2' ' HA ' ' A' ' 87' ' ' ALA . 29.9 mm-40 -69.01 127.52 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.085 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -97.07 124.62 41.12 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 92.6 m95 -122.32 160.01 26.23 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.029 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.622 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 6.8 ptpp? -131.25 162.48 29.91 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.6 t -63.74 128.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.64 13.64 37.25 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.918 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.622 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 49.6 m-20 -100.64 141.5 33.43 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -83.02 143.62 30.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.5 p -153.97 -169.48 3.27 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 m -132.59 145.98 51.54 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.37 161.2 36.94 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 123.781 0.676 . . . . 0.0 110.08 -174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.0 119.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.27 125.14 25.78 Favored 'General case' 0 C--O 1.198 -1.609 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -58.77 -24.59 61.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -85.0 -41.74 15.53 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.933 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -111.51 -17.86 12.97 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 118.733 -1.187 . . . . 0.0 111.187 -176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.38 5.26 89.73 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.181 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -93.19 162.29 14.08 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -77.58 129.79 37.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 123.856 0.723 . . . . 0.0 109.687 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -137.8 151.4 70.41 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 123.639 0.776 . . . . 0.0 109.137 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.96 128.62 14.25 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.11 149.46 36.58 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.976 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -111.51 147.5 35.22 Favored 'General case' 0 C--N 1.272 -2.769 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 96' ' ' ASP . 64.4 mt -77.12 122.09 30.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.505 -177.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -95.89 -33.11 12.33 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.735 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.7 m -160.58 148.73 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.595 HG23 HD21 ' A' ' 138' ' ' LEU . 93.2 mt -126.44 135.72 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.91 99.86 8.44 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -66.43 -23.94 66.38 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.079 -174.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -72.24 -37.65 69.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.235 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -87.79 -8.9 55.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.994 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 30.4 tt0 61.03 24.74 14.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.215 1.006 . . . . 0.0 109.316 -173.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p -122.77 161.08 24.64 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.0 p -146.53 151.9 38.1 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.427 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.7 t -95.37 130.21 44.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 34.1 m -118.04 145.68 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.7 t -111.0 118.67 57.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -69.07 118.67 12.26 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 123.718 0.636 . . . . 0.0 110.21 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 53.1 m -63.66 131.02 46.64 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.403 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.39 -26.56 10.08 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.896 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -96.84 -47.27 5.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.967 0.413 . . . . 0.0 110.616 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.28 9.8 60.1 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.363 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -82.76 152.1 25.86 Favored 'General case' 0 CA--C 1.484 -1.589 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.1 ppt_? -139.03 136.31 35.16 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.169 0.293 . . . . 0.0 110.77 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.5 pt-20 -153.07 158.07 41.38 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 25.5 tt0 -95.8 133.21 40.2 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.455 0.645 . . . . 0.0 112.077 -175.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.478 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 8.5 mp0 -131.98 163.78 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 125.157 1.383 . . . . 0.0 109.967 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 25.4 m-80 -81.15 148.2 29.69 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 116' ' ' ILE . 65.2 mt -59.21 -36.11 74.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.261 1.029 . . . . 0.0 108.933 175.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.429 ' HB3' ' HA ' ' A' ' 88' ' ' SER . 42.3 m -75.53 -18.09 59.9 Favored 'General case' 0 N--CA 1.401 -2.92 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.992 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -98.06 -7.29 30.03 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.379 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.64 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.7 mt -72.97 139.89 47.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.417 0.627 . . . . 0.0 111.042 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.9 166.06 11.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.781 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.3 t -64.84 137.83 97.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.0 171.47 11.2 Favored 'Trans proline' 0 CA--C 1.508 -0.808 0 C-N-CA 123.04 2.493 . . . . 0.0 112.969 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.6 pt -79.79 162.67 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.7 m -92.46 133.13 36.2 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--N 1.285 -2.215 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -179.096 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.2 m 65.39 76.24 0.33 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.776 0.672 . . . . 0.0 111.672 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 63.07 17.36 10.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.654 1.182 . . . . 0.0 112.283 175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . -105.71 22.91 14.74 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.467 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.6 p -81.22 24.53 0.53 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 123.645 0.778 . . . . 0.0 111.712 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 pp -114.41 15.87 17.87 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 124.265 1.026 . . . . 0.0 111.385 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 85.6 mm-40 -71.84 136.49 47.02 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -122.41 135.29 54.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.469 ' NE1' ' HB3' ' A' ' 90' ' ' GLN . 87.8 m95 -133.96 164.31 27.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 63.5 pttt -126.36 157.95 37.16 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.72 131.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 18.71 54.74 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.737 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 4.7 t0 -100.8 133.21 45.6 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG2' HG23 ' A' ' 112' ' ' THR . 68.0 mttt -80.47 148.01 30.66 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.115 174.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 24.6 p -155.1 -168.76 2.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.981 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 m -131.71 145.29 51.55 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.06 160.79 37.23 Favored 'General case' 0 C--N 1.277 -2.585 0 O-C-N 123.569 0.543 . . . . 0.0 110.189 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -92.15 117.16 34.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.422 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 9.8 t90 -67.54 122.92 19.04 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -59.67 -23.57 63.2 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 24.9 mm-40 -84.83 -42.11 15.42 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -108.47 -18.45 13.74 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.451 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.69 6.93 89.07 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.679 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.8 m -94.42 161.91 14.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.19 128.26 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 O-C-N 123.904 0.753 . . . . 0.0 109.796 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.35 148.87 67.97 Favored Pre-proline 0 C--N 1.288 -2.104 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.665 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.16 129.94 15.78 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.404 2.07 . . . . 0.0 111.289 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.79 151.27 35.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.145 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.421 HG23 ' HG2' ' A' ' 97' ' ' LYS . 12.5 m -112.36 147.64 35.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 96' ' ' ASP . 71.3 mt -77.08 120.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.913 0.387 . . . . 0.0 111.133 -177.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -92.59 -31.99 14.97 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.613 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.0 m -162.38 151.64 15.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.606 HG23 HD21 ' A' ' 138' ' ' LEU . 97.5 mt -127.6 135.87 62.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 122.712 0.405 . . . . 0.0 110.754 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -112.32 98.14 7.1 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -67.65 -23.84 65.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.017 0.437 . . . . 0.0 111.367 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -73.2 -36.4 66.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.473 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -90.61 -8.8 49.15 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 59.81 29.61 19.17 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.514 1.126 . . . . 0.0 108.645 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 72.0 p -122.06 162.18 21.67 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.869 -0.519 . . . . 0.0 110.088 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 141' ' ' LEU . 5.6 p -148.69 153.74 38.66 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 122.796 0.439 . . . . 0.0 110.071 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -97.37 130.44 46.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 26.6 m -119.06 146.02 24.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 90.6 t -109.69 118.21 56.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -69.8 119.31 13.83 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 123.731 0.645 . . . . 0.0 110.811 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -61.66 131.74 50.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.32 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.64 -23.22 17.27 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.271 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -101.73 -46.83 4.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.24 6.65 61.34 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.865 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -80.09 151.57 29.79 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.6 ppt_? -135.77 136.84 41.07 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.55 158.79 41.76 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 20.3 tt0 -94.7 132.22 39.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.655 0.74 . . . . 0.0 110.253 -176.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -127.3 165.31 19.94 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 126.037 1.735 . . . . 0.0 108.484 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.6 m-80 -87.51 145.29 26.31 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 116' ' ' ILE . 78.7 mt -58.02 -38.44 76.2 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -75.28 -22.69 57.58 Favored 'General case' 0 N--CA 1.398 -3.031 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.75 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 1.6 m-20 -89.5 -12.86 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.299 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.7 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.2 mt -68.55 146.61 52.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.317 0.58 . . . . 0.0 110.733 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.43 165.19 13.25 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.1 t -64.51 139.08 97.64 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.167 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.24 173.17 12.67 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.198 2.598 . . . . 0.0 112.418 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 pt -100.06 157.34 3.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.879 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 m -74.19 132.61 42.35 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--N 1.292 -1.93 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.793 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.51 -0.575 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.1 m -80.01 113.04 17.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.64 -59.99 3.1 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.506 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.61 147.56 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -130.38 22.95 5.16 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.895 0.855 . . . . 0.0 110.032 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.07 38.02 2.96 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.136 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -62.12 132.52 53.1 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.704 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -127.5 131.74 50.07 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 87.5 m95 -129.64 163.75 25.4 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.037 -174.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.4 ptpp? -130.2 158.72 38.94 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.75 127.85 23.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.19 11.67 48.16 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.48 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.547 ' HB2' HD12 ' A' ' 113' ' ' ILE . 18.2 m-20 -92.76 135.67 33.91 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -81.9 146.1 29.99 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.411 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.5 p -159.58 -172.78 3.83 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.636 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.6 m -129.02 144.19 51.11 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.12 161.09 36.32 Favored 'General case' 0 C--N 1.278 -2.537 0 O-C-N 123.798 0.686 . . . . 0.0 110.412 -174.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.28 116.74 34.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -67.21 121.17 15.07 Favored 'General case' 0 C--O 1.193 -1.881 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.508 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 20.6 t -64.2 -17.2 63.31 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 118.146 0.43 . . . . 0.0 111.752 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -83.28 -41.95 17.72 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.335 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -112.75 -17.76 12.47 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.881 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.43 3.89 90.36 Favored Glycine 0 C--N 1.308 -0.977 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.115 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 81.2 m -93.63 162.95 13.74 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.8 mm -77.66 130.34 36.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.431 ' CG ' HC11 ' A' 1148 ' ' DA2 . 89.1 m-85 -139.77 151.52 66.08 Favored Pre-proline 0 C--N 1.303 -1.443 0 C-N-CA 123.455 0.702 . . . . 0.0 110.271 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.34 128.35 15.38 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.958 2.438 . . . . 0.0 111.789 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.57 149.67 31.98 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.121 0.486 . . . . 0.0 111.019 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 m -112.63 147.04 37.56 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 96' ' ' ASP . 67.6 mt -78.13 121.39 30.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.199 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.86 -35.7 13.22 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.578 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.1 m -159.52 149.78 18.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.564 HG23 HD21 ' A' ' 138' ' ' LEU . 94.5 mt -125.67 138.18 55.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.742 0.417 . . . . 0.0 110.777 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -112.97 98.32 7.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -65.27 -25.79 67.8 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.536 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -73.27 -38.6 65.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.214 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.45 -8.55 58.32 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.864 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 63.07 25.62 15.04 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 124.646 1.178 . . . . 0.0 108.772 -174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' A' ' 135' ' ' GLU . 74.2 p -124.76 163.99 20.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.345 -0.847 . . . . 0.0 111.072 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.8 p -148.63 153.41 38.28 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 122.693 0.397 . . . . 0.0 110.312 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.4 t -96.07 130.25 45.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.1 m -118.46 147.38 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 94.7 t -110.32 118.73 57.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.45 116.92 10.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.825 0.703 . . . . 0.0 110.468 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -65.04 131.47 46.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.96 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.76 -20.48 38.7 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -104.51 -47.65 4.03 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.978 0.418 . . . . 0.0 110.447 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.53 18.41 41.75 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.991 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -91.05 155.62 18.54 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.4 ppt_? -134.95 136.5 42.31 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.514 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.7 pt-20 -153.96 158.55 40.82 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 17.4 tt0 -95.39 132.85 39.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.71 0.767 . . . . 0.0 111.228 -176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.408 ' OE1' HG22 ' A' ' 125' ' ' VAL . 9.0 mp0 -125.44 164.64 20.0 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 125.84 1.656 . . . . 0.0 109.61 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 24.1 m-80 -88.11 143.67 26.93 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.564 HD21 HG23 ' A' ' 116' ' ' ILE . 84.5 mt -58.03 -36.28 72.5 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.357 0.598 . . . . 0.0 110.683 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.6 m -75.16 -23.71 57.81 Favored 'General case' 0 N--CA 1.407 -2.623 0 C-N-CA 123.856 0.863 . . . . 0.0 111.459 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 2.5 m-20 -91.06 -11.54 38.42 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.806 -178.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.706 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.7 mt -68.71 142.11 55.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.03 163.85 14.61 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.3 t -63.17 143.43 97.65 Favored Pre-proline 0 C--O 1.252 1.189 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.38 160.79 12.88 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 123.499 2.799 . . . . 0.0 114.071 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.79 -173.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.343 -175.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 61.0 m -57.37 139.1 53.98 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.8 0.688 . . . . 0.0 111.045 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--N 1.3 -1.55 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.605 -176.05 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.431 HC11 ' CG ' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.1 m -84.89 82.44 8.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 122.054 0.931 . . . . 0.0 110.118 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 177.87 -40.48 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.91 29.43 2.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.136 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 m -83.73 2.51 37.52 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.851 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.71 4.55 24.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.915 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -83.56 141.77 31.35 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.96 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -132.18 121.78 24.24 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -116.47 160.66 20.27 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.639 -171.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -125.06 163.31 22.64 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.85 127.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.85 7.99 52.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.13 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 113' ' ' ILE . 21.2 m-20 -91.35 135.42 33.83 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -74.44 146.4 42.88 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.368 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -160.04 -172.59 3.68 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.894 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.5 m -129.36 142.92 50.69 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.56 160.6 37.55 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.392 0.433 . . . . 0.0 110.699 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.0 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.435 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.0 t90 -65.61 119.53 11.3 Favored 'General case' 0 C--O 1.199 -1.585 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.504 ' HB2' ' OE1' ' A' ' 134' ' ' GLU . 6.4 t -66.95 -14.96 63.37 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.677 -175.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -83.37 -42.39 17.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.602 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.435 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.8 t70 -109.49 -18.61 13.48 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.484 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.38 7.79 88.2 Favored Glycine 0 C--N 1.313 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.119 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.3 m -94.3 161.71 14.14 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.0 mm -79.14 129.33 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -137.52 150.85 69.73 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.99 127.84 14.98 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.566 2.178 . . . . 0.0 110.97 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.61 147.67 30.29 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.076 0.465 . . . . 0.0 110.465 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.4 m -112.53 147.16 37.19 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 96' ' ' ASP . 78.0 mt -75.47 126.21 35.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.919 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.41 12.13 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.7 m -159.34 148.32 18.18 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 138' ' ' LEU . 87.0 mt -127.53 135.67 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 122.911 0.484 . . . . 0.0 110.025 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.09 96.36 5.99 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.15 -24.17 65.87 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.556 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -74.11 -34.08 63.81 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.233 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.69 -8.95 57.89 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.783 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 61.7 30.76 18.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.752 1.221 . . . . 0.0 108.624 -173.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 69.0 p -124.89 165.24 18.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.714 -0.616 . . . . 0.0 110.86 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.737 ' SG ' HD11 ' A' ' 141' ' ' LEU . 6.7 p -148.66 155.18 40.69 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.313 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.1 130.02 51.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -118.52 147.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 99.5 t -109.83 118.89 57.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -70.59 119.97 15.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.638 0.586 . . . . 0.0 110.72 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.8 m -64.56 131.45 47.08 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.096 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.07 -22.78 30.06 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -105.54 -41.81 5.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.16 0.505 . . . . 0.0 111.14 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.94 81.31 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.8 m-20 -77.63 154.67 32.0 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -135.97 138.02 41.87 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' A' ' 103' ' ' SER . 4.0 pt-20 -154.02 159.3 41.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -94.18 133.63 37.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.991 0.9 . . . . 0.0 111.57 -176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 125' ' ' VAL . 10.3 mp0 -128.87 164.85 22.21 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 125.75 1.62 . . . . 0.0 108.989 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 25.8 m-80 -89.92 145.82 24.85 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 116' ' ' ILE . 79.5 mt -59.39 -34.79 72.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.394 0.616 . . . . 0.0 110.907 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -25.41 54.95 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.519 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.2 -13.28 38.64 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.139 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.737 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.2 mt -66.77 145.5 55.45 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.048 0.451 . . . . 0.0 110.754 176.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.93 160.96 18.23 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.1 t -67.53 145.71 98.39 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.33 170.39 9.48 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.828 2.352 . . . . 0.0 113.131 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.0 pt -103.93 175.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 35.3 t -84.3 144.33 28.94 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.863 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.051 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.501 -0.926 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.5 m 60.41 90.13 0.06 Allowed 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.247 1.019 . . . . 0.0 111.97 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.45 -19.28 39.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.136 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.4 38.94 0.95 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.652 0.381 . . . . 0.0 110.969 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.6 p -69.79 -3.51 15.91 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.525 0.678 . . . . 0.0 112.091 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.11 31.45 0.1 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.204 1.401 . . . . 0.0 112.483 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -66.26 138.53 57.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.304 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.37 139.0 49.24 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 92.8 m95 -125.73 161.5 27.18 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.48 0.181 . . . . 0.0 111.421 -174.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.7 ptpp? -131.25 157.26 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.48 129.17 28.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.54 13.26 57.26 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.95 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 1.6 t0 -95.35 140.69 29.88 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -84.65 144.84 28.33 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.1 p -153.73 -170.06 3.47 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.1 m -130.81 141.25 50.33 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.94 160.62 37.14 Favored 'General case' 0 C--N 1.279 -2.458 0 O-C-N 123.624 0.578 . . . . 0.0 110.456 -174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.21 115.84 32.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 9.6 t90 -66.33 121.98 16.48 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 t -63.19 -21.65 66.35 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.301 0.572 . . . . 0.0 111.68 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 15.2 mm-40 -84.65 -33.36 23.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 9.4 t70 -117.04 -18.27 10.13 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.65 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.7 88.86 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.882 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.26 162.73 13.73 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mm -78.64 131.43 34.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.208 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.425 ' CD2' HC11 ' A' 1148 ' ' DA2 . 92.6 m-85 -139.62 151.21 65.78 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.728 175.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.62 127.98 15.49 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 111.166 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.66 149.02 32.66 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.994 0.426 . . . . 0.0 109.971 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -111.92 147.81 35.05 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.0 mt -79.13 121.57 32.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.568 0.223 . . . . 0.0 111.069 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.95 -32.21 13.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.087 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 m -159.4 147.73 17.69 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.552 HG23 HD21 ' A' ' 138' ' ' LEU . 89.7 mt -126.91 141.22 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.41 96.36 6.06 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 172.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -67.92 -24.02 65.15 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 120.761 0.315 . . . . 0.0 111.345 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.58 -39.31 64.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.293 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -90.63 -8.11 50.93 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.733 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 64.44 33.43 11.13 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.517 1.135 . . . . 0.0 109.245 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 81.5 p -123.79 164.83 18.39 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.935 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.716 ' SG ' HD11 ' A' ' 141' ' ' LEU . 6.3 p -149.91 157.28 43.01 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 123.013 0.525 . . . . 0.0 110.768 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 61.4 t -102.2 131.42 50.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.2 m -118.58 146.04 23.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 121.231 0.539 . . . . 0.0 109.831 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 92.3 t -111.09 118.61 57.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -71.19 119.84 15.91 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.696 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 m -67.2 130.67 43.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.727 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.71 -16.52 59.99 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.009 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -111.97 -35.09 5.79 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.76 4.0 90.25 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.492 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.6 m-20 -78.18 157.2 29.46 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 1.4 ppt_? -141.41 136.42 31.36 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.501 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 5.8 pt-20 -152.95 158.41 42.05 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 29.7 tt0 -95.51 137.39 34.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.123 0.487 . . . . 0.0 111.185 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.501 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -137.94 159.0 43.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 124.402 1.081 . . . . 0.0 109.699 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 30.8 m-80 -81.39 147.67 29.69 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.552 HD21 HG23 ' A' ' 116' ' ' ILE . 81.7 mt -60.81 -36.07 78.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.094 0.473 . . . . 0.0 111.414 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 t -80.89 -16.27 54.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.045 0.45 . . . . 0.0 110.418 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.82 -32.26 40.67 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.716 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.5 mt -56.92 141.11 46.33 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.7 1.25 . . . . 0.0 111.718 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.2 159.92 19.57 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.561 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.8 t -63.11 141.9 97.73 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.86 161.46 43.89 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.263 1.975 . . . . 0.0 113.274 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 pt -104.88 177.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.714 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 39.1 t -77.42 142.41 39.24 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 121.158 0.504 . . . . 0.0 109.812 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.379 -178.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.427 HC21 ' HNE' ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 m -73.51 101.5 3.56 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.46 -33.15 1.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.461 ' HB1' ' NE2' ' A' ' 90' ' ' GLN . . . -124.99 23.55 7.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.567 0.698 . . . . 0.0 111.158 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -87.66 9.86 20.02 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.449 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -107.89 7.23 27.97 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.391 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.461 ' NE2' ' HB1' ' A' ' 87' ' ' ALA . 46.3 mt-30 -87.83 122.79 31.9 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.415 -177.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.0 129.44 55.45 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 82.5 m95 -115.78 162.33 17.44 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.524 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.579 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.0 ptpp? -130.84 160.15 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.69 128.16 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.61 13.35 41.29 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.196 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.579 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 13.2 m-20 -98.03 135.29 39.94 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -78.41 145.49 35.1 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.407 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.454 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 26.4 p -157.04 -169.23 2.88 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.817 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 m -133.6 146.14 50.68 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -138.21 161.64 36.32 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.356 0.41 . . . . 0.0 110.183 -174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.3 mm -92.16 118.71 38.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' A' ' 105' ' ' ASP . 10.3 t90 -68.17 127.52 33.22 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.556 0.535 . . . . 0.0 109.954 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.0 m -56.36 -30.85 63.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -85.18 -41.12 15.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' HB2' ' CE3' ' A' ' 102' ' ' TRP . 8.3 t70 -109.19 -17.15 13.92 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.1 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.22 4.81 84.52 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.968 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.5 m -93.58 162.46 13.95 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.7 mm -78.48 126.88 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.868 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.415 ' CD2' HC11 ' A' 1148 ' ' DA2 . 94.8 m-85 -136.18 148.39 64.34 Favored Pre-proline 0 C--N 1.283 -2.288 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.832 175.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.58 128.67 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.659 2.239 . . . . 0.0 111.259 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.98 152.47 41.1 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.2 m -112.24 147.81 35.45 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 96' ' ' ASP . 74.5 mt -79.28 118.03 25.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 123.221 0.326 . . . . 0.0 110.937 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.78 -30.49 15.46 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.76 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.1 m -161.47 145.64 13.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.586 HG23 HD21 ' A' ' 138' ' ' LEU . 87.7 mt -123.39 134.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 120.852 0.358 . . . . 0.0 110.125 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' ' HG3' ' A' ' 120' ' ' ARG . 11.3 t70 -111.89 96.85 6.3 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -65.86 -23.71 66.72 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.112 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -71.52 -40.67 69.97 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.195 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' OD1' ' A' ' 117' ' ' ASP . 93.2 mtt180 -82.58 -9.45 59.39 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.466 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 62.91 29.61 16.54 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.195 1.398 . . . . 0.0 108.135 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 137' ' ' ASN . 74.8 p -131.08 168.47 17.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.106 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.751 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -148.79 155.46 40.98 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.502 0.321 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.8 t -95.86 130.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.9 m -118.55 145.52 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 133' ' ' ARG . 89.5 t -109.73 118.62 57.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.91 120.3 15.43 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 123.758 0.661 . . . . 0.0 111.576 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 131.2 45.38 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.462 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.42 -21.93 42.85 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.548 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -111.39 -43.14 3.74 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.612 0.244 . . . . 0.0 111.378 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 8.3 64.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.443 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 6.5 m-20 -80.39 153.33 28.38 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.76 -0.259 . . . . 0.0 110.419 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.0 ppt_? -137.69 135.24 36.29 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.057 0.456 . . . . 0.0 111.417 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 6.2 pt-20 -153.42 158.71 41.84 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 27.4 tt0 -94.44 135.11 36.23 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.174 0.511 . . . . 0.0 111.392 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.504 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.6 mp0 -131.85 160.25 36.2 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.266 1.026 . . . . 0.0 110.478 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 26.1 m-80 -79.42 144.32 34.2 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 116' ' ' ILE . 75.3 mt -62.4 -33.2 74.3 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.945 0.879 . . . . 0.0 110.376 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.9 t -80.04 -21.46 43.45 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.71 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 23.1 t70 -83.6 -32.79 25.56 Favored 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.751 HD11 ' SG ' ' A' ' 123' ' ' CYS . 69.0 mt -51.07 134.48 26.51 Favored 'General case' 0 CA--C 1.491 -1.305 0 O-C-N 125.046 1.466 . . . . 0.0 111.902 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.31 161.96 14.53 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.6 m -63.03 146.87 95.31 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.51 174.34 7.52 Favored 'Trans proline' 0 CA--C 1.511 -0.647 0 C-N-CA 122.986 2.457 . . . . 0.0 113.661 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.08 160.92 5.05 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.784 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.9 m -83.44 127.69 33.91 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.294 -1.828 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.359 -179.267 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.429 ' HNE' HC21 ' A' 1148 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.2 m 61.94 77.57 0.32 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.732 0.813 . . . . 0.0 109.963 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.89 -42.75 63.27 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.312 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.44 112.31 16.12 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -98.32 13.67 30.66 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.409 0.623 . . . . 0.0 110.289 -175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 pp -103.23 16.48 26.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.142 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -71.26 137.81 48.91 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -136.23 136.89 40.27 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.42 ' CZ3' ' HB3' ' A' ' 98' ' ' CYS . 86.2 m95 -116.27 157.17 25.36 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.37 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 7.6 ptpp? -129.76 162.61 28.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -63.68 127.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.06 15.05 40.25 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.491 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.526 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 22.5 m-20 -98.0 136.78 37.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 117.133 0.466 . . . . 0.0 109.878 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -77.47 145.07 37.3 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.48 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.7 p -156.18 -165.87 2.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.499 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 m -139.42 149.44 44.07 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB1' ' NE2' ' A' ' 136' ' ' GLN . . . -140.32 161.53 37.47 Favored 'General case' 0 C--N 1.278 -2.502 0 O-C-N 123.877 0.735 . . . . 0.0 110.078 -173.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.82 120.05 40.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.446 ' CE2' ' HB2' ' A' ' 104' ' ' GLU . 10.1 t90 -69.65 125.89 28.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 m -58.93 -25.04 63.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 102' ' ' TRP . 21.0 mm-40 -84.87 -37.73 20.3 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -174.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -117.41 -18.22 9.89 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 118.263 -1.375 . . . . 0.0 110.982 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.6 86.95 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.212 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.2 m -92.93 160.19 15.0 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.85 126.12 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 C-N-CA 123.848 0.859 . . . . 0.0 109.016 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.439 ' CD2' HC11 ' A' 1148 ' ' DA2 . 86.2 m-85 -134.58 149.51 71.11 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.18 128.09 17.89 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.914 2.409 . . . . 0.0 110.902 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.88 149.52 34.42 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.843 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.3 m -113.85 147.76 37.84 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.461 HD12 ' HB2' ' A' ' 96' ' ' ASP . 75.8 mt -76.89 126.23 37.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.63 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -98.22 -33.1 11.24 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.813 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 m -161.33 149.57 15.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.579 HG23 HD21 ' A' ' 138' ' ' LEU . 87.3 mt -128.82 140.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.513 0.725 . . . . 0.0 109.966 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -113.04 98.87 7.43 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -65.03 -23.76 67.29 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.447 -174.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -73.42 -40.52 64.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -87.8 -8.32 56.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.026 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 61.4 28.29 17.73 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.856 0.862 . . . . 0.0 108.793 -175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 68.9 p -122.02 159.56 26.76 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 121.7 -0.625 . . . . 0.0 110.55 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.66 ' SG ' HD11 ' A' ' 141' ' ' LEU . 7.4 p -148.22 152.37 37.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.654 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 59.4 t -95.99 130.56 44.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 33.5 m -118.06 145.77 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 66.1 t -111.53 118.55 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.36 116.67 10.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 124.042 0.839 . . . . 0.0 110.503 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 m -62.93 131.13 47.69 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.072 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.79 -27.98 12.78 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -101.81 -42.97 5.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.938 0.399 . . . . 0.0 110.758 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.21 1.58 75.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.826 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 5.4 m-20 -72.24 149.39 44.6 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.3 ppt_? -133.64 136.18 44.63 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.507 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' HG3' ' OE1' ' A' ' 136' ' ' GLN . 7.7 pt-20 -153.46 158.39 41.29 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 23.6 tt0 -95.95 134.53 38.84 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.528 ' OE1' ' HG3' ' A' ' 134' ' ' GLU . 7.3 mp0 -134.05 157.51 45.93 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.374 1.069 . . . . 0.0 109.802 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 32.3 m-80 -79.43 147.26 32.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.579 HD21 HG23 ' A' ' 116' ' ' ILE . 77.8 mt -58.28 -34.32 70.39 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.674 0.75 . . . . 0.0 110.078 177.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -76.59 -24.65 53.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.199 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.23 -12.87 45.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.176 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.66 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -70.29 143.09 52.17 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 123.479 0.487 . . . . 0.0 111.41 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.31 160.67 18.82 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.617 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -63.15 140.88 97.73 Favored Pre-proline 0 N--CA 1.401 -2.89 0 C-N-CA 124.602 1.161 . . . . 0.0 110.327 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.39 179.18 5.76 Favored 'Trans proline' 0 C--O 1.252 1.197 0 C-N-CA 122.714 2.276 . . . . 0.0 112.807 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.3 pt -124.27 173.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.451 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.22 132.9 35.23 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-O 121.649 0.738 . . . . 0.0 109.022 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 C--N 1.272 -2.769 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.666 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1148 ' ' DA2 . . . . . 0.439 HC11 ' CD2' ' A' ' 109' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_